Physical O
mapping O
220 O
kb O
centromeric O
of O
the O
human B
MHC I
and O
DNA O
sequence O
analysis O
of O
the O
43 O
- O
kb O
segment O
including O
the O
RING1 O
, O
HKE6 B
, O
and O
HKE4 B
genes I
. O

DNA O
elements O
recognizing O
NF O
- O
Y O
and O
Sp1 O
regulate O
the O
human B
multidrug I
- I
resistance I
gene I
promoter I
. O

Radioimmunoassay O
of O
plasma B
gonadotropins I
; O
problems O
of O
specificity O

To O
clarify O
the O
difference O
, O
both O
the O
Crk O
II O
and O
Crk B
II I
- I
23 I
, O
proteins O
were O
expressed O
in O
E O
. O
coli O
and O
examined O
their O
binding O
capacity O
in O
vitro O
. O

Thus O
, O
in O
V O
. O
furnissii O
, O
the O
E B
. I
coli I
manX I
equivalent I
comprises O
two O
genes O
, O
which O
are O
separated O
in O
the O
genome O
by O
two O
other O
genes O
of O
the O
ptsM B
complex I
. O

Id B
- I
1H I
and O
Id B
- I
2H I
seem O
to O
be O
human O
homologues O
of O
mouse B
Id I
- I
1 I
and O
Id B
- I
2 I
, O
respectively O
, O
and O
have O
potential O
to O
encode O
154 O
and O
135 O
amino O
acid O
proteins O
. O

Characterization O
of O
insertion O
mutations O
in O
the O
Saccharomyces B
cerevisiae I
MSH1 I
and O
MSH2 B
genes I
: O
evidence O
for O
separate O
mitochondrial O
and O
nuclear O
functions O
. O

Transcription O
of O
FN B
promoter I
- O
chloramphenicol O
acetyltransferase O
fusion O
genes O
carrying O
the O
base O
substitution O
in O
one O
or O
more O
of O
these O
G O
- O
rich O
sequences O
both O
in O
vivo O
and O
in O
vitro O
revealed O
that O
the O
base O
substitution O
in O
any O
G O
- O
rich O
sequence O
results O
in O
reduction O
of O
promoter O
activity O
, O
although O
the O
downstream O
GC O
box O
( O
GCd O
) O
plays O
a O
primary O
role O
. O

A O
GT O
- O
rich O
sequence O
binding O
the O
transcription O
factor O
Sp1 O
is O
crucial O
for O
high O
expression O
of O
the O
human B
type I
VII I
collagen I
gene I
( O
COL7A1 B
) O
in O
fibroblasts O
and O
keratinocytes O
. O

The O
XPR2 B
gene I
from O
Yarrowia O
lipolytica O
encodes O
an O
inducible O
alkaline B
extracellular I
protease I
. O

It O
was O
found O
that O
Nopp140 O
binds O
primarily O
to O
the O
CK2 B
regulatory I
subunit I
, I
beta I
. O

Previous O
analysis O
of O
this O
motif O
in O
the O
lactose B
permease I
( O
A O
. O

Like O
other O
IAPs B
, O
ch B
- I
IAP1 I
contains O
the O
N B
- I
terminal I
baculovirus I
IAP I
repeats I
and O
C O
- O
terminal O
RING O
finger O
motifs O
. O

Alternative O
splicing O
of O
the O
human B
serotonin I
transporter I
gene I
. O

Thus O
, O
primate O
vs O
. O
rodent O
promoter O
selectivity O
mediated O
by O
the O
TBP O
- O
TAFI B
complex O
is O
likely O
to O
be O
the O
result O
of O
cumulative O
subtle O
differences O
between O
individual O
subunits O
that O
lead O
to O
species O
- O
specific O
properties O
of O
RNA O
polymerase O
I O
transcription O
. O

In O
this O
reconstituted O
system O
, O
RNAP B
IIA I
, O
but O
not O
RNAP B
IIB I
, O
can O
transcribe O
from O
the O
DHFR B
promoter I
. O

The O
cDNA O
clones O
encode O
a O
polypeptide O
of O
657 O
amino O
acids O
with O
a O
bHLH O
( O
basic O
- O
helix O
- O
loop O
- O
helix O
) O
domain O
, O
characteristic O
of O
a O
large O
family O
of O
transcription O
factors O
, O
and O
a O
PAS O
( O
Per B
- O
Arnt O
- O
Sim O
) O
domain O
in O
the O
amino O
- O
terminal O
half O
region O
. O

Synergy O
between O
interferon O
- O
gamma O
and O
tumor O
necrosis O
factor O
- O
alpha O
in O
transcriptional O
activation O
is O
mediated O
by O
cooperation O
between O
signal B
transducer I
and I
activator I
of I
transcription I
1 I
and O
nuclear O
factor O
kappaB O
. O

1H O
and O
15N O
magnetic O
resonance O
assignments O
, O
secondary O
structure O
, O
and O
tertiary O
fold O
of O
Escherichia B
coli I
DnaJ I
( I
1 I
- I
78 I
) I
. O

A O
cDNA O
for O
human B
microfibril I
- I
associated I
glycoprotein I
- I
2 I
( O
MAGP B
- I
2 I
) O
was O
used O
to O
screen O
a O
human O
leukocyte O
genomic O
DNA O
library O
in O
EMBL O
- O
3 O
vector O
. O

The O
cholesterol B
7alpha I
- I
hydroxylase I
gene I
( O
CYP7A B
) O
is O
transcriptionally O
regulated O
by O
a O
number O
of O
factors O
, O
including O
hormones O
, O
bile O
acids O
, O
and O
diurnal O
rhythm O
. O

A O
Meis1 B
cDNA I
clone O
that O
encoded O
a O
novel O
member O
of O
the O
homeobox B
gene I
family I
was O
identified O
. O

The O
S B
. I
typhimurium I
aspartyl I
/ I
asparaginyl I
beta I
- I
hydroxylase I
homologue I
( O
designated O
lpxO B
) O
was O
cloned O
into O
pBluescriptSK O
and O
expressed O
in O
Escherichia O
coli O
K O
- O
12 O
, O
which O
does O
not O
contain O
lpxO B
. O

The O
levels O
of O
soluble O
L O
- O
selectin O
and O
ICAM B
- I
1 I
in O
the O
serum O
were O
determined O
by O
the O
ELISA O
method O
. O

The O
highest O
TTX B
content O
is O
10 O
. O
0 O
microg O
/ O
g O
in O
N O
. O
livescens O
. O

Here O
, O
we O
describe O
the O
nucleotide O
( O
nt O
) O
sequence O
and O
genomic O
organization O
of O
ipiB B
and O
ipiO B
. O

Comparison O
to O
the O
murine O
homologues O
of O
these O
molecules O
reveals O
a O
high O
degree O
of O
conservation O
between O
the O
products O
of O
one O
of O
these O
genes O
, O
Fc B
gamma I
RIIb I
, O
and O
the O
murine B
beta I
gene I
in O
primary O
sequence O
, O
splicing O
pattern O
, O
and O
tissue O
distribution O
. O

EMT B
was O
localized O
to O
chromosome O
5q31 O
- O
32 O
, O
a O
region O
that O
contains O
the O
genes O
for O
several O
growth O
factors O
and O
receptors O
as O
well O
as O
early O
activation O
genes O
, O
particularly O
those O
involved O
in O
the O
hematopoietic O
system O
. O

Importin B
beta I
mediates O
nuclear O
translocation O
of O
Smad B
3 I
. O

The O
results O
of O
the O
transient O
- O
transfection O
assay O
showed O
that O
the O
Sp1 B
binding I
element I
located O
in O
the O
core O
region O
( O
positions O
- O
- O
64 O
to O
+ O
1 O
) O
of O
the O
alpha2 B
- I
integrin I
promoter I
plays O
an O
essential O
role O
in O
the O
alpha2 B
- I
integrin I
promoter I
activity O
and O
its O
downregulation O
by O
Erb O
- O
B2 B
. O

Expression O
of O
FNCAT B
increased O
on O
serum O
treatment O
indicating O
that O
the O
region O
of O
the O
FN B
gene I
between O
positions O
+ O
69 O
and O
- O
510 O
bp O
mediated O
serum O
responsiveness O
. O

Interaction O
of O
the O
v B
- I
rel I
protein I
with O
an O
NF B
- I
kappa I
B I
DNA I
binding I
site I
. O

To O
test O
this O
hypothesis O
, O
we O
developed O
a O
system O
of O
transient O
transfection O
of O
rat O
adipocytes O
with O
constructs O
containing O
glyceraldehyde O
- O
3 O
- O
phosphate O
dehydrogenase O
( O
GAPDH O
) O
and O
fatty B
acid I
synthetase I
( O
FAS O
) O
promoters O
fused O
to O
gene B
reporter I
CAT I
. O

Simvastatin O
decreased O
levels O
of O
total O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL O
cholesterol O
by O
29 O
. O
7 O
% O
, O
triglycerides O
by O
13 O
. O
6 O
% O
, O
apolipoprotein B
B I
by O
22 O
. O
4 O
% O
, O
alpha O
- O
tocopherol O
by O
16 O
. O
2 O
% O
, O
beta O
- O
carotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
levels O
of O
HDL O
cholesterol O
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
serum O
insulin O
by O
13 O

To O
investigate O
the O
in O
vivo O
role O
of O
this O
chimeric B
bZIP I
protein I
in O
oncogenic O
transformation O
, O
its O
expression O
was O
directed O
to O
the O
lymphoid O
compartments O
of O
transgenic O
mice O
. O

This O
is O
consistent O
with O
the O
need O
for O
a O
nuclear O
retinoid B
receptor I
function O
in O
RA O
- O
induced O
ERK2 O
activation O
. O

In O
the O
virus O
- O
infected O
cells O
, O
translation O
of O
the O
M1 B
protein I
was O
reduced O
to O
10 O
to O
20 O
% O
of O
that O
of O
the O
wild O
- O
type O
virus O
; O
however O
, O
the O
translation O
of O
neither O
the O
nucleoprotein O
nor O
NS1 O
was O
significantly O
interfered O
with O
, O
indicating O
the O
important O
role O
of O
NS1 O
in O
translational O
stimulation O
of O
the O
M1 B
protein I
. O

LT B
- I
beta I
transcription O
is O
maximal O
in O
the O
thymic O
medulla O
and O
in O
splenic O
white O
pulp O
. O

A O
novel O
Cdc42Hs B
mutant I
induces O
cellular O
transformation O
. O

Interactions O
were O
also O
detected O
between O
full O
- O
length O
HSF1 O
and O
the O
small O
subunit O
( O
gamma O
) O
of O
TFIIA B
. O

We O
report O
that O
Nim1 B
possesses O
intrinsic O
serine B
- I
kinase I
, O
threonine B
- I
kinase I
and O
tyrosine O
- O
kinase O
activities O
. O

A O
short O
conserved O
motif O
is O
required O
for O
repressor O
domain O
function O
in O
the O
myeloid O
- O
specific O
transcription O
factor O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
epsilon I
. O

In O
conclusion O
, O
ORCA3 B
regulates O
jasmonate O
- O
responsive O
expression O
of O
the O
Str B
gene I
via O
direct O
interaction O
with O
the O
JERE O
. O

ORF3 O
encodes O
a O
putative O
periplasmic B
c I
- I
type I
cytochrome I
with O
a O
molecular O
mass O
of O
94 O
, O
000 O
Da O
and O
contains O
seven O
c O
- O
heme O
- O
binding O
motifs O
but O
shows O
no O
sequence O
homology O
to O
occ B
or O
ORF1 O
. O

TFEC B
RNA I
is O
found O
in O
many O
tissues O
of O
adult O
rats O
, O
but O
the O
relative O
concentrations O
of O
TFEC O
and O
TFE3 B
RNAs I
vary O
considerably O
in O
these O
different O
tissues O
. O

Our O
results O
show O
that O
unlike O
the O
case O
for O
sos1 O
, O
sos2 B
gene I
function O
is O
dispensable O
for O
normal O
mouse O
development O
, O
growth O
, O
and O
fertility O
. O

Studies O
of O
HS2 B
- I
gamma I
gene I
reporter I
constructs I
carrying O
CACCC O
box O
deletions O
revealed O
that O
the O
CACCC O
box O
sequence O
of O
the O
gamma O
gene O
promoter O
mediates O
the O
activation O
of O
the O
gamma O
gene O
by O
FKLF B
. O

First O
, O
a O
GATA B
- I
1 I
motif I
was O
found O
to O
bind O
nuclear O
factor O
( O
s O
) O
, O
presumably O
the O
GATA B
- I
1 I
factor I
, O
present O
in O
K O
- O
562 O
cell O
extracts O
and O
in O
living O
K O
- O
562 O
cells O
. O

This O
inhibition O
was O
due O
to O
competition O
from O
the O
EMC O
virus O
IRES O
present O
in O
pEP B
- I
2A I
transcripts I
, O
as O
well O
as O
the O
expression O
of O
proteolytically O
active O
2Apro B
. O

Some O
may O
affect O
the O
folding O
pathway O
or O
the O
affinity O
for O
chaperonins B
. O

The O
effect O
on O
FIV B
LTR I
promoter I
activity O
of O
progressively O
deleting O
these O
nuclear O
factor O
binding O
sites O
was O
examined O
by O
linking O
LTR O
deletion O
mutants O
to O
the O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
gene O
. O

Module O
2 O
of O
RifA B
lacks O
a O
beta B
- I
ketoacyl I
: I
acyl I
carrier I
protein I
reductase I
( O
KR O
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH B
binding I
motif I
, O
similar O
to O
one O
found O
in O
the O
Er B
PKS I
, O
while O
the O
other O
eight O
KR B
domains I
of O
the O
Rf B
PKS I
should O
be O
functional O
. O

The O
GST O
- O
CBL O
- O
LZIP B
fusion O
protein O
contains O
a O
binding O
site O
for O
the O
SH2 O
domain O
of O
the O
p85 O
subunit O
of O
phosphatidylinositol O
3 O
- O
kinase O
, O
which O
mapped O
to O
Tyr731 O
, O
which O
is O
present O
in O
the O
sequence O
YEAM O
. O

We O
have O
previously O
shown O
that O
UNC B
- I
4 I
expression O
in O
the O
VA O
motor O
neurons O
specifies O
the O
wild O
- O
type O
pattern O
of O
presynaptic O
input O
. O

Significant O
differences O
were O
observed O
in O
the O
composition O
of O
nuclear O
transcription O
factors O
bound O
to O
cis O
- O
elements O
within O
the O
LDH B
/ I
C I
proximal I
promoter I
region I
in O
somatic O
versus O
germ O
cells O
. O

It O
has O
become O
clear O
that O
there O
is O
not O
one O
mediator O
responsible O
for O
ALI O
, O
but O
rather O
a O
complex O
interplay O
exists O
between O
diverse O
proinflammatory O
( O
e O
. O
g O
. O
, O
lipopolysaccharide O
, O
complement O
products O
, O
cytocains O
, O
chemocains O
, O
reactive O
oxygen O
species O
and O
arachidonic O
acid O
products O
) O
and O
anti O
- O
inflammatory O
( O
IL B
- I
10 I
, O
IL B
- I
1 I
- I
RA I
, O
PGI2 O
) O
mediators O
. O

A O
Brassica O
cDNA O
clone O
encoding O
a O
bifunctional O
hydroxymethylpyrimidine B
kinase I
/ O
thiamin B
- I
phosphate I
pyrophosphorylase I
involved O
in O
thiamin O
biosynthesis O
. O

Differential O
decay O
of O
a O
polycistronic O
Escherichia O
coli O
transcript O
is O
initiated O
by O
RNaseE B
- O
dependent O
endonucleolytic O
processing O
. O

Defects O
in O
RT6 B
expression O
coincide O
with O
increased O
susceptibility O
in O
animal O
models O
for O
insulin O
- O
dependent O
diabetes O
mellitus O
and O
other O
autoimmune O
diseases O
. O

We O
have O
previously O
described O
the O
partial O
purification O
of O
Ap4A B
hydrolase I
from O
S O
. O
pombe O
[ O
Robinson O
, O
de O
la O
Pena O
and O
Barnes O
( O
1993 O
) O
Biochim O
. O

The O
unc B
- I
101 I
, O
sli O
- O
1 O
, O
and O
rok B
- I
1 I
genes I
encode O
a O
distinct O
set O
of O
negative O
regulators O
of O
vulval O
differentiation O
. O

SYC1 B
( O
suppressor B
of I
yeast I
cbf5 I
- I
1 I
) O
was O
identified O
as O
a O
multicopy O
suppressor O
of O
cbf5 B
- I
1 I
and O
subsequently O
was O
found O
to O
be O
identical O
to O
RRN3 B
, O
an O
RNA B
polymerase I
I I
transcription I
factor I
. O

Both O
sequence O
analysis O
and O
restriction O
fragment O
length O
polymorphism O
analysis O
revealed O
a O
high O
degree O
of O
sequence O
( O
97 O
% O
homology O
) O
and O
structural O
similarity O
among O
members O
of O
the O
ART B
- O
CH O
family O
, O
indicating O
their O
common O
origin O
and O
recent O
penetration O
into O
chicken O
DNA O
. O

The O
elevated O
levels O
of O
inositol O
phosphates O
resulting O
from O
N B
( I
epi I
) I
alpha I
qQ209L I
expression O
were O
similar O
to O
those O
obtained O
with O
carbachol O
activation O
of O
the O
M1 B
muscarinic I
acetylcholine I
receptor I
. O

RESULTS O
: O
BMK B
- I
1 I
and O
other O
19 O
contents O
significantly O
decreased O
depolarization O
parameters O
Vmax O
, O
APA O
, O
OS O
, O
and O
MDP O
, O
which O
was O
similar O
to O
that O
of O
TTX B
and O
different O
from O
that O
of O
Nim O
and O
BaCl2 O
. O

Previous O
work O
has O
shown O
that O
glucose O
repression O
of O
PRB1 B
transcription O
is O
not O
mediated O
by O
HXK2 B
or O
by O
the O
SNF1 O
, O
SNF4 O
, O
and O
SNF6 B
genes I
( O
C O
. O

Comparison O
of O
the O
encoded O
ERCC3Dm B
protein I
with O
the O
homologous O
proteins O
of O
mouse O
and O
man O
shows O
a O
strong O
amino O
acid O
conservation O
( O
71 O
% O
identity O
) O
, O
especially O
in O
the O
postulated O
DNA O
binding O
region O
and O
seven O
' B
helicase I
' I
domains I
. O

This O
enzyme O
is O
distinct O
from O
other O
known O
E3s B
, O
including O
E3 B
alpha I
/ O
UBR1 B
, O
E3 B
beta I
, O
and O
E6 B
- I
AP I
. O

This O
evidence O
, O
together O
with O
the O
ability O
of O
a O
carboxyl O
- O
terminal O
coding O
sequence O
starting O
from O
the O
BamHI B
site I
to O
complement O
a O
shy1 B
mutant I
, O
suggests O
that O
the O
Shy1p B
contains O
two O
domains O
that O
can O
be O
separately O
expressed O
to O
form O
a O
functional O
protein O
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor O
necrosis O
factor O
( O
TNF O
) O
- O
and O
interleukin O
1 O
( O
IL O
- O
1 O
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear O
factor O
- O
kappa O
B O
( O
NF O
- O
kappaB O
) O
- O
dependent O
gene O
expression O
. O

At O
least O
one O
such O
complex O
is O
eliminated O
by O
preincubating O
the O
nuclear O
extract O
with O
an O
antibody O
with O
broad O
cross O
- O
reactivity O
with O
Ets O
- O
1 O
and O
Ets B
- I
2 I
proteins I
, O
thus O
confirming O
that O
an O
ETS B
transcription I
factor I
( I
s I
) I
recognizes O
the O
- O
12 O
motif O
. O

Mutant O
beta2 B
- I
adrenergic I
receptors I
with O
a O
Tyr O
- O
to O
- O
Phe O
substitution O
at O
Tyr O
- O
350 O
do O
not O
display O
agonist O
- O
induced O
desensitization O
, O
Src O
recruitment O
, O
or O
Src O
activation O
. O

Role O
of O
distinct O
mitogen O
- O
activated O
protein O
kinase O
pathways O
and O
cooperation O
between O
Ets O
- O
2 O
, O
ATF O
- O
2 O
, O
and O
Jun B
family I
members I
in O
human B
urokinase I
- I
type I
plasminogen I
activator I
gene I
induction O
by O
interleukin O
- O
1 O
and O
tetradecanoyl O
phorbol O
acetate O
. O

Immunoblot O
analysis O
of O
purified O
and O
protease O
- O
digested O
intracellular O
mature O
virus O
( O
IMV O
) O
and O
extracellular O
enveloped O
virus O
( O
EEV O
) O
showed O
that O
the O
A36R B
proteins I
were O
present O
on O
the O
surface O
of O
EEV O
with O
type O
II O
membrane O
topology O
, O
but O
were O
absent O
from O
IMV O
. O

These O
data O
may O
indicate O
redundancy O
between O
members O
of O
the O
NGFI O
- O
B O
/ O
Nurr1 B
/ O
Nor1 B
subfamily O
and O
could O
explain O
why O
no O
phenotypic O
disturbances O
have O
yet O
been O
found O
in O
mice O
in O
which O
the O
NGFI B
- I
B I
gene I
has O
been O
inactivated O
. O

These O
results O
indicate O
that O
H B
- I
2RIIBP I
( O
i O
) O
is O
a O
member O
of O
the O
superfamily O
of O
nuclear B
hormone I
receptors I
and O
( O
ii O
) O
may O
regulate O
not O
only O
MHC B
class I
I I
genes I
but O
also O
genes O
containing O
the O
ERE O
and O
related O
sequences O
. O

We O
show O
here O
that O
Spb1p B
is O
able O
to O
bind O
[ O
( O
3 O
) O
H O
] O
AdoMet O
in O
vitro O
, O
suggesting O
that O
it O
is O
a O
novel O
methylase O
, O
whose O
possible O
substrates O
will O
be O
discussed O
. O

Serum B
angiogenin I
concentrations O
in O
young O
patients O
with O
diabetes O
mellitus O
. O

This O
duplicated O
genomic O
region O
is O
also O
linked O
tightly O
to O
D1Z2 B
, O
a O
genetic O
marker O
containing O
a O
highly O
polymorphic O
VNTR O
( O
variable O
number O
tandem O
repeat O
) O
consisting O
of O
an O
unusual O
40 O
- O
bp O
reiterated O
sequence O
. O

ATF6 O
, O
a O
basic B
- I
leucine I
zipper I
protein I
, O
was O
isolated O
by O
binding O
to O
SRF O
and O
in O
particular O
to O
its O
transcriptional O
activation O
domain O
. O

Cetn1 B
possesses O
the O
sequence O
features O
of O
an O
expressed O
retroposon O
: O
the O
gene O
lacks O
introns O
, O
the O
open O
reading O
frame O
is O
not O
interrupted O
by O
stop O
codons O
, O
and O
the O
coding O
region O
is O
flanked O
by O
a O
pair O
of O
direct O
repeats O
. O

The O
Aspergillus B
uvsH I
gene I
encodes O
a O
product O
homologous O
to O
yeast B
RAD18 I
and O
Neurospora B
UVS I
- I
2 I
. O

VAV O
and O
SOCS1 B
form O
a O
protein O
complex O
through O
interactions O
between O
the O
VAV B
NH I
( I
2 I
) I
- I
terminal I
regulatory I
region I
and O
the O
SH2 O
domain O
of O
SOCS1 B
in O
a O
phosphotyrosine O
- O
independent O
manner O
. O

The O
originally O
embryonic B
gamma I
- I
globin I
locus I
duplicated O
and O
acquired O
a O
novel O
( O
fetal O
) O
pattern O
of O
expression O
in O
a O
defined O
time O
period O
( O
55 O
- O
40 O
million O
years O
ago O
) O
during O
primate O
phylogeny O
. O

Northern O
blot O
analysis O
with O
GPR37 B
probes O
revealed O
a O
main O
3 O
. O
8 O
- O
kb O
mRNA O
and O
a O
less O
abundant O
8 O
- O
kb O
mRNA O
, O
both O
expressed O
in O
human O
brain O
tissues O
, O
particularly O
in O
corpus O
callosum O
, O
medulla O
, O
putamen O
, O
and O
caudate O
nucleus O
. O

Our O
studies O
indicate O
no O
single O
trans O
- O
acting O
factor O
is O
absolutely O
essential O
for O
enhancer O
activity O
, O
and O
that O
the O
enhancer O
activity O
of O
MerI B
is O
mediated O
via O
a O
combinatorial O
and O
additive O
mechanism O
. O

In O
human O
WI38 O
cells O
, O
the O
E1B B
19K I
gene I
mutant I
viruses O
had O
a O
substantial O
growth O
advantage O
over O
the O
wild O
- O
type O
virus O
, O
yielding O
500 O
- O
fold O
- O
higher O
titers O
. O

To O
elucidate O
the O
mechanism O
of O
these O
hormonal O
effects O
, O
we O
have O
studied O
the O
regulatory O
regions O
of O
the O
PFK B
- I
2 I
gene I
in O
transfection O
experiments O
. O

Consequently O
, O
during O
the O
evolution O
of O
mammals O
, O
it O
is O
the O
CKbeta4GT B
- I
I I
gene I
lineage O
that O
has O
been O
recruited O
for O
the O
biosynthesis O
of O
lactose O
. O

In O
solution O
, O
[ O
( O
125 O
) O
I O
] O
- O
labeled O
ankyrin O
was O
found O
by O
ND O
- O
PAGE3 O
to O
enhance O
the O
affinity O
of O
spectrin B
self O
- O
association O
by O
10 O
- O
fold O
. O

Transcription O
analysis O
of O
the O
EcoRI B
D I
region I
of O
the O
baculovirus O
Autographa O
californica O
nuclear O
polyhedrosis O
virus O
identifies O
an O
early O
4 O
- O
kilobase O
RNA O
encoding O
the O
essential O
p143 B
gene I
. O

In O
this O
study O
, O
the O
subcellular O
location O
, O
domain O
structure O
, O
and O
biochemical O
function O
of O
metaxin B
were O
investigated O
. O

Flux O
of O
the O
paramyxovirus O
hemagglutinin O
- O
neuraminidase B
glycoprotein O
through O
the O
endoplasmic O
reticulum O
activates O
transcription O
of O
the O
GRP78 O
- O
BiP O
gene O
. O

The O
preference O
for O
third O
base O
codon O
in O
Y O
position O
prolines O
is O
U O
for O
the O
alpha B
2 I
( I
VI I
) I
collagen I
as O
it O
is O
for O
the O
human B
fibrillar I
collagen I
genes I
. O

Soggy B
, O
a O
spermatocyte O
- O
specific O
gene O
, O
lies O
3 O
. O
8 O
kb O
upstream O
of O
and O
antipodal O
to O
TEAD B
- I
2 I
, O
a O
transcription O
factor O
expressed O
at O
the O
beginning O
of O
mouse O
development O
. O

The O
goals O
of O
these O
experiments O
were O
to O
determine O
whether O
lactational O
anestrus O
would O
be O
prolonged O
by O
a O
48 O
- O
h O
fast O
at O
days O
13 O
and O
14 O
postpartum O
( O
pp O
) O
and O
, O
if O
so O
, O
to O
determine O
whether O
this O
effect O
could O
be O
reversed O
by O
treatment O
with O
the O
Ob B
protein I
leptin O
. O

In O
pituitary O
GH3 O
cells O
, O
vitamin O
D O
increases O
the O
levels O
of O
PRL B
transcripts I
and O
stimulates O
the O
PRL B
promoter I
. O

However O
, O
electron O
microscopy O
revealed O
that O
while O
sec4 B
mutant I
cells O
accumulate O
secretory O
vesicles O
, O
ypt31 B
/ I
32 I
mutant I
cells O
accumulate O
aberrant O
Golgi O
structures O
. O

Complete O
activation O
of O
signal B
transducer I
and I
activator I
of I
transcription I
1 I
( O
STAT1 O
) O
requires O
phosphorylation O
at O
both O
Y701 O
and O
a O
conserved O
PMS O
( O
727 O
) O
P O
sequence O
. O

The O
Ras B
GTPase I
- I
activating I
- I
protein I
- I
related I
human I
protein I
IQGAP2 B
harbors O
a O
potential O
actin B
binding I
domain I
and O
interacts O
with O
calmodulin O
and O
Rho B
family I
GTPases I
. O

The O
adoption O
of O
a O
twisted O
structure O
of O
importin B
- I
beta I
is O
essential O
for O
the O
protein O
- O
protein O
interaction O
required O
for O
nuclear O
transport O
. O

The O
presence O
of O
a O
short O
( O
70 O
bp O
) O
intron O
near O
the O
N O
- O
terminus O
of O
the O
atX B
gene I
was O
predicted O
that O
contains O
the O
canonical O
GT O
and O
AG O
dinucleotides O
at O
its O
5 O
' O
- O
and O
3 O
' O
- O
splicing O
junctions O
. O

Moreover O
, O
a O
hybrid O
protein O
composed O
of O
a O
PvALF B
activation I
domain I
and O
the O
DNA O
binding O
and O
dimerization O
domain O
of O
ROM2 B
activated O
gene O
expression O
, O
indicating O
that O
ROM2 B
recognizes O
the O
DLEC2 B
enhancer I
in O
vivo O
; O
consequently O
, O
ROM2 B
functions O
as O
a O
DNA O
binding O
site O
- O
dependent O
repressor O
. O

On O
the O
other O
hand O
, O
NE O
transport O
and O
antagonist O
( O
[ O
125I O
] O
RTI O
- O
55 O
) O
binding O
assays O
on O
whole O
LLC O
- O
NET O
cells O
treated O
with O
tunicamycin O
reveal O
a O
pronounced O
reduction O
in O
NE O
transport O
activity O
and O
hNET B
membrane O
density O
paralleled O
by O
an O
inability O
of O
NET B
proteins I
to O
replenish O
the O
higher O
M O
( O
r O
) O
hNET B
pool O
. O

We O
show O
that O
the O
upstream O
region O
of O
the O
beta B
- I
MyHC I
gene I
( O
- O
5518 O
to O
- O
2490 O
relative O
to O
the O
transcriptional O
start O
site O
) O
directed O
high O
levels O
of O
transcriptional O
activity O
only O
when O
stably O
integrated O
, O
but O
not O
when O
expressed O
extrachromosomally O
in O
transient O
assays O
. O

In O
transient O
transfections O
using O
luciferase B
reporter I
genes I
driven O
by O
1 O
kb O
of O
the O
5 O
' O
flanking O
DNA O
of O
the O
three O
CALM B
genes I
, O
the O
promoter O
activity O
correlated O
with O
the O
endogenous B
CALM I
transcriptional O
activity O
, O
but O
only O
when O
the O
5 O
' O
untranslated O
regions O
were O
included O
in O
the O
constructs O
. O

The O
derepressed O
expression O
of O
fixN B
was O
not O
observed O
in O
a O
purH B
mutant I
. O

Both O
viruses O
express O
the O
mil B
/ O
raf O
oncogene O
product O
as O
a O
gag B
- I
fusion I
polyprotein O
, O
while O
the O
myc O
oncogene O
of O
MH2 O
is O
expressed O
via O
a O
subgenomic O
mRNA O
. O

Recombinant O
protein O
encoded O
by O
ESX B
( O
for O
epithelial B
- I
restricted I
with I
serine I
box I
) O
exhibits O
Ets B
- I
like I
DNA O
binding O
specificity O
in O
electrophoretic O
mobility O
shift O
assays O
and O
, O
in O
transient O
transfection O
assays O
, O
transactivates O
Ets B
- I
responsive I
promoter I
elements I
including O
that O
found O
in O
the O
HER2 O
/ O
neu O
oncogene O
. O

The O
temporal O
changes O
in O
the O
plasma O
concentration O
of O
immunoreactive B
atrial I
natriuretic I
factor I
( O
iANF B
) O
were O
studied O
in O
six O
conscious O
dogs O
with O
an O
arteriovenous O
( O
AV O
) O
fistula O
, O
a O
model O
of O
chronic O
high O
- O
output O
heart O
failure O
. O

Two O
closely O
related O
groups O
of O
transcripts O
, O
Sagrp1 B
and O
Sagrp2 B
, O
controlled O
by O
a O
circadian O
rhythm O
have O
been O
isolated O
. O

These O
findings O
suggest O
that O
eIF5 O
- O
eIF2beta B
interaction O
plays O
an O
essential O
role O
in O
eIF5 O
function O
in O
eukaryotic O
cells O
. O

Non O
- O
finger O
- O
coding O
modules O
conserved O
among O
members O
of O
subfamilies O
of O
zinc B
finger I
genes I
have O
been O
described O
in O
the O
murine O
genome O
( O
finger O
- O
associated O
boxes O
, O
or O
FAX O
domain O
) O
and O
the O
human O
genome O
( O
Kruppel B
- I
associated I
boxes I
, O
or O
KRAB B
domain I
) O
. O

Comparison O
of O
the O
5 O
' O
flanking O
regions O
of O
the O
mouse B
J I
kappa I
elements I
, O
including O
the O
conserved O
putative O
recombination O
target O
sequences O
, O
shows O
no O
obvious O
differences O
consistent O
with O
the O
variation O
in O
recombinational O
efficiency O
, O
so O
we O
conclude O
that O
, O
although O
the O
consensus O
heptamer O
and O
nonamer O
signals O
may O
be O
sufficient O
to O
identify O
a O
recombination O
site O
, O
the O
probability O
that O
that O
site O
will O
be O
used O
depends O
also O
on O
other O
determinants O
. O

The O
melanoma B
growth I
stimulatory I
activity I
/ I
growth I
- I
regulated I
protein I
, O
CXCL1 B
, O
is O
constitutively O
expressed O
at O
high O
levels O
during O
inflammation O
and O
progression O
of O
melanocytes O
into O
malignant O
melanoma O
. O

Genetic O
analysis O
places O
CWH43 B
upstream O
of O
the O
BCK2 O
branch O
of O
the O
PKC1 B
signalling O
pathway O
, O
since O
cwh43 B
mutations O
were O
synthetic O
lethal O
with O
pkc1 B
deletion O
, O
whereas O
the O
cwh43 B
defects O
could O
be O
rescued O
by O
overexpression O
of O
BCK2 O
and O
not O
by O
high O
- O
copy O
- O
number O
expression O
of O
genes O
encoding O
downstream O
proteins O
of O
the O
PKC1 B
pathway O
However O
, O
unlike O
BCK2 O
, O
whose O
disruption O
in O
a O
cln3 B
mutant I
resulted O
in O
growth O
arrest O
in O
G O
( O
1 O
) O
, O
no O
growth O
defect O
was O
observed O
in O
a O
double O
cwh43 B
cln3 B
mutants I
. O

To O
clarify O
the O
mechanisms O
that O
regulate O
transcription O
of O
the O
GTP B
cyclohydrolase I
I I
gene I
and O
to O
generate O
multiple O
species O
of O
mRNA O
, O
we O
isolated O
genomic O
DNA O
clones O
for O
the O
human O
and O
mouse O
GTP B
cyclohydrolase I
I I
genes I
. O

Therefore O
, O
a O
structural O
interaction O
between O
PsaL B
and O
PsaI B
may O
stabilize O
the O
association O
of O
PsaL B
with O
the O
photosystem B
I I
core I
. O

Negative O
modulation O
of O
alpha1 B
( I
I I
) I
procollagen I
gene I
expression O
in O
human O
skin O
fibroblasts O
: O
transcriptional O
inhibition O
by O
interferon O
- O
gamma O
. O

We O
next O
developed O
a O
rapid O
purification O
method O
for O
bacterial B
recombinant I
MyoD I
- I
bHLH I
domain I
by O
affinity O
chromatography O
using O
a O
calmodulin O
- O
Sepharose O
column O
and O
investigated O
the O
phosphorylation O
of O
that O
peptide O
by O
PKC O
and O
its O
interactions O
with O
calmodulin O
and O
S100a B
. O

Epstein O
- O
Barr O
virus O
nuclear O
antigen O
2 O
exerts O
its O
transactivating O
function O
through O
interaction O
with O
recombination B
signal I
binding I
protein I
RBP I
- I
J I
kappa I
, O
the O
homologue O
of O
Drosophila B
Suppressor I
of I
Hairless I
. O

We O
constructed O
a O
stable O
, O
doubly O
transfected O
cell O
line O
( O
TIS O
- O
10 O
) O
carrying O
a O
chromosomally O
integrated O
ptetO7 B
- I
CMV I
- I
L I
reporter O
construct O
and O
expressing O
the O
TetR O
- O
KRAB O
protein O
. O

Together O
with O
previous O
work O
our O
results O
suggest O
that O
C O
/ O
EBP O
may O
be O
a O
general O
cooperation O
partner O
for O
v B
- I
Myb I
in O
myelomonocytic O
cells O
. O

Both O
DMP2 B
and O
DMP3 B
are O
closely O
localized O
on O
mouse O
chromosome O
5q21 O
, O
corresponding O
to O
human O
chromosome O
4q21 O
. O

A O
novel O
alternative O
spliced O
variant O
of O
the O
transcription O
factor O
AP2alpha B
is O
expressed O
in O
the O
murine O
ocular O
lens O
. O

Fig1p B
and O
Fig2p B
are O
likely O
to O
act O
at O
the O
cell O
surface O
as O
Fig1 B
: O
: O
beta O
- O
gal O
and O
Fig2 B
: O
: O
beta B
- I
gal I
fusion I
proteins I
localize O
to O
the O
periphery O
of O
mating O
cells O
. O

Crystals O
of O
the O
triple O
mutant O
A42D B
/ O
D47P B
/ O
A63L B
, O
which O
are O
stable O
for O
days O
in O
its O
oxidized O
form O
, O
were O
grown O
from O
ammonium O
sulfate O
, O
with O
the O
cell O
constants O
a O
= O
b O
= O
34 O
. O
3 O
A O
and O
c O
= O
111 O
. O
8 O
A O
belonging O
to O
space O
group O
P3 O
( O
2 O
) O
21 O
. O

Normal O
replication O
of O
DNA B
A I
still O
carrying O
the O
AC3 B
ORF I
mutation O
was O
found O
in O
extracts O
from O
these O
plants O
. O

Muscle O
and O
liver O
biopsies O
demonstrated O
the O
same O
anomalies O
, O
again O
without O
branching B
enzyme I
deficiency O
in O
the O
liver O
. O

Clinical O
development O
of O
interleukin B
- I
10 I
. O

By O
cloning O
genes O
encoding O
benzene O
- O
degradative O
enzymes O
, O
we O
found O
that O
strain O
JS150 O
also O
carries O
genes O
for O
a O
toluene B
/ I
benzene I
- I
2 I
- I
monooxygenase I
. O

It O
was O
previously O
shown O
that O
Vi B
antigen I
expression O
was O
regulated O
by O
a O
system O
similar O
to O
the O
rcs B
regulatory O
system O
involved O
in O
colanic O
acid O
synthesis O
in O
Escherichia O
coli O
. O

To O
identify O
the O
GRK6 B
homologue I
on O
chromsome O
13 O
, O
several O
sets O
of O
closely O
- O
spaced O
primers O
were O
designed O
based O
on O
the O
GRK6 B
cDNA I
sequence I
and O
then O
used O
to O
amplify O
human O
genomic O
DNA O
by O
PCR O
. O

Serum B
alpha I
- I
amylase I
, O
trypsin O
, O
trypsin B
inhibitor I
, O
lipase O
and O
total O
protease O
activity O
in O
the O
pancreatic O
tissue O
was O
studied O
as O
indicator O
of O
the O
treatment O
efficacy O
with O
5 O
- O
fluorouracil O
electro O
- O
cumulation O
. O

This O
effect O
is O
independent O
of O
the O
Gal4 O
protein O
, O
as O
it O
operates O
in O
a O
gal4 B
mutant I
background O
as O
well O
. O

Amplification O
of O
4q21 O
- O
q22 O
and O
the O
MXR B
gene I
in O
independently O
derived O
mitoxantrone O
- O
resistant O
cell O
lines O
. O

DSS4 B
- I
1 I
is O
a O
dominant O
suppressor O
of O
sec4 O
- O
8 O
that O
encodes O
a O
nucleotide O
exchange O
protein O
that O
aids O
Sec4p B
function O
. O

The O
interleukin B
- I
2 I
receptor I
alpha I
( O
IL O
- O
2R O
alpha O
) O
chain O
gene O
contains O
a O
sequence O
similar O
to O
the O
immunoglobulin B
( I
Ig I
) I
kappa I
( O
kappa O
) O
enhancer O
NF B
- I
kappa I
B I
binding I
site I
. O

Comparison O
of O
the O
derived O
amino O
acid O
sequence O
with O
that O
of O
the O
HCMV B
UL99 I
gene I
product I
reveals O
34 O
. O
8 O
% O
identity O
in O
an O
overlap O
of O
66 O
amino O
acids O
. O

Although O
mutant B
pex5delta I
cells O
expressing O
a O
yeast B
/ I
tobacco I
Pex5p I
chimaera I
failed O
to O
import O
a O
GFP O
- O
Eci1p B
reporter O
protein O
, O
they O
were O
able O
to O
grow O
on O
oleic O
acid O
. O

Consistent O
with O
this O
observation O
, O
introduction O
of O
Smad B
sites I
into O
a O
TGFbeta O
- O
insensitive O
LEF1 O
/ O
TCF O
target O
gene O
confers O
cooperative O
TGFbeta O
and O
Wnt O
responsiveness O
to O
the O
promoter O
. O

In O
analogy O
to O
human B
CD70 I
, O
mCD70 B
transcript I
levels O
are O
strongly O
but O
transiently O
up O
- O
regulated O
during O
lymphocyte O
activation O
, O
which O
is O
in O
line O
with O
a O
role O
for O
the O
CD27 B
- I
CD70 I
receptor I
pair O
early O
in O
the O
immune O
response O
. O

Vk8 B
/ O
Jk2 B
and O
Vk1 B
/ O
Jk5 B
rearrangements O
encoded O
the O
respective O
L B
chain I
V I
- I
regions I
. O

In O
the O
fungus O
Neurospora O
crassa O
, O
nit B
- I
2 I
, O
the O
major O
nitrogen O
regulatory O
gene O
, O
activates O
the O
expression O
of O
unlinked O
structural O
genes O
that O
specify O
nitrogen O
- O
catabolic O
enzymes O
during O
conditions O
of O
nitrogen O
limitation O
. O

The O
matrix O
of O
the O
CBs O
contains O
the O
diagnostic O
protein O
p80 B
- O
coilin B
, O
which O
is O
colocalized O
with O
the O
U7 B
small I
nuclear I
ribonucleoprotein I
( O
snRNP O
) O
, O
whereas O
the O
attached O
and O
embedded O
B O
- O
snurposomes O
contain O
splicing O
snRNPs O
. O

Anti B
- I
Jo I
- I
1 I
antibody I
was O
not O
present O
. O

The O
first O
operon O
, O
orf1 O
- O
tolQRA B
, O
is O
iron O
regulated O
throughout O
growth O
, O
but O
iron O
- O
regulated O
expression O
of O
tolB B
and O
oprL B
fusions I
occurs O
only O
in O
late O
log O
phase O
. O

Using O
green O
fluorescent O
protein O
fusions O
we O
demonstrate O
that O
the O
SYT B
, O
SSX B
and O
the O
SYT B
- O
SSX B
proteins O
are O
nuclear O
proteins O
. O

These O
data O
suggested O
that O
mutant B
PS1 I
may O
cause O
disease O
as O
a O
result O
of O
reduction O
in O
PS1 O
function O
. O

The O
analysis O
of O
the O
organization O
of O
the O
sequence O
of O
the O
human O
ABP B
/ O
DAO B
gene O
reveals O
that O
the O
2 O
. O
4 O
- O
kilobase O
messenger O
RNA O
is O
transcribed O
from O
two O
close O
origins O
identifying O
the O
proximal O
promoter O
. O

To O
investigate O
the O
step O
of O
spliceosome O
assembly O
at O
which O
Snu17p B
acts O
, O
we O
have O
used O
nondenaturing O
gel O
electrophoresis O
. O

We O
also O
show O
that O
an O
internal O
fragment O
of O
U24 B
methylation I
guide I
snoRNA I
, O
encompassing O
the O
upstream O
antisense O
element O
and O
the O
D O
' O
and O
C O
' O
box O
motifs O
, O
can O
support O
the O
site O
- O
specific O
methylation O
of O
rRNA O
. O

Mammalian O
ribonucleotide O
reductase O
shows O
S O
- O
phase O
specific O
expression O
and O
consists O
of O
two O
non O
- O
identical O
subunits O
, O
proteins B
R1 I
( O
large O
subunit O
) O
and O
R2 O
( O
small O
subunit O
) O
. O

Recombinant B
MsERK1 I
( O
rMsERK1 B
) O
, O
when O
overexpressed O
in O
Escherichia O
coli O
, O
is O
recognized O
by O
antibodies O
raised O
against O
MAP B
kinases I
from I
rat I
, I
Xenopus I
, I
and I
sea I
star I
and O
by O
anti O
- O
phosphotyrosine O
antibodies O
. O

The O
identification O
of O
SRP54sc B
and O
SRP54sp B
provides O
the O
first O
evidence O
for O
SRP O
related O
proteins O
in O
yeast O
. O

We O
previously O
demonstrated O
that O
AKT2 B
, O
a O
member O
of O
protein B
kinase I
B I
family I
, O
is O
activated O
by O
a O
number O
of O
growth O
factors O
via O
Ras O
and O
PI O
3 O
- O
kinase O
signaling O
pathways O
. O

The O
expected O
products O
of O
the O
cloned O
bph B
genes I
, O
except O
bphA3 B
, O
were O
observed O
in O
E O
. O
coli O
in O
an O
in O
vitro O
transcription O
- O
translation O
system O
. O

The O
consensus O
mammalian O
ER O
stress O
response O
element O
( O
ERSE O
) O
conserved O
among O
grp B
promoters I
consists O
of O
a O
tripartite O
structure O
CCAAT O
( O
N9 O
) O
CCACG O
, O
with O
N O
being O
a O
strikingly O
GC O
- O
rich O
region O
of O
9 O
bp O
. O

A O
positive O
correlation O
was O
also O
established O
between O
the O
level O
of O
FP9C B
binding O
and O
the O
degree O
of O
cell O
differentiation O
in O
vitro O
. O

Unlike O
CSK O
, O
the O
SH3 O
domain O
of O
HYL B
was O
unique O
since O
the O
ALYDY O
motif O
was O
absent O
. O

Its O
phosphorylation O
strongly O
potentiates O
its O
ability O
to O
activate O
transcription O
of O
the O
c O
- O
fos O
promoter O
through O
a O
ternary O
complex O
assembled O
on O
the O
c B
- I
fos I
serum I
response I
element I
. O

Fus3p B
and O
Kss1p B
together O
increase O
the O
expression O
of O
CLN3 O
and O
PCL2 B
genes I
that O
promote O
budding O
, O
and O
Kss1p B
inhibits O
the O
MAP O
kinase O
cascade O
. O

We O
found O
4 O
highly O
conserved O
regions O
to O
vertebrate B
Hsp90 I
exclusively O
and O
27 O
amino O
acids O
conserved O
among O
but O
differing O
between O
Hsp90 B
alpha I
and O
Hsp90 B
beta I
sequences I
. O

We O
present O
here O
the O
complete O
primary O
structure O
of O
human B
gp330 I
, O
the O
human O
variant O
of O
the O
principal O
kidney O
autoantigen O
causing O
Heymann O
membranous O
glomerulonephritis O
in O
rats O
. O

The O
platelet B
membrane I
glycoprotein I
IIb I
/ I
IIIa I
receptor I
inhibitor O
abciximab O
is O
used O
for O
the O
treatment O
of O
patients O
undergoing O
high O
- O
risk O
percutaneous O
coronary O
interventions O
and O
is O
used O
in O
approximately O
one O
third O
of O
coronary O
interventions O
in O
the O
United O
States O
and O
a O
growing O
number O
of O
procedures O
in O
Europe O
. O

Human B
epidermal I
growth I
factor I
( O
EGF O
) O
, O
a O
naturally O
occurring O
protein O
, O
has O
been O
implicated O
in O
the O
protection O
of O
gastrointestinal O
mucosal O
integrity O
. O

Site O
- O
directed O
mutagenesis O
of O
the O
T4 B
endonuclease I
V I
gene I
: O
role O
of O
lysine O
- O
130 O
. O

The O
library O
will O
thus O
be O
useful O
for O
the O
selection O
of O
cosmid O
clones O
which O
carry O
CDC B
genes I
from I
yeast I
by O
complementing O
first O
, O
with O
the O
vectorial O
yeast B
gene I
URA1 I
, O
the O
pyrimidine O
auxotrophy O
of O
most O
cdc B
- O
strains O
and O
then O
, O
with O
the O
respective O
CDC B
wild I
- I
type I
genes I
, O
of O
the O
temperature O
- O
sensitive O
mutant O
alleles O
. O

These O
mutant B
rps7 I
leaders O
were O
ligated O
into O
an O
aadA O
expression O
cassette O
and O
transformed O
into O
the O
chloroplast O
of O
C O
. O
reinhardtii O
and O
into O
E O
. O
coli O
. O

In O
addition O
, O
both O
activated O
Ral B
- I
GDS I
- I
like I
factor O
and O
Raf O
stimulate O
cyclin B
D I
( I
1 I
) I
transcription O
and O
E2F O
activity O
and O
act O
in O
synergy O
with O
PI O
3 O
- O
kinase O
. O

Like O
the O
DMA B
, O
but O
unlike O
all O
other O
mammalian B
class I
II I
A I
genes I
, O
the O
zebrafish O
gene O
codes O
for O
two O
cysteine O
residues O
which O
might O
potentially O
be O
involved O
in O
the O
formation O
of O
a O
disulfide O
bond O
in O
the O
alpha O
1 O
domain O
. O

Down O
- O
regulation O
of O
Id1 B
mRNA I
correlated O
with O
mitogenesis O
and O
occurred O
when O
quiescent O
cells O
were O
treated O
with O
growth O
factors O
that O
activate O
G O
protein O
- O
coupled O
receptors O
and O
receptor B
protein I
tyrosine I
kinases I
but O
not O
with O
a O
non O
- O
mitogenic O
cAMP O
analog O
. O

Secretogranin B
II I
( O
SgII B
) O
is O
a O
secretory O
polypeptide O
stored O
in O
large O
dense O
core O
vesicles O
of O
neuroendocrine O
and O
neuronal O
cells O
. O

BK B
- O
induced O
translocation O
and O
overexpression O
of O
PKC B
isoforms I
as O
well O
as O
coexpression O
of O
inactive O
or O
constitutively O
active O
mutants O
of O
different O
PKC B
isozymes I
provided O
evidence O
for O
a O
role O
of O
the O
diacylglycerol O
- O
sensitive O
PKCs B
alpha I
and I
epsilon I
in O
BK B
signaling O
toward O
MAPK O
. O

Here O
we O
describe O
the O
characterization O
of O
cDNAs O
encoding O
two O
unusual O
E2Fs B
, O
E2F B
- I
4 I
and O
E2F B
- I
5 I
, O
each O
identified O
by O
the O
ability O
of O
their O
gene O
product O
to O
interact O
with O
p130 O
in O
a O
yeast O
two O
- O
hybrid O
system O
. O

Interestingly O
, O
unlike O
PAK65 B
, O
HPK1 O
does O
not O
contain O
the O
small O
GTPase O
Rac1 O
/ O
Cdc42 O
- O
binding O
domain O
and O
does O
not O
bind O
to O
either O
Rac1 O
or O
Cdc42 O
, O
suggesting O
that O
HPK1 O
. O
activation O
is O
Rac1 O
/ O
Cdc42 O
- O
independent O
. O

Analysis O
of O
deletion O
and O
substitution O
mutations O
in O
the O
MER2 B
5 I
' I
exon I
demonstrates O
that O
the O
unusually O
large O
size O
of O
this O
exon O
plays O
an O
important O
role O
in O
splicing O
regulation O
. O

Reexamination O
of O
the O
cdc4 B
- I
1 I
mutant I
revealed O
that O
, O
in O
addition O
to O
being O
defective O
in O
the O
onset O
of O
S O
phase O
, O
it O
is O
also O
defective O
in O
G O
( O
2 O
) O
/ O
M O
transition O
when O
released O
from O
hydroxyurea O
- O
induced O
S O
- O
phase O
arrest O
. O

All O
such O
polypeptides O
containing O
263 O
or O
more O
residues O
derived O
from O
the O
C O
- O
terminus O
of O
P130gag B
- O
fps O
( O
i O
. O
e O
. O
residues O
920 O
- O
1182 O
) O
were O
enzymatically O
active O
as O
tyrosine O
kinases O
. O

A O
structural O
model O
for O
Vpu O
is O
proposed O
in O
which O
the O
membrane O
anchor O
precedes O
a O
region O
comprising O
two O
amphipathic O
alpha O
- O
helices O
of O
opposed O
polarity O
, O
joined O
by O
a O
strongly O
acidic O
turn O
that O
protrudes O
into O
the O
cytoplasm O
and O
contains O
the O
CK B
- I
2 I
phosphorylation I
sites I
. O

The O
recombinant O
containing O
the O
full O
- O
length O
polyhedrin B
leader O
sequence O
gave O
levels O
of O
N B
mRNA I
comparable O
to O
those O
of O
AcNPV B
polyhedrin I
mRNA I
. O

Thus O
, O
CARP O
is O
a O
YB B
- I
1 I
associated I
factor I
and O
represents O
the O
first O
identified O
cardiac O
- O
restricted O
downstream O
regulatory O
gene O
in O
the O
homeobox O
gene O
Nkx2 O
- O
5 O
pathway O
and O
may O
serve O
as O
a O
negative O
regulator O
of O
HF B
- I
1 I
- O
dependent O
pathways O
for O
ventricular O
muscle O
gene O
expression O
. O

Each O
receptor O
must O
therefore O
engage O
a O
unique O
subset O
of O
the O
available O
signaling O
elements O
- O
- O
at O
least O
partly O
through O
the O
selection O
of O
proteins O
with O
src O
- O
homology O
2 O
domains O
( O
SH2 B
proteins I
) O
. O

A O
model O
for O
the O
SMase B
- O
sphingomyelin O
complex O
structure O
was O
built O
to O
investigate O
how O
the O
SMase B
specifically O
recognizes O
its O
substrate O
. O

When O
recombinant B
gE I
produced O
in O
HeLa O
cells O
was O
probed O
with O
the O
same O
antiphosphotyrosine O
antibody O
, O
a O
dimeric B
gE I
form O
at O
130 O
kDa O
was O
detected O
on O
the O
cell O
surface O
. O

Mutations O
that O
extend O
the O
specificity O
of O
the O
endonuclease O
activity O
of O
lambda B
terminase I
. O

The O
prosomal B
RNA I
- I
binding I
protein I
p27K I
is O
a O
member O
of O
the O
alpha B
- I
type I
human I
prosomal I
gene I
family I
. O

A O
single O
clone O
, O
which O
was O
conserved O
and O
had O
near O
- O
perfect O
homology O
to O
eight O
human O
/ O
rodent O
expressed O
sequence O
tags O
, O
was O
used O
as O
template O
for O
5 O
' O
and O
3 O
' O
rapid O
amplification O
of O
cDNA O
ends O
and O
SPICE O
( O
system O
for O
polymerase O
chain O
reaction O
amplification O
of O
cDNA O
ends O
) O
reactions O
to O
obtain O
the O
3 O
. O
6 O
- O
kb O
cDNA O
, O
LGL2 B
( O
Genbank B
, I
AF I
110195 I
) O
encoding O
a O
deduced O
polypeptide O
( O
lgl2 B
) O
of O
963 O
amino O
acids O
. O

In O
vitro O
death O
assays O
with O
transient O
overexpression O
of O
deletion O
constructs O
of O
both O
isoforms O
using O
beta O
- O
galactosidase O
as O
a O
reporter O
gene O
in O
MCF7 O
cells O
suggest O
the O
following O
: O
1 O
) O
the O
nucleotide O
binding O
domain O
may O
act O
as O
a O
negative O
regulator O
of O
the O
killing O
activity O
of O
DEFCAP B
; O
2 O
) O
the O
LRR B
/ O
CARD B
represents O
a O
putative O
constitutively O
active O
inducer O
of O
apoptosis O
; O
3 O
) O
the O
killing O
activity O
of O
LRR B
/ O
CARD B
is O
inhibitable O
by O
benzyloxycarbonyl O
- O
Val O
- O
Ala O
- O

Asp O
( O
OMe O
) O
- O
fluoromethyl O
ketone O
and O
to O
a O
lesser O
extent O
by O
Asp O
- O
Glu O
- O
Val O
- O
Asp O
( O
OMe O
) O
- O
fluoromethyl O
ketone O
; O
and O
4 O
) O
the O
CARD B
is O
critical O
for O
killing O
activity O
of O
DEFCAP B
. O

The O
use O
of O
sigma B
54 I
promoters I
, O
known O
to O
require O
cognate O
binding O
proteins O
, O
could O
allow O
the O
fine O
- O
tuning O
that O
provides O
the O
temporal O
ordering O
of O
flagellar O
gene O
transcription O
. O

The O
association O
of O
I B
- I
92 I
with O
p92 B
, O
p84 B
, O
p75 B
, O
p73 O
, O
p69 B
, O
and O
p57 B
was O
completely O
reversible O
after O
treatment O
with O
the O
detergent O
deoxycholate O
( O
DOC O
) O
. O

Human B
parvovirus I
B19 I
gene I
expression O
from O
the O
viral B
p6 I
promoter I
( O
B19p6 B
) O
is O
restricted O
to O
primary O
human O
hematopoietic O
cells O
undergoing O
erythroid O
differentiation O
. O

Hetero O
- O
oligomerization O
of O
Smad4 O
with O
the O
pathway O
- O
restricted O
SMAD B
proteins I
is O
essential O
for O
Smad4 O
- O
mediated O
transcription O
. O

This O
fragment O
contains O
two O
complete O
endo B
- I
beta I
- I
1 I
, I
4 I
- I
glucanase I
- I
encoding I
genes I
, O
designated O
celCCC B
and O
celCCG B
. O

Analysis O
of O
the O
5 O
' O
and O
3 O
' O
termini O
of O
the O
transcripts O
produced O
in O
vivo O
from O
the O
puf B
operon I
of I
R I
. I
sphaeroides I
PUF B
delta I
348 I
- I
420 I
( O
three O
transcripts O
; O
0 O
. O
59 O
, O
0 O
. O
64 O
, O
and O
2 O
. O
63 O
kilobases O
) O
lacking O
the O
puf O
- O
intercistronic O
terminator O
structure O
were O
identical O
to O
those O
of O
the O
corresponding O
puf B
transcripts I
derived O
from O
wild O
- O
type O
R O
. O
sphaeroides O
2 O
. O
4 O
. O
1 O
( O
four O
transcripts O
; O
0 O
. O
50 O
, O
0 O
. O
66 O
, O
0 O
. O
71 O
, O
and O
2 O
. O
7 O
kilobases O
) O
showing O

Strains O
lacking O
a O
functional B
RPL16A I
gene I
grow O
as O
rapidly O
as O
wild O
type O
, O
whereas O
those O
containing O
a O
null O
allele O
of O
RPL16B B
grow O
more O
slowly O
than O
wild O
type O
. O

After O
Northern O
blot O
hybridization O
, O
two O
Cx31 B
transcripts I
of I
2 I
. I
2 I
and I
1 I
. I
8 I
kb I
were O
detected O
in O
total O
RNA O
of O
the O
human O
keratinocyte O
cell O
line O
HaCaT O
and O
two O
transcripts O
of O
2 O
. O
2 O
and O
1 O
. O
9 O
kb O
in O
total O
RNA O
of O
E6 O
/ O
E7 O
transfected O
human O
keratinocytes O
( O
HEK O
cells O
) O
. O

In O
summary O
, O
FGFR3 O
signaling O
pathway O
utilizes O
two O
GRB2 B
- I
containing I
complexes I
; O
Shc O
. O
GRB2 O
. O
Sos O
and O
80K O
- O
H O
. O
pp66 B
. O
GRB2 O
. O
Sos O
; O
these O
two O
complexes O
may O
alternatively O
link O
FGFG3 B
to O
mitogen O
- O
activated O
protein O
kinase O
. O

In O
an O
effort O
to O
identify O
factors O
involved O
in O
the O
expression O
of O
this O
important O
erythroid O
- O
specific O
regulatory O
protein O
, O
we O
have O
isolated O
the O
mouse B
EKLF I
gene I
and O
systematically O
analyzed O
the O
promoter O
region O
. O

Four O
families O
of O
homing B
endonucleases I
have O
been O
identified O
, O
including O
the O
LAGLIDADG B
, O
the O
His B
- I
Cys I
box I
, O
the O
GIY B
- I
YIG I
and O
the O
H B
- I
N I
- I
H I
endonucleases I
. O

The O
GvpE B
protein I
involved O
in O
the O
regulation O
of O
gas O
vesicles O
synthesis O
in O
halophilic O
archaea O
has O
been O
identified O
as O
the O
transcriptional O
activator O
for O
the O
promoter O
located O
upstream O
of O
the O
gvpA B
gene I
encoding O
the O
major O
gas O
vesicle O
structural O
protein O
GvpA B
. O

Phylogenetic O
analysis O
using O
a O
neighbor O
- O
joining O
algorithm O
showed O
closest O
similarity O
of O
the O
horse B
mu I
chain I
- I
encoding I
constant I
region I
gene I
to O
human O
and O
dog O
sequences O
. O

Cloning O
and O
nucleotide O
sequence O
analysis O
reveals O
that O
BUR6 B
encodes O
a O
homolog O
of O
DRAP1 B
( O
also O
called O
NC2alpha B
) O
, O
a O
mammalian O
repressor O
of O
basal O
transcription O
. O

BRAP2 B
also O
shares O
significant O
homology O
with O
a O
hypothetical O
protein O
from O
yeast O
Saccharomyces O
cerevisiae O
, O
especially O
in O
the O
zinc O
finger O
region O
. O

Earlier O
published O
data O
, O
indicating O
Sp1 O
binding O
to O
the O
R1 B
alpha I
/ I
beta I
regions I
, O
could O
not O
be O
confirmed O
, O
suggesting O
that O
the O
R1 O
initiator O
element O
may O
function O
independent O
of O
Sp1 O
. O

The O
yeast B
mitochondrial I
Hsp70 I
, O
Ssc1p B
, O
functions O
as O
a O
molecular O
chaperone O
with O
its O
partner O
proteins O
, O
Mdj1p B
( O
DnaJ B
homologue I
) O
and O
Yge1p B
( O
GrpE B
homologue I
) O
. O

However O
, O
and O
in O
contrast O
to O
other O
MMP B
genes I
, O
no O
significative O
synergistic O
effect O
on O
CAT O
activity O
between O
the O
AP O
- O
1 O
and O
PEA B
- I
3 I
elements I
found O
in O
the O
collagenase B
- I
3 I
gene I
promoter I
was O
found O
. O

In O
contrast O
, O
postmitotic O
neurons O
possessed O
extremely O
low O
levels O
of O
E2F1 B
protein I
as O
assessed O
by O
the O
electrophoretic O
mobility O
shift O
assay O
and O
Western O
blotting O
. O

The O
human B
parvalbumin I
mRNA I
contains O
the O
putative O
polyadenylation O
signal O
AATAAA O
13 O
nucleotides O
upstream O
from O
the O
polyadenylation O
site O
. O

The O
delta O
Mo O
+ O
SV O
tumor O
DNAs O
from O
B O
- O
lineage O
tumors O
were O
typically O
rearranged O
at O
the O
immunoglobulin B
gene I
loci I
and O
contained O
germ O
line O
configurations O
of O
the O
T B
- I
cell I
receptor I
beta I
gene I
. O

To O
examine O
the O
effect O
of O
the O
cAMP O
signal O
transduction O
pathway O
on O
transcription O
of O
the O
gene O
encoding O
the O
catalytic O
subunit O
of O
glucose B
- I
6 I
- I
phosphatase I
( O
G6Pase B
) O
, O
G6Pase B
- O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
fusion O
genes O
were O
transiently O
transfected O
into O
either O
the O
liver O
- O
derived O
HepG2 O
or O
kidney O
- O
derived O
LLC O
- O
PK O
cell O
line O
. O

Whereas O
the O
sequence O
of O
alpha B
- I
actinin I
( O
Noegel O
, O
A O
. O
, O
W O
. O

The O
shift O
from O
complex O
I O
to O
complex O
II O
seen O
only O
in O
SCM B
- I
1 I
- O
producer O
T O
cell O
lines O
upon O
activation O
was O
completely O
suppressed O
by O
cyclosporin O
A O
. O

ER B
beta I
was O
less O
potent O
than O
ER B
alpha I
in O
activating O
E2 O
- O
stimulated O
ERELuc O
activity O
( O
4 O
- O
vs O
. O

The O
expression O
pattern O
of O
LjEmx B
changed O
dramatically O
during O
embryogenesis O
; O
expression O
was O
seen O
initially O
in O
the O
entire O
neural O
tube O
and O
mesoderm O
, O
which O
were O
secondarily O
downregulated O
, O
and O
secondarily O
in O
cranial O
nerve O
ganglia O
and O
in O
the O
craniofacial O
mesenchyme O
. O

Disruption O
of O
PML B
subnuclear I
domains I
by O
the O
acidic B
IE1 I
protein I
of O
human O
cytomegalovirus O
is O
mediated O
through O
interaction O
with O
PML O
and O
may O
modulate O
a O
RING O
finger O
- O
dependent O
cryptic O
transactivator O
function O
of O
PML O
. O

Furthermore O
, O
the O
GC O
- O
rich O
sequences O
could O
confer O
Sp1 O
- O
dependent O
transactivation O
to O
a O
heterologous O
prolactin B
minimal I
promoter I
. O

Twelve O
patients O
of O
leprosy O
with O
arthritis O
and O
161 O
patients O
without O
arthritis O
were O
studied O
for O
immunological O
parameters O
like O
immunoglobulins B
( O
IgG O
, O
IgM O
, O
IgA O
) O
, O
C B
- I
reactive I
proteins I
and O
rheumatoid O
factor O
. O

Several O
reports O
assert O
that O
prolactin O
affects O
the O
delta O
5 O
and O
delta O
4 O
pathways O
through O
its O
effect O
on O
the O
activity O
of O
3beta B
- I
hydroxysteroid I
dehydrogenase I
( O
3beta B
- I
OHSD I
) O
. O

The O
NrfC B
polypeptide I
, O
M B
( I
r I
) I
24 I
, I
567 I
, O
contains O
16 O
cysteine O
residues O
arranged O
in O
four O
clusters O
typical O
of O
the O
CooF B
super I
- I
family I
of O
non O
- O
haem O
iron O
- O
sulphur O
proteins O
. O

( O
i O
) O
p60 B
bound O
fast O
- O
migrating O
, O
underprocessed O
wild B
- I
type I
ICP22 I
and O
ICP22 B
lacking O
the O
carboxyl O
- O
terminal O
24 O
amino O
acids O
but O
not O
ICP22 B
lacking O
the O
carboxyl O
- O
terminal O
40 O
amino O
acids O
, O
whereas O
the O
previously O
identified O
cellular B
protein I
p78 I
( O
R O
. O

Y1 B
, O
Y2 B
, O
and O
Y4 O
/ O
PP1 O
. O

Developmentally O
- O
regulated O
interaction O
of O
a O
transcription O
factor O
complex O
containing O
CDP O
/ O
cut O
with O
the O
early B
histone I
H3 I
gene I
promoter I
of I
the I
sea I
urchin I
Tetrapygus I
niger I
is O
associated O
with O
changes O
in O
chromatin O
structure O
and O
gene O
expression O
. O

After O
a O
shift O
to O
37 O
degrees O
C O
, O
the O
mutant O
Rat7 B
- I
1p I
/ O
Nup159 B
- I
1p I
is O
lost O
from O
the O
nuclear O
rim O
of O
rat7 O
- O
1 O
cells O
and O
NPCs O
, O
which O
are O
clustered O
together O
in O
these O
cells O
grown O
under O
permissive O
conditions O
become O
substantially O
less O
clustered O
. O

The O
mRNA O
for O
this O
protein O
is O
expressed O
in O
the O
T O
- O
ALL O
cell O
line O
Jurkat O
and O
has O
been O
designated O
HUG1 O
, O
for O
HOX11 B
Upstream I
Gene I
. O

The O
STS B
sequence I
WI I
- I
14920 I
is O
in O
fact O
derived O
from O
the O
3 O
' O
- O
untranslated O
region O
of O
the O
human B
PUNC I
gene I
. O

Its O
activity O
was O
twice O
that O
of O
a O
construct O
where O
the O
CAT O
gene O
was O
driven O
by O
the O
H B
- I
2Kb I
5 I
' I
enhancer I
region I
( O
H2TF1 O
/ O
KBF1 B
site O
) O
and O
comparable O
to O
that O
of O
pRSVCAT O
construct B
carrying I
the I
strong I
Rous I
sarcoma I
virus I
LTR I
enhancer I
. O

ORF3 O
appears O
to O
encode O
the O
homologue O
of O
the O
well O
- O
conserved O
proteasomal B
26S I
regulatory I
subunit I
. O

The O
tam B
A I
gene I
of I
Aspergillus I
nidulans I
encodes O
a O
739 O
- O
amino O
acid O
protein O
with O
similarity O
to O
Uga35p B
/ O
Dal81p B
/ O
DurLp B
of O
Saccharomyces O
cerevisiae O
. O

No O
promoter O
activity O
could O
be O
detected O
with O
various O
mouse B
Fli I
- I
1 I
promoter I
- O
CAT O
constructs O
containing O
600 O
bp O
of O
the O
5 O
' O
flanking O
region O
, O
the O
complete O
exon O
1 O
, O
the O
5 O
' O
end O
of O
intron O
1 O
and O
/ O
or O
retroviral O
LTR O
sequence O
. O

The O
D O
. O
discoideum O
proteins O
were O
entirely O
conserved O
over O
the O
four O
regions O
known O
to O
be O
important O
for O
GTP O
binding O
and O
all O
contained O
the O
C O
- O
terminal O
CAAX O
aa O
motifs O
shared O
by O
other O
Rho B
proteins I
. O

An O
81 O
- O
nt O
tandem O
duplication O
of O
the O
C O
- O
terminal O
coding O
region O
is O
located O
adjacent O
to O
the O
termination O
codon O
of O
the O
CyIIIb B
gene I
, O
a O
potential O
relic O
of O
a O
slipped O
mispairing O
and O
replication O
event O
. O

Here O
we O
examine O
the O
population O
of O
gammaS B
transcripts I
in O
adult O
human O
lens O
and O
the O
structure O
of O
the O
human B
CRYGS I
genes I
. O

Mouse B
macrophage I
beta I
subunit I
( I
CD11b I
) I
cDNA I
for O
the O
CR3 B
complement I
receptor I
/ O
Mac B
- I
1 I
antigen I
. O

The O
80 O
kb O
preceding O
the O
expression O
site O
has O
few O
, O
if O
any O
, O
functional O
ORFs O
, O
but O
contains O
50 O
bp O
repeats O
, O
INGI B
retrotransposon I
- I
like I
elements I
, O
and O
novel O
4 O
- O
12 O
kb O
repeats O
found O
near O
other O
telomeres O
. O

The O
predicted O
proteins O
show O
strong O
homology O
to O
an O
ABA B
- I
inducible I
glycine I
- I
rich I
protein I
from O
maize O
embryos O
and O
to O
the O
mammalian B
RNA I
- I
binding I
protein I
A1 I
of O
the O
heterogeneous O
nuclear O
ribonucleoprotein O
complex O
involved O
in O
pre O
- O
mRNA O
splicing O
. O

Cbl O
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 O
domain O
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin O
ligase O
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL O
and O
the O
p85 O
subunit O
of O
PI O
3 O
- O
kinase O
, O
and O
a O
nuclear O
localization O
signal O
. O

Surprisingly O
, O
apo B
- I
iso I
- I
1 I
- I
cytochrome I
c I
is O
absent O
in O
cyc3 B
- I
strains O
, O
although O
apo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
present O
at O
approximately O
the O
same O
level O
at O
which O
holo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
found O
in O
CYC3 B
+ I
strains O
. O

IRA2 O
, O
a O
second O
gene O
of O
Saccharomyces O
cerevisiae O
that O
encodes O
a O
protein O
with O
a O
domain O
homologous O
to O
mammalian O
ras B
GTPase I
- I
activating I
protein I
. O

Co O
- O
operativity O
of O
functional O
domains O
in O
the O
muscle B
- I
specific I
transcription I
factor I
Myf I
- I
5 I
. O

The O
glyoxysomal O
and O
plastid O
molecular O
chaperones O
( O
70 B
- I
kDa I
heat I
shock I
protein I
) O
of O
watermelon O
cotyledons O
are O
encoded O
by O
a O
single O
gene O
. O

The O
hematopoietic O
form O
of O
PTPN6 B
transcript I
is O
initiated O
at O
a O
downstream O
promoter O
separated O
by O
7 O
kb O
from O
the O
first O
. O

Unconventional O
mRNA O
processing O
in O
the O
expression O
of O
two O
calcineurin B
B I
isoforms I
in O
Dictyostelium O
. O

The O
deduced O
amino O
acid O
sequence O
of O
this O
open O
reading O
frame O
is O
significantly O
homologous O
to O
the O
HSV B
1 I
UL49 I
. I
5 I
gene I
product I
, O
and O
as O
with O
UL49 B
. I
5 I
, O
it O
contains O
a O
potential O
signal O
sequence O
and O
transmembrane O
domain O
characteristic O
of O
membrane O
- O
associated O
proteins O
. O

GAGA B
factor I
is O
known O
to O
remodel O
the O
chromatin O
structure O
in O
concert O
with O
nucleosome B
- I
remodeling I
factor I
NURF B
in O
a O
Drosophila O
embryonic O
S150 O
extract O
. O

Also O
, O
like O
TUB B
, O
it O
has O
a O
wider O
pattern O
of O
tissue O
expression O
than O
either O
TULP1 B
or O
TULP2 B
. O

First O
, O
ste12Delta B
cells O
differ O
from O
cells O
with O
disruptions O
of O
the O
upstream O
signaling O
elements O
( O
e O
. O
g O
. O
, O
ste4Delta B
, O
ste20Delta B
, O
ste5Delta B
, O
ste11Delta B
, O
ste7Delta B
, O
or O
fus3Delta B
kss1Delta B
cells O
) O
in O
that O
they O
clearly O
retain O
some O
capacity O
for O
inducing O
Ste3p B
phosphorylation O
. O

Identification O
of O
a O
putative O
chromosomal O
replication O
origin O
from O
Helicobacter O
pylori O
and O
its O
interaction O
with O
the O
initiator B
protein I
DnaA I
. O

The O
primary O
structure O
of O
cholesterol B
esterase I
displayed O
no O
significant O
homology O
with O
other O
lipases B
, O
although O
the O
putative O
lipid O
interfacial O
recognition O
site O
of O
G O
- O
X O
- O
S O
- O
X O
- O
G O
is O
present O
in O
the O
cholesterol B
esterase I
sequence I
. O

The O
transcriptional O
initiation O
site O
of O
RAG1 B
was O
localized O
at O
A O
, O
26 O
bp O
upstream O
of O
the O
putative O
translational O
initiation O
codon O
, O
ATG O
, O
by O
the O
primer O
extension O
assay O
. O

Visualization O
of O
the O
cells O
by O
phase O
contrast O
microscopy O
indicated O
that O
murine B
PKCepsilon I
expression O
in O
the O
presence O
of O
glycerol O
resulted O
in O
a O
significant O
increase O
in O
the O
number O
of O
yeast O
cells O
exhibiting O
very O
small O
buds O
. O

Protein O
kinase O
C O
transiently O
activated O
heteromeric B
N I
- I
methyl I
- I
D I
- I
aspartate I
receptor I
channels I
independent O
of O
the O
phosphorylatable O
C O
- O
terminal O
splice O
domain O
and O
of O
consensus O
phosphorylation O
sites O
. O

Highly O
significant O
similarities O
were O
detected O
between O
the O
N O
- O
terminal O
region O
of O
P30 O
and O
those O
of O
GENA B
[ O
the O
product O
of O
another O
unidentified O
gene O
( O
geneA B
) O
located O
upstream O
of O
the O
aceEF B
- O
lpd B
operon O
] O
, O
and O
GNTR B
( O
a O
putative O
transcriptional O
repressor O
of O
the O
gluconate B
operon I
of O
Bacillus O
subtilis O
) O
. O

In O
vitro O
DNA O
binding O
assays O
indicate O
that O
the O
elements O
identified O
can O
specifically O
interact O
with O
c B
- I
Ets I
- I
1 I
protein I
. O

Siglec B
- I
9 I
is O
predicted O
to O
contain O
three O
extracellular O
immunoglobulin B
- I
like I
domains I
that O
comprise O
an O
N B
- I
terminal I
V I
- I
set I
domain I
and O
two O
C2 B
- I
set I
domains I
, O
a O
transmembrane O
region O
and O
a O
cytoplasmic O
tail O
containing O
two O
putative O
tyrosine O
- O
based O
signaling O
motifs O
. O

The O
COR B
biosynthetic O
gene O
cluster O
in O
P O
. O
syringae O
pv O
. O
glycinea O
PG4180 O
is O
encoded O
by O
a O
32 O
- O
kb O
region O
which O
contains O
both O
the O
structural O
and O
regulatory O
genes O
needed O
for O
COR B
synthesis O
. O

Both O
claR B
and O
car O
are O
expressed O
as O
monocistronic O
transcripts O
; O
the O
level O
of O
transcript O
declined O
rapidly O
after O
48h O
in O
complex O
media O
, O
but O
low O
sustained O
levels O
of O
both O
transcripts O
were O
observed O
in O
defined O
GSPG O
medium O
until O
96h O
. O

claR B
and O
car O
were O
not O
significantly O
expressed O
in O
mutants O
disrupted O
in O
the O
ccaR B
gene I
, O
a O
regulatory O
gene O
that O
controls O
positively O
clavulanic O
acid O
and O
cephamycin O
biosynthesis O
. O

Whereas O
mutant B
6C4 I
specified O
a O
wild B
- I
type I
- I
size I
Pol I
protein I
, O
we O
detected O
no O
full B
- I
length I
Pol I
protein I
in O
7E4 O
- O
infected O
cell O
extracts O
. O

The O
hepatic O
isoform O
of O
6 B
- I
phosphofructo I
- I
2 I
- I
kinase I
/ O
fructose O
- O
2 O
, O
6 O
- O
bisphosphatase O
( O
PF2K B
/ O
Fru B
- I
2 I
, I
6 I
- I
BPase I
) O
is O
transcriptionally O
stimulated O
by O
glucocorticoids O
, O
whereas O
insulin O
blocks O
this O
stimulatory O
effect O
. O

Being O
implicated O
in O
insulin O
and O
GK B
gene I
regulations O
as O
a O
common O
transcription O
factor O
, O
IPF1 B
/ O
STF B
- I
1 I
/ O
PDX B
- I
1 I
is O
likely O
to O
play O
an O
essential O
role O
in O
maintaining O
normal O
beta O
- O
cell O
functions O
. O

The O
Caenorhabditis B
elegans I
NK I
- I
2 I
class I
homeoprotein I
CEH I
- I
22 I
is O
involved O
in O
combinatorial O
activation O
of O
gene O
expression O
in O
pharyngeal O
muscle O
. O

We O
demonstrate O
that O
the O
WRM B
- I
1 I
protein I
binds O
to O
LIT B
- I
1 I
in O
vivo O
and O
that O
WRM B
- I
1 I
can O
activate O
the O
LIT B
- I
1 I
protein I
kinase I
when O
coexpressed O
in O
vertebrate O
tissue O
culture O
cells O
. O

RESULTS O
: O
All O
primary O
tumors O
were O
positive O
for O
CAM5 B
. I
2 I
. O

To O
determine O
the O
transactivation O
potential O
of O
each O
of O
the O
four O
Ahr O
Sp1 O
sites O
, O
we O
fused O
the O
Ahr B
promoter I
to O
a O
luciferase O
( O
LUC O
) O
reporter O
gene O
and O
transfected O
the O
construct O
into O
the O
Drosophila O
cell O
line O
Schneider O
- O
2 O
, O
which O
contains O
no O
Sp1 O
or O
Sp1 B
- I
like I
factors I
. O

We O
determined O
that O
Hop B
( I
T42 I
) I
contains O
a O
glutamic O
acid O
- O
to O
- O
lysine O
substitution O
at O
amino O
acid O
residue O
695 O
( O
E695K O
) O
. O

The O
psh3 B
( I
+ I
) I
gene I
encodes O
a O
protein O
of O
215 O
amino O
acids O
, O
which O
shares O
a O
high O
degree O
of O
structural O
and O
functional O
similarity O
with O
Shr3p B
. O

This O
growth O
- O
inhibitory O
effect O
was O
suppressed O
by O
the O
mpk1 B
delta I
mutation O
, O
suggesting O
that O
hyperactivation O
of O
the O
Mpk1 B
pathway O
is O
toxic O
to O
cells O
. O

The O
chicken O
genome O
contains O
two O
functional O
nonallelic O
beta1 B
, I
4 I
- I
galactosyltransferase I
genes I
. O

Homodimers O
of O
RIP60 B
( O
replication B
initiation I
- I
region I
protein I
60 I
kDA I
) O
purified O
from O
nuclear O
extract O
bind O
two O
ATT O
- O
rich O
sites O
in O
oribeta O
and O
foster O
the O
formation O
of O
a O
twisted O
720 O
bp O
DNA O
loop O
in O
vitro O
. O

To O
test O
the O
role O
of O
myb B
family I
members I
in O
progression O
through O
the O
cell O
cycle O
, O
we O
comicroinjected O
c O
- O
myc O
and O
myb O
expression O
vectors O
into O
serum O
- O
deprived O
quiescent O
SMCs O
. O

LAC9 B
is O
a O
DNA O
- O
binding O
protein O
that O
regulates O
transcription O
of O
the O
lactose B
- I
galactose I
regulon I
in O
Kluyveromyces O
lactis O
. O

We O
determined O
the O
complete O
nucleotide O
sequence O
of O
the O
gypsy B
element I
present O
at O
the O
forked B
locus I
of O
Drosophila O
melanogaster O
in O
the O
f1 O
allele O
. O

The O
same O
high O
degree O
of O
sequence O
homology O
between O
the O
two O
F O
. O
diplosiphon O
PC B
alpha I
and O
PC B
beta I
sequences I
( O
85 O
and O
77 O
% O
, O
respectively O
) O
was O
found O
at O
both O
the O
nucleotide O
and O
amino O
acid O
levels O
, O
and O
similar O
results O
were O
obtained O
for O
interspecies O
comparisons O
. O

A O
wound O
model O
for O
decubitus O
and O
leg O
ulcers O
consisting O
of O
human O
dermal O
fibroblasts O
in O
type B
I I
collagen I
dermal O
" O
equivalent O
" O
matrix O
( O
DEM O
) O
was O
exposed O
in O
vitro O
to O
electric O
fields O
similar O
to O
postulated O
endogenous O
fields O
in O
wounds O
. O

The O
vertebrate B
transcription I
factors I
TCF I
( O
T B
cell I
factor I
) O
and O
LEF O
( O
lymphocyte B
enhancer I
binding I
factor I
) O
interact O
with O
beta O
- O
catenin O
and O
are O
hypothesized O
to O
mediate O
Wingless O
/ O
Wnt O
signaling O
. O

Some O
of O
these O
DNA O
: O
protein O
complexes O
were O
also O
present O
, O
but O
at O
lower O
levels O
, O
in O
nuclear O
extracts O
from O
untransformed O
rat O
cells O
suggesting O
the O
possible O
involvement O
of O
cellular O
factors O
in O
the O
mechanism O
of O
down O
- O
regulation O
mediated O
by O
Ad12 B
E1A I
. O

Mouse B
GRK6 I
- I
C I
displays O
none O
of O
these O
motifs O
. O

The O
132 B
- I
bp I
PHO8p I
fragment I
, O
connected O
at O
position O
- O
281 O
of O
the O
5 O
' O
upstream O
region O
of O
a O
HIS5 B
' I
- O
' O
lacZ O
fused O
gene O
, O
could O
sense O
Pi O
signals O
in O
vivo O
, O
but O
a O
20 O
- O
bp O
synthetic O
oligonucleotide O
having O
the O
same O
sequence O
from O
- O
544 O
to O
- O
525 O
of O
the O
PHO8p B
DNA I
could O
not O
. O

Sequences O
within O
the O
UAS2 O
element O
of O
the O
ENO2 B
gene I
bound O
a O
second O
protein O
which O
corresponded O
to O
the O
ABFI O
( O
autonomously B
replicating I
sequence I
- I
binding I
factor I
) O
protein O
. O

Plasmid O
subclones O
of O
recombinant O
phage O
lambda O
Asm152 O
were O
able O
to O
complement O
both O
Escherichia B
coli I
gltB I
and O
A O
. O
sesbaniae O
Asm O
- O
Vi O
mutants O
; O
NADPH B
- I
glutamate I
synthase I
activity O
was O
detected O
in O
all O
such O
strains O
complemented O
to O
Asm O
+ O
. O

The O
sequence O
of O
LZ321 B
matched O
that O
of O
RREB1 B
, O
a O
transcription O
factor O
that O
bound O
to O
a O
Ras B
responsive I
element I
( O
RRE O
) O
very O
different O
from O
the O
sequence O
with O
which O
we O
isolated O
LZ321 B
. O

Steady O
- O
state O
levels O
of O
murine B
MMR I
mRNA I
were O
measured O
in O
the O
macrophage O
cell O
line O
J774E O
, O
which O
is O
known O
to O
express O
the O
protein O
at O
the O
cell O
surface O
. O

Coronatine B
( O
COR B
) O
is O
a O
plasmid O
- O
encoded O
phytotoxin O
synthesized O
by O
several O
pathovars O
of O
phytopathogenic O
Pseudomonas O
syringae O
. O

The O
transcriptional O
activity O
of O
P B
- I
450 I
( I
11 I
beta I
) I
gene I
was O
studied O
with O
an O
in O
vitro O
transcription O
system O
using O
nuclear O
extracts O
prepared O
from O
bovine O
adrenal O
cortex O
. O

This O
bud O
morphology O
results O
at O
least O
in O
part O
from O
a O
cell O
cycle O
delay O
imposed O
by O
the O
Cdc28p O
- O
inhibitory O
kinase O
Swe1p B
. O

Eleven O
of O
the O
12 O
exons O
have O
complete O
sequence O
homology O
with O
the O
RBM B
- I
1 I
sequence I
. O

The O
three O
proteins O
copurified O
through O
several O
biochemical O
fractionation O
steps O
and O
could O
be O
coimmunoprecipitated O
by O
using O
antibodies O
against O
GCD1 B
or O
GCD2 B
. O

Cellular O
fractionation O
and O
Percoll O
gradient O
centrifugation O
combined O
with O
immunoblotting O
show O
that O
p67 B
cofractionates O
with O
nuclei O
and O
is O
enriched O
in O
resistant O
structure O
that O
is O
insoluble O
in O
2 O
M O
NaCl O
, O
25 O
mM O
lithium O
3 O
, O
5 O
' O
- O
diiodosalicylate O
, O
and O
1 O
% O
Triton O
but O
is O
soluble O
in O
8 O
M O
urea O
. O

For O
the O
first O
time O
also O
a O
genomic O
sequence O
for O
a O
red B
algal I
lhc I
gene I
is O
presented O
. O

In O
vitro O
, O
c O
- O
Src O
phosphorylated O
FAK B
Tyr I
- I
925 I
in O
a O
glutathione O
S O
- O
transferase O
- O
FAK O
C O
- O
terminal O
domain O
fusion O
protein O
, O
whereas O
FAK O
did O
not O
. O

Gel O
shift O
analysis O
of O
protein O
binding O
from O
nuclear O
extracts O
to O
these O
caveolin B
promoter I
DNA I
sequences I
, O
together O
with O
DNase O
I O
footprinting O
, O
confirmed O
nucleoprotein O
binding O
to O
the O
SRE O
- O
like O
elements O
as O
part O
of O
the O
transcriptional O
response O
to O
LDL B
- I
FC I
. O

The O
phP1 B
mutation O
was O
induced O
by O
insertion O
of O
a O
1 O
. O
2 O
- O
kb O
P O
element O
into O
the O
5 O
' O
transcribed O
nontranslated O
region O
of O
the O
proximal O
polyhomeotic B
gene I
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human B
retinoblastoma I
binding I
protein I
1 I
( O
RBP B
- I
1 I
) O
, O
Drosophila B
melanogaster I
male I
specific I
lethal I
- I
3 I
( O
Msl B
- I
3 I
) O
, O
S B
. I
pombe I
altered I
polarity I
- I
13 I
( O
Alp13 B
) O
and O
S B
. I
cerevisiae I
Eaf3p I
, O
a O
component O
of O
the O
yeast B
NuA4 I
HAT O
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

In O
this O
report O
, O
we O
identify O
Tyr319 O
as O
a O
functionally O
important O
phosphorylation O
site O
in O
the O
ZAP B
- I
70 I
interdomain I
B I
region I
. O

Previously O
, O
a O
cDNA O
( O
GT2 B
) O
encoding O
this O
protein O
was O
isolated O
from O
a O
mouse O
3T3 O
- O
L1 O
adipocyte O
library O
and O
was O
sequenced O
. O

Expression O
of O
human B
complement I
receptor I
type I
2 I
( O
CR2 B
/ O
CD21 B
) O
is O
primarily O
restricted O
to O
mature O
B O
cells O
and O
follicular O
dendritic O
cells O
. O

The O
apparent O
binding O
constant O
of O
6 O
to O
calf O
thymus O
DNA O
is O
1 O
. O
68 O
X O
10 O
( O
5 O
) O
M O
- O
1 O
whereas O
netropsin B
under O
similar O
conditions O
gives O
a O
value O
of O
1 O
. O
85 O
X O
10 O
( O
7 O
) O
M O
- O
1 O
. O

Phenotypic O
screening O
of O
mutations O
in O
Pmr1 B
, O
the O
yeast B
secretory I
pathway I
Ca2 I
+ I
/ I
Mn2 I
+ I
- I
ATPase I
, O
reveals O
residues O
critical O
for O
ion O
selectivity O
and O
transport O
. O

Molecular O
cloning O
of O
cDNAs O
encoding O
alpha O
- O
subunits O
of O
guanine B
nucleotide I
- I
binding I
regulatory I
proteins I
( O
G O
- O
proteins O
) O
has O
revealed O
the O
existence O
of O
nine O
species O
of O
alpha O
- O
subunits O
. O

No O
transactivation O
of O
the O
ovalbumin B
promoter I
( O
pLovTATA B
) O
template O
control O
was O
observed O
. O

Pros O
and O
cons O
of O
selective O
inhibition O
of O
cyclooxygenase O
- O
2 O
versus O
dual O
lipoxygenase B
/ O
cyclooxygenase O
inhibition O
: O
is O
two O
better O
than O
one O
? O

HDE B
was O
found O
to O
be O
exclusively O
targeted O
to O
and O
imported O
into O
peroxisomes O
in O
both O
heterologous O
expression O
systems O
. O

The O
other O
regions O
include O
potential O
binding O
sites O
for O
transcription O
factors O
ATF O
, O
NF1 O
, O
and O
a O
CCAAT B
- I
binding I
protein I
. O

Both O
purH B
and O
purD B
genes I
constitute O
a O
single O
operon O
and O
are O
coregulated O
in O
expression O
by O
purines O
as O
other O
purine B
genes I
are O
. O

In O
situ O
hybridization O
reveals O
strong O
signals O
for O
Zep B
mRNA I
in O
the O
cerebellum O
and O
olfactory O
bulb O
with O
moderate O
signals O
detected O
in O
the O
hippocampus O
and O
cortex O
. O

TNF O
- O
alpha O
effect O
was O
eliminated O
by O
a O
2 O
- O
bp O
substitution O
mutation O
in O
the O
NF B
- I
kappa I
B1 I
binding I
half I
site I
of O
the O
NF B
- I
kappa I
B I
cis I
element I
. O

UV O
- O
cross O
- O
linking O
studies O
suggested O
that O
these O
two O
complexes O
represent O
one O
and O
two O
molecules O
of O
ADR1 B
bound O
to O
DNA O
. O

As O
already O
available O
for O
the O
other O
known O
mammalian O
members O
of O
this O
enzyme O
family O
, O
we O
here O
define O
structural O
and O
functional O
features O
of O
human B
lymphoma I
proprotein I
convertase I
( O
LPC B
) O
. O

The O
M O
- O
phase O
induction O
activity O
of O
Cdc2 O
- O
Cdc13 O
is O
inhibited O
by O
Wee1 B
tyrosine I
kinase I
, O
which O
phosphorylates O
Cdc2 O
on O
tyrosine O
- O
15 O
. O

Single O
substitutions O
of O
three O
highly O
conserved O
phenylalanine O
residues O
( O
Phe O
- O
15 O
, O
Phe O
- O
17 O
, O
Phe O
- O
27 O
) O
by O
alanine O
and O
substitution O
of O
one O
histidine O
( O
His O
- O
29 O
) O
by O
glutamine O
, O
all O
located O
within O
the O
putative O
RNA O
- O
binding O
sites O
RNP B
- I
1 I
and O
RNP B
- I
2 I
, O
abolished O
the O
nucleic O
acid O
- O
binding O
activity O
of O
CspB B
. O

The O
results O
show O
that O
while O
a O
larger O
polypeptide O
substrate O
carrying O
the O
HD1 B
/ I
3C I
site I
was O
processed O
more O
efficiently O
than O
a O
polypeptide O
substrate O
carrying O
the O
POL B
/ I
Zn I
site I
, O
cleavage O
of O
the O
synthetic O
peptide O
substrates O
containing O
these O
two O
cleavage O
sites O
occurred O
at O
similar O
efficiencies O
. O

Using O
transgenic O
lines O
a O
detailed O
analysis O
of O
the O
Hoxa B
- I
7 I
enhancer O
- O
directed O
expression O
during O
embryogenesis O
was O
performed O
. O

An O
ERp60 B
- I
like I
protein I
from O
the O
filarial O
parasite O
Dirofilaria O
immitis O
has O
both O
transglutaminase O
and O
protein O
disulfide O
isomerase O
activity O
. O

At O
promoters O
that O
initiate O
with O
+ O
1 O
GGG O
, O
T7 B
RNAP I
synthesizes O
a O
ladder O
of O
poly O
( O
G O
) O
products O
as O
a O
result O
of O
slippage O
of O
the O
transcript O
on O
the O
three O
C O
residues O
in O
the O
template O
strand O
from O
+ O
1 O
to O
+ O
3 O
. O

The O
UL3 B
ORF I
of O
204 O
amino O
acids O
shows O
significant O
homology O
to O
UL3 O
( O
nuclear O
phosphoprotein O
) O
of O
HSV O
- O
1 O
( O
62 O
% O
) O
and O
PRV O
( O
53 O
% O
) O
. O

On O
Western O
blots O
, O
the O
same O
antibodies O
recognized O
the O
recombinant O
protein O
migrating O
slightly O
slower O
on O
SDS O
/ O
PAGE O
than O
chicken B
axonin I
- I
1 I
. O

The O
remaining O
77 O
nucleotides O
at O
the O
3 O
' O
end O
of O
domain O
II O
and O
all O
of O
domains O
III O
( O
655 O
nucleotides O
) O
and O
IV O
( O
770 O
nucleotides O
) O
are O
not O
present O
in O
DIssE B
RNA I
. O

The O
biological O
actions O
of O
VHR B
in O
oocytes O
clearly O
distinguish O
it O
from O
other O
dual O
specificity O
phosphatases O
, O
which O
have O
shown O
inhibitory O
effects O
when O
tested O
in O
oocytes O
. O

The O
gp41 B
peptide I
( I
Glu I
- I
Leu I
- I
Asp I
- I
Lys I
- I
Trp I
- I
Ala I
) I
fused O
to O
the O
C O
- O
terminus O
of O
Sj B
GST I
forms O
a O
loop O
stabilized O
by O
symmetry O
- O
related O
GSTs O
. O

Also O
, O
PTx B
had O
no O
effect O
on O
shear O
- O
dependent O
activation O
of O
JNK O
. O

We O
tested O
several O
growth O
regulatory O
genes O
that O
are O
repressed O
in O
senescent O
cells O
for O
ability O
to O
restore O
activity O
to O
T B
[ I
K1 I
] I
. O

We O
analyzed O
the O
contribution O
of O
the O
three O
different O
types O
of O
UV O
- O
inducible O
mitogen O
- O
activated O
protein O
( O
MAP O
) O
kinases O
( O
ERK O
, O
JNK O
/ O
SAPK O
, O
and O
p38 O
) O
to O
the O
activation O
of O
the O
murine O
uPA B
promoter O
by O
UV O
. O

The O
high O
degree O
of O
sequence O
conservation O
together O
with O
the O
ability O
to O
direct O
nucleolar O
protein O
transport O
supports O
the O
hypothesis O
that O
MAK16 B
proteins I
play O
a O
key O
role O
in O
the O
biogenesis O
of O
60S B
subunits I
. O

Characterization O
of O
a O
nuclear B
deformed I
epidermal I
autoregulatory I
factor I
- I
1 I
( O
DEAF B
- I
1 I
) O
- O
related O
( O
NUDR B
) O
transcriptional O
regulator O
protein O
. O

Here O
we O
show O
that O
the O
sck1 B
gene I
, O
cloned O
as O
a O
high O
copy O
number O
suppressor O
of O
a O
mutation O
in O
git3 B
, O
is O
able O
to O
suppress O
the O
defects O
conferred O
by O
a O
mutation O
in O
any O
of O
these O
git B
genes I
. O

The O
longest O
cDNA O
insert O
identified O
was O
2 O
. O
2 O
kb O
and O
encoded O
the O
entire O
462 O
- O
amino O
acid O
open O
reading O
frame O
of O
rat B
CgA I
including O
an O
18 O
- O
amino O
acid O
hydrophobic O
signal O
peptide O
. O

In O
contrast O
to O
the O
p16 O
- O
mediated O
G1 O
block O
, O
G1 O
arrest O
mediated O
by O
the O
cdk O
inhibitors O
p21Cip1 O
or O
p27Kip1 O
cannot O
be O
bypassed O
either O
by O
inactivation O
of O
pRb O
or O
overexpression O
of O
E2F B
family I
members I
. O

In O
addition O
, O
the O
authors O
found O
one O
an3 B
allele I
( O
an3 B
- I
W138A I
) O
in O
which O
a O
dTph1 B
element I
had O
inserted O
30 O
bp O
upstream O
the O
translation O
start O
, O
without O
inactivating O
the O
gene O
. O

To O
investigate O
the O
role O
of O
bHLH O
proteins O
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin B
gene I
expression O
by O
stable O
transfection O
of O
an O
osteocalcin B
promoter I
- O
luciferase O
chimeric O
gene O
( O
p637OC B
- I
luc I
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin B
promoter I
by O
DNA O
binding O
assays O
. O

In O
this O
study O
, O
we O
show O
that O
HNF O
- O
4 O
, O
a O
member O
of O
the O
steroid B
hormone I
receptor I
superfamily I
, O
binds O
the O
AF B
- I
1 I
site I
on O
the O
apoB B
promoter I
and O
through O
it O
activates O
transcription O
in O
transient O
transfection O
assays O
in O
both O
liver O
and O
non O
- O
liver O
cell O
lines O
, O
HepG2 O
and O
HeLa O
, O
respectively O
. O

Our O
current O
study O
aims O
at O
clarifying O
the O
role O
of O
myristoylation O
in O
caveolar O
targeting O
using O
well O
- O
characterized O
acylation O
mutants O
of O
two O
model O
proteins O
, O
namely O
Gi1 B
alpha I
and O
c O
- O
Src O
. O

The O
Rep O
proteins O
of O
adeno O
- O
associated O
virus O
type O
2 O
( O
AAV O
) O
are O
known O
to O
bind O
to O
Rep B
recognition I
sequences I
( O
RRSs B
) O
in O
the O
AAV O
inverted O
terminal O
repeats O
( O
ITRs O
) O
, O
the O
AAV B
p5 I
promoter I
, O
and O
the O
preferred O
AAV O
integration O
site O
in O
human O
chromosome O
19 O
, O
called O
AAVS1 O
. O

The O
levels O
of O
TPAR1 B
mRNAs I
were O
dramatically O
down O
- O
regulated O
in O
regenerating O
rat O
liver O
when O
compared O
to O
normal O
adult O
liver O
. O

The O
authors O
suggest O
that O
alprazolam O
may O
have O
enhanced O
specificity O
for O
a O
subpopulation O
of O
benzodiazepine B
receptors I
. O

Southern O
hybridization O
analysis O
of O
BenR B
and O
BenS B
transformants I
suggested O
that O
plasmid O
integration O
occurred O
most O
frequently O
at O
the O
chromosomal O
bens B
locus I
, O
however O
evidence O
for O
gene O
conversion O
and O
heterologous O
recombination O
was O
also O
observed O
. O

The O
analysis O
of O
the O
effects O
of O
eight O
signaling O
molecules O
in O
the O
TGFbeta O
, O
FGF O
, O
Hh O
, O
Wnt O
, O
and O
EGF B
families I
in O
tooth O
explant O
cultures O
revealed O
that O
the O
expression O
of O
edar B
was O
induced O
by O
activinbetaA B
, O
whereas O
Wnt6 B
induced O
ectodysplasin B
expression O
. O

In O
turn O
, O
production O
of O
sufficient O
amounts O
of O
TraR O
apparently O
is O
sensitive O
to O
a O
cellular O
function O
requiring O
RNase B
D I
. O

The O
predicted O
product O
exhibits O
91 O
% O
amino O
acid O
identity O
to O
the O
murine B
voltage I
- I
gated I
potassium I
channel I
protein I
Kv1 I
. I
7 I
( O
Kcna7 B
) O
, O
which O
plays O
an O
important O
role O
in O
the O
repolarization O
of O
cell O
membranes O
. O

Phytohemagglutinin O
( O
PHA O
) O
, O
the O
seed B
lectin I
of O
the O
common O
bean O
, O
accumulates O
in O
protein O
storage O
vacuoles O
of O
storage O
parenchyma O
cells O
in O
cotyledons O
. O

Overexpression O
of O
p50 O
in O
transient O
cotransfection O
studies O
using O
the O
proximal O
CRP B
promoter I
( O
- O
125 O
/ O
+ O
9 O
) O
linked O
to O
a O
luciferase O
reporter O
caused O
a O
3 O
- O
fold O
increase O
of O
luciferase O
activity O
, O
while O
C O
/ O
EBPbeta O
overexpression O
caused O
an O
18 O
- O
fold O
increase O
; O
simultaneous O
overexpression O
of O
both O
transcription O
factors O
increased O
luciferase O
activity O
approximately O
600 O
- O
fold O
. O

Our O
results O
suggest O
that O
it O
might O
be O
possible O
to O
augment O
IN B
function O
in O
vivo O
through O
a O
heterologous O
domain O
. O

While O
differential O
expression O
of O
the O
two O
transcripts O
was O
not O
found O
, O
the O
promoter O
controlling O
LT1 B
/ O
LT2 B
transcription O
is O
regulated O
in O
a O
cell O
cycle O
- O
dependent O
manner O
. O

A O
survey O
of O
children O
with O
HBsAg B
markers I
related O
to O
their O
parents O
HBV O
markers O
. O

Genetic O
analyses O
indicate O
that O
most O
of O
the O
dominant O
mutants O
are O
cis O
- O
acting O
and O
that O
the O
recessive O
mutants O
define O
a O
minimum O
of O
three O
complementation O
groups O
, O
indicating O
that O
defects O
in O
several O
different O
genes O
can O
restore O
higher O
levels O
of O
HIS4C B
expression O
. O

Rat B
cholesterol I
side I
- I
chain I
cleavage I
cytochrome I
P I
- I
450 I
( O
P O
- O
450scc O
) O
gene O
. O

Pig O
uPA B
promoter O
- O
CAT O
constructs O
were O
more O
active O
than O
mouse O
constructs O
in O
this O
assay O
. O

Cloning O
the O
cDNA O
for O
a O
new O
human B
zinc I
finger I
protein I
defines O
a O
group O
of O
closely O
related O
Kruppel B
- I
like I
transcription I
factors I
. O

By O
computed O
homology O
search O
, O
we O
noticed O
significant O
similarities O
between O
US3 B
PK I
and O
p21 O
- O
activated O
kinase O
( O
PAK O
) O
, O
which O
is O
activated O
by O
the O
Cdc42 O
or O
Rac O
. O

These O
8 B
- I
oxoguanine I
DNA I
glycosylases I
, O
hOgg1 O
( O
human O
) O
and O
mOgg1 B
( O
murine O
) O
, O
are O
homologous O
to O
each O
other O
and O
to O
yeast B
Ogg1 I
. O

The O
CHED B
protein I
includes O
the O
consensus O
ATP O
binding O
and O
phosphorylation O
domains O
characteristic O
of O
kinases O
, O
displays O
34 O
- O
42 O
% O
identically O
aligned O
amino O
acid O
residues O
with O
other O
cdc2 B
- I
related I
kinases I
, O
and O
is O
considerably O
longer O
at O
its O
amino O
and O
carboxyl O
termini O
. O

We O
report O
that O
Gcn5 O
, O
a O
histone B
H3 I
acetylase I
, O
plays O
a O
central O
role O
in O
initiation O
of O
meiosis O
via O
effects O
on O
IME2 B
expression O
. O

Interferon O
- O
alpha O
inducibility O
of O
IFI16 O
may O
be O
regulated O
by O
an O
interferon B
- I
alpha I
/ I
beta I
- O
stimulated O
response O
consensus O
element O
in O
the O
5 O
' O
UT O
exon O
, O
as O
a O
similar O
motif O
is O
conserved O
in O
the O
corresponding O
position O
in O
the O
related O
myeloid B
cell I
nuclear I
differentiation I
antigen I
gene O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

In O
the O
present O
study O
we O
use O
a O
tnaC O
- O
UGA O
- O
' O
lacZ O
construct O
lacking O
the O
tnaC O
- O
tnaA B
spacer O
region O
to O
analyze O
the O
effect O
of O
TnaC O
synthesis O
on O
the O
behavior O
of O
the O
ribosome O
that O
translates O
tnaC O
. O

Antisense O
oligonucleotides O
complementary O
to O
the O
5 O
' O
end O
of O
PKC B
- I
zeta I
mRNA I
sequences I
significantly O
reduced O
the O
collagen O
lattice O
- O
stimulated O
alpha2 O
and O
MMP B
- I
1 I
mRNA I
levels O
. O

Residues O
crucial O
for O
Ras O
interaction O
with O
GDP B
- I
GTP I
exchangers I
. O

In O
serum O
- O
starved O
NIH O
3T3 O
cells O
, O
v B
- I
raf I
increased O
mdr1 O
promoter O
activity O
approximately O
10 O
- O
fold O
compared O
to O
a O
v B
- I
raf I
frame O
- O
shift O
control O
. O

Searching O
the O
human O
DNA O
data O
base O
of O
expressed O
sequence O
tags O
( O
EST O
) O
revealed O
novel O
partial O
sequences O
similar O
to O
, O
but O
distinct O
from O
, O
the O
sequences O
of O
the O
previously O
known O
PEF B
proteins I
. O

It O
is O
also O
affected O
by O
the O
HAP2 B
/ I
3 I
/ I
4 I
transcription I
factor I
complex I
and O
by O
SNF1 O
and O
SSN6 B
. O

Two O
different O
genes O
( O
polA B
and O
polB B
) O
encoding O
family B
B I
DNA I
polymerases I
were O
cloned O
from O
the O
organism O
by O
PCR O
using O
degenerated O
primers O
based O
on O
the O
two O
conserved O
motifs O
( O
motif O
A O
and O
B O
) O
. O

Structure O
and O
regulation O
of O
the O
luteinizing B
hormone I
receptor I
gene I
. O

Western O
immunoblot O
analysis O
detected O
p55gag B
and O
its O
cleavage O
products O
p39 B
and O
p27 O
in O
purified O
particles O
derived O
by O
expression O
of O
gag O
and O
gag O
- O
pol O
, O
respectively O
. O

3 O
- O
5 O
- O
fold O
increases O
in O
EGF O
receptor O
but O
not O
p185 B
( O
neu O
) O
tyrosine O
phosphorylation O
occur O
following O
Gi B
- I
coupled I
receptor I
stimulation O
. O

Next O
, O
to O
examine O
the O
regulation O
mechanism O
of O
CD44 B
/ O
ERM O
interaction O
in O
vivo O
, O
we O
reexamined O
the O
immunoprecipitated O
CD44 B
/ O
ERM O
complex O
from O
BHK O
cells O
and O
found O
that O
it O
contains O
Rho B
- I
GDP I
dissociation I
inhibitor I
( O
GDI B
) O
, O
a O
regulator O
of O
Rho B
GTPase I
. O

To O
determine O
cis O
- O
acting O
elements O
controlling O
the O
rat O
B B
- I
50 I
/ O
GAP O
- O
43 O
gene O
expression O
, O
the O
genomic O
DNA O
encoding O
exon O
1 O
and O
the O
5 O
' O
flanking O
sequence O
was O
isolated O
. O

Through O
genomic O
library O
screening O
and O
PCR O
- O
based O
genomic O
walking O
we O
have O
now O
cloned O
the O
mouse B
E I
- I
Tmod I
gene I
, O
whose O
coding O
region O
spans O
approximately O
60kb O
containing O
nine O
exons O
and O
eight O
introns O
. O

TNF O
- O
alpha O
stimulated O
these O
changes O
in O
part O
by O
increasing O
transcription O
and O
stabilization O
of O
RNA O
for O
amphiregulin B
, O
an O
EGF O
receptor O
ligand O
, O
and O
amphiregulin B
directly O
increased O
HPV O
- O
16 O
E6 O
/ O
E7 O
and O
cyclin B
A I
RNAs I
. O

Fusions O
between O
the O
GAL B
DNA I
binding I
domain I
and O
full B
- I
length I
mSin3 I
were O
also O
capable O
of O
repression O
. O

Antibodies O
against O
REAP B
- I
1 I
inhibit O
in O
vitro O
RNA O
editing O
reactions O
confirming O
its O
role O
in O
RNA O
editing O
. O

The O
full O
- O
length O
cDNA O
was O
cloned O
and O
sequenced O
, O
and O
the O
inferred O
amino O
acid O
sequence O
was O
found O
to O
encode O
a O
novel O
protein O
, O
which O
we O
named O
cystatin B
M I
, O
with O
40 O
% O
homology O
to O
human B
family I
2 I
cystatins I
and O
similar O
overall O
structure O
. O

BAG B
- I
1 I
also O
prevented O
growth O
arrest O
following O
UV O
- O
irradiation O
- O
induced O
genotoxic O
injury O
without O
interfering O
with O
accumulation O
of O
p53 O
protein O
or O
p21 O
( O
waf B
- I
1 I
) O
expression O
. O

We O
have O
isolated O
a O
unique O
murine B
FLT3 I
cDNA I
that O
codes O
for O
a O
variant O
isoform O
of O
FLT3 B
, O
devoid O
of O
the O
fifth O
Ig B
- I
like I
domain I
, O
by O
comparison O
with O
the O
prototypic O
form O
. O

Particle O
bombardment O
of O
barley O
aleurone O
with O
a O
B22EL8 B
promoter I
- O
GUS O
( O
beta O
- O
glucuronidase O
) O
construct O
demonstrates O
that O
the O
promoter O
( O
3 O
kb O
) O
is O
active O
in O
developing O
barley O
grains O
. O

Elements O
regulating O
cell O
- O
and O
stage O
- O
specific O
expression O
of O
the O
C O
. O
elegans O
MyoD O
family O
homolog O
hlh B
- I
1 I
. O

An O
analysis O
of O
the O
c B
- I
kit I
5 I
' I
flanking I
region I
using O
the O
bacterial B
chloramphenicol I
acetyltransferase I
gene I
( O
CAT O
assay O
) O
in O
human O
erythroleukemia O
HEL O
cells O
, O
which O
express O
the O
endogenous O
c B
- I
kit I
mRNA I
at O
high O
levels O
, O
showed O
that O
a O
region O
from O
- O
180 O
to O
- O
22 O
is O
important O
for O
the O
expression O
of O
the O
c B
- I
kit I
gene I
. O

Sox8 O
maps O
to O
the O
t B
complex I
on O
mouse O
chromosome O
17 O
and O
to O
human O
chromosome O
16p13 O
. O
3 O
, O
a O
region O
associated O
with O
the O
microphthalmia O
- O
cataract O
syndrome O
CATM O
and O
the O
alpha O
- O
thalassemia O
/ O
mental O
retardation O
syndrome O
ATR O
- O
16 O
. O

The O
TCR B
beta I
enhancer I
was O
active O
on O
both O
the O
minimal B
simian I
virus I
40 I
promoter I
and O
a O
TCR B
beta I
variable I
gene I
promoter I
in O
both O
TCR B
alpha I
/ I
beta I
+ O
and O
TCR B
gamma I
/ I
delta I
+ O
T O
cells O
. O

Recently O
, O
we O
demonstrated O
that O
platelet B
- I
derived I
growth I
factor I
( I
PDGF I
) I
- I
beta I
receptor I
stimulation O
, O
but O
not O
various O
other O
growth O
factors O
, O
inhibits O
transcription O
of O
alpha1D B
- O
, O
but O
not O
alpha1A B
- O
or O
alpha1B B
- I
ARs I
, O
resulting O
in O
reduced O
norepinephrine O
- O
mediated O
SMC O
growth O
. O

Southern O
blot O
analysis O
following O
reverse O
transcription O
and O
PCR O
showed O
that O
B2R B
is O
expressed O
in O
most O
mouse O
tissues O
, O
except O
the O
liver O
and O
spleen O
, O
which O
is O
consistent O
with O
the O
wide O
distribution O
of O
B2R B
activity O
as O
deduced O
from O
pharmacological O
studies O
. O

Mean O
CD4 O
percentages O
were O
lower O
postpartum O
( O
21 O
. O
9 O
+ O
/ O
- O
3 O
. O
4 O
) O
than O
prepartum O
( O
45 O
. O
1 O
+ O
/ O
- O
6 O
. O
7 O
) O
in O
all O
five O
patients O
studied O
, O
although O
proliferative O
responses O
to O
the O
mitogens B
phytohemagglutinin I
and I
pokeweed I
were O
unchanged O
during O
the O
study O
period O
. O

The O
STP1 B
locus I
is O
located O
on O
chromosome O
IV O
close O
to O
at O
least O
two O
other O
genes O
involved O
in O
RNA O
splicing O
: O
PRP3 B
and O
SPP41 O
. O

Like O
pimethixene O
and O
cyproheptadine O
, O
WA O
335 O
has O
no O
distinct O
antagonistic O
qualities O
against O
bradykinin B
. O

The O
WEB2 B
gene I
encodes O
a O
1 O
, O
522 O
- O
amino O
- O
acid O
protein O
with O
homology O
to O
nucleic B
acid I
- I
dependent I
ATPases I
. O

Evidence O
that O
the O
AT1A B
receptor I
activates O
transcription B
factor I
- I
Stat91 I
and O
/ O
or O
a O
related O
protein O
. O

These O
results O
demonstrate O
the O
preferential O
endometrial O
cell O
- O
type O
expression O
of O
BTEB B
and O
suggest O
its O
regulatory O
role O
in O
pregnancy O
- O
associated O
endometrial O
epithelial O
gene O
expression O
. O

Spen B
is O
the O
only O
known O
homeotic B
protein I
with O
RNP O
binding O
motifs O
, O
which O
indicates O
that O
splicing O
, O
transport O
, O
or O
other O
RNA O
regulatory O
steps O
are O
involved O
in O
the O
diversification O
of O
segmental O
morphology O
. O

The O
majority O
of O
the O
human B
Ig I
heavy I
chain I
( I
IgH I
) I
constant I
( I
C I
) I
region I
locus I
has O
been O
cloned O
and O
mapped O
. O

The O
transcriptional O
start O
site O
( O
s O
) O
of O
the O
IA B
- I
2 I
gene I
was O
mapped O
by O
5 O
' O
rapid O
amplification O
of O
cDNA O
ends O
to O
97 O
bp O
upstream O
of O
the O
translational O
start O
site O
. O

The O
RAG B
- I
2 I
gene I
encodes O
a O
component O
of O
the O
V B
( I
D I
) I
J I
recombinase I
which O
is O
essential O
for O
the O
assembly O
of O
antigen O
receptor O
genes O
in O
B O
and O
T O
lymphocytes O
. O

We O
have O
characterized O
21 O
mutations O
in O
the O
type B
VII I
collagen I
gene I
( O
COL7A1 B
) O
encoding O
the O
anchoring O
fibrils O
, O
18 O
of O
which O
were O
not O
previously O
reported O
, O
in O
patients O
from O
15 O
unrelated O
families O
with O
recessive O
dystrophic O
epidermolysis O
bullosa O
( O
RDEB O
) O
. O

Both O
residues O
are O
conserved O
in O
the O
three O
phosphorylated O
paralogs O
but O
are O
absent O
in O
the O
ones O
that O
were O
not O
substrates O
of O
RsbT B
: O
YetI B
and O
YezB B
, O
each O
of O
which O
bears O
only O
one O
of O
the O
conserved O
residues O
; O
and O
YtvA B
, O
which O
lacks O
both O
residues O
and O
instead O
possesses O
an O
N O
- O
terminal O
PAS O
domain O
. O

The O
Zn B
- I
15 I
DNA I
- I
binding I
domain I
comprises O
three O
zinc O
fingers O
separated O
by O
unusually O
long O
linker O
sequences O
that O
would O
be O
expected O
to O
interrupt O
specific O
DNA O
site O
recognition O
. O

Consistently O
, O
we O
show O
that O
phosphorylation O
by O
protein O
kinase O
A O
inhibits O
Sfl1 B
DNA O
binding O
in O
vitro O
, O
and O
that O
a O
tpk2Delta B
mutation O
increases O
the O
levels O
of O
Sfl1 B
protein I
associated O
with O
specific O
promoter O
elements O
in O
vivo O
. O

The O
response O
sequences O
were O
localized O
between O
- O
67 O
and O
+ O
30 O
in O
the O
simian O
cytomegalovirus O
IE94 B
promoter I
and O
upstream O
of O
position O
+ O
9 O
in O
the O
HCMV B
IE68 I
promoter I
. O

To O
identify O
and O
determine O
the O
function O
of O
Ino2p B
in O
yeast O
cells O
, O
we O
raised O
antibodies O
to O
a O
beta O
- O
galactosidase O
/ O
Ino2 O
fusion O
protein O
. O

Northern O
blot O
analyses O
were O
used O
to O
examine O
the O
regulated O
expression O
of O
the O
cys B
- I
14 I
+ I
gene I
. O

The O
arrangement O
of O
amino O
acids O
in O
the O
helix O
1 O
and O
helix O
2 O
regions O
is O
quite O
similar O
to O
those O
of O
Mxi B
and O
Mad O
, O
but O
different O
from O
those O
of O
E2F O
- O
1 O
and O
DP O
- O
1 O
. O

The O
present O
study O
also O
emphasizes O
the O
need O
of O
establishing O
dose O
- O
response O
curves O
to O
correctly O
assess O
the O
relative O
contribution O
of O
the O
different O
regions O
of O
steroid B
hormone I
receptors I
in O
activation O
of O
transcription O
. O

By O
contrast O
with O
ama B
- I
1 I
, O
rpc B
- I
1 I
was O
not O
deleted O
by O
mDf4 O
or O
larger O
deficiencies O
examined O
, O
indicating O
that O
these O
genes O
are O
no O
closer O
than O
150 O
kb O
. O

Accordingly O
, O
constitutive O
downregulation O
of O
expression O
of O
accessory O
molecules O
of O
the O
MHC B
class I
I I
pathway I
can O
reveal O
differences O
between O
H2 B
class I
I I
alleles I
in O
antigen O
presentation O
not O
encountered O
when O
the O
expression O
levels O
are O
augmented O
. O

Legionella B
antibodies I
in O
domestic O
animals O

We O
further O
examined O
the O
interaction O
of O
JAK2 O
with O
the O
GHR B
cytoplasmic O
domain O
by O
two O
lines O
of O
investigation O
. O

There O
is O
little O
similarity O
among O
the O
sequences O
upstream O
from O
the O
CAP O
site O
of O
the O
Spec2 B
genes I
except O
the O
TATA O
consensus O
sequence O
and O
a O
repeating O
trinucleotide O
, O
AAC O
. O

Our O
results O
indicate O
that O
GCN4 O
contains O
two O
activation O
domains O
of O
similar O
potency O
that O
can O
function O
independently O
to O
promote O
high O
- O
level O
transcription O
of O
the O
target O
genes O
HIS3 O
and O
HIS4 B
. O

Tax O
was O
demonstrated O
to O
interact O
directly O
with O
CREB1 B
but O
not O
with O
other O
bZIP O
proteins O
, O
including O
CREB2 B
and O
Jun O
. O

We O
also O
demonstrate O
that O
a O
p110RB1 O
mutant O
, O
which O
is O
refractory O
to O
cell O
cycle O
phosphorylation O
but O
intact O
in O
E1a B
/ O
large O
T O
antigen O
- O
binding O
properties O
, O
represses O
EIIaE O
with O
50 O
- O
to O
80 O
- O
fold O
greater O
efficiency O
than O
wild B
- I
type I
p110RB1 I
. O

The O
IGFBP O
- O
1 O
IRS O
and O
PEPCK O
IRS O
both O
bind O
the O
alpha O
and O
beta O
forms O
of O
hepatic B
nuclear I
factor I
3 I
( O
HNF O
- O
3 O
) O
, O
although O
the O
latter O
does O
so O
with O
a O
sixfold O
- O
lower O
relative O
affinity O
. O

Sucrose O
- O
specific O
signalling O
represses O
translation O
of O
the O
Arabidopsis B
ATB2 I
bZIP I
transcription I
factor I
gene I
. O

Within O
any O
cell O
line O
, O
several O
Tcfs B
and O
TLEs B
are O
co O
- O
expressed O
. O

Mutations O
away O
from O
splice O
site O
recognition O
sequences O
might O
cis O
- O
modulate O
alternative O
splicing O
of O
goat O
alpha B
s1 I
- I
casein I
transcripts I
. O

Promoter O
, O
spliced O
leader O
, O
and O
coding O
sequence O
for O
BICP4 B
, O
the O
largest O
of O
the O
immediate B
- I
early I
proteins I
of I
bovine I
herpesvirus I
1 I
. O

Our O
data O
suggest O
that O
the O
ZF B
- I
HD I
class O
of O
homeodomain B
proteins I
may O
be O
involved O
in O
the O
establishment O
of O
the O
characteristic O
expression O
pattern O
of O
the O
C4 B
PEPCase I
gene I
. O

We O
investigated O
whether O
two O
WT1 B
splice I
variants I
lacking O
or O
including O
a O
three O
- O
amino O
- O
acid O
( O
KTS O
) O
insertion O
between O
the O
third O
and O
fourth O
zinc O
finger O
in O
the O
DNA O
- O
binding O
domain O
could O
repress O
the O
IR B
promoter I
in O
vitro O
. O

The O
deduced O
amino O
acid O
sequence O
exhibits O
95 O
. O
3 O
and O
76 O
. O
1 O
% O
identity O
with O
the O
CAD B
sequences I
of I
hamster I
and I
Squalus I
acanthias I
. O

In O
contrast O
translocation O
of O
G1 O
to O
the O
Golgi O
was O
not O
observed O
when O
G1 O
was O
coexpressed O
with O
NSm B
, O
although O
NSm B
itself O
was O
still O
detected O
in O
the O
Golgi O
. O

Since O
simian B
virus I
40 I
( I
SV40 I
) I
large I
T I
antigen I
and O
human B
papillomavirus I
type I
16 I
( I
HPV16 I
) I
E7 I
protein I
also O
bind O
host O
regulatory O
factors O
, O
we O
investigated O
whether O
these O
viral O
proteins O
can O
complement O
E1A B
mutants I
which O
are O
defective O
in O
early O
gene O
activation O
. O

We O
further O
showed O
a O
significant O
repression O
of O
promoter O
activity O
( O
> O
40 O
fold O
) O
by O
E2 B
- I
2 I
( O
lacking O
the O
amino O
acid O
sequence O
RSRS O
) O
when O
the O
E47 B
reporter I
construct I
, O
containing O
a O
hexameric O
E O
- O
box O
site O
, O
was O
used O
. O

A O
400 O
- O
bp O
fragment O
( O
bp O
- O
339 O
through O
+ O
71 O
) O
of O
the O
CD22 B
promoter I
region I
was O
subcloned O
into O
a O
pGEM O
- O
chloramphenicol O
acetyltransferase O
vector O
and O
after O
transfection O
into O
B O
and O
T O
cells O
was O
found O
to O
be O
active O
in O
both O
B O
and O
T O
cells O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
between O
viral O
RNA O
and O
BMV B
CP I
peptides I
with O
either O
proline O
or O
alanine O
substitutions O
revealed O
that O
the O
interaction O
is O
nonspecific O
. O

No O
significant O
difference O
in O
plasma O
ET B
levels O
was O
found O
between O
cardiac O
and O
peripheral O
sampling O
sites O
( O
pulmonary O
artery O
; O
1 O
. O
07 O
+ O
/ O
- O
0 O
. O
28 O
, O
right O
atrium O
; O
1 O
. O
02 O
+ O
/ O
- O
0 O
. O
28 O
, O
peripheral O
artery O
; O
1 O
. O
12 O
+ O
/ O
- O
0 O
. O
23 O
, O
peripheral O
vein O
; O
1 O
. O
14 O
+ O
/ O
- O
0 O
. O
38 O
fmol O
/ O
ml O
: O
N O
. O
S O
. O
) O
, O
or O
among O
patients O
with O
uncomplicated O
MI O
, O
unstable O
angina O
( O
1 O
. O
00 O
+ O
/ O
- O
0 O
. O
32 O
fmol O
/ O
ml O
) O
, O
and O
healthy O
subjects O
( O
1 O
. O
01 O
+ O
/ O
- O
0 O
. O
29 O

Inhibition O
of O
DNA B
topoisomerase I
II I
alpha I
gene I
expression O
by O
the O
p53 B
tumor I
suppressor I
. O

The O
gap O
protein O
knirps B
mediates O
both O
quenching O
and O
direct O
repression O
in O
the O
Drosophila O
embryo O
. O

Here O
we O
demonstrate O
that O
CD40 O
or O
IgM B
receptor I
stimulation O
of O
primary O
B O
cells O
results O
in O
transactivation O
of O
this O
enhancer O
. O

This O
cell O
line O
expresses O
productively O
rearranged O
immunoglobulin B
genes I
as O
well O
as O
the O
Oct B
- I
2 I
gene I
at O
high O
levels O
which O
are O
comparable O
to O
those O
observed O
in O
activated O
murine O
splenic O
B O
cells O
. O

The O
relationship O
between O
CSF B
somatostatin I
and O
peripheral O
thyroid O
hormones O
was O
assessed O
in O
11 O
affectively O
ill O
patients O
before O
and O
during O
carbamazepine O
treatment O
. O

Both O
RNA14 O
and O
RNA15 B
wild I
- I
type I
genes I
, O
when O
cloned O
on O
a O
multicopy O
plasmid O
, O
are O
able O
to O
suppress O
the O
temperature O
- O
sensitive O
phenotype O
of O
strains O
bearing O
either O
the O
rna14 O
or O
the O
rna15 B
mutation I
, O
suggesting O
that O
the O
encoded O
proteins O
could O
interact O
with O
each O
other O
. O

Treatments O
were O
two O
adrenocorticotrophin B
( O
ACTH O
) O
preparations O
given O
intramuscularly O
at O
2 O
. O
2 O
U O
/ O
kg O
, O
one O
of O
the O
ACTH O
preparations O
given O
intramuscularly O
at O
1 O
U O
/ O
kg O
and O
a O
synthetic O
polypeptide O
with O
ACTH B
- I
like I
activity O
( O
tetracosactrin O
, O
cosyntropin O
) O
given O
intravenously O
at O
5 O
micrograms O
/ O
kg O
. O

PRIP B
contains O
two O
LXXLL O
signature O
motifs O
. O

Like O
the O
human O
gene O
, O
the O
Drosophila O
gene O
encodes O
at O
least O
three O
isoforms O
of O
full B
length I
dystrophin I
- I
like I
proteins I
( O
dmDLP1 B
, O
dmDLP2 B
and O
dmDLP3 B
, O
) O
, O
regulated O
by O
different O
promoters O
located O
at O
the O
5 O
' O
end O
of O
the O
gene O
, O
and O
a O
smaller O
product O
regulated O
by O
an O
internal O
promoter O
( O
dmDp186 B
) O
. O

Accordingly O
, O
infection O
of O
IFN O
- O
pretreated O
HeLa O
S3 O
cells O
with O
an O
E3L O
- O
deficient O
VV O
( O
VVDeltaE3L O
) O
resulted O
in O
increased O
phosphorylation O
levels O
of O
both O
PKR O
and O
eIF2alpha B
. O

Vibrio O
cholerae O
iron O
transport O
: O
haem O
transport O
genes O
are O
linked O
to O
one O
of O
two O
sets O
of O
tonB B
, O
exbB B
, O
exbD B
genes I
. O

To O
examine O
the O
biochemical O
mechanism O
of O
Tax1 O
transactivation O
, O
we O
have O
developed O
an O
in O
vitro O
transactivation O
assay O
in O
which O
wild O
- O
type O
Tax1 O
is O
able O
to O
specifically O
transactivate O
a O
polymerase B
II I
promoter O
through O
upstream O
Tax1 B
- I
responsive I
elements I
. O

Interestingly O
, O
PMA O
- O
, O
PDGF O
- O
, O
and O
serum O
- O
induced O
GHR B
proteolysis O
was O
associated O
with O
substantial O
decreases O
in O
GH O
- O
induced O
activation O
of O
Janus B
kinase I
- I
2 I
, O
which O
were O
also O
prevented O
by O
IC3 O
. O

Recombinant O
propeptides O
containing O
mutations O
of O
one O
of O
the O
three O
tryptophan O
residues O
were O
three O
orders O
of O
magnitude O
less O
effective O
as O
inhibitors O
of O
mature B
cathepsin I
S I
than O
the O
wild O
- O
type O
propeptide O
. O

In O
patients O
with O
active O
TB O
, O
cytokines O
that O
were O
elevated O
in O
serum O
were O
IFN O
- O
gamma O
, O
IL O
- O
6 O
and O
IL B
- I
10 I
. O

Isolation O
and O
properties O
of O
Drosophila B
melanogaster I
ferritin I
- O
- O
molecular O
cloning O
of O
a O
cDNA O
that O
encodes O
one O
subunit O
, O
and O
localization O
of O
the O
gene O
on O
the O
third O
chromosome O
. O

This O
study O
demonstrates O
a O
novel O
link O
between O
alterations O
in O
platelet O
- O
derived O
growth O
factor O
( O
PDGF O
) O
regulation O
of O
ornithine B
decarboxylase I
( O
ODC O
) O
expression O
during O
malignant O
conversion O
. O

The O
human B
IFI16 I
gene I
is O
a O
member O
of O
an O
interferon O
- O
inducible O
family O
of O
mouse O
and O
human O
genes O
closely O
linked O
on O
syntenic O
regions O
of O
chromosome O
1 O
. O

In O
agreement O
with O
this O
model O
, O
elimination O
of O
the O
ADAM13 B
cytoplasmic I
domain I
increased O
developmental O
alterations O
attributable O
to O
ADAM13 B
proteolytic O
activity O
. O

A O
third O
GEF O
, O
GRP3 B
( O
KIAA0846 B
) O
, O
activated O
both O
Ras O
and O
Rap1 O
and O
shared O
significant O
sequence O
homology O
with O
the O
calcium O
- O
and O
diacylglycerol O
- O
activated O
GEFs B
, O
GRP1 B
and O
GRP2 B
. O

Previous O
studies O
have O
shown O
that O
the O
IME1 B
gene I
is O
required O
for O
sporulation O
and O
the O
expression O
of O
meiosis O
specific O
genes O
in O
Saccharomyces O
cerevisiae O
. O

Intrathecal O
injections O
of O
small O
volumes O
of O
the O
alpha B
2 I
- I
adrenoceptor I
agonists O
, O
xylazine O
and O
clonidine O
, O
into O
the O
cervical O
region O
of O
the O
spinal O
cord O
of O
conscious O
unrestrained O
sheep O
produced O
a O
dose O
- O
dependent O
analgesia O
of O
the O
forelimbs O
as O
measured O
using O
a O
mechanical O
pressure O
device O
. O

Second O
, O
CGGA O
- O
containing O
sequences O
placed O
at O
- O
88 O
in O
the O
delta B
MTV I
- I
CAT I
reporter I
plasmid O
conferred O
insulin O
responsiveness O
to O
the O
mammary B
tumor I
virus I
promoter I
. O

In O
the O
absence O
of O
c O
- O
fos O
gene O
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos O
family O
( O
Fra O
- O
1 O
) O
and O
ATF O
family O
( O
ATF O
- O
2 O
and O
ATFa B
) O
. O

The O
dopamine B
D1 I
dopamine I
receptor I
antagonist O
SCH O
23390 O
dose O
dependently O
( O
7 O
. O
5 O
- O
30 O
micrograms O
/ O
kg O
s O
. O
c O
. O
) O
antagonized O
the O
stimulant O
locomotor O
effect O
on O
both O
drugs O
but O
did O
not O
prevent O
their O
antiimmobility O
effect O
on O
the O
behavioral O
despair O
test O
. O

Basic B
helix I
- I
loop I
- I
helix I
proteins I
can O
act O
at O
the O
E O
- O
box O
within O
the O
serum O
response O
element O
of O
the O
c O
- O
fos O
promoter O
to O
influence O
hormone O
- O
induced O
promoter O
activation O
in O
Sertoli O
cells O
. O

Using O
yeast O
two O
- O
hybrid O
screening O
, O
we O
isolated O
histone O
H3 O
as O
an O
interacting O
factor O
of O
CIA B
. O

Gene O
expression O
is O
in O
part O
controlled O
by O
chromatin O
remodeling O
factors O
and O
the O
acetylation O
state O
of O
nucleosomal B
histones I
. O

Furthermore O
, O
Grap B
is O
associated O
with O
a O
Ras B
guanine I
nucleotide I
exchange I
factor I
mSos1 B
, O
primarily O
through O
its O
N B
- I
terminal I
SH3 I
domain I
. O

After O
3 O
months O
of O
intervention O
, O
sustained O
physical O
training O
was O
associated O
with O
the O
decrease O
of O
FVII B
and O
PAI O
- O
1 O
levels O
. O

Xa4 B
is O
a O
dominantly O
inherited O
rice O
gene O
that O
confers O
resistance O
to O
Philippine O
race O
1 O
of O
the O
bacterial O
blight O
pathogen O
Xanthomonas O
oryzae O
pv O
. O
oryzae O
in O
rice O
. O

When O
a O
longer O
- O
714 O
to O
+ O
78 O
fragment O
of O
the O
PBGD B
promoter I
is O
used O
, O
the O
- O
70 O
GATA O
mutant O
still O
displays O
erythroid O
- O
specific O
activity O
and O
is O
cis O
- O
activated O
by O
the O
5 B
' I
HS I
- I
2 I
enhancer I
, O
while O
the O
- O
100 O
CCACC O
mutant O
is O
completely O
inactive O
in O
the O
absence O
or O
in O
the O
presence O
of O
the O
5 B
' I
HS I
- I
2 I
enhancer I
. O

Surprisingly O
, O
in O
adult O
animals O
, O
the O
suprabasal O
expression O
of O
dnRXR B
alpha I
significantly O
reduced O
the O
ability O
of O
topically O
applied O
tRA O
to O
stimulate O
proliferation O
of O
undifferentiated O
keratinocytes O
in O
the O
basal O
layer O
of O
epidermis O
. O

For O
il8ra B
, O
it O
is O
formed O
from O
two O
exons O
, O
whereas O
for O
il8rb B
, O
seven O
distinct O
neutrophil O
mRNAs O
are O
formed O
by O
alternative O
splicing O
of O
11 O
exons O
. O

The O
gene O
encoding O
the O
cellulase B
( O
Avicelase B
) O
Cel1 B
from O
Streptomyces O
reticuli O
and O
analysis O
of O
protein O
domains O
. O

From O
this O
comparison O
of O
aa O
sequences O
, O
the O
ATPK7 B
protein I
is O
considered O
to O
be O
a O
member O
of O
a O
novel O
subfamily O
of O
Ser B
/ I
Thr I
PKs I
in O
plants O
. O

SATB1 B
interacted O
with O
CDP O
through O
its O
DNA O
- O
binding O
domain O
, O
as O
demonstrated O
by O
glutathione O
S O
- O
transferase O
( O
GST O
) O
pull O
- O
down O
assays O
. O

The O
predicted O
5 O
' O
and O
3 O
' O
ends O
of O
the O
transcript O
are O
in O
very O
good O
agreement O
with O
the O
previously O
determined O
size O
of O
the O
LEU3 B
message O
. O

This O
cDNA O
corresponded O
to O
FGF B
- I
binding I
protein I
( O
FGF B
- I
BP I
) O
, O
a O
secreted O
protein O
previously O
shown O
to O
bind O
acidic O
and O
basic B
FGF I
and O
to O
modulate O
their O
activities O
. O

Rewarding O
properties O
of O
methylphenidate O
: O
sensitization O
by O
prior O
exposure O
to O
the O
drug O
and O
effects O
of O
dopamine B
D1 I
- I
and I
D2 I
- I
receptor I
antagonists O
. O

Similar O
to O
what O
was O
observed O
for O
P O
. O
putida O
, O
a O
psrA B
null O
mutant O
of O
P O
. O
aeruginosa O
also O
showed O
a O
90 O
% O
reduction O
in O
rpoS B
promoter I
activity O
; O
both O
mutants O
could O
be O
complemented O
for O
rpoS B
promoter I
activity O
when O
the O
psrA B
gene I
was O
provided O
in O
trans O
. O

psrA B
mutants I
of O
both O
Pseudomonas O
species O
lost O
the O
ability O
to O
induce O
rpoS O
expression O
at O
stationary O
phase O
, O
but O
they O
retained O
the O
ability O
to O
produce O
quorum O
- O
sensing O
autoinducer O
molecules O
. O

ZF87 B
specifically O
binds O
the O
ME1a1 O
element O
with O
higher O
affinity O
than O
the O
ME1a2 O
element O
. O

This O
new O
receptor O
, O
TOR B
( O
thymus B
orphan I
receptor I
) O
, O
is O
most O
closely O
related O
in O
both O
its O
DNA O
- O
binding O
domain O
and O
ligand O
- O
binding O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectively O
, O
to O
ROR B
alpha I
/ O
RZR B
alpha I
and O
clusters O
with O
these O
two O
receptors O
and O
RZR O
beta O
in O
a O
phylogenetic O
tree O
, O
when O
both O
the O
DNA O
- O
binding O
domain O
and O
the O
ligand O
- O
binding O
domain O
sequences O
of O
nuclear O
receptors O
are O
compared O
. O

Association O
of O
Smads B
with O
lymphoid B
enhancer I
binding I
factor I
1 I
/ O
T B
cell I
- I
specific I
factor I
mediates O
cooperative O
signaling O
by O
the O
transforming O
growth O
factor O
- O
beta O
and O
wnt O
pathways O
. O

The O
three O
OAS B
genes I
are O
flanked O
by O
markers B
WI I
- I
10614 I
( O
cen B
) O
and O
D12S2293 B
( O
tel O
) O
and O
are O
contained O
within O
three O
sets O
of O
overlapping O
cosmid O
clones O
. O

The O
isolation O
of O
crt5 B
- I
262 I
, O
an O
additional O
cdc B
allele I
of O
POL1 O
/ O
CDC17 O
, O
suggests O
for O
the O
first O
time O
that O
directly O
blocking O
DNA O
replication O
can O
provide O
a O
signal O
to O
induce O
the O
DNA O
damage O
response O
. O

crt2 B
mutants I
show O
a O
defect O
in O
basal O
level O
expression O
of O
RNR1 B
- O
lacZ O
reporter O
constructs O
. O

However O
, O
both O
peptides O
1 O
- O
49 O
and O
63 O
- O
87 O
bound O
to O
PDE B
alpha I
/ I
beta I
in O
a O
solid O
- O
phase O
binding O
assay O
. O

The O
mutation O
also O
preferentially O
limits O
( O
compared O
with O
total O
protein O
synthesis O
) O
translation O
of O
an O
induced O
gene O
that O
depends O
on O
five O
AGA O
codons O
, O
i O
. O
e O
. O
, O
the O
lambda B
cI I
repressor I
gene I
. O

Five O
RNA O
transcripts O
of O
about O
1 O
. O
2 O
to O
1 O
. O
7 O
kilobases O
were O
mapped O
to O
a O
part O
of O
the O
genome O
of O
insect O
iridescent O
virus O
type O
6 O
( O
Chilo O
iridescent O
virus O
; O
CIV O
) O
between O
genome O
coordinates O
0 O
. O
832 O
and O
0 O
. O
856 O
within O
the O
EcoRI B
DNA I
fragment I
F I
. O

Portions O
of O
the O
3 O
' O
- O
coding O
and O
3 O
' O
- O
untranslated O
regions O
were O
found O
to O
be O
missing O
from O
the O
7 B
. I
2 I
- I
and I
4 I
. I
8 I
- I
kb I
topo I
II I
alpha I
mRNAs I
by O
Northern O
blot O
analysis O
. O

Phenotypic O
analysis O
demonstrates O
that O
trio B
and O
Abl O
cooperate O
in O
regulating O
axon O
outgrowth O
in O
the O
embryonic O
central O
nervous O
system O
( O
CNS O
) O
. O

Recombinant B
caspases I
are O
typically O
produced O
in O
Escherichia O
coli O
expression O
systems O
with O
the O
attendant O
problems O
of O
solubilization O
, O
re O
- O
folding O
and O
activation O
of O
the O
protease O
. O

The O
gene O
encoding O
rat O
peptidylglycine B
alpha I
- I
amidating I
monooxygenase I
( O
PAM B
) O
contains O
26 O
protein O
- O
coding O
exons O
. O

The O
NF O
- O
kappa O
B O
precursor O
p100 B
( O
lyt B
- I
10 I
, O
p97 O
, O
p98 B
) O
generates O
after O
proteolytic O
processing O
a O
52 O
kDa O
subunit O
, O
which O
can O
bind O
to O
kappa B
B I
- I
motifs I
. O

Receptor B
- I
type I
serine I
/ I
threonine I
kinases I
( O
RSKs B
) O
have O
been O
organized O
into O
two O
distinct O
classes O
known O
as O
types O
I O
and O
II O
on O
the O
basis O
of O
sequence O
similarity O
. O

In O
a O
previous O
study O
of O
transforming O
growth O
factor O
- O
beta1 O
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF O
site O
; O
in O
the O
present O
study O
of O
IFN O
- O
gamma O
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF O
, O
NF O
- O
Y O
, O
or O
CDE O
elements O
. O

The O
RsmA B
- I
mutant I
, O
like O
its O
parent O
, O
produces O
N O
- O
( O
3 O
- O
oxohexanoyl O
) O
- O
L O
- O
homoserine O
lactone O
( O
HSL O
) O
, O
a O
starvation O
/ O
cell O
density O
- O
sensing O
signal O
required O
for O
extracellular O
enzyme O
production O
. O

Analysis O
of O
the O
DNA O
- O
binding O
and O
transcriptional O
activation O
functions O
of O
human B
Fli I
- I
1 I
protein I
. O

This O
pattern O
of O
expression O
and O
differential O
processing O
suggests O
a O
role O
for O
inrpk1 B
in O
some O
aspect O
of O
SD O
photoperiodic O
- O
induced O
flowering O
in O
morning O
glory O
. O

We O
conclude O
from O
these O
observations O
that O
the O
cTnC B
3 I
' I
Ile I
element I
is O
a O
composite O
enhancer O
that O
functions O
through O
the O
combined O
interactions O
of O
at O
least O
five O
regulatory O
elements O
and O
their O
cognate O
binding O
factors O
: O
three O
or O
four O
E O
- O
boxes O
, O
a O
MEF O
- O
2 O
site O
, O
and O
a O
MEF B
- I
3 I
site I
. O

We O
identified O
Tyr O
( O
112 O
) O
and O
Leu O
( O
175 O
) O
within O
the O
RNA O
- O
binding O
domain O
of O
the O
U1 B
70K I
protein I
to O
be O
cross O
- O
linked O
to O
G O
( O
28 O
) O
and O
U O
( O
30 O
) O
in O
stem O
- O
loop O
I O
, O
respectively O
. O

Furthermore O
, O
the O
data O
suggest O
an O
immunological O
non O
- O
responsiveness O
to O
enterotoxin B
A I
in O
a O
considerable O
portion O
of O
the O
patients O
. O

BCV B
mRNAs I
5 I
and I
5 I
- I
1 I
appear O
to O
be O
used O
for O
the O
synthesis O
of O
the O
12 O
. O
7 O
- O
and O
9 O
. O
5 O
- O
kDa O
proteins O
, O
respectively O
, O
which O
demonstrates O
a O
pattern O
of O
expression O
strikingly O
different O
from O
that O
utilized O
by O
MHV O
. O

The O
use O
of O
specific O
somatic O
cell O
hybrids O
have O
allowed O
us O
to O
locate O
the O
YAC O
contig O
telomeric O
to O
the O
D3F15S2 B
locus I
, O
in O
a O
region O
which O
is O
frequently O
deleted O
in O
lung O
carcinomas O
. O

This O
regulation O
is O
mediated O
by O
several O
kinases O
that O
phosphorylate O
specific O
residues O
in O
the O
different O
functional O
domains O
of O
the O
p53 B
molecule I
. O

These O
data O
show O
that O
the O
processing O
of O
specific O
target O
transcripts O
, O
such O
as O
the O
P B
- I
element I
mRNA I
, O
is O
regulated O
by O
a O
functional O
PSI B
- O
U1 O
snRNP O
interaction O
in O
Drosophila O
. O

Here O
, O
we O
provide O
direct O
evidence O
that O
the O
meiotic O
defect O
caused O
by O
either O
unregulated O
cAPK O
activity O
or O
unregulated O
ran1 B
+ I
kinase I
activity O
is O
due O
to O
inability O
to O
induce O
transcription O
of O
the O
mei2 B
+ I
gene I
, O
which O
is O
required O
for O
meiotic O
initiation O
. O

Optical O
rotation O
of O
the O
second O
harmonic O
radiation O
from O
retinal O
in O
bacteriorhodopsin B
monomers I
in O
Langmuir O
- O
Blodgett O
film O
: O
evidence O
for O
nonplanar O
retinal O
structure O
. O

In O
K562 O
cells O
, O
using O
the O
bicistronic O
vector O
, O
selection O
with O
colchicine O
led O
to O
at O
least O
20 O
- O
fold O
higher O
expression O
of O
the O
MDR1 B
gene I
product I
than O
did O
selection O
with O
G418 O
, O
suggesting O
that O
the O
stringent O
MDR1 O
selection O
system O
is O
very O
efficient O
for O
obtaining O
overexpression O
of O
foreign O
genes O
. O

Our O
analysis O
indicates O
that O
a O
gene O
correction O
mechanism O
has O
been O
operating O
on O
the O
Hbbs B
chromosome O
to O
keep O
beta B
s I
and O
beta B
t I
evolving O
in O
concert O
, O
whereas O
on O
the O
Hbbd B
chromosome O
, O
beta B
dmin I
has O
diverged O
considerably O
from O
beta B
dmaj I
. O

Structure O
and O
regulation O
of O
KGD2 B
, O
the O
structural O
gene O
for O
yeast B
dihydrolipoyl I
transsuccinylase I
. O

We O
identify O
YY1 O
recognition O
sequences O
within O
the O
vitamin O
D O
response O
element O
( O
VDRE O
) O
of O
the O
osteocalcin B
gene I
that O
are O
critical O
for O
YY1 O
- O
dependent O
repression O
of O
vitamin O
D O
- O
enhanced O
promoter O
activity O
. O

Point O
mutations O
of O
Stat3 O
within O
the O
interacting O
domains O
blocked O
both O
physical O
interaction O
of O
Stat3 O
with O
c O
- O
Jun O
and O
their O
cooperation O
in O
IL O
- O
6 O
- O
induced O
transcription O
directed O
by O
the O
alpha B
( I
2 I
) I
- I
macroglobulin I
enhancer I
. O

From O
the O
comparison O
of O
the O
nod B
box I
sequences I
of O
( O
brady O
) O
rhizobia O
with O
a O
more O
divergent O
nod B
box I
from O
Azorhizobium O
caulinodans O
, O
we O
now O
propose O
a O
modular O
build O
- O
up O
of O
the O
nod B
box I
with O
the O
sequence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
binding O
target O
of O
the O
NodD B
protein I
( O
the O
NodD B
box I
) O
. O

The O
prgX B
gene I
is O
adjacent O
to O
prgQ O
which O
provides O
the O
promoter O
for O
prgB B
expression O
. O

Genetic O
analysis O
of O
the O
role O
of O
herpes B
simplex I
virus I
type I
1 I
glycoprotein I
K I
in O
infectious O
virus O
production O
and O
egress O
. O

A O
conventional O
N O
- O
terminal O
signal O
sequence O
was O
not O
detected O
in O
the O
NodO B
protein I
. O

Dynamic O
expression O
of O
broad B
- I
complex I
isoforms I
mediates O
temporal O
control O
of O
an O
ecdysteroid O
target O
gene O
at O
the O
onset O
of O
Drosophila O
metamorphosis O
. O

These O
findings O
suggest O
that O
the O
proteolipids O
of O
the O
vacuolar B
H I
+ I
- I
ATPases I
were O
evolved O
in O
parallel O
with O
the O
eubacterial O
proteolipid O
, O
from O
a O
common O
ancestral O
gene O
that O
underwent O
gene O
duplication O
. O

Homology O
is O
much O
higher O
( O
64 O
% O
) O
between O
the O
28 O
- O
kDa O
protein O
and O
regions O
that O
are O
strongly O
conserved O
among O
the O
members O
of O
the O
serine B
protease I
family I
. O

We O
have O
isolated O
and O
structurally O
characterized O
genomic O
DNA O
and O
cDNA O
sequences O
encoding O
ribulose B
- I
1 I
, I
5 I
- I
bisphosphate I
carboxylase I
/ I
oxygenase I
( I
Rbu I
- I
P2 I
carboxylase I
) I
activase I
from O
barley O
( O
Hordeum O
vulgare O
L O
. O
) O
. O

Expression O
of O
putative O
constitutively O
active O
forms O
of O
DdMEK1 B
in O
a O
ddmek1 B
null O
background O
is O
capable O
, O
at O
least O
partially O
, O
of O
complementing O
the O
small O
aggregate O
size O
defect O
and O
the O
ability O
to O
activate O
guanylyl B
cyclase I
. O

Moreover O
, O
such O
mutations O
lead O
to O
a O
dramatic O
transition O
in O
chromatin O
structure O
: O
the O
DNase B
I I
hypersensitive I
region I
is O
replaced O
by O
two O
stable O
, O
sequence O
- O
positioned O
nucleosomes O
. O

Because O
of O
the O
structural O
similarities O
the O
new O
gene O
will O
be O
termed O
scERV2 B
from O
now O
on O
. O

The O
2 B
. I
3 I
x I
10 I
( I
3 I
) I
base I
SUF12 I
+ I
transcript I
contains O
an O
open O
reading O
frame O
sufficient O
to O
encode O
a O
88 O
x O
10 O
( O
3 O
) O
Mr O
protein O
. O

This O
ligand O
- O
independent O
pathway O
can O
function O
through O
another O
androgen O
- O
regulated O
promoter O
as O
shown O
by O
the O
use O
of O
the O
mouse B
mammary I
tumor I
virus I
MMTV I
- I
CAT I
reporter I
. O

Expression O
of O
the O
Asp O
but O
not O
the O
Ala O
gB B
mutation O
resulted O
in O
an O
increase O
in O
the O
steady O
- O
state O
expression O
of O
gB B
at O
the O
plasma O
membrane O
( O
PM O
) O
in O
U373 O
cells O
. O

Thus O
integration O
host O
factor O
is O
required O
for O
normal O
type B
1 I
fimbriae I
phase O
variation O
in O
E O
. O
coli O
. O

Insulin O
therapy O
has O
been O
expanded O
by O
development O
of O
human B
insulin I
and O
new O
modes O
of O
injection O
, O
including O
insulin O
pumps O
. O

However O
, O
coligation O
of O
Fc O
gamma O
RIIB1 O
with O
B B
cell I
Ag I
receptors I
( O
BCR O
) O
inhibits O
BCR O
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP O
- O
2 O
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP O
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

11 O
: O
5801 O
- O
5812 O
, O
1991 O
) O
present O
evidence O
that O
the O
Vps18 B
/ O
Pep3 B
protein O
colocalizes O
with O
the O
Vps11 B
/ O
Pep5 B
protein O
to O
the O
cytosolic O
face O
of O
the O
vacuolar O
membrane O
. O

We O
conclude O
that O
the O
BR B
- I
C I
early I
gene I
directly O
activates O
late O
gene O
transcription O
by O
interacting O
with O
late O
gene O
cis O
- O
acting O
regulatory O
elements O
and O
that O
this O
interaction O
is O
responsible O
for O
the O
temporal O
linkage O
of O
early O
and O
late O
ecdysone O
- O
induced O
gene O
expression O
. O

We O
have O
identified O
the O
gene O
encoding O
sigma B
E I
using O
a O
genetic O
screen O
designed O
to O
isolate O
trans O
- O
acting O
mutations O
that O
abolish O
expression O
from O
either O
htrA B
or O
rpoHP3 B
, O
two O
promoters O
recognized O
uniquely O
by O
sigma B
E I
- O
containing O
RNA O
polymerase O
. O

One O
promoter O
, O
p53P1 B
, O
is O
located O
100 O
- O
250 O
bp O
upstream O
of O
the O
218 O
- O
bp O
noncoding O
first O
exon O
; O
a O
second O
, O
stronger O
promoter O
, O
p53P2 O
, O
maps O
within O
the O
first O
intron O
. O

Both O
PMP20 B
gene I
products I
contain O
the O
carboxyl O
- O
terminal O
sequence O
AKL O
, O
similar O
to O
the O
putative O
SKL O
peroxisomal O
sorting O
sequence O
( O
Gould O
, O
S O
. O

The O
corresponding O
tetrapeptide O
sequences O
SSPD O
and O
SATD O
for O
human B
and I
mouse I
PKC I
- I
epsilon I
, O
respectively O
, O
are O
unusual O
for O
caspase O
- O
3 O
. O

The O
lipopolysaccharide O
- O
binding O
protein O
is O
a O
secretory B
class I
1 I
acute I
- I
phase I
protein I
whose O
gene O
is O
transcriptionally O
activated O
by O
APRF B
/ O
STAT O
/ O
3 O
and O
other O
cytokine O
- O
inducible O
nuclear O
proteins O
. O

These O
proteins O
, O
called O
variant B
surface I
glycoproteins I
( O
VSGs B
) O
, O
are O
expressed O
from O
a O
specific O
locus O
, O
the O
VSG B
gene I
expression I
site I
( I
ES I
) I
. O

A O
deletion O
analysis O
of O
the O
FAS1 B
promoter I
lacking O
the O
previously O
characterized O
inositol O
/ O
choline O
- O
responsive O
- O
element O
motif O
defined O
a O
region O
( O
nucleotides O
- O
760 O
to O
- O
850 O
) O
responsible O
for O
most O
of O
the O
remaining O
activation O
potency O
. O

The O
homeodomain O
transcription O
factor O
CDP O
/ O
cut O
interacts O
with O
the O
cell O
cycle O
regulatory O
element O
of O
histone B
H4 I
genes I
packaged O
into O
nucleosomes O
. O

They O
encode O
proteins O
whose O
core O
regions O
display O
great O
similarity O
to O
Aspergillus B
HAPB I
, O
HAPC B
and O
HAPE B
and O
to O
known O
HAP B
homologs I
from O
other O
organisms O
. O

Cotransfection O
of O
pINV O
- O
2473 O
, O
a O
construct O
containing O
2473 O
base O
pairs O
of O
hINV B
upstream I
sequence I
linked O
to O
luciferase O
, O
with O
POU B
homeodomain I
transcription I
factors I
Oct1 O
, O
Oct2 O
, O
Brn4 B
, O
SCIP B
, O
Skn1a B
or O
Skn1i B
, O
results O
in O
a O
strong O
suppression O
of O
basal O
promoter O
activity O
. O

Genomic O
DNA O
blot O
analysis O
indicates O
that O
the O
trout B
L2 I
locus I
has O
a O
cluster O
- O
like O
organization O
similar O
to O
the O
trout B
L1 I
locus I
and O
the O
IgL B
locus I
of O
several O
teleost O
fish O
. O

Pancreatic O
expression O
of O
the O
glucagon B
gene I
depends O
on O
multiple O
transcription O
factors O
interacting O
with O
at O
least O
three O
DNA O
control O
elements O
: O
G1 O
, O
the O
upstream O
promoter O
element O
, O
and O
G2 O
and O
G3 O
, O
two O
enhancer O
- O
like O
sequences O
. O

We O
have O
compared O
the O
ability O
of O
GST O
- O
Bem3 B
to O
serve O
as O
a O
GAP O
for O
Cdc42Hs O
relative O
to O
other O
members O
of O
the O
rho O
- O
GAP O
subfamily O
and O
found O
the O
following O
order O
of O
potency O
: O
human B
platelet I
Cdc42Hs I
GAP I
> O
p190 O
> O
Bem3 B
> O
break B
point I
cluster I
region I
protein I
, O
whereas O
p85 O
, O
like O
Bem2 B
, O
shows O
no O
GAP O
activity O
or O
any O
ability O
to O
bind O
to O
the O
GTP O
- O
bound O
form O
of O
Cdc42Hs O
. O

Single O
amino O
acid O
substitutions O
were O
shown O
to O
result O
from O
the O
mutations O
pdr1 B
- I
2 I
( O
M308I O
) O
, O
pdr1 B
- I
3 I
( O
F815S O
) O
, O
pdr1 B
- I
6 I
( O
K302Q O
) O
, O
pdr1 B
- I
7 I
( O
P298A O
) O
and O
pdr1 B
- I
8 I
( O
L1036 O
W O
) O
, O
whereas O
the O
intragenic O
suppressor O
mutant O
pdr1 B
- I
100 I
is O
deleted O
for O
the O
two O
amino O
acids O
L537 O
and O
A538 O
. O

Both O
merR B
genes I
consist O
of O
a O
408 O
bp O
ORF O
coding O
for O
135 O
amino O
acids O
. O

Amniotic O
fluid O
ionic O
concentration O
in O
response O
to O
chronic O
fetal B
vasopressin I
infusion O
. O

Molecular O
cloning O
of O
the O
alpha B
- I
globin I
transcription I
factor I
CP2 B
. O

The O
most O
distal O
active O
site O
in O
TIGA B
is O
created O
by O
excision O
of O
a O
66 O
- O
bp O
intron O
. O

Denaturing O
gradient O
gel O
electrophoresis O
( O
DGGE O
) O
with O
sequence O
analysis O
showed O
that O
PGCL4 B
is O
a O
major O
member O
in O
the O
female O
mammary O
gland O
, O
and O
in O
the O
submaxillary O
and O
lachrymal O
glands O
of O
both O
sexes O
, O
while O
the O
counterpart O
in O
male O
liver O
and O
the O
coagulate O
glands O
was O
found O
to O
be O
PGCL1 B
. O

Ligand O
binding O
of O
multi O
- O
chain O
antigen O
receptors O
and O
hematopoietin B
/ O
cytokine O
receptors O
results O
in O
rapid O
activation O
of O
protein O
tyrosine O
kinase O
( O
PTK O
) O
- O
dependent O
signalling O
molecules O
such O
as O
phosphatidylinositol O
3 O
- O
kinase O
( O
PI O
3 O
- O
kinase O
) O
. O

Previous O
data O
suggested O
a O
subtle O
increase O
in O
serum O
P O
at O
the O
time O
of O
hCG O
injection O
without O
LH O
surge O
reduces O
the O
PR O
of O
women O
having O
oocyte O
retrievals O
for O
IVF O
; O
this O
study O
compared O
PRs O
of O
recipients O
in O
a O
shared O
oocyte O
program O
according O
to O
the O
donors O
' O
pre B
- I
hCG I
P O
level O
. O

The O
architecture O
of O
the O
hRap1 B
Myb O
domain O
is O
very O
close O
to O
that O
of O
each O
of O
the O
Myb O
domains O
from O
TRF1 B
, O
scRap1p B
and O
c O
- O
Myb O
. O

80 O
v O
- O
ets O
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v O
- O
ets O
junction O
are O
not O
found O
in O
P54 O
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 O
/ O
56c B
- I
ets I
. O

The O
phosphoprotein B
pUL69 I
of O
human O
cytomegalovirus O
( O
HCMV O
) O
, O
which O
is O
a O
herpesvirus O
of O
considerable O
medical O
importance O
in O
immunosuppressed O
patients O
and O
newborns O
, O
has O
previously O
been O
identified O
as O
an O
early B
- I
late I
viral I
protein I
that O
can O
stimulate O
several O
viral O
and O
cellular O
promoters O
and O
thus O
exerts O
a O
rather O
broad O
activation O
pattern O
. O

Previous O
studies O
have O
shown O
that O
TGFbeta1 O
expression O
is O
upregulated O
in O
mouse O
keratinocytes O
infected O
with O
a O
v B
- I
rasHa I
retrovirus O
, O
although O
the O
functional O
significance O
of O
this O
has O
not O
been O
clear O
. O

Regulation O
of O
the O
human B
stress I
response I
gene I
GADD153 I
expression O
: O
role O
of O
ETS1 O
and O
FLI B
- I
1 I
gene I
products I
. O

The O
PRP4 B
protein I
of I
Saccharomyces I
cerevisiae I
is O
an O
essential O
part O
of O
the O
U4 O
/ O
U6 O
snRNP O
, O
a O
component O
of O
the O
mRNA O
splicing O
apparatus O
. O

Here O
RFX B
/ O
X2BP B
/ O
DNA O
complexes O
were O
formed O
on O
all O
class O
II O
isotypes O
regardless O
of O
the O
ability O
of O
the O
X O
box O
region O
to O
bind O
either O
factor O
individually O
. O

The O
psi B
zeta I
gene I
has O
a O
nonsense O
mutation O
in O
exon O
1 O
but O
has O
identical O
promoter O
sequence O
and O
RNA O
processing O
sites O
to O
the O
zeta B
gene I
, O
raising O
the O
possibility O
that O
both O
psi B
zeta I
and O
zeta B
are O
transcriptionally O
active O
. O

The O
Id4 B
protein I
contains O
a O
HLH O
domain O
highly O
conserved O
among O
the O
dnHLH B
proteins I
from O
mouse O
and O
drosophila O
. O

The O
coding O
region O
of O
nifA O
was O
determined O
using O
a O
translational O
lacZ B
fusion I
and O
by O
site O
- O
directed O
mutagenesis O
to O
identify O
which O
of O
four O
in O
frame O
AUG O
codons O
was O
used O
. O

Peptide O
competition O
studies O
have O
localized O
a O
cyclin B
A I
interaction I
site I
to O
a O
Lys381Lys382Leu383Met384Phe385 O
sequence O
within O
C O
- O
terminal O
negative O
regulatory O
domain O
of O
human O
p53 O
. O

Heterodimerization B
mutant I
RXR I
failed O
to O
alter O
GFP O
- O
VDR O
and O
nlsGFP B
- O
VDR O
distribution O
or O
activity O
. O

Like O
troponin B
Cs I
and O
calmodulins B
, O
PfCPK B
also O
contains O
four O
EF O
hand O
calcium O
- O
binding O
motifs O
. O

Upstream O
of O
the O
afa B
- I
3 I
gene I
cluster I
, O
a O
1 O
. O
2 O
- O
kb O
region O
was O
found O
to O
be O
96 O
% O
identical O
to O
the O
RepFIB B
sequence I
of O
one O
of O
the O
enterotoxigenic O
E O
. O
coli O
plasmids O
( O
P307 O
) O
, O
suggesting O
a O
common O
ancestor O
plasmid O
. O

In O
F9 O
, O
which O
is O
a O
prototype O
of O
embryonal O
carcinoma O
cells O
expressing O
hst B
, O
the O
expression O
of O
hst B
gene I
is O
positively O
regulated O
by O
a O
downstream O
octamer O
motif O
that O
functions O
as O
an O
enhancer O
. O

Two O
putative O
ATP O
- O
binding O
domains O
were O
identified O
, O
one O
in O
the O
amino O
- O
terminal O
half O
of O
the O
argA B
- I
encoded I
protein I
and O
the O
other O
in O
the O
carboxy O
- O
terminal O
half O
. O

Purified O
phosphorylated O
PhoP O
( O
PhoPP B
) O
had O
a O
half O
- O
life O
of O
approximately O
2 O
. O
5 O
h O
, O
which O
was O
reduced O
to O
about O
15 O
min O
by O
addition O
of O
the O
same O
molar O
amount O
of O
* B
PhoR I
( O
the O
cytoplasmic O
region O
of O
PhoR B
) O
. O

Overexpression O
of O
N O
- O
terminal O
mutations O
disturbs O
mitosis O
and O
produces O
elongated O
cells O
, O
Using O
a O
PCR O
approach O
, O
we O
isolated O
a O
putative O
homologue O
of O
Prp4 B
from O
human O
and O
mouse O
cells O
. O

Biochemical O
studies O
and O
studies O
of O
cells O
expressing O
mutant O
IL B
- I
2 I
receptors I
indicate O
that O
IL O
- O
2 O
- O
induced O
tyrosine O
kinase O
activation O
initiates O
a O
complex O
signaling O
cascade O
. O

BACKGROUND O
: O
Peripheral O
kappa B
receptor I
agonists O
may O
provide O
a O
new O
therapeutic O
approach O
for O
the O
treatment O
of O
functional O
dyspepsia O
. O

The O
yeast O
genome O
contains O
a O
single O
ORD1 B
gene I
that O
resides O
on O
chromosome O
XI O
. O

The O
N O
- O
terminal O
sequence O
of O
the O
extracellular B
MEP20 I
, O
TKVAS B
, O
was O
found O
at O
aa O
194 O
- O
198 O
within O
the O
ORF O
. O

Cloning O
of O
the O
GATA O
- O
binding O
protein O
that O
regulates O
endothelin B
- I
1 I
gene I
expression O
in O
endothelial O
cells O
. O

The O
Synechococcus B
gene I
rps1 I
encoding O
S1 O
is O
located O
1 O
. O
1 O
kb O
downstream O
from O
psbB O
, O
which O
encodes O
the O
photosystem B
II I
P680 I
chlorophyll I
a I
apoprotein I
. O

As O
in O
IncP O
alpha O
plasmids O
, O
these O
operons O
are O
transcribed O
from O
a O
bidirectional O
promoter O
region O
consisting O
of O
trfAp B
for O
the O
trfA B
operon I
and O
trbAp B
and O
trbBp B
for O
the O
trb B
operon I
. O

The O
BHV B
- I
1 I
UL24 I
, O
UL25 B
, O
UL26 O
and O
UL26 B
. I
5 I
transcripts I
all O
terminated O
at O
a O
common O
3 O
' O
- O
polyadenylation O
site O
and O
varied O
significantly O
in O
their O
relative O
abundance O
. O

Electrophoretic O
mobility O
shift O
analysis O
of O
protein O
- O
DNA O
complexes O
formed O
with O
nuclear O
proteins O
isolated O
from O
I3C O
- O
treated O
and O
- O
untreated O
cells O
, O
in O
combination O
with O
supershift O
assays O
using O
Sp1 B
antibodies I
, O
demonstrated O
that O
the O
Sp1 O
- O
binding O
site O
in O
the O
CDK6 B
promoter I
forms O
a O
specific O
I3C O
- O
responsive O
DNA O
- O
protein O
complex O
that O
contains O
the O
Sp1 B
transcription I
factor I
. O

These O
results O
suggest O
that O
both O
the O
distinct O
DNA O
binding O
properties O
of O
PMLRAR B
homodimers I
and O
the O
sequestration O
of O
RXR O
by O
PMLRARs B
may O
contribute O
to O
the O
molecular O
mechanisms O
which O
underlie O
the O
pathogenesis O
of O
APL O
. O

Low O
- O
affinity O
E2 B
- I
binding I
site I
mediates O
downmodulation O
of O
E2 O
transactivation O
of O
the O
human B
papillomavirus I
type I
8 I
late I
promoter I
. O

Untransformed O
3T3 O
cells O
carry O
abundant O
1 O
. O
9 O
kb O
Hox B
1 I
. I
3 I
RNA O
, O
whereas O
the O
methylcholanthrene O
- O
transformed O
MB66 O
and O
LTK O
- O
cells O
or O
3T3 O
cells O
transformed O
by O
the O
oncogenes O
src O
, O
fos O
or O
SV40 O
T O
antigen O
express O
only O
low O
levels O
. O

Although O
analysis O
of O
the O
similarity O
between O
the O
44 O
- O
kDa O
protein O
and O
the O
E B
. I
coli I
RecA I
protein I
did O
not O
show O
any O
significant O
homology O
between O
them O
, O
it O
revealed O
their O
identity O
by O
five O
amino O
- O
acid O
residues O
involved O
in O
the O
formation O
of O
the O
epitope O
that O
recognized O
the O
paratope O
of O
the O
RecA B
protein I
antibody I
for O
subsequent O
epitope O
- O
paratope O
binding O
of O
these O
proteins O
. O

Ureases B
were O
purified O
from O
the O
recombinant O
cells O
and O
shown O
to O
be O
identical O
to O
control O
enzyme O
when O
analyzed O
by O
gel O
filtration O
chromatography O
and O
sodium O
dodecyl O
sulfate O
- O
polyacrylamide O
gel O
electrophoresis O
; O
however O
, O
in O
every O
case O
the O
activity O
levels O
correlated O
to O
nickel O
contents O
as O
analyzed O
by O
atomic O
absorption O
analysis O
. O

These O
results O
demonstrate O
that O
the O
entire O
E3L B
gene I
is O
required O
for O
pathogenesis O
in O
the O
mouse O
model O
. O

Recently O
, O
we O
have O
demonstrated O
that O
mouse O
microglial O
cells O
, O
the O
brain O
macrophages O
, O
express O
both O
IL B
- I
15 I
and O
IL B
- I
15 I
/ I
IL I
- I
2 I
receptors I
. O

We O
have O
analyzed O
the O
role O
of O
the O
HU B
protein I
in O
invertasome O
assembly O
when O
the O
enhancer O
is O
located O
at O
variable O
positions O
close O
to O
one O
of O
the O
recombination O
sites O
. O

A O
wide O
conservation O
of O
iscSUA B
genes I
in O
nature O
and O
evidence O
that O
NifU B
and O
NifS B
participate O
in O
the O
mobilization O
of O
iron O
and O
sulfur O
for O
nitrogenase B
- O
specific O
iron O
- O
sulfur O
cluster O
formation O
suggest O
that O
the O
products O
of O
the O
iscSUA B
genes I
could O
play O
a O
general O
role O
in O
the O
formation O
or O
repair O
of O
iron O
- O
sulfur O
clusters O
. O

The O
pattern O
of O
expression O
of O
this O
and O
other O
Chi26 B
/ O
Chi33 B
chimeric O
promoters O
suggest O
that O
the O
E B
- I
region I
contains O
cis O
- O
acting O
sequences O
which O
activate O
transcription O
in O
aleurone O
and O
silence O
transcription O
in O
leaves O
. O

Effectively O
, O
the O
upstream O
, O
housekeeping O
- O
type O
promoter O
responds O
to O
FIXK B
and O
positively O
regulates O
the O
downstream O
, O
sigma B
54 I
- I
type I
promoter I
. O

A O
5789 B
- I
nucleotide I
- I
long I
EcoRI I
fragment I
from O
the O
genome O
of O
Thermotoga O
maritima O
, O
identified O
by O
cross O
- O
hybridization O
to O
L11 O
, O
L1 O
, O
L10 B
, O
and O
L12 B
ribosomal I
protein I
gene I
sequences I
from I
Escherichia I
coli I
, O
was O
cloned O
and O
sequenced O
. O

These O
data O
suggest O
that O
reduction O
in O
PRA O
may O
have O
contributed O
to O
the O
hemodynamic O
effects O
of O
this O
peak B
III I
PDE I
inhibitor O
. O

Prematurely O
inactivating O
p42 B
MAPK I
in O
egg O
extracts O
resulted O
in O
a O
corresponding O
hastening O
of O
the O
first O
mitosis O
. O

Binding O
of O
C O
/ O
EBPs O
to O
all O
three O
spi B
2 I
. I
3 I
3 I
' I
UTR I
repressor I
sites I
, O
although O
rather O
weak O
, O
was O
confirmed O
by O
electrophoretic O
mobility O
shift O
assays O
that O
otherwise O
failed O
to O
reveal O
specific O
interactions O
with O
other O
liver O
nuclear O
proteins O
in O
vitro O
. O

Cell O
cycle O
regulatory O
components O
have O
been O
largely O
conserved O
in O
eukaryotes O
; O
however O
, O
orthologs O
of O
neither O
CAK1 O
nor O
csk1 B
have O
been O
identified O
in O
other O
species O
to O
date O
. O

In O
this O
study O
, O
we O
cloned O
the O
full O
- O
length O
cDNA O
of O
mouse O
PAX4 B
by O
RACE O
( O
rapid O
amplification O
of O
cDNA O
ends O
) O
using O
RNA O
from O
MIN6 O
cells O
, O
a O
mouse O
insulinoma O
cell O
line O
. O

Hence O
the O
GAP1 B
gene I
encodes O
a O
protein O
with O
characteristics O
typical O
of O
integral O
membrane O
proteins O
translocating O
ligants O
across O
cellular O
membranes O
. O

The O
results O
suggest O
that O
proenzyme O
processing O
is O
not O
essential O
for O
secretion O
of O
PC2 B
, O
but O
peptides O
containing O
mutations O
that O
affect O
the O
ability O
of O
the O
propeptide O
( O
and O
cleavage O
sites O
) O
to O
fold O
within O
the O
catalytic O
pocket O
are O
not O
transferred O
beyond O
the O
early O
stages O
of O
the O
secretory O
pathway O
. O

One O
of O
these O
clones O
encodes O
Xenopus B
N I
- I
ras I
. O

The O
median O
levels O
of O
t B
- I
PA I
Ag I
and O
PAI O
in O
plasma O
were O
respectively O
10 O
. O
7 O
ng O
/ O
ml O
( O
interquartile O
range O
8 O
. O
6 O
ng O
/ O
ml O
) O
and O
15 O
. O
7 O
IU O
/ O
ml O
( O
interquartile O
range O
12 O
. O
2 O
IU O
/ O
ml O
) O
. O

In O
the O
remaining O
91 O
patients O
( O
group O
2 O
) O
, O
Pseudomonas O
( O
18 O
) O
, O
coagulase B
- O
negative O
Staphylococci O
( O
15 O
) O
, O
Staphylococcus O
epidermidis O
( O
23 O
) O
, O
Staphylococcus O
aureus O
( O
16 O
) O
, O
Corynebacterium O
species O
( O
12 O
) O
, O
and O
others O
( O
seven O
) O
were O
isolated O
. O

The O
leucine O
zipper O
region O
of O
ATF B
proteins I
is O
also O
similar O
to O
that O
of O
the O
AP O
- O
1 O
/ O
c O
- O
jun O
family O
of O
transcription O
factors O
, O
whose O
DNA O
- O
binding O
site O
differs O
from O
the O
ATF O
- O
binding O
site O
at O
a O
single O
position O
. O

Were O
this O
hypothesis O
correct O
, O
the O
requirement O
for O
elF4A B
should O
correlate O
with O
the O
degree O
of O
mRNA O
secondary O
structure O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta O
c O
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

When O
the O
measured O
beta O
- O
galactosidase O
activity O
in O
the O
pWP O
- O
transfected O
cells O
was O
normalized O
to O
the O
pCH110 O
- O
transfected O
cells O
( O
an O
appropriate O
control O
if O
the O
SV40 B
early I
region I
promoter I
functions O
constitutively O
in O
various O
cell O
lines O
) O
, O
the O
results O
suggested O
that O
the O
promoter O
region O
of O
the O
PLP O
gene O
contains O
the O
information O
necessary O
for O
initiation O
of O
transcription O
in O
a O
C6 O
cell O
- O
specific O
manner O
. O

PKK B
exists O
in O
three O
discernible O
forms O
at O
steady O
state O
: O
an O
underphosphorylated O
form O
of O
100 O
kDa O
; O
a O
soluble O
, O
cytosolic O
, O
phosphorylated O
form O
of O
110 O
kDa O
; O
and O
a O
phosphorylated O
, O
detergent O
- O
insoluble O
form O
of O
112 O
kDa O
. O

The O
P B
- I
ITIM I
- I
compelled I
multi I
- I
phosphoprotein I
complex I
binds O
to O
and O
activates O
SHP O
- O
2 O
, O
which O
in O
turn O
dephosphorylates O
SHIP O
and O
Shc O
and O
probably O
other O
substrates O
. O

We O
now O
report O
that O
both O
HSCR B
mutations O
impair O
the O
fixation O
of O
Shc O
to O
RET O
and O
consequently O
prevent O
its O
phosphorylation O
. O

We O
propose O
that O
U73 B
is O
involved O
in O
methylation O
of O
the O
G1739 O
residue O
of O
the O
human B
28S I
rRNA I
. O

Lysates O
of O
COS O
cells O
transfected O
with O
modified B
hGrzB I
cDNA I
were O
able O
to O
hydrolyze O
tert O
- O
butyloxycarbonyl O
- O
Ala O
- O
Ala O
- O
Asp O
- O
thiobenzyl O
ester O
( O
Boc O
- O
Ala O
- O
Ala O
- O
Asp O
- O
SBzl O
) O
, O
whereas O
lysates O
transfected O
with O
unmodified B
hGrzB I
cDNA I
were O
inactive O
. O

Proteins O
PBP B
- I
1 I
and O
PBP B
- I
2 I
bind O
to O
two O
of O
the O
three O
promoter O
elements O
in O
the O
trypanosomatid O
Leptomonas O
seymouri O
. O

The O
enzyme O
encoded O
by O
the O
cloned O
fragment O
is O
equally O
active O
on O
pyruvate O
and O
hydroxypyruvate O
, O
indicating O
that O
the O
enzyme O
has O
both O
D B
- I
lactate I
and I
D I
- I
glycerate I
dehydrogenase I
activities O
. O

The O
human O
sequence O
contains O
the O
element O
TGACTCT O
that O
also O
is O
found O
in O
a O
murine B
ras I
- I
responsive I
enhancer I
. O

There O
is O
an O
overall O
functional O
similarity O
between O
IL O
- O
6 O
and O
c B
- I
fos I
promoters I
, O
since O
transfection O
of O
excess O
amounts O
of O
either O
promoter O
DNA O
into O
intact O
HeLa O
cells O
modulates O
the O
function O
of O
the O
heterologous O
promoter O
construct O
. O

To O
determine O
whether O
the O
transcript O
encodes O
an O
active O
enzyme O
, O
we O
developed O
a O
novel O
transient O
embryonic O
excision O
assay O
in O
which O
zebrafish O
fertilized O
eggs O
were O
co O
- O
injected O
with O
RNA O
transcribed O
in O
vitro O
using O
the O
Tol2 B
cDNA I
as O
a O
template O
and O
a O
plasmid O
DNA O
harboring O
a O
nonautonomous O
Tol2 B
element I
, O
which O
has O
a O
deletion O
in O
the O
transposase B
coding I
region I
. O

We O
suggest O
that O
this O
relatively O
small O
deletion O
affects O
a O
segment O
containing O
3 B
' I
VH I
genes I
with O
important O
regulatory O
functions O
, O
the O
loss O
of O
which O
leads O
to O
the O
ali O
phenotype O
. O

A O
homologue O
of O
the O
MAP B
/ O
ERK O
family O
of O
protein O
kinase O
genes O
is O
expressed O
in O
vegetative O
and O
in O
female O
reproductive O
organs O
of O
Petunia O
hybrida O
. O

It O
encodes O
a O
sequence O
- O
specific O
transcription O
factor O
that O
controls O
, O
in O
concert O
with O
other O
gene O
products O
, O
differentiative O
pathways O
of O
tissues O
in O
which O
Scr B
is O
expressed O
. O

Escherichia O
coli O
cells O
expressing O
a O
mutant B
glyV I
( O
glycine B
tRNA I
) O
gene O
have O
a O
UVM O
- O
constitutive O
phenotype O
: O
implications O
for O
mechanisms O
underlying O
the O
mutA B
or O
mutC B
mutator I
effect O
. O

This O
result O
suggests O
that O
the O
target O
protein O
specificity O
of O
E2s B
can O
be O
altered O
by O
the O
addition O
of O
appropriate O
C O
- O
terminal O
extensions O
, O
thus O
providing O
a O
way O
to O
modify O
the O
selectivity O
of O
the O
ubiquitin O
system O
. O

Here O
we O
report O
the O
cloning O
of O
the O
hemF B
gene I
, O
encoding O
the O
aerobic O
coproporphyrinogen B
III I
oxidase I
from I
Escherichia I
coli I
, O
by O
functional O
complementation O
of O
a O
Saccharomyces B
cerevisiae I
HEM13 I
mutant I
. O

Previous O
studies O
showed O
that O
a O
palindromic O
sequence O
located O
at O
- O
159 O
base O
pairs O
is O
essential O
for O
induction O
of O
cutinase B
gene I
in O
Fusarium O
solani O
f O
. O

We O
conclude O
that O
these O
cDNAs O
belong O
to O
a O
novel O
GST O
class O
hereby O
designated O
Kappa O
, O
with O
the O
rat B
GST I
subunit I
13 I
gene I
designated O
rGSTK1 B
and O
the O
human O
gene O
being O
called O
hGSTK1 B
. O

Based O
on O
PCR O
strategies O
and O
expression O
studies O
, O
we O
define O
the O
genomic O
organization O
of O
the O
FUT8b B
gene I
. O

The O
present O
study O
demonstrates O
that O
the O
proto B
- I
oncogene I
c I
- I
jun I
represses O
transcription O
of O
the O
human B
CG I
alpha I
and O
CG B
beta I
promoters I
. O

c O
- O
Jun O
repressed O
the O
CG B
alpha I
promoter I
through O
a O
canonical O
cAMP O
response O
element O
( O
CRE O
) O
that O
is O
known O
to O
bind O
c O
- O
Jun O
and O
other O
members O
of O
the O
B B
- I
Zip I
transcription I
factor I
family I
. O

Previous O
studies O
using O
partial O
sequences O
have O
suggested O
the O
potential O
of O
26S B
or O
large B
- I
subunit I
( O
LSU B
) O
rDNA O
for O
phylogeny O
retrieval O
at O
taxonomic O
levels O
comparable O
to O
those O
investigated O
with O
18S O
rDNA O
. O

Similarly O
, O
an O
increase O
in O
CAT O
expression O
from O
the O
same O
construct O
( O
pBLCAT O
- O
ENDOA B
) O
was O
also O
observed O
in O
7AQS2 O
. O
1 O
cells O
. O

The O
prevalence O
of O
antibodies O
to O
HRES B
- I
1 I
peptides I
pep14 I
- I
24 I
and I
pep117 I
- I
127 I
was O
determined O
in O
65 O
normal O
blood O
donors O
and O
146 O
patients O
with O
immunological O
disorders O
. O

We O
recently O
reported O
the O
cloning O
and O
sequencing O
of O
the O
alpha B
7 I
integrin I
chain I
and O
its O
regulated O
expression O
during O
the O
development O
of O
skeletal O
muscle O
( O
Song O
et O
al O
. O

These O
involve O
( O
1 O
) O
subcloning O
a O
promoterless O
sucCD B
fragment I
downstream O
of O
the O
lac O
promoter O
in O
M13mp10 O
, O
and O
( O
2 O
) O
precise O
splicing O
of O
the O
suc B
coding I
regions I
with O
the O
efficient O
atpE B
ribosome I
- I
binding I
site I
and O
expression O
from O
the O
thermoinducible O
lambda O
promoters O
in O
the O
pJLA503 O
vector O
. O

These O
mutations O
prevent O
FKBP12 B
- O
rapamycin O
binding O
to O
TOR2 O
, O
as O
assayed O
with O
the O
two O
- O
hybrid O
system O
. O

High O
- O
level O
expression O
of O
sccypB B
as O
well O
as O
of O
sccypA B
cloned O
into O
the O
expression O
vector O
pIJ702 O
did O
not O
produce O
detectable O
changes O
in O
growth O
and O
morphology O
of O
S O
. O
chrysomallus O
and O
S O
. O
lividans O
. O

Fas O
( O
APO B
- I
1 I
/ O
CD95 B
) O
, O
which O
is O
a O
member O
of O
the O
tumor B
necrosis I
factor I
receptor I
superfamily I
, O
is O
a O
cell O
surface O
receptor O
that O
induces O
apoptosis O
. O

Viral O
complementary O
15 B
S I
mRNA I
that O
directs O
the O
synthesis O
of O
N B
protein I
and O
hybridizes O
to O
the O
predicted O
N O
gene O
DNA O
has O
been O
identified O
in O
infected O
cell O
extracts O
. O

Electrophoretic O
mobility O
shift O
assays O
and O
DNase O
I O
protection O
analyses O
revealed O
that O
FP B
I I
was O
bound O
by O
the O
transcription O
factor O
PU O
. O
1 O
/ O
Spi B
- I
1 I
. O

Retroviral O
vector O
producer O
cell O
populations O
and O
cell O
clones O
were O
established O
for O
each O
chLTR O
vector O
, O
and O
all O
were O
capable O
of O
yielding O
high O
vector O
titers O
( O
> O
10 O
( O
5 O
) O
G418R B
cfu O
/ O
ml O
on O
NIH O
- O
3T3 O
) O
. O

However O
, O
a O
few O
sites O
in O
the O
genomes O
of O
EC O
cells O
permit O
M B
- I
MuLVneo I
delta I
Enh I
proviral O
expression O
. O

Several O
of O
the O
drugs O
used O
in O
the O
management O
of O
MAC O
have O
been O
associated O
with O
significant O
drug O
interactions O
involving O
the O
cytochrome B
P450 I
( O
CYP B
) O
enzyme O
system O
. O

Using O
the O
two O
- O
hybrid O
screening O
method O
, O
we O
have O
identified O
an O
additional O
component O
of O
the O
CCAAT B
- I
binding I
factor I
. O

The O
myb B
proto I
oncogene I
product I
( O
c O
- O
Myb O
) O
is O
a O
transcriptional O
regulator O
and O
its O
expression O
and O
function O
are O
tightly O
linked O
to O
the O
cellular O
entry O
into O
S O
phase O
and O
DNA O
synthesis O
. O

Both O
the O
p38 O
kinase O
inhibitor O
SB205380 O
( O
SB O
) O
and O
cotransfection O
of O
a O
dominant O
- O
negative O
mutant O
of O
p38 O
kinase O
reduced O
IL O
- O
1beta O
stimulation O
of O
the O
hBNP B
promoter I
. O

The O
TaqI B
and O
HaeIII B
RFLPs O
will O
provide O
tools O
for O
the O
genetic O
analysis O
of O
CR2 B
. O

Ptx1 O
belongs O
to O
an O
expanding O
family O
of O
bicoid B
- I
related I
vertebrate O
homeobox O
genes O
. O

Differential O
transcription O
of O
plastome O
- O
encoded O
genes O
in O
the O
mesophyll O
and O
bundle O
- O
sheath O
chloroplasts O
of O
the O
monocotyledonous O
NADP O
- O
malic B
enzyme I
- O
type O
C4 O
plants O
maize O
and O
Sorghum O
. O

Sequential O
immunoprecipitation O
showed O
all O
detectable O
p53 O
to O
be O
of O
the O
PAb246 B
+ I
class O
in O
each O
LPV O
- O
transformed O
cell O
line O
, O
suggesting O
that O
the O
stable O
p53 O
was O
indeed O
wild O
type O
. O

These O
results O
suggest O
that O
E6010 B
may O
be O
of O
clinical O
value O
in O
the O
treatment O
of O
coronary O
occlusion O
. O

To O
better O
understand O
the O
relationship O
between O
expression O
of O
an O
oncogene O
and O
genetic O
instability O
, O
we O
have O
studied O
a O
cell O
line O
expressing O
an O
activated B
human I
Ha I
- I
ras I
under O
the O
control O
of O
bacterial B
lactose I
operon I
regulatory I
elements I
for O
changes O
in O
methotrexate O
resistance O
and O
dihydrofolate B
reductase I
( O
dhfr O
) O
gene O
amplification O
following O
mutant B
Ha I
- I
ras I
induction O
. O

Inspection O
of O
X B
. I
tropicalis I
, I
mouse I
and I
human I
U6 I
DNA I
upstream I
sequences I
revealed O
the O
presence O
of O
a O
TATA O
box O
as O
well O
as O
of O
the O
proximal O
and O
enhancer O
( O
octamer O
motif O
) O
elements O
contained O
in O
snRNA O
genes O
transcribed O
by O
RNA O
polymerase O
II O
. O

The O
human B
PAX8 I
gene I
generates O
at O
least O
five O
different O
alternatively O
spliced O
transcripts O
encoding O
different O
PAX8 B
isoforms I
. O

These O
data O
show O
that O
both O
Sp1 O
and O
Sp3 B
transcription I
factors I
upregulate O
HGF B
promoter I
activity O
by O
binding O
to O
the O
Sp1 O
binding O
site O
at O
position O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF O
gene O
promoter O
. O

Mammalian O
homologues O
of O
the O
Polycomb B
- I
group I
gene I
Enhancer O
of O
zeste O
mediate O
gene O
silencing O
in O
Drosophila O
heterochromatin O
and O
at O
S O
. O
cerevisiae O
telomeres O
. O

The O
results O
obtained O
with O
[ B
F304 I
] I
R2 I
indicate O
that O
structural O
changes O
in O
E B
. I
coli I
R2 I
in O
the O
vicinity O
of O
this O
helix O
distortion O
can O
influence O
the O
catalytic O
activity O
of O
the O
holoenzyme O
. O

Cloning O
and O
characterization O
of O
the O
5 O
' O
flanking O
region O
of O
human B
ATP I
- I
citrate I
lyase I
gene I
. O

The O
S3 B
protein I
also O
contains O
a O
DNA O
repair O
activity O
, O
efficiently O
processing O
8 O
- O
oxoguanine O
residues O
in O
DNA O
via O
an O
N O
- O
glycosylase O
/ O
apurinic B
- I
apyrimidinic I
( I
AP I
) I
lyase I
activity O
. O

We O
conclude O
, O
therefore O
, O
that O
in O
the O
absence O
of O
E1A O
, O
E4orf4 B
is O
sufficient O
by O
itself O
to O
trigger O
a O
p53 O
- O
independent O
apoptosis O
pathway O
that O
may O
operate O
independently O
of O
the O
known O
zVAD O
- O
inhibitable O
caspases O
, O
and O
that O
may O
involve O
an O
as O
yet O
uncharacterized O
mechanism O
. O

The O
antiserum O
used O
for O
immunoblotting O
specifically O
supershifts O
uteroglobin B
promoter I
- I
protein I
complexes I
in O
gel O
shift O
experiments O
. O

The O
nucleotide O
sequence O
of O
the O
estrogen B
receptor I
gene I
of I
Oreochromis I
aureus I
( O
OaER B
) O
indicates O
that O
the O
hormone O
- O
binding O
E O
domain O
is O
composed O
of O
4 O
exons O
interspersed O
by O
short O
introns O
of O
only O
0 O
. O
18 O
- O
1 O
. O
3 O
kb O
each O
. O

The O
expression O
of O
Scmh1 O
and O
rae28 B
/ O
mph1 B
is O
well O
correlated O
in O
most O
tissues O
of O
embryos O
. O

The O
nucleoporin B
98 I
gene I
( O
NUP98 O
) O
, O
which O
is O
rearranged O
in O
several O
acute O
myeloid O
leukemia O
translocations O
, O
is O
located O
within O
this O
region O
. O

CERIP B
interaction O
. O

The O
encoded O
Arabidopsis B
U3 I
snRNAs I
can O
be O
folded O
into O
a O
secondary O
structure O
which O
is O
more O
similar O
to O
that O
of O
U3 B
RNAs I
from O
lower O
eukaryotes O
rather O
than O
from O
metazoa O
. O

The O
LT B
- I
beta I
gene I
is O
expressed O
in O
lymphoid O
cells O
and O
organs O
, O
but O
little O
is O
known O
about O
its O
inducible O
regulation O
. O

Dmyd B
clone O
encodes O
a O
polypeptide O
of O
332 O
amino O
acids O
with O
82 O
% O
identity O
to O
MyoD O
in O
the O
41 O
amino O
acids O
of O
the O
putative O
helix O
- O
loop O
- O
helix O
region O
and O
100 O
% O
identity O
in O
the O
13 O
amino O
acids O
of O
the O
basic O
domain O
proposed O
to O
contain O
the O
essential O
recognition O
code O
for O
muscle O
- O
specific O
gene O
activation O
. O

Identification O
of O
an O
osteocalcin B
gene I
promoter I
sequence I
that O
binds O
AP1 O
. O

Mutations O
abolishing O
MalK B
function O
not O
only O
result O
in O
inability O
to O
transport O
maltose O
but O
also O
cause O
constitutive O
expression O
of O
the O
maltose B
regulon I
. O

Drosophila B
melanogaster I
casein I
kinase I
II I
( O
DmCKII B
) O
is O
composed O
of O
catalytic O
( O
alpha O
) O
and O
regulatory O
( O
beta O
) O
subunits O
associated O
as O
an O
alpha2beta2 O
heterotetramer O
. O

Cell O
rounding O
was O
abrogated O
by O
expression O
of O
either O
kinase O
- O
dead O
forms O
of O
US3 B
PK I
or O
a O
mutant O
protein O
lacking O
the O
acidic O
cluster O
in O
the O
kinase O
regulatory O
domain O
. O

Three O
distinct O
human B
HDACs I
are O
homologous O
to O
RPD3 B
, O
a O
yeast O
transcriptional O
regulator O
. O

Expression O
of O
these O
chemokines O
is O
similar O
in O
that O
both O
require O
the O
NF B
- I
kappa I
B I
element I
and O
additional O
regions O
such O
as O
the O
CAAT B
/ I
enhancer I
binding I
protein I
( O
C O
/ O
EBP O
) O
element O
of O
the O
IL O
- O
8 O
promoter O
. O

The O
AP O
- O
1 O
recruited O
by O
ARF1 B
. I
GTP I
is O
released O
from O
the O
Golgi O
membrane O
by O
treatment O
with O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upon O
reincubation O
at O
37 O
degreesC O
, O
whereas O
AP O
- O
1 O
recruited O
with O
GTPgammaS O
or O
by O
a O
constitutively O
active O
point O
mutant O
, O
ARF1 B
( I
Q71L I
) I
, O
remains O
membrane O
bound O
after O
either O
treatment O
. O

We O
found O
remarkable O
differences O
in O
the O
expression O
patterns O
of O
MTB B
- I
Zf I
mRNA I
and O
two O
other O
hybridizable O
mRNAs O
of O
5kb O
and O
8 O
. O
5 O
kb O
when O
human O
brain O
and O
primary O
brain O
tumors O
were O
compared O
. O

The O
pra2 B
gene I
encodes O
a O
pea B
( I
Pisum I
sativum I
) I
small I
GTPase I
belonging O
to O
the O
YPT O
/ O
rab B
family O
, O
and O
its O
expression O
is O
down O
- O
regulated O
by O
light O
, O
mediated O
by O
phytochrome O
. O

Human B
and I
murine I
cytotoxic I
T I
lymphocyte I
serine I
proteases I
: O
subsite O
mapping O
with O
peptide O
thioester O
substrates O
and O
inhibition O
of O
enzyme O
activity O
and O
cytolysis O
by O
isocoumarins O
. O

To O
explore O
further O
the O
role O
of O
the O
carboxyl O
- O
terminal O
domain O
in O
determining O
the O
cell O
cycle O
function O
of O
CDC34 O
, O
we O
constructed O
and O
characterized O
genes O
encoding O
chimeric B
E2s I
incorporating O
sequences O
from O
CDC34 O
and O
the O
related O
but O
functionally O
distinct O
E2 O
RAD6 O
( O
UBC2 O
) O
. O

MAPKK B
kinase I
/ O
MEKK B
phosphorylates O
and O
activates O
its O
downstream O
protein O
kinase O
, O
MAPK B
kinase I
/ O
MEK O
, O
which O
in O
turn O
activates O
MAPK O
. O

However O
, O
ADAR1 B
and O
the O
related O
deaminase B
ADAR2 I
showed O
significant O
expression O
in O
all O
regions O
of O
the O
brain O
examined O
, O
including O
cortex O
, O
hippocampus O
, O
olfactory O
bulb O
, O
and O
striatum O
, O
where O
the O
5 B
- I
HT2CR I
pre I
- I
mRNA I
was O
extensively O
edited O
. O

Temporal O
recruitment O
of O
the O
mSin3A B
- O
histone O
deacetylase O
corepressor O
complex O
to O
the O
ETS B
domain I
transcription I
factor I
Elk O
- O
1 O
. O

In O
addition O
, O
FOP B
- O
FGFR1 O
- O
expressing O
cells O
show O
constitutive O
phosphorylation O
of O
the O
positive O
regulator O
of O
translation O
p70S6 B
kinase I
; O
this O
phosphorylation O
is O
inhibited O
by O
PI3 B
- I
kinase I
and O
mTOR O
( O
mammalian B
target I
of I
rapamycin I
) O
inhibitors O
. O

We O
identified O
clones O
of O
Chlamydomonas O
genomic O
DNA O
that O
rescued O
the O
Ca O
( O
2 O
+ O
) O
- O
dependent O
axonemal O
microtubule O
severing O
defect O
of O
fa1 B
mutants I
. O

Plasma B
hemopexin I
homeostasis O
during O
the O
acute O
phase O
response O
. O

The O
nramp2 B
gene I
is O
comprised O
of O
17 O
exons O
and O
spans O
more O
than O
36 O
kb O
. O

This O
is O
similar O
to O
previous O
reports O
of O
muscle B
creatine I
phosphokinase I
release O
in O
psychiatric O
patients O
. O

The O
majority O
of O
putative O
TSC2 B
mutations I
were O
found O
in O
sporadic O
rather O
than O
TSC2 O
- O
linked O
families O
. O

Murine B
ELAM I
- I
1 I
is O
encoded O
by O
a O
single O
- O
copy O
gene O
, O
spanning O
about O
13 O
kb O
, O
which O
is O
structurally O
organized O
into O
14 O
exons O
and O
13 O
introns O
; O
very O
similar O
to O
that O
of O
its O
human O
counterpart O
. O

We O
found O
that O
the O
PRP20 B
gene I
is O
identical O
to O
the O
yeast B
SRM1 I
gene I
( O
Clark O
and O
Sprague O
1989 O
) O
. O

Basal O
JNK B
MAPK I
kinase I
activity O
was O
also O
specifically O
induced O
by O
deltaEGFR B
, O
which O
correlated O
with O
increased O
phosphorylation O
of O
a O
54 B
- I
kDa I
JNK2 I
protein I
observed O
in O
deltaEGFR B
- O
containing O
cells O
. O

Deletion O
analysis O
defines O
distinct O
functional O
domains O
for O
protein O
- O
protein O
and O
nucleic O
acid O
interactions O
in O
the O
ORF1 B
protein I
of O
mouse O
LINE B
- I
1 I
. O

PMA O
produced O
similar O
results O
, O
but O
the O
induction O
of O
the O
WT B
AP1 I
c O
- O
jun O
promoter O
- O
CAT O
plasmid O
was O
smaller O
. O

Deletion O
of O
CDC5 B
was O
lethal O
and O
resulted O
in O
a O
dumbbell O
- O
shaped O
terminal O
morphology O
, O
with O
the O
nuclei O
almost O
divided O
but O
still O
connected O
. O

These O
cDNAs O
were O
found O
to O
be O
derived O
from O
the O
3 O
" O
- O
untranslated O
region O
( O
3 O
" O
- O
UTR O
) O
of O
the O
methyl B
- I
CpG I
- I
binding I
protein I
2 I
gene I
( O
MeCP2 B
) O
. O

The O
generation O
of O
dorso O
- O
ventral O
polarity O
during O
Drosophila O
embryogenesis O
is O
regulated O
by O
the O
action O
of O
12 O
maternally O
expressed O
gene O
products O
, O
the O
dorsal B
group I
. O

As O
a O
test O
of O
this O
hypothesis O
, O
we O
predicted O
that O
mice O
which O
have O
altered O
expression O
of O
class O
I O
gene O
products O
, O
the O
beta2 B
- I
microglobulin I
knockout O
mice O
, O
[ B
beta2m I
( I
- I
/ I
- I
) I
] I
, O
would O
develop O
Fe O
overload O
. O

On O
the O
basis O
of O
the O
physical O
interactions O
between O
Sxl B
and O
Snf O
, O
we O
present O
a O
model O
for O
Sxl B
splicing O
regulation O
. O

We O
cloned O
the O
BamHI B
- I
F I
fragment I
from O
the O
left O
end O
of O
Ad4 O
in O
pUC13 O
- O
1 O
between O
the O
SalI O
and O
BamHI B
sites I
in O
order O
to O
carry O
out O
the O
structural O
analysis O
of O
the O
E1A B
region I
of I
Ad4 I
. O

In O
both O
RAW O
cells O
and O
the O
microglia O
cell O
line O
EOC20 O
, O
two O
IFN O
- O
gamma O
- O
activated O
transcription O
factors O
, O
STAT B
- I
1alpha I
and O
IRF O
- O
1 O
, O
bind O
the O
GAS O
and O
IRF B
elements I
, O
respectively O
. O

Helenalin O
triggers O
a O
CD95 B
death I
receptor I
- O
independent O
apoptosis O
that O
is O
not O
affected O
by O
overexpression O
of O
Bcl O
- O
x O
( O
L O
) O
or O
Bcl O
- O
2 O
. O

The O
DF3 B
/ O
MUC1 B
gene O
encodes O
a O
high B
molecular I
weight I
mucin I
- I
like I
glycoprotein I
which O
is O
overexpressed O
at O
the O
transcriptional O
level O
in O
the O
majority O
of O
human O
breast O
cancers O
. O

The O
organization O
of O
the O
MBP B
- I
A I
gene I
is O
very O
similar O
to O
the O
arrangement O
of O
the O
gene O
encoding O
the O
highly O
homologous B
pulmonary I
surfactant I
apoprotein I
, O
although O
one O
of O
the O
intron O
positions O
is O
shifted O
by O
a O
single O
amino O
acid O
. O

Although O
hSSTR5 B
displays O
approximately O
75 O
% O
sequence O
identity O
with O
rat B
SSTR5 I
, O
the O
two O
receptors O
display O
significantly O
different O
pharmacological O
profiles O
, O
especially O
with O
respect O
to O
their O
binding O
affinities O
for O
the O
SST B
analogue O
SMS O
201 O
- O
995 O
. O

Arg O
- O
130 O
, O
Gly O
- O
132 O
and O
Lys O
- O
167 O
are O
conserved O
in O
all O
members O
of O
the O
type B
IB I
topoisomerase I
family I
. O

Four O
cDNAs O
( O
Kox4 B
, O
Kox7 B
, O
Kox12 B
, O
and O
Kox15 B
) O
were O
identified O
that O
match O
one O
or O
more O
genomic O
clones O
; O
these O
matches O
were O
confirmed O
by O
nucleotide O
sequence O
analysis O
. O

Prevalence O
of O
use O
, O
claims O
volume O
, O
and O
expenditures O
were O
compared O
for O
cisapride O
, O
proton O
pump O
inhibitors O
, O
histamine B
- I
2 I
receptor I
antagonists O
, O
and O
the O
prokinetic O
agent O
metoclopramide O
during O
these O
periods O
. O

Sequence O
analysis O
and O
electrophoretic O
mobility O
shift O
experiments O
suggest O
that O
GnSE B
response I
elements I
interact O
, O
in O
these O
two O
regions O
, O
with O
GATA B
- I
and I
LIM I
- I
related I
factors I
, O
respectively O
. O

Wild O
type O
MEKK1 O
enhances O
promoter O
activity O
and O
the O
activity O
can O
be O
inhibited O
by O
dominant O
negative O
MEKK1 O
, O
MEK1 O
, O
MEK7 B
, O
MEK3 B
, O
p38 O
/ O
RK B
, O
and O
c O
- O
Jun O
. O

An O
scrR B
promoter I
fragment I
, O
which O
dose O
not O
contain O
a O
sequence O
resembling O
OB B
, O
was O
not O
shifted O
by O
the O
fusion O
protein O
. O

Using O
the O
conflict O
drinking O
test O
as O
a O
model O
, O
we O
studied O
in O
rats O
the O
effect O
of O
the O
nonselective O
beta O
- O
adrenoceptor O
blockers O
pindolol O
and O
cyanopindolol O
which O
bind O
to O
5 B
- I
HT1A I
and I
5 I
- I
HT1B I
receptors I
, O
and O
of O
the O
selective O
beta B
1 I
- I
and I
beta I
2 I
- I
adrenoceptor I
antagonists O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
which O
have O
a O
negligible O
affinity O
for O
5 B
- I
HT I
receptors I
. O

Glycoprotein O
biosynthesis O
in O
Saccharomyces O
cerevisiae O
: O
ngd29 B
, O
an O
N O
- O
glycosylation O
mutant O
allelic O
to O
och1 B
having O
a O
defect O
in O
the O
initiation O
of O
outer O
chain O
formation O
. O

The O
ZAG1 B
protein I
from O
in O
vitro O
translations O
binds O
to O
a O
consensus O
target O
site O
that O
is O
recognized O
by O
the O
AG B
protein I
. O

The O
uap100 B
cis O
- O
acting O
, O
up O
- O
promoter O
, O
constitutive O
mutation O
is O
a O
duplication O
that O
comprises O
two O
GATA O
sites O
and O
suppresses O
weakly O
the O
AREA B
zinc I
finger I
mutation I
but O
does O
not O
alleviate O
the O
need O
for O
functional O
UAY B
and O
AREA B
proteins I
. O

Indeed O
, O
after O
a O
single O
oral O
dose O
, O
the O
role O
of O
the O
mu B
- I
receptor I
agonist O
component O
of O
the O
antinociceptive O
effect O
of O
tramadol O
appears O
to O
be O
minor O
, O
with O
most O
of O
the O
analgesic O
effect O
being O
attributable O
to O
nonopioid O
properties O
of O
the O
parent O
compound O
. O

We O
have O
produced O
the O
Ure2 B
protein I
to O
high O
yield O
in O
Escherichia O
coli O
from O
a O
synthetic O
gene O
. O

Transfection O
of O
both O
Calu O
- O
6 O
and O
JEG O
- O
3 O
cells O
with O
a O
PKA O
expression O
vector O
resulted O
in O
a O
10 O
- O
fold O
induction O
of O
human B
renin I
transcriptional O
activity O
in O
constructs O
containing O
the O
native O
or O
consensus O
CRE O
and O
5 O
- O
fold O
activation O
in O
a O
construct O
containing O
a O
nonfunctional O
CRE O
. O

Cloning O
and O
sequence O
analysis O
of O
a O
chymotrypsinlike B
protease I
from I
Treponema I
denticola O
. O

V B
- I
ErbB I
- I
mediated I
complex I
formation O
and O
transformation O
have O
been O
shown O
to O
occur O
independently O
of O
Ras O
activation O
. O

Organization O
of O
exons O
suggests O
that O
, O
similar O
to O
the O
human B
VEGF I
gene I
, O
alternative O
splicing O
generates O
the O
120 O
- O
, O
164 O
- O
, O
and O
188 O
- O
amino O
acid O
isoforms O
, O
but O
does O
not O
predict O
a O
fourth O
VEGF B
isoform I
corresponding O
to O
human B
VEGF206 I
. O

Electron O
microscopy O
of O
pH O
7 O
. O
5 O
- O
treated O
TMV O
particles O
incubated O
in O
SPN B
- O
treated O
wheatgerm O
extract O
or O
rabbit O
reticulocyte O
lysate O
, O
showed O
that O
approximately O
10 O
% O
of O
virions O
complexed O
with O
one O
ribosome O
and O
approximately O
10 O
% O
with O
two O
bound O
ribosomes O
, O
confirming O
that O
omega O
at O
least O
had O
been O
uncoated O
. O

Genomic O
organization O
of O
the O
human B
multidrug I
resistance I
( I
MDR1 I
) I
gene I
and O
origin O
of O
P B
- I
glycoproteins I
. O

Since O
nearly O
all O
transformants O
involving O
homeologous O
DNAs O
carried O
a O
single O
recombinant O
plasmid O
in O
both O
Pms B
+ I
and O
Pms B
- I
strains O
, O
stable O
heteroduplex O
DNA O
appears O
less O
likely O
than O
for O
homologous O
DNAs O
. O

One O
new O
ORF O
, O
YBR0224 B
, O
was O
detected O
, O
coding O
for O
a O
protein O
with O
918 O
amino O
acids O
. O

A O
sequence O
- O
ready O
3 O
- O
Mb O
PAC O
contig O
covering O
16 O
breakpoints O
of O
the O
Wilms B
tumor I
/ I
anirida I
region I
of O
human O
chromosome O
11p13 O
. O

The O
MAP B
kinase I
kinase I
kinase I
MLK2 B
co O
- O
localizes O
with O
activated O
JNK O
along O
microtubules O
and O
associates O
with O
kinesin B
superfamily I
motor O
KIF3 B
. O

Although O
polyubiquitin B
chains I
linked O
through O
Lys O
( O
29 O
) O
of O
ubiquitin O
have O
been O
implicated O
in O
the O
targeting O
of O
certain O
substrates O
to O
proteasomes O
, O
the O
signaling O
properties O
of O
these O
chains O
are O
poorly O
understood O
. O

An O
in O
vitro O
Raf O
- O
1 O
kinase O
assay O
, O
however O
, O
failed O
to O
detect O
LPS O
- O
induced O
Raf O
- O
1 O
kinase O
activity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesting O
that O
in O
RAW O
264 O
. O
7 O
cells O
, O
Raf O
- O
1 O
kinase O
is O
not O
an O
activating O
component O
of O
the O
LPS O
signaling O
pathway O
regulating O
MAPK O
activity O
or O
sIL B
- I
1Ra I
promoter I
activity O
. O

Phosphorylation O
of O
the O
ras O
GTPase O
- O
activating O
protein O
( O
GAP O
) O
by O
the O
p93c B
- I
fes I
protein O
- O
tyrosine O
kinase O
in O
vitro O
and O
formation O
of O
GAP O
- O
fes O
complexes O
via O
an O
SH2 O
domain O
- O
dependent O
mechanism O
. O

RET O
/ O
PTC O
oncogenes O
, O
generated O
by O
chromosomal O
rearrangements O
in O
papillary O
thyroid O
carcinomas O
, O
are O
constitutively O
activated O
versions O
of O
proto B
- I
RET I
, O
a O
gene O
coding O
for O
a O
receptor B
- I
type I
tyrosine I
kinase I
( O
TK O
) O
whose O
ligand O
is O
still O
unknown O
. O

Northern O
blot O
analysis O
of O
liver O
, O
muscle O
, O
fat O
, O
and O
pituitary O
RNA O
from O
normal O
( O
DwDw O
) O
chickens O
shows O
a O
major O
transcript O
of O
4 O
. O
3 O
kilobases O
( O
kb O
) O
and O
three O
minor O
transcripts O
( O
0 O
. O
8 O
, O
1 O
. O
7 O
, O
and O
3 O
. O
2 O
kb O
) O
, O
which O
correspond O
to O
the O
cGHR B
. O

The O
Htf9 B
- I
a I
gene I
encodes O
the O
RanBP1 B
protein I
, O
a O
major O
partner O
of O
the O
Ran B
GTPase I
. O

Our O
studies O
suggest O
that O
the O
helicase O
assembly O
protein O
is O
responsible O
for O
loading O
T4 B
gene I
41 I
helicase I
specifically O
at O
replication O
forks O
, O
and O
that O
its O
binding O
sites O
for O
each O
arm O
must O
hold O
more O
than O
six O
, O
but O
not O
more O
than O
12 O
nucleotides O
. O

Previously O
identified O
mutations O
in O
this O
variant O
have O
been O
within O
or O
close O
to O
the O
coding O
region O
of O
exon O
1 O
of O
the O
HMBS B
gene I
, O
the O
only O
exon O
that O
is O
expressed O
solely O
in O
the O
ubiquitous O
isoform O
. O

As O
an O
approach O
to O
the O
determination O
of O
structure O
- O
function O
relationships O
in O
the O
PRP4 B
protein I
, O
we O
have O
isolated O
more O
than O
fifty O
new O
alleles O
of O
the O
PRP4 B
gene I
through O
random O
and O
site O
- O
directed O
mutagenesis O
, O
and O
have O
analyzed O
the O
phenotypes O
of O
many O
of O
them O
. O

We O
find O
that O
Fus3p B
and O
Kss1p B
both O
control O
G1 O
arrest O
through O
multiple O
functions O
that O
operate O
in O
parallel O
with O
Far1p B
. O

The O
time O
- O
dependent O
changes O
in O
measured O
facility O
of O
outflow O
or O
" O
washout O
phenomenon O
" O
appeared O
to O
result O
from O
the O
gradual O
dissolution O
of O
the O
hyaluronidase B
- O
sensitive O
component O
of O
the O
barriers O
to O
aqueous O
outflow O
in O
the O
canine O
eye O
. O

To O
test O
for O
progesterone O
receptor O
- O
mediated O
activation O
of O
transcription O
in O
yeast O
, O
reporter O
plasmids O
were O
constructed O
to O
transform O
yeast O
cells O
expressing O
PRB O
or O
C1C2 B
receptors I
. O

The O
results O
corroborate O
the O
proposed O
physiological O
function O
of O
CCoAOMT B
in O
elicited O
plant O
cells O
and O
may O
shed O
new O
light O
on O
the O
sequential O
action O
of O
trans O
- O
active O
factors O
in O
the O
regulation O
of O
phenylpropanoid O
genes O
. O

In O
src O
- O
transformed O
cells O
GAP O
forms O
heteromeric O
complexes O
, O
notably O
with O
a O
highly O
tyrosine O
phosphorylated O
62 B
- I
kDa I
protein I
( I
p62 I
) I
. O

Cell O
- O
free O
extracts O
of O
E O
. O
coli O
( O
fpg B
mutY O
) O
harboring O
pYSB10 O
possess O
an O
enzymatic O
activity O
that O
cleaves O
a O
34 O
- O
mer O
oligonucleotide O
containing O
a O
single O
8 O
- O
oxoG O
opposite O
a O
cytosine O
( O
8 O
- O
OxoG O
/ O
C O
) O
. O

These O
sequences O
were O
further O
tested O
for O
the O
presence O
of O
an O
enhancer O
element O
, O
by O
their O
ability O
to O
activate O
a O
fusion O
reporter O
gene O
consisting O
of O
the O
CAT O
gene O
linked O
to O
the O
gamma B
- I
globin I
gene I
promoter I
, O
in O
erythroid O
( O
K562 O
) O
and O
non O
- O
erythroid O
( O
HeLa O
) O
cells O
. O

Further O
comparative O
analysis O
identified O
an O
ADNP B
paralog O
( O
33 O
% O
identity O
and O
46 O
% O
similarity O
) O
, O
indicating O
that O
these O
genes O
belong O
to O
a O
novel O
protein O
family O
with O
a O
nine O
- O
zinc O
finger O
motif O
followed O
by O
a O
homeobox O
domain O
. O

Subclones O
stably O
expressing O
alpha1A B
- O
, O
alpha1B B
- O
, O
and O
alpha1D B
- O
ARs O
under O
control O
of O
an O
inducible O
promoter O
, O
or O
at O
high O
and O
low O
receptor O
density O
, O
were O
isolated O
and O
characterized O
. O

Analysis O
of O
WT1 B
target I
gene I
expression O
in O
stably O
transfected O
cell O
lines O
. O

Soluble O
recombinant O
RI O
and O
soluble O
recombinant O
C B
alpha I
can O
associate O
in O
vitro O
and O
be O
activated O
by O
cyclic O
AMP O
. O

IRIS B
/ O
GAS O
DNA O
also O
formed O
a O
number O
of O
specific O
complexes O
with O
constitutively O
expressed O
factors O
, O
none O
of O
which O
were O
affected O
by O
the O
above O
Abs O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
with O
nuclear O
extracts O
from O
COS O
- O
1 O
cells O
transfected O
with O
expression O
vectors O
for O
SMADs B
1 I
- I
5 I
indicate O
that O
SMAD3 O
forms O
a O
complex O
with O
a O
migration O
similar O
to O
that O
of O
the O
endogenous B
TGF I
- I
beta I
- I
specific I
complex I
observed O
in O
fibroblast O
extracts O
. O

The O
newly O
identified O
NF B
kappa I
B I
enhancer I
( O
TGGAAATTCC O
) O
is O
bound O
by O
a O
TNF O
alpha O
- O
induced O
nuclear O
protein O
and O
appears O
to O
be O
the O
key O
element O
in O
rapid O
transcription O
induction O
by O
TNF O
alpha O
( O
and O
TPA O
) O
, O
while O
transactivation O
of O
this O
element O
is O
repressed O
by O
the O
ligand O
- O
bound O
glucocorticoid O
receptor O
. O

The O
polypeptide O
encoded O
by O
the O
cDNA O
contained O
450 O
amino O
acids O
with O
a O
calculated O
M O
( O
r O
) O
of O
52 O
, O
057 O
, O
and O
showed O
significant O
homology O
with O
human O
and O
mouse B
CAD I
( O
22 O
% O
identity O
) O
. O

In O
situ O
localization O
of O
PCP B
- I
A1 I
transcripts I
revealed O
that O
they O
accumulate O
specifically O
in O
pollen O
at O
the O
late O
binucleate O
/ O
trinucleate O
stage O
of O
development O
rather O
than O
in O
the O
tapetum O
, O
which O
previously O
was O
taken O
to O
be O
the O
principal O
source O
of O
the O
pollen O
coat O
. O

Here O
we O
report O
the O
cloning O
, O
by O
either O
peptide O
sequencing O
or O
by O
sequence O
similarity O
to O
the O
human O
cDNAs O
, O
of O
the O
S O
. O
cerevisiae O
genes O
RFC1 B
, O
RFC2 B
, O
RFC3 B
, O
RFC4 B
, O
and O
RFC5 B
. O

This O
sequence O
can O
interact O
with O
at O
least O
two O
proteins O
in O
a O
fibroblast O
nuclear O
extract O
that O
have O
binding O
characteristics O
of O
an O
Ets B
family I
protein I
and O
a O
serum B
response I
factor I
- I
like I
protein I
. O

As O
much O
thrombin O
was O
formed O
during O
cardiopulmonary O
bypass O
( O
measured O
by O
the O
prothrombin B
activation I
fragment I
F1 I
+ I
2 I
and O
thrombin O
- O
antithrombin O
complexes O
) O
as O
in O
normal O
patients O
, O
showing O
that O
factor O
XII O
was O
not O
necessary O
for O
thrombin O
generation O
. O

MUS81 B
encodes O
a O
novel O
helix B
- I
hairpin I
- I
helix I
protein I
involved O
in O
the O
response O
to O
UV O
- O
and O
methylation O
- O
induced O
DNA O
damage O
in O
Saccharomyces O
cerevisiae O
. O

Several O
positive O
clones O
were O
isolated O
, O
one O
of O
which O
encoded O
the O
C O
- O
terminal O
253 O
amino O
acids O
of O
a O
putative O
RNA B
helicase I
, O
a O
DEAD B
box I
protein I
designated O
DDX3 B
. O

In O
vitro O
binding O
studies O
previously O
showed O
that O
NF O
- O
kappa O
B O
p50 O
homodimer O
binds O
the O
switch B
nuclear I
B I
- I
site I
protein I
( O
SNIP B
) O
of O
the O
S B
gamma I
3 I
tandem I
repeat I
. O

It O
is O
concluded O
that O
the O
atherogenic O
process O
includes O
stimulation O
of O
collagen O
and O
elastin B
synthesis O
. O

These O
results O
indicate O
that O
( O
1 O
) O
RXR O
- O
TR O
heterodimers O
play O
a O
role O
in O
basal O
transactivation O
and O
T3 O
suppression O
of O
negatively O
regulated O
genes O
, O
and O
( O
2 O
) O
RXRs B
increase O
the O
dominant O
negative O
effect O
of O
some O
mutant O
TRs O
on O
specific O
negative O
TREs O
. O

Phenotypic O
responses O
of O
additional O
mutants O
, O
including O
exo1 B
, O
srs2 B
, O
rad5 O
, O
and O
rdh54 B
strains O
, O
suggest O
roles O
in O
recombinational O
repair O
, O
but O
not O
in O
NHEJ O
. O

Furthermore O
, O
the O
induction O
of O
cytochrome B
P I
- I
450 I
1A1 I
observed O
in O
the O
cormorant O
indicates O
that O
the O
Ah B
receptor I
- O
mediated O
process O
, O
by O
which O
TCDD O
and O
related O
chemicals O
exert O
many O
of O
their O
toxicities O
, O
has O
been O
activated O
. O

In O
this O
work O
, O
we O
determined O
the O
sequences O
of O
eight O
VirF B
- I
binding I
sites I
from O
four O
different O
genes O
, O
by O
DNase O
I O
or O
hydroxyl O
radical O
footprinting O
. O

Although O
they O
are O
similar O
to O
the O
IL9R B
gene I
( O
approximately O
90 O
% O
identity O
) O
, O
none O
of O
these O
copies O
encodes O
a O
functional O
receptor O
: O
none O
of O
them O
contains O
sequences O
homologous O
to O
the O
5 O
' O
flanking O
region O
or O
exon O
1 O
of O
the O
IL9R B
gene I
, O
and O
the O
remaining O
ORFs O
have O
been O
inactivated O
by O
various O
point O
mutations O
and O
deletions O
. O

To O
investigate O
whether O
the O
two O
RPG B
- I
boxes I
mediate O
transcription O
activation O
of O
both O
the O
L46 B
and O
S24 B
gene I
, O
two O
experimental O
strategies O
were O
followed O
: O
cloning O
of O
the O
respective O
genes O
on O
multicopy O
vectors O
and O
construction O
of O
fusion O
genes O
. O

When O
the O
opioid O
antagonist O
was O
administered O
to O
animals O
24 O
hr O
after O
termination O
of O
single O
or O
multiple O
exposures O
to O
restraint O
, O
NALT O
- O
induced O
increases O
in O
basal O
plasma B
LH I
were O
significantly O
attenuated O
in O
the O
chronically O
stressed O
rats O
compared O
to O
animals O
subjected O
to O
stress O
only O
once O
or O
not O
at O
all O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

This O
was O
further O
suggested O
by O
transactivation O
assays O
in O
which O
mouse O
fibroblasts O
were O
transiently O
transfected O
with O
a O
human B
beta I
- I
globin I
reporter I
gene I
in O
the O
absence O
and O
presence O
of O
an O
LKLF B
cDNA I
construct I
. O

Plasma B
colony I
- I
stimulating I
factor I
analysis O
and O
the O
clinical O
significance O

Thus O
, O
in O
addition O
to O
the O
previously O
characterized O
FAS B
- I
binding I
factor I
1 I
interacting O
with O
the O
inositol O
/ O
choline O
- O
responsive O
- O
element O
motif O
, O
a O
second O
motif O
common O
to O
the O
promoter O
regions O
of O
both O
FAS B
genes I
could O
be O
identified O
. O

Sequence O
analysis O
identifies O
a O
ras B
- I
associating I
( O
RA B
) O
- O
like O
domain O
in O
the O
N O
- O
termini O
of O
band B
4 I
. I
1 I
/ I
JEF I
domains I
and O
in O
the O
Grb7 B
/ I
10 I
/ I
14 I
adapter I
family I
. O

Patients O
received O
BPB O
using O
bupivacaine O
2 O
mg O
kg O
- O
1 O
with O
adrenaline O
1 O
in O
200 O
, O
000 O
, O
either O
with O
or O
without O
hyaluronidase B
3000 O
iu O
, O
in O
a O
volume O
of O
0 O
. O
5 O
ml O
per O
2 O
. O
54 O
cm O
of O
the O
patient O
' O
s O
height O
. O

Rhinovirus B
2A I
protease I
and O
foot B
- I
and I
- I
mouth I
- I
disease I
virus I
L I
protease I
were O
used O
to O
analyze O
the O
association O
of O
eIF4G B
with O
eIF4A O
, O
eIF4E O
, O
and O
eIF3 O
. O

In O
EGF O
receptor O
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt O
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol O
3 O
- O
kinase O
( O
PI O
3 O
- O
kinase O
) O
. O

Immunoprecipitation O
of O
cell O
lysates O
with O
anti B
- I
phosphotyrosine I
and O
immunoblotting O
showed O
phosphorylated O
forms O
of O
the O
mitogenic O
pathway O
proteins O
Shc O
and O
MAPK O
in O
addition O
to O
p185 B
( O
neu O
) O
, O
suggesting O
that O
the O
Ras O
to O
MAPK O
mitogenic O
pathway O
is O
activated O
. O

These O
data O
suggest O
that O
certain O
of O
the O
nuclear O
protein O
import O
functions O
of O
NTF2 O
and O
Ran O
/ O
TC4 B
are O
closely O
linked O
and O
that O
NTF2 O
may O
serve O
to O
modulate O
a O
transport O
step O
involving O
Ran O
/ O
TC4 B
. O

Although O
FKH2 B
is O
redundant O
with O
FKH1 B
in O
controlling O
pseudohyphal O
growth O
, O
the O
two O
genes O
have O
different O
functions O
in O
silencing O
HMRa B
. O

Molecular O
analysis O
indicated O
that O
inactivation O
of O
H B
- I
2L I
expression O
in O
nearly O
every O
null O
clone O
resulted O
from O
an O
apparent O
deletion O
or O
rearrangement O
of O
5 B
' I
- I
flanking I
and I
5 I
' I
- I
coding I
H I
- I
2L I
sequences I
, O
with O
breakpoints O
consistently O
mapping O
to O
within O
a O
550 O
bp O
GC O
- O
rich O
region O
between O
exon O
1 O
and O
the O
middle O
of O
intron O
2 O
. O

However O
, O
the O
molecular O
mechanisms O
by O
which O
specific O
cis O
- O
and O
trans O
- O
acting O
factors O
control O
activity O
of O
the O
prodynorphin B
promoter I
are O
not O
as O
clearly O
defined O
. O

Finally O
, O
antisense O
mediated O
reduction O
of O
Elk O
- O
1 O
in O
GH4 O
cells O
decreased O
insulin O
- O
increased O
prolactin B
gene I
expression O
and O
confirmed O
the O
requirement O
for O
Elk O
- O
1 O
for O
insulin O
- O
increased O
prolactin B
gene I
expression O
. O

cDNA O
cloning O
, O
sequencing O
and O
chromosome O
mapping O
of O
a O
non B
- I
erythroid I
spectrin I
, O
human B
alpha I
- I
fodrin I
. O

The O
aromatic B
hydrocarbon I
receptor I
( O
AHR O
) O
is O
a O
ligand O
- O
activated O
transcription O
factor O
that O
regulates O
the O
expression O
of O
several O
drug O
- O
metabolizing O
enzymes O
and O
has O
been O
implicated O
in O
immunosuppression O
, O
teratogenesis O
, O
cell O
- O
specific O
hyperplasia O
, O
and O
certain O
types O
of O
malignancies O
and O
toxicities O
. O

Moreover O
, O
FACT B
specifically O
interacts O
with O
nucleosomes O
and O
histone O
H2A O
/ O
H2B O
dimers O
, O
indicating O
that O
it O
may O
work O
by O
promoting O
nucleosome O
disassembly O
upon O
transcription O
. O

ER O
and O
DR O
were O
significantly O
correlated O
with O
MIB B
- I
1 I
LI O
( O
P O
< O
0 O
. O
01 O
and O
P O
< O
0 O
. O
05 O
, O
respectively O
) O
, O
but O
RI O
and O
Td O
/ O
Te O
were O
not O
. O

The O
program O
for O
myogenic O
differentiation O
is O
subject O
to O
negative O
control O
by O
several O
peptide O
growth O
factors O
and O
by O
the O
products O
of O
mutationally O
activated O
ras B
oncogenes I
, O
which O
persistently O
activate O
intracellular O
cascades O
normally O
triggered O
by O
specific O
growth O
factors O
. O

Mutation O
of O
the O
distal O
E2F O
binding O
site O
in O
the O
cdc25A B
promoter I
abolished O
E2 O
- O
induced O
repression O
, O
whereas O
mutation O
of O
the O
proximal O
E2F B
site I
or O
the O
E2 O
site O
had O
no O
effect O
. O

Plasmid O
pNK21 O
, O
in O
which O
2 O
. O
05 O
- O
kb O
sequence O
covering O
the O
region O
encoding O
the O
nitrilase B
was O
was O
placed O
under O
the O
control O
of O
the O
lac O
promoter O
, O
directed O
overproduction O
of O
enzymatically B
active I
nitrilase I
in O
response O
to O
addition O
of O
isopropyl O
beta O
- O
D O
- O
thiogalactopyranoside O
in O
Escherichia O
coli O
. O

Insertion O
of O
alternatively O
spliced O
exon O
W O
into O
CREB B
mRNA I
during O
spermatogenesis O
results O
in O
a O
polycistronic O
RNA O
that O
encodes O
two O
novel O
internally O
translated O
CREB B
repressor I
isoforms I
called O
I B
- I
CREBs I
, O
consisting O
of O
the O
carboxy O
- O
terminal O
DNA O
- O
binding O
domain O
devoid O
of O
the O
transactivation O
domains O
. O

Consistent O
with O
this O
hypothesis O
, O
alpha1 B
- I
PDX I
prevents O
cleavage O
of O
BMP O
- O
4 O
in O
an O
oocyte O
translation O
assay O
. O

A O
p53 B
cDNA I
deletion O
mutant O
( O
delta O
pro O
AE O
) O
, O
which O
lacks O
this O
entire O
proline O
- O
rich O
domain O
( O
deleted O
for O
amino O
acids O
62 O
- O
91 O
) O
, O
was O
created O
and O
characterized O
for O
a O
variety O
of O
p53 O
functions O
. O

Multiple O
aortic O
thrombi O
associated O
with O
protein O
C O
and O
S B
deficiency O
. O

Our O
results O
suggest O
that O
Bry1 B
/ O
Skn7 B
can O
influence O
the O
expression O
of O
MCB O
- O
and O
SCB O
- O
driven O
gene O
expression O
in O
budding O
yeast O
, O
perhaps O
including O
genes O
involved O
in O
cell O
wall O
metabolism O
, O
via O
a O
two O
- O
component O
signal O
transduction O
pathway O
which O
activates O
Bry1 B
/ O
Skn7 B
in O
response O
to O
an O
unidentified O
signal O
. O

A O
constructed O
phylogenetic O
tree O
suggests O
that O
the O
UbcP1 B
protein I
may O
represent O
a O
member O
of O
a O
distinct O
subfamily O
of O
E2s B
. O

Platelet B
factor I
4 I
levels O
in O
patients O
with O
coronary O
artery O
disease O
. O

We O
functionally O
characterised O
AtXPO1 B
by O
its O
interaction O
with O
NESs O
of O
animal O
and O
plant O
proteins O
, O
which O
is O
inhibited O
by O
the O
cytotoxin O
leptomycin O
B O
( O
LMB O
) O
, O
and O
also O
by O
its O
interaction O
with O
the O
small O
GTPase O
Ran1 B
in O
the O
yeast O
two O
- O
hybrid O
system O
. O

The O
expression O
of O
cor14b B
was O
strongly O
impaired O
in O
the O
barley O
albino O
mutant O
an O
, O
suggesting O
the O
involvement O
of O
a O
plastidial O
factor O
in O
the O
control O
of O
gene O
expression O
. O

In O
addition O
, O
the O
results O
suggest O
that O
N O
region O
diversity O
at O
V B
( O
D B
) O
J B
junctions O
within O
rearranged O
immunoglobulin O
and O
T B
cell I
receptor I
gene I
loci I
can O
only O
be O
introduced O
after O
the O
generation O
of O
RAG O
- O
catalyzed O
DNA O
double O
- O
strand O
breaks O
, O
i O
. O
e O
. O
during O
the O
DNA O
end O
joining O
phase O
of O
the O
V B
( O
D B
) O
J B
recombination O
reaction O
. O

We O
have O
now O
isolated O
cDNA O
for O
an O
invertebrate B
Pax I
- I
6 I
protein I
from I
sea I
urchin I
embryos I
. O

To O
study O
structural O
diversity O
of O
the O
three O
homologous O
loci O
encoding O
a O
KN1 B
- I
like I
homeobox I
protein I
in O
the O
hexaploid O
wheat O
genome O
, O
we O
isolated O
clones O
from O
a O
cDNA O
library O
of O
young O
spikes O
of O
Japanese O
common O
wheat O
cultivar O
' O
Norin O
26 O
' O
. O

Whether O
or O
not O
these O
novel O
repeated O
sequences O
throughout O
the O
SMA B
region I
are O
involved O
in O
the O
disease O
remains O
to O
be O
determined O
. O

However O
, O
elimination O
of O
the O
kinase O
activity O
of O
DCAMKL1 B
has O
no O
detectable O
effect O
on O
its O
microtubule O
polymerization O
activity O
. O

We O
have O
thus O
cloned O
two O
yeast O
homologs O
of O
mammalian B
p220 I
. O

The O
glucose O
effect O
on O
the O
pyruvate B
kinase I
gene I
is O
reversibly O
antagonized O
by O
agents O
increasing O
intracellular O
cAMP O
. O

Coexpression O
of O
CREB O
- O
binding O
protein O
( O
CBP O
) O
/ O
p300 O
with O
TReP B
- I
132 I
has O
an O
additive O
effect O
on O
promoter O
activity O
, O
and O
the O
proteins O
were O
demonstrated O
to O
interact O
physically O
. O

Recent O
developments O
in O
the O
study O
of O
growth O
factors O
: O
GRF O
and O
somatomedins B
. O

Acetoacetate B
decarboxylase I
( O
ADC B
) O
( O
EC4 B
. I
1 I
. I
1 I
. I
4 I
) O
of O
Clostridium O
acetobutylicum O
DSM O
792 O
was O
purified O
to O
homogeneity O
, O
and O
its O
first O
25 O
N O
- O
terminal O
amino O
acids O
were O
determined O
. O

The O
sequence O
of O
the O
127 B
residue I
NrfF I
polypeptide I
, I
M I
( I
r I
) I
14 I
, I
522 I
, O
is O
strikingly O
similar O
to O
the O
CcI2 B
protein I
of O
R O
. O
capsulatus O
, O
especially O
in O
the O
putative O
haem O
- O
binding O
motif O
, O
RCPQCQNQN O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

CAT O
assays O
demonstrated O
that O
overexpression O
of O
RXRalpha O
conferred O
the O
best O
RA O
response O
, O
consistent O
with O
our O
previous O
observation O
that O
9 O
- O
cis O
- O
RA O
is O
more O
potent O
than O
all O
- O
trans O
- O
RA O
for O
inducing O
the O
expression O
of O
the O
AFP B
gene I
. O

Each O
fusion O
leads O
, O
in O
principle O
, O
to O
the O
same O
effect O
: O
The O
ret B
tyrosine I
kinase I
is O
uncoupled O
from O
its O
stringent O
physiological O
regulation O
by O
replacement O
of O
its O
5 O
' O
end O
and O
is O
aberrantly O
activated O
by O
the O
5 O
' O
parts O
of O
fused O
genes O
in O
thyrocytes O
that O
do O
not O
normally O
express O
ret B
tyrosine I
kinase I
. O

In O
the O
predicted O
amino O
acid O
sequence O
of O
NPS1 B
, O
sequences O
homologous O
to O
the O
catalytic O
domain O
of O
protein O
kinases O
were O
found O
. O

Carcinoma B
- I
related I
protein I
production O
may O
have O
played O
a O
role O
in O
the O
development O
of O
the O
observed O
renal O
lesions O
. O

These O
results O
provide O
strong O
evidence O
that O
conserved O
interhelical O
packing O
interactions O
in O
the O
gp41 B
core I
are O
important O
determinants O
of O
HIV O
- O
1 O
entry O
and O
its O
inhibition O
. O

Like O
the O
human B
erythrocyte I
P4 I
. I
2 I
, O
mouse B
erythrocyte I
P4 I
. I
2 I
contains O
regions O
strikingly O
homologous O
with O
the O
transglutaminase O
( O
TGase O
) O
proteins O
although O
it O
too O
most O
likely O
lacks O
TGase O
crosslinking O
activity O
. O

Nine O
months O
after O
the O
end O
of O
the O
vaccination O
anti B
- I
HBsAg I
levels O
had O
dropped O
to O
9 O
+ O
/ O
- O
4 O
IU O
/ O
1 O
( O
M O
+ O
/ O
- O
SE O
) O
, O
with O
a O
geometric O
mean O
of O
5 O
IU O
/ O
1 O
, O
in O
the O
nine O
remaining O
evaluable O
patients O
. O

DRAP27 B
is O
recognized O
by O
CD9 B
antibodies I
. O

Control O
oligomers O
of O
scrambled O
sequence O
but O
identical O
base O
composition O
were O
ineffective O
, O
and O
no O
TFO O
- O
induced O
recombination O
was O
seen O
in O
a O
control O
LTK O
( O
- O
) O
cell O
line O
carrying O
an O
otherwise O
identical O
dual O
TK B
gene I
construct I
lacking O
the O
30 O
- O
bp O
polypurine O
target O
site O
. O

These O
three O
chromosomes O
share O
the O
transferrin B
gene I
( O
TF O
) O
, O
the O
myosin B
light I
polypeptide I
3 I
gene I
( O
MYL3 B
) O
, O
and O
the O
acylpeptide B
hydrolase I
gene I
( O
APEH B
) O
. O

These O
data O
indicate O
that O
SB O
203580 O
sensitive O
p38 B
MAP I
kinases I
are O
not O
involved O
in O
okadaic O
acid O
mediated O
increases O
in O
TRE O
DNA O
binding O
and O
transactivation O
. O

Together O
, O
these O
results O
indicate O
that O
YTS1 B
is O
a O
bifunctional O
protein O
active O
in O
both O
splicing O
and O
protein O
synthesis O
. O

Sgs B
- I
4 I
is O
one O
of O
the O
eight O
known O
genes O
coding O
for O
larval O
secretion O
proteins O
in O
Drosophila O
melanogaster O
. O

Human B
myotonic I
dystrophy I
protein I
kinase I
( O
DMPK B
) O
is O
a O
member O
of O
a O
novel O
class O
of O
multidomain O
protein O
kinases O
that O
regulate O
cell O
size O
and O
shape O
in O
a O
variety O
of O
organisms O
. O

The O
human B
BRCA1 I
promoter I
also O
contains O
a O
conserved O
E2F B
site I
and O
is O
similarly O
regulated O
by O
E2F1 O
and O
Rb O
. O

The O
translated O
sequence O
of O
the O
FLI B
LRR I
associated I
protein I
( O
FLAP B
) O
encodes O
a O
novel O
protein O
not O
represented O
in O
the O
data O
base O
. O

In O
this O
respect O
, O
the O
promoter O
structure O
of O
COX B
genes I
resemble O
those O
of O
many O
house O
- O
keeping O
genes O
. O

Using O
unidirectional O
PCR O
we O
isolated O
a O
361 O
- O
bp O
5 O
' O
promoter O
region O
and O
delineated O
the O
intronic O
/ O
exonic O
boundaries O
which O
include O
a O
non O
- O
coding O
exon O
1 O
, O
a O
single O
intron O
, O
and O
a O
coding O
exon O
2 O
, O
a O
structure O
that O
is O
typical O
of O
genes O
of O
the O
RNase B
A I
superfamily I
. O

When O
severe O
hypoxia O
was O
acutely O
produced O
by O
ventilation O
with O
low O
- O
oxygen O
mixtures O
in O
experimental O
( O
PaO2 O
, O
23 O
. O
7 O
+ O
/ O
- O
1 O
. O
7 O
torr O
) O
and O
control O
animals O
( O
PaO2 O
, O
26 O
. O
3 O
+ O
/ O
- O
1 O
. O
0 O
torr O
) O
, O
plasma B
insulin I
responses O
were O
markedly O
inhibited O
in O
both O
. O

Uptake O
of O
colicins B
required O
different O
domains O
in O
TonB B
, O
for O
colicin B
B I
and I
M I
around O
residue O
160 O
and O
for O
colicin B
Ia I
, O
a O
domain O
closer O
to O
the O
C O
- O
terminal O
end O
. O

Cells O
were O
cotransfected O
with O
this O
plasmid O
, O
and O
the O
appropriate O
responder O
plasmids O
and O
clonies O
were O
selected O
on O
the O
basis O
of O
their O
resistance O
to O
Geneticin O
( O
via O
the O
neomycin B
aminoglycoside I
phosphotransferase I
gene I
) O
. O

This O
C O
- O
terminal O
domain O
contains O
several O
YxxI O
/ O
L O
motifs O
reminiscent O
of O
LMP2A O
and O
a O
putative O
TRAF B
binding I
site I
as O
in O
LMP1 O
. O

This O
mutation O
was O
associated O
with O
reduced O
or O
absent O
expression O
of O
TGF B
- I
beta I
RI I
protein I
and O
p53 O
protein O
in O
tumor O
tissues O
. O

SCAN B
boxes O
are O
found O
in O
eight O
other O
genes O
in O
the O
GenBank O
database O
, O
five O
of O
which O
are O
also O
in O
the O
Kruppel B
family I
of O
zinc B
finger I
proteins I
lacking O
KRAB B
A I
and I
B I
domains O
and O
thereby O
define O
a O
new O
subclass O
of O
zinc B
finger I
proteins I
. O

YACs O
selected O
from O
our O
contig O
will O
be O
the O
starting O
point O
for O
the O
cloning O
of O
the O
LGMD2B B
gene I
and O
thereby O
establish O
the O
biological O
basis O
for O
this O
form O
of O
muscular O
dystrophy O
and O
its O
relationship O
with O
the O
other O
limb O
- O
girdle O
muscular O
dystrophies O
. O

The O
amount O
of O
ERCC1 B
detectable O
by O
immunoblotting O
is O
reduced O
in O
group O
1 O
, O
group O
4 O
and O
XP O
- O
F O
extracts O
. O

In O
the O
plant B
malate I
synthases I
, O
the O
extension O
is O
probably O
involved O
in O
routing O
to O
the O
microbodies O
, O
since O
it O
contains O
the O
potential O
peroxisomal O
targeting O
signal O
, O
Ser O
- O
Arg O
/ O
Lys O
- O
Leu O
, O
at O
the O
carboxy O
terminus O
. O

Optimized O
USF O
and O
MYC O
DNA O
- O
binding O
sites O
, O
which O
differ O
in O
the O
nucleotides O
bordering O
the O
hexanucleotide O
box O
displace O
the O
E B
- I
C4 I
factor I
in O
competition O
assays O
but O
with O
lesser O
efficiency O
than O
the O
E B
- I
C4 I
site I
itself O
. O

Screening O
of O
human O
cDNA O
libraries O
has O
identified O
two O
different O
5 O
' O
- O
termini O
and O
alternatively O
spliced O
forms O
of O
the O
human B
Fli I
- I
1 I
gene I
( O
Fli B
- I
1b I
) O
, O
suggesting O
the O
possible O
existence O
of O
two O
independent O
promoters O
. O

After O
5 O
- O
h O
thermal O
induction O
of O
cells O
carrying O
the O
runaway O
recombinant O
pBS1 O
, O
protein B
B2 I
constituted O
40 O
% O
of O
the O
soluble O
protein O
fraction O
of O
the O
cells O
. O

A O
regulatory O
element O
of O
the O
empty B
spiracles I
homeobox O
gene O
is O
composed O
of O
three O
distinct O
conserved O
regions O
that O
bind O
regulatory O
proteins O
. O

Most O
interestingly O
, O
although O
the O
effector O
plasmid O
containing O
the O
ICP27 B
gene I
had O
little O
effect O
on O
its O
own O
, O
two O
different O
and O
marked O
effects O
depending O
on O
the O
target O
were O
observed O
when O
ICP27 O
was O
combined O
with O
ICP4 O
or O
ICP0 O
or O
both O
. O

TOM1 B
encodes O
a O
member O
of O
the O
hect B
- O
domain O
- O
containing O
E3 O
ubiquitin B
- I
protein I
ligase I
family O
that O
is O
required O
for O
growth O
at O
elevated O
temperatures O
. O

Genomic O
clones O
containing O
the O
C O
. O
briggsae O
gene O
are O
able O
to O
completely O
rescue O
the O
unc B
- I
119 I
phenotype I
in O
transgenic O
C O
. O
elegans O
mutants O
. O

Region O
- O
specific O
enhancers O
near O
two O
mammalian B
homeo I
box I
genes I
define O
adjacent O
rostrocaudal O
domains O
in O
the O
central O
nervous O
system O
. O

In O
this O
study O
, O
we O
report O
the O
cloning O
and O
sequencing O
of O
several O
overlapping O
cDNAs O
encoding O
approximately O
4 O
. O
1 O
kb O
of O
the O
human B
homologue I
of I
Wnt I
- I
5A I
. O

Subtype O
- O
and O
response O
element O
- O
dependent O
differences O
in O
transactivation O
by O
peroxisome B
proliferator I
- I
activated I
receptors I
alpha I
and I
gamma I
. O

We O
suggest O
that O
the O
induction O
of O
IFNA B
promoter I
region I
requires O
cooperation O
between O
alpha B
F1 I
binding I
proteins I
and O
IRF O
- O
1 O
. O

Heterologous O
hybridization O
with O
a O
rps12 B
gene I
specific O
probe O
from O
Euglena O
has O
revealed O
the O
presence O
of O
rps12 B
homologous I
sequences I
within O
the O
inverted O
repeat O
of O
Spirodela O
chloroplast O
DNA O
on O
the O
fragment B
BamHI I
- I
V I
. O

This O
raises O
the O
possibility O
that O
recombination O
occurred O
between O
corresponding O
LTR O
and O
vif B
loci I
of O
the O
quasi O
- O
species O
present O
in O
the O
isolates O
described O
here O
. O

In O
HMEC O
stably O
transfected O
with O
an O
ER B
mutant I
containing O
a O
deletion O
in O
the O
second O
zinc O
finger O
of O
the O
DNA O
- O
binding O
domain O
, O
E O
and O
HT O
had O
different O
effects O
on O
EBBP B
gene I
expression O
; O
EBBP B
regulation O
by O
E O
was O
dramatically O
reduced O
while O
the O
effects O
of O
HT O
were O
augmented O
. O

The O
gene B
atp6 I
, O
encoding O
subunit O
6 O
of O
the O
mitochondrial O
F0 B
- O
ATPase O
complex O
, O
has O
been O
characterized O
from O
both O
the O
normal O
( O
fertile O
) O
and O
Ogura O
( O
male O
- O
sterile O
) O
radish O
cytoplasms O
in O
order O
to O
determine O
if O
previously O
identified O
atp6 O
transcriptional O
differences O
could O
play O
a O
role O
in O
cytoplasmic O
male O
sterility O
. O

Hpr1 B
forms O
, O
together O
with O
Tho2 B
, O
Mft1 B
, O
and O
Thp2 B
, O
the O
THO B
complex I
, O
which O
controls O
transcription O
elongation O
and O
genome O
stability O
in O
Saccharomyces O
cerevisiae O
. O

UPR O
elements O
present O
in O
other O
ER O
chaperone O
genes O
, O
such O
as O
yeast B
KAR2 I
( O
BiP O
) O
, O
mammalian B
GRP78 I
( O
BiP O
) O
, O
and O
GRP94 B
, O
function O
in O
an O
analogous O
manner O
to O
that O
in O
FKB2 B
. O

Strains O
carrying O
a O
snf1 B
mutation I
are O
unable O
to O
grow O
on O
sucrose O
, O
galactose O
, O
maltose O
, O
melibiose O
, O
or O
nonfermentable O
carbon O
sources O
; O
utilization O
of O
these O
carbon O
sources O
is O
regulated O
by O
glucose O
repression O
. O

Plasmid O
subclones O
of O
the O
hr1a B
- O
containing O
AcMNPV O
HindIII O
- O
N O
fragment O
were O
examined O
for O
their O
ability O
to O
replicate O
in O
virus O
- O
infected O
( O
Spodoptera O
frugiperda O
) O
Sf9 O
cells O
, O
and O
to O
stimulate O
transcription O
when O
linked O
in O
cis O
with O
a O
39K B
gene I
promoter I
- I
beta I
- I
glucuronidase I
fusion I
and O
cotransfected O
into O
cells O
along O
with O
a O
plasmid O
( O
ple O
- O
1 O
) O
containing O
the O
gene O
encoding O
the O
trans O
- O
acting O
factor O
IE B
- I
1 I
. O

Transfection O
of O
H B
chain I
loss I
variant I
myeloma O
with O
the O
complete O
12 O
kb O
construct O
, O
termed O
238H B
- I
Cmicro I
, O
resulted O
in O
secretion O
of O
intact O
Ig O
pairing O
238H B
- I
Cmicro I
, O
with O
a O
lambda B
L I
chain I
; O
however O
, O
transfectant B
Ig I
lacked O
autoreactivity O
and O
pathogenicity O
. O

In O
normal O
B O
cells O
stimulated O
by O
LPS O
or O
IL O
- O
4 O
, O
new O
complexes O
appear O
that O
bind O
to O
C O
/ O
EBP O
and O
NF B
- I
IL I
- I
4 I
elements I
, O
respectively O
, O
located O
within O
the O
- O
125 O
/ O
- O
101 O
region O
. O

Here O
, O
we O
describe O
the O
crystal O
structure O
at O
2 O
. O
5 O
A O
resolution O
of O
a O
fragment O
of O
the O
integrase B
of I
Rous I
sarcoma I
virus I
( I
residues I
49 I
- I
286 I
) I
containing O
both O
the O
conserved O
catalytic O
domain O
and O
a O
modulatory O
DNA O
- O
binding O
domain O
( O
C O
domain O
) O
. O

The O
B B
. I
aphidicola I
argS I
- I
rrn I
DNA I
fragments I
from O
endosymbionts O
from O
seven O
species O
of O
aphids O
had O
promoter O
activities O
in O
E O
. O
coli O
which O
ranged O
from O
6 O
to O
135 O
% O
of O
that O
observed O
with O
a O
comparable O
DNA O
fragment O
of O
E B
. I
coli I
rrnB I
. O

Role O
of O
the O
CCAAT B
/ I
enhancer I
binding I
protein I
- I
alpha I
transcription I
factor I
in O
the O
glucocorticoid O
stimulation O
of O
p21waf1 O
/ O
cip1 O
gene O
promoter O
activity O
in O
growth O
- O
arrested O
rat O
hepatoma O
cells O
. O

The O
highly O
conserved O
region O
of O
U6 B
snRNA I
has O
a O
structural O
similarity O
with O
the O
catalytic O
domain O
of O
the O
negative O
strand O
of O
the O
satellite O
RNA O
of O
tobacco O
ring O
spot O
virus O
[ O
( O
- O
) O
sTRSV O
] O
, O
suggesting O
that O
the O
highly O
conserved O
region O
of O
U6 B
snRNA I
forms O
the O
catalytic O
center O
. O

Here O
we O
show O
that O
one O
nudF B
suppressor I
also O
suppresses O
hs O
- O
mutations O
in O
nudA B
, O
nudC B
, O
and O
nudG B
and O
deletions O
in O
nudA B
and O
nudF B
. O

Treatment O
of O
cells O
for O
10 O
min O
with O
TNF O
- O
alpha O
resulted O
in O
activation O
of O
p44 B
/ I
42 I
MAPK O
, O
p38 O
, O
and O
JNK O
. O

This O
report O
describes O
the O
isolation O
and O
recombinant O
expression O
of O
a O
cDNA O
clone O
encoding O
HER4 B
, O
the O
fourth O
member O
of O
the O
human B
epidermal I
growth I
factor I
receptor I
( O
EGFR O
) O
family O
. O

Excess O
recombinant B
PTB I
squelches O
the O
splicing O
switch O
and O
reestablishes O
exon O
skipping O
as O
the O
predominant O
splicing O
pathway O
. O

A O
child O
presumed O
to O
have O
the O
21 B
- I
hydroxylase I
deficiency O
form O
of O
congenital O
adrenal O
hyperplasia O
was O
studied O
extensively O
as O
an O
infant O
. O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

the O
rabbit B
beta I
- I
globin I
gene I
. O

Deletion O
analysis O
of O
the O
3 O
. O
5kb O
DNA O
fragment O
revealed O
that O
the O
region O
between O
- O
125 O
to O
+ O
1 O
, O
containing O
a O
single O
Sp1 O
binding O
site O
, O
is O
essential O
for O
transcription O
of O
the O
embigin B
gene I
. O

Activated O
FGFR3 O
predominantly O
interacts O
with O
GRB2 B
. I
Sos I
in O
complex O
with O
a O
previously O
identified O
90 O
- O
kDa O
protein O
and O
designated O
protein B
80K I
- I
H I
. O

Evidence O
for O
a O
role O
of O
Smad6 B
in O
chick O
cardiac O
development O
. O

The O
LIF B
appeared O
to O
be O
released O
by O
the O
patient O
' O
s O
peripheral O
blood O
lymphocytes O
when O
cultured O
with O
optimal O
doses O
of O
propranolol O
. O

Co O
- O
expression O
of O
PLD1 O
in O
COS O
- O
7 O
cells O
with O
the O
two O
recombinant B
CK2 I
subunits I
, O
alpha O
or O
beta O
, O
suggests O
that O
the O
association O
of O
PLD1 O
with O
the O
kinase O
is O
through O
the O
beta O
subunit O
. O

Human B
recombinant I
erythropoietin I
( O
r O
- O
HuEPO O
, O
EprexR B
) O
was O
administered O
to O
8 O
children O
with O
chronic O
renal O
failure O
and O
high O
transfusion O
requirement O
. O

Northern O
analyses O
further O
confirm O
that O
the O
expression O
of O
endogenous O
alpha B
- I
ENaC I
gene I
in O
salivary O
Pa O
- O
4 O
cells O
is O
suppressed O
by O
an O
ectopic O
HMGI O
- O
C O
overexpression O
. O

Removal O
of O
cyclin B
- I
dependant I
kinases I
( O
cdks O
) O
or O
cdk2 O
from O
these O
extracts O
using O
affinity O
matrices O
severely O
inhibits O
initiation O
of O
S O
phase O
. O

Gel O
mobility O
shift O
analyses O
reveal O
that O
FRTL O
- O
5 O
thyroid O
cell O
nuclear O
extracts O
form O
a O
specific O
protein O
/ O
DNA O
complex O
with O
this O
region O
, O
which O
is O
prevented O
by O
the O
TTF B
- I
1 I
binding I
element I
from O
the O
TG B
promoter I
; O
FRT O
and O
BRL O
cell O
nuclear O
extracts O
do O
not O
have O
TTF O
- O
1 O
and O
do O
not O
form O
this O
complex O
. O

The O
Sty1 B
kinase I
is O
stimulated O
by O
a O
variety O
of O
different O
stress O
conditions O
including O
osmotic O
and O
oxidative O
stress O
and O
heat O
shock O
. O

Comparison O
of O
the O
genes O
coding O
for O
mouse O
and O
human O
p36 O
( O
annexin B
II I
) O
and O
mouse O
, O
rat O
and O
human O
p35 O
( O
annexin B
I I
) O
and O
pigeon O
cp35 B
( O
an O
annexin B
I I
- I
related I
protein I
) O
shows O
strong O
genomic O
structural O
conservation O
supporting O
the O
hypothesis O
that O
these O
genes O
had O
a O
common O
ancestor O
. O

Collectively O
, O
these O
studies O
suggest O
that O
the O
major O
EGF O
- O
stimulated O
mitotic O
growth O
pathways O
may O
not O
be O
absolutely O
linked O
to O
the O
stat91 B
signaling O
pathways O
and O
that O
such O
transcription O
complexes O
are O
more O
complex O
than O
previously O
reported O
. O

The O
oxalate B
oxidase I
method O
results O
in O
a O
mean O
and O
reference O
interval O
for O
oxalate O
excretion O
that O
are O
comparable O
with O
those O
by O
isotope O
dilution O
, O
gas O
- O
chromatographic O
, O
colorimetric O
, O
and O
other O
enzymic O
procedures O
. O

The O
amino O
acid O
sequence O
of O
the O
protein O
encoded O
by O
MSK1 O
is O
homologous O
to O
yeast B
cytoplasmic I
lysyl I
- I
tRNA I
synthetase I
and O
to O
the O
product O
of O
the O
herC B
gene I
, O
which O
has O
recently O
been O
suggested O
to O
code O
for O
the O
Escherichia O
coli O
enzyme O
. O

Similar O
to O
the O
D B
, O
B O
/ O
B O
' O
and O
E B
proteins I
, O
the O
F O
and O
G O
proteins O
do O
not O
possess O
any O
of O
the O
known O
RNA O
binding O
motifs O
, O
suggesting O
that O
other O
types O
of O
RNA O
- O
protein O
interactions O
occur O
in O
the O
snRNP O
core O
. O

These O
observations O
suggest O
that O
clr4 B
+ I
and O
rik1 B
+ I
must O
play O
a O
role O
in O
the O
assembly O
of O
Swi6p B
into O
a O
transcriptionally O
silent O
, O
inaccessible O
chromatin O
structure O
at O
fission O
yeast O
centromeres O
which O
is O
required O
to O
facilitate O
interactions O
with O
spindle O
microtubules O
and O
to O
ensure O
normal O
chromosome O
segregation O
. O

Characterization O
of O
a O
DEAD B
box I
ATPase I
/ O
RNA B
helicase I
protein O
of O
Arabidopsis O
thaliana O
. O

Neither O
symptoms O
, O
virions O
, O
nor O
viral O
RNA O
was O
detectable O
in O
plants O
inoculated O
with O
this O
mutant O
or O
a O
mutant O
with O
a O
frameshift O
mutation O
in O
the O
coat B
gene I
. O

The O
AtNMT1 B
expression O
profile O
indicated O
ubiquity O
in O
roots O
, O
stem O
, O
leaves O
, O
flowers O
, O
and O
siliques O
( O
approximately O
1 O
. O
7 O
kb O
transcript O
and O
approximately O
50 O
kDa O
immunoreactive O
polypeptide O
) O
but O
a O
greater O
level O
in O
the O
younger O
tissue O
, O
which O
are O
developmentally O
very O
active O
. O

Following O
replicate O
control O
measurements O
, O
test O
ramps O
were O
repeated O
in O
the O
presence O
of O
sodium O
nitroprusside O
( O
1 O
microM O
) O
and O
phentolamine O
( O
1 O
microM O
) O
to O
eliminate O
potential O
smooth O
muscle O
and O
alpha B
1 I
- I
adrenoceptor I
effects O
, O
respectively O
. O

Further O
analysis O
of O
the O
CAP59 B
locus I
of I
Cryptococcus I
neoformans I
: O
structure O
defined O
by O
forced O
expression O
and O
description O
of O
a O
new O
ribosomal B
protein I
- I
encoding I
gene I
. O

We O
speculate O
that O
the O
enhancing O
effect O
of O
glucose O
and O
galactose O
on O
fructose O
absorption O
may O
be O
due O
to O
activation O
of O
the O
fructose B
carrier I
. O

The O
DFGF B
- I
R I
protein I
may O
thus O
participate O
in O
receiving O
spatial O
cues O
that O
guide O
tracheal O
cell O
outgrowth O
. O

The O
NS B
- I
2 I
isoforms I
were O
resolved O
at O
a O
pI O
value O
close O
to O
5 O
. O
5 O
as O
three O
groups O
of O
unevenly O
phosphorylated O
polypeptides O
, O
each O
composed O
of O
at O
least O
two O
protein O
species O
. O

A O
. O
nidulans O
transformants O
secreted O
high O
amounts O
of O
PGI B
and O
PGII B
in O
comparison O
to O
the O
previously O
characterized O
A O
. O
niger O
transformants O
and O
a O
novel O
polygalacturonase B
( O
PGC B
) O
was O
produced O
at O
high O
levels O
by O
A O
. O
nidulans O
transformed O
with O
the O
subcloned O
pgaC B
gene I
. O

The O
orf2 O
gene O
product O
is O
a O
protein O
of O
79 O
amino O
acids O
with O
characteristics O
similar O
to O
those O
of O
the O
Tat O
( O
transactivator B
) O
proteins O
of O
the O
ungulate O
lentiviruses O
. O

Rac2 O
, O
a O
member O
of O
the O
Rho O
family O
of O
GTPases O
, O
is O
highly O
expressed O
in O
myeloid O
cells O
and O
is O
a O
regulator O
of O
the O
NADPH B
- I
oxidase I
complex I
. O

KatA B
, O
AhpCF B
, O
heme O
biosynthesis O
enzymes O
, O
and O
MrgA B
are O
also O
induced O
upon O
entry O
into O
stationary O
phase O
under O
conditions O
of O
iron O
and O
manganese O
limitation O
. O

This O
region O
shows O
46 O
% O
identity O
with O
the O
calmodulin B
- I
binding I
region I
of O
rat B
brain I
Ca2 I
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinase I
II I
and O
32 O
% O
identity O
with O
the O
equivalent O
region O
of O
chicken B
smooth I
muscle I
myosin I
light I
chain I
kinase I
. O

It O
contains O
31 O
exons O
and O
a O
high O
proportion O
of O
class O
0 O
introns O
, O
alternative O
splicing O
of O
which O
results O
in O
significant O
levels O
of O
variant O
transcripts O
that O
maintain O
the O
original O
open O
reading O
frame O
of O
MRP B
mRNA I
. O

The O
distinct O
spatial O
pattern O
of O
expression O
, O
and O
unusual O
amino O
acid O
sequence O
in O
its O
DNA O
binding O
domain O
, O
may O
indicate O
a O
particular O
role O
for O
DTEF B
- I
1 I
in O
cell O
- O
specific O
gene O
regulation O
. O

Scleraxis B
overexpression O
enhanced O
expression O
of O
the O
aggrecan B
gene I
, O
which O
is O
not O
normally O
expressed O
at O
high O
levels O
in O
these O
osteoblastic O
cells O
. O

Finally O
, O
we O
tested O
whether O
activation O
by O
either O
of O
these O
factors O
is O
dependent O
on O
components O
of O
the O
SAGA B
complex I
. O

Eight O
of O
the O
17 O
seropositive O
patients O
failed O
to O
develop O
detectable O
hepatitis B
B I
surface I
antibody I
within O
three O
months O
of O
the O
third O
injection O
compared O
with O
only O
one O
of O
the O
18 O
seronegative O
patients O
( O
p O
less O
than O
0 O
. O
01 O
) O
. O

Repression O
of O
the O
herpes B
simplex I
virus I
1 I
alpha I
4 I
gene I
by O
its O
gene O
product O
( O
ICP4 O
) O
within O
the O
context O
of O
the O
viral O
genome O
is O
conditioned O
by O
the O
distance O
and O
stereoaxial O
alignment O
of O
the O
ICP4 B
DNA I
binding I
site I
relative O
to O
the O
TATA O
box O
. O

As O
anticipated O
, O
both O
intracellular O
p54 O
- O
SAPKbeta B
activation O
and O
Bcl O
- O
2 O
phosphorylation O
are O
blocked O
by O
co O
- O
transfection O
with O
the O
MAP O
kinase O
specific O
phosphatase O
MKP3 B
/ O
PYST1 B
. O

Treatment O
of O
excessive O
bleeding O
after O
cardiopulmonary O
bypass O
was O
based O
on O
an O
algorithm O
using O
point O
- O
of O
- O
care O
testing O
with O
whole O
blood B
prothrombin I
time O
, O
activated O
partial O
thromboplastin O
time O
, O
heparinase B
activated O
clotting O
time O
, O
and O
platelet O
count O
. O

We O
have O
previously O
reported O
the O
first O
isolation O
of O
a O
c B
- I
myc I
- I
null I
cell O
line O
. O

Antibodies O
specific O
to O
the O
different O
members O
of O
the O
Jun O
and O
Fos B
family I
of I
transcription I
factors I
show O
that O
, O
in O
gel O
retardation O
assays O
, O
a O
Jun B
- I
like I
factor I
is O
a O
component O
of O
the O
H3 B
. I
2 I
specific I
complex I
. O

The O
recombinant B
L I
/ I
F I
- I
transferase I
is O
as O
active O
as O
the O
previously O
purified O
wild O
type O
enzyme O
and O
contains O
no O
detectable O
RNA O
component O
. O

Moreover O
, O
site O
- O
specific O
integration O
of O
the O
ITR O
- O
flanked O
DNA O
was O
also O
detected O
by O
PCR O
amplification O
of O
the O
ITR B
- I
aavs1 I
junction I
in O
transduced O
human O
fibroblasts O
. O

Oct O
- O
1 O
is O
a O
ubiquitously O
expressed O
regulatory O
gene O
of O
the O
POU B
domain I
family I
. O

In O
both O
study O
stages O
. O
post O
- O
exposure O
treatment O
consisted O
of O
five O
injections O
of O
vaccine O
[ O
( O
D O
) O
ays O
0 O
, O
3 O
, O
7 O
, O
14 O
, O
28 O
] O
, O
together O
with O
a O
dose O
of O
rabies B
immunoglobulin I
( O
RIG B
) O
of O
equine O
or O
human O
origin O
on O
D0 O
. O

The O
virus O
must O
progress O
past O
the O
immediate O
- O
early O
phase O
and O
express O
an O
early B
gene I
product I
( I
s I
) I
for O
activation O
of O
cyclin O
E O
expression O
. O

In O
CYP7A1 B
transgenic O
mice O
, O
livers O
contained O
approximately O
3 O
- O
fold O
more O
sterol B
response I
element I
- I
binding I
protein I
- I
2 I
mRNA I
. O

Binding O
of O
the O
TorR B
regulator I
to O
cis O
- O
acting O
direct O
repeats O
activates O
tor B
operon I
expression O
. O

This O
is O
a O
consensus O
casein B
kinase I
II I
( O
CKII O
) O
site O
and O
, O
using O
purified O
wild O
- O
type O
and O
mutant O
proteins O
, O
we O
show O
that O
it O
is O
the O
main O
CKII B
site I
in O
the O
body O
of O
the O
N O
- O
terminal O
complex O
- O
forming O
region O
. O

Treatment O
with O
polyinosinic O
- O
polycytidylic O
acid O
to O
induce O
expression O
of O
Cre B
resulted O
in O
complete O
disruption O
of O
the O
Arnt B
gene I
and O
loss O
of O
ARNT B
messenger I
RNA I
( O
mRNA O
) O
expression O
in O
liver O
. O

Tubular O
dysfunction O
in O
renal O
lithiasis O
: O
cause O
or O
consequence O
? O
] O
To O
investigate O
whether O
overall O
tubular O
dysfunction O
is O
encountered O
in O
a O
particular O
subgroup O
of O
patients O
with O
urolithiasis O
, O
the O
following O
parameters O
of O
renal O
tubular O
function O
have O
been O
measured O
in O
fasting O
morning O
urine O
in O
124 O
male O
stone O
formers O
: O
excretion O
of O
lysozyme O
and O
gamma O
- O
glutamyl O
transpeptidase O
( O
gamma B
- I
GT I
) O
, O
fractional O
excretion O
( O
FE O
) O
or O
glucose O
, O
insulin O
, O
bicarbonate O
after O
an O
alkali O
load O
, O
and O
theoretical O
phosphate O
threshold O
( O
TmP O
/ O

Interaction O
between O
the O
tobacco O
DNA O
- O
binding O
activity O
CBF O
and O
the O
cyt B
- I
1 I
promoter I
element I
of O
the O
Agrobacterium O
tumefaciens O
T O
- O
DNA O
gene O
T B
- I
CYT I
correlates O
with O
cyt B
- I
1 I
directed O
gene O
expression O
in O
multiple O
tobacco O
tissue O
types O
. O

Sequence O
analysis O
of O
AEBP2 B
cDNA I
revealed O
that O
it O
encodes O
a O
protein O
containing O
three O
Gli B
- O
Kruppel B
( O
Cys2 O
- O
His2 O
) O
- O
type O
zinc O
fingers O
. O

In O
the O
case O
of O
the O
pT181 O
plasmid O
, O
inactivation O
of O
the O
initiator B
RepC I
protein I
occurs O
by O
the O
attachment O
of O
an O
oligonucleotide O
to O
its O
active O
tyrosine O
residue O
. O

Extracellular B
regulated I
kinases I
( I
ERK I
) I
1 I
and O
ERK2 O
are O
authentic O
substrates O
for O
the O
dual B
- I
specificity I
protein I
- I
tyrosine I
phosphatase I
VHR I
. O

The O
regulatory O
genes O
cnrYXH B
have O
been O
cloned O
, O
overexpressed O
, O
and O
purified O
in O
Escherichia O
coli O
. O

Examination O
of O
the O
Coomassie O
- O
stained O
gels O
revealed O
that O
the O
capsid O
- O
like O
particles O
composed O
of O
the O
N11 B
- I
VP1 I
protein O
did O
not O
contain O
any O
host O
- O
derived O
histones B
. O

Protein O
binding O
to O
UAS1MLS1 B
was O
observed O
with O
extracts O
from O
derepressed O
but O
not O
from O
repressed O
cells O
, O
and O
could O
be O
competed O
for O
by O
an O
excess O
of O
the O
unlabelled O
CSRE O
( O
ICL1 B
) O
sequence O
. O

We O
then O
isolated O
the O
full O
- O
length O
coding O
region O
of O
the O
human B
BACH1 I
gene I
using O
expressed O
sequence O
tags O
, O
reverse O
transcription O
- O
polymerase O
chain O
reaction O
and O
rapid O
amplification O
of O
cDNA O
ends O
. O

The O
7 B
. I
2 I
kb I
EcoRI I
fragment I
of I
AfMNPV I
was O
cloned O
and O
the O
nucleotide O
sequences O
of O
the O
polyhedrin B
coding O
region O
and O
its O
flanking O
regions O
were O
determined O
. O

Coexpression O
of O
c O
- O
Rel O
in O
combination O
with O
ATF O
- O
1 O
, O
CREB2 B
, O
or O
ATF O
- O
1 O
/ O
CREB2 B
leads O
to O
synergistic O
transactivation O
of O
a O
CD28RE B
- I
TRE I
reporter I
plasmid O
in O
quiescent O
Jurkat O
T O
- O
cells O
. O

A O
search O
was O
conducted O
for O
suppressors O
of O
the O
inositol O
auxotrophic O
phenotype O
of O
the O
ino4 B
- I
8 I
mutant I
of O
yeast O
. O

This O
novel O
TRPC7 B
gene I
could O
be O
a O
candidate O
gene O
for O
genetic O
disorders O
such O
as O
bipolar O
affective O
disorder O
, O
nonsyndromic O
hereditary O
deafness O
, O
Knobloch O
syndrome O
, O
and O
holoprosencephaly O
, O
which O
were O
mapped O
to O
this O
region O
. O

Paradoxically O
, O
loop O
3i O
from O
the O
M1Ach B
- I
muscarinic I
receptor I
also O
maximally O
inhibited O
GnRH O
agonist O
- O
stimulated O
cAMP O
accumulation O
and O
PRL O
release O
by O
40 O
% O
( O
both O
effects O
mediated O
through O
activation O
of O
the O
Gs B
protein I
) O
. O

Using O
beta B
1 I
- I
AR I
- O
luciferase O
reporter O
recombinants O
, O
we O
have O
previously O
determined O
that O
important O
beta B
1 I
- I
AR I
genetic O
elements O
controlling O
expression O
within O
the O
C6 O
glioma O
cell O
line O
are O
contained O
within O
the O
region O
- O
396 O
to O
- O
299 O
, O
relative O
to O
the O
translational O
start O
site O
. O

Our O
case O
, O
however O
, O
had O
no O
histologic O
evidence O
of O
malignancy O
, O
no O
serum B
alpha I
fetoprotein I
at O
7 O
months O
of O
age O
, O
and O
no O
recurrence O
at O
1 O
years O
. O

Analysis O
of O
tobacco O
mRNA O
using O
the O
ACBF B
cDNA I
as O
probe O
showed O
that O
while O
ACBF B
mRNA I
was O
present O
in O
all O
tissues O
examined O
, O
the O
highest O
transcript O
accumulation O
occurred O
in O
stem O
tissues O
. O

Cotransfection O
experiments O
revealed O
that O
both O
hGATA B
- I
4 I
and O
PMA O
/ O
A23187 O
stimulation O
are O
necessary O
for O
the O
IL B
- I
5 I
promoter I
activation O
. O

Here O
we O
show O
that O
expression O
of O
KRAB B
domain I
suppresses O
in O
vivo O
the O
activating O
function O
of O
various O
defined O
activating O
transcription O
factors O
, O
and O
we O
demonstrate O
that O
the O
KRAB B
domain I
specifically O
silences O
the O
activity O
of O
promoters O
whose O
initiation O
is O
dependent O
on O
the O
presence O
of O
a O
TATA O
box O
. O

These O
results O
support O
an O
in O
vivo O
interaction O
between O
Nck O
and O
CKI B
- I
gamma2 I
and O
suggest O
that O
CKI B
- I
gamma2 I
could O
be O
involved O
in O
signaling O
pathways O
downstream O
of O
RTKs O
. O

A O
minimal O
region O
which O
stimulates O
origin O
function O
mapped O
to O
50 O
amino O
acids O
within O
the O
C O
- O
terminus O
of O
Abf1p B
. O

Treatment O
of O
JEA2 O
cells O
with O
interleukin B
( I
IL I
) I
- I
7 I
induces O
CBLB B
phosphorylation O
as O
well O
. O

Phosphorylation O
by O
Cdc28 O
activates O
the O
Cdc20 B
- O
dependent O
activity O
of O
the O
anaphase O
- O
promoting O
complex O
. O

Assays O
of O
APRE O
- O
luciferase O
reporter O
plasmids O
transfected O
into O
HepG2 O
cells O
show O
that O
a O
mutated O
APRE O
that O
binds O
only O
BPi B
functions O
as O
an O
IL O
- O
1 O
alpha O
inducible O
enhancer O
, O
whereas O
a O
mutated O
APRE O
that O
binds O
only O
BPc B
does O
not O
. O

RNA O
unwinding O
in O
U4 O
/ O
U6 O
snRNPs O
requires O
ATP O
hydrolysis O
and O
the O
DEIH O
- O
box O
splicing O
factor O
Brr2 B
. O

Northern O
blot O
analysis O
linked O
Plk B
expression O
to O
the O
proliferative O
activity O
of O
cells O
and O
tissues O
. O

It O
also O
showed O
which O
amino O
acid O
residues O
would O
contact O
an O
extended O
TATA O
box O
with O
a O
B B
recognition I
element I
, O
and O
evolutionary O
conservation O
of O
the O
TBP O
- O
TFB B
- O
DNA O
complex O
orientation O
between O
two O
archaeal O
organisms O
with O
widely O
different O
optimal O
temperature O
for O
growth O
( O
37 O
and O
100 O
degrees O
C O
) O
. O

Comparison O
of O
this O
gene O
with O
the O
available O
databases O
reveals O
very O
significant O
homology O
to O
the O
ETS B
factor I
PE B
- I
1 I
and O
probable O
near O
- O
identity O
with O
the O
recently O
cloned O
factor O
ERF B
. O

Similarly O
, O
beta B
adrenoceptors I
blockade O
has O
been O
shown O
to O
be O
of O
value O
in O
achieving O
continence O
in O
a O
small O
group O
of O
patients O
. O

These O
data O
also O
demonstrate O
that O
insulin O
and O
TPA O
activate O
MBP O
/ O
MAP2 B
kinase O
activity O
by O
de O
novo O
phosphorylation O
of O
threonine O
and O
tyrosine O
residues O
via O
a O
very O
similar O
pathway O
. O

Such O
tetranucleotides O
are O
common O
in O
promoter O
regions O
, O
particularly O
in O
activating B
transcription I
factor I
/ O
cyclic B
AMP I
response I
element I
- I
binding I
protein I
( O
ATF O
/ O
CREB O
) O
and O
E O
- O
box O
motifs O
, O
suggesting O
that O
PIF B
may O
modulate O
the O
transcription O
of O
many O
genes O
. O

The O
dominant O
inhibitory O
biological O
activity O
of O
the O
N O
terminus O
correlated O
with O
its O
ability O
to O
impair O
EGF O
- O
dependent O
activation O
of O
GTP O
- O
Ras O
and O
of O
MAP O
kinase O
, O
as O
well O
with O
the O
ability O
of O
endogenous O
Sos O
to O
form O
a O
stable O
complex O
with O
activated O
EGF B
receptors I
. O

The O
characterization O
of O
fly O
receptors O
with O
features O
similar O
to O
mammalian B
glycoprotein I
hormone I
receptors I
allows O
a O
better O
understanding O
of O
the O
evolution O
of O
this O
unique O
group O
of O
GPCRs B
and O
future O
elucidation O
of O
their O
ligand O
signaling O
mechanisms O
. O

Here O
we O
show O
that O
these O
sequences O
are O
essential O
for O
processing O
of O
U18 B
and O
snR38 B
snoRNAs I
and O
that O
they O
compensate O
for O
the O
lack O
of O
a O
canonical O
terminal O
stem O
. O

Ras O
involvement O
in O
signal O
transduction O
by O
the O
serotonin B
5 I
- I
HT2B I
receptor I
. O

Analysis O
of O
exon O
2 O
of O
the O
factor B
IX I
gene I
revealed O
a O
C O
- O
- O
> O
T O
mutation O
in O
codon O
10 O
of O
the O
propeptide O
region O
, O
resulting O
in O
the O
substitution O
of O
alanine O
by O
valine O
. O

Three O
putative O
ORFs O
have O
significant O
homology O
with O
known O
proteins O
: O
L0968 B
is O
a O
new O
member O
of O
the O
very O
large O
' B
seripauperins I
' I
family O
, O
comprising O
at O
least O
20 O
yeast O
members O
; O
L1313 B
is O
a O
new O
ABC O
transporter O
highly O
homologous O
to O
the O
yeast O
cadmium O
resistance O
protein O
Ycf1p B
and O
to O
the O
human B
multidrug I
resistance I
protein I
hMRP1 B
; O
the O
C O
- O
terminal O
part O
of O
L1325 B
present O
in O
our O
sequence O
is O
very O
homologous O
to O
the O
fruit O
fly O
abdominal O
segment O
formation O
protein O
Pumilio B
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI B
SigmaI I
/ I
+ I
+ I
betaI I
SigmaI I
spectrin I
and O
Abl B
tyrosine I
kinase I
but O
not O
against O
alphaII B
/ I
betaII I
spectrin I
colocalized O
with O
the O
overexpressed O
green O
fluorescent O
protein O
- O
SH3 B
- I
binding I
protein I
. O

Extracellular B
protein I
kinase I
A I
as O
a O
cancer O
biomarker O
: O
its O
expression O
by O
tumor O
cells O
and O
reversal O
by O
a O
myristate O
- O
lacking O
Calpha O
and O
RIIbeta O
subunit O
overexpression O
. O

This O
B O
- O
box O
is O
not O
present O
in O
ETS1 O
, O
ETS2 O
, O
PEA3 O
or O
PU O
. O
1 O
and O
these O
proteins O
were O
unable O
to O
form O
ternary O
complexes O
with O
SRF O
and O
Egrl B
- O
SREs O
or O
c O
- O
fos O
SRE O
. O

MADS B
- I
box I
genes I
in O
plants O
are O
a O
diverse O
class O
of O
transcription O
factors O
that O
are O
involved O
in O
regulating O
developmental O
processes O
, O
particularly O
meristem O
and O
organ O
identity O
during O
floral O
development O
. O

Viral B
protein I
U I
( O
Vpu O
) O
is O
a O
protein O
encoded O
by O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
that O
promotes O
the O
degradation O
of O
the O
virus O
receptor O
, O
CD4 O
, O
and O
enhances O
the O
release O
of O
virus O
particles O
from O
cells O
. O

CSEn B
stimulated O
transcription O
of O
a O
variety O
of O
promoters O
, O
including O
the O
hCS B
, O
human O
growth O
hormone O
, O
thymidine O
kinase O
, O
and O
Rous B
sarcoma I
virus I
promoters I
, O
in O
human O
choriocarcinoma O
cell O
lines O
( O
BeWo O
and O
JEG O
- O
3 O
) O
but O
not O
HeLa O
cells O
or O
rat O
somatolactotrophes O
( O
GC O
) O
. O

Pretreatment O
of O
human O
skin O
with O
tRA O
inhibited O
UV O
induction O
of O
c B
- I
Jun I
protein I
and O
, O
consequently O
, O
AP O
- O
1 O
. O

c B
- I
Jun I
protein I
inhibition O
occurred O
via O
a O
posttranscriptional O
mechanism O
, O
since O
tRA O
did O
not O
inhibit O
UV O
induction O
of O
c B
- I
Jun I
mRNA I
. O

Effect O
of O
age O
on O
glucose O
, O
reducing O
sugars O
and O
plasma B
insulin I
in O
blood O
of O
milk O
- O
fed O
calves O
. O

During O
seed O
maturation O
, O
the O
transcriptional O
activity O
of O
napin B
genes I
is O
regulated O
by O
developmental O
signals O
involving O
the O
transcriptional B
activator I
ABI3 I
and O
abscisic O
acid O
( O
ABA O
) O
. O

This O
results O
in O
a O
decreased O
secretion O
of O
immunoglobulin B
A I
, O
and O
, O
consequently O
, O
a O
decreased O
resistance O
against O
infections O
. O

To O
study O
the O
mechanisms O
and O
the O
signaling O
pathways O
involved O
, O
IGF B
- I
1R I
promoter I
reporter I
constructs I
were O
transiently O
transfected O
in O
CHO O
- O
AT1 O
cells O
that O
overexpress O
angiotensin B
AT1 I
receptors I
. O

With O
this O
study O
, O
a O
total O
of O
13 O
operators O
for O
the O
glp B
regulon I
have O
been O
characterized O
. O

Coexpression O
of O
a O
dominant B
negative I
c I
- I
jun I
antagonized O
the O
ras O
- O
dependent O
stimulation O
of O
the O
92 B
- I
kDa I
gelatinase I
B I
promoter O
- O
driven O
CAT B
reporter I
. O

However O
, O
LXRalpha B
inhibited O
binding O
of O
PPARalpha O
/ O
RXRalpha O
heterodimers O
to O
PPREs O
, O
and O
coexpression O
of O
LXRalpha B
in O
mammalian O
cells O
antagonized O
peroxisome O
proliferator O
signaling O
mediated O
by O
PPARalpha O
/ O
RXRalpha O
in O
vivo O
. O

This O
communication O
presents O
two O
patients O
with O
clinically O
massive O
PE O
of O
recent O
onset O
( O
confirmed O
by O
lung O
perfusion O
scans O
) O
who O
were O
successfully O
treated O
with O
a O
single O
i O
. O
v O
. O
dose O
of O
30 O
mg O
of O
anisoylated B
lys I
- I
plasminogen I
streptokinase I
activator I
complex I
( O
APSAC B
, O
comparable O
to O
1 O
, O
500 O
, O
000 O
U O
of O
streptokinase B
) O
followed O
by O
systemic O
heparinization O
for O
7 O
days O
. O

NGF O
also O
induced O
a O
synthetic O
promoter O
with O
repeated O
Sp1 O
sites O
linked O
to O
a O
core O
promoter O
, O
and O
a O
plasmid O
regulated O
by O
a O
chimeric O
transactivator O
in O
which O
the O
Gal4 O
DNA O
binding O
domain O
is O
fused O
to O
the O
Sp1 B
transactivation I
domain I
, O
indicating O
that O
this O
transactivation O
domain O
is O
regulated O
by O
NGF O
. O

p107 O
induction O
of O
E2F O
DNA O
binding O
was O
observed O
primarily O
in O
S O
phase O
cells O
coincident O
with O
the O
increase O
in O
p107 B
protein I
levels O
. O

Both O
flavoproteins O
are O
active O
as O
AhpC B
reductases I
and O
mediate O
electron O
transfer O
, O
resulting O
in O
the O
NADH O
- O
dependent O
reduction O
of O
hydrogen O
peroxide O
and O
cumene O
hydroperoxide O
. O

Transcriptional O
regulation O
of O
the O
murine B
k I
- I
fgf I
gene I
. O

Further O
, O
cells O
cotransfected O
with O
a O
UF B
promoter I
- O
luciferase O
( O
- O
1935UF B
- O
Luc O
) O
reporter O
gene O
and O
the O
BTEB B
expression O
vector O
had O
2 O
- O
fold O
higher O
Luc O
activity O
than O
those O
cotransfected O
with O
reporter O
gene O
and O
pcDNA O
- O
3 O
. O

In O
agreement O
with O
this O
, O
archaea O
appear O
to O
lack O
eIF5 O
, O
eIF2B B
and O
the O
lysine O
- O
rich O
binding O
domain O
for O
these O
factors O
in O
their O
eIF2beta B
homolog I
. O

Lastly O
, O
several O
restriction O
length O
polymorphisms O
were O
identified O
and O
mapped O
within O
a O
1 O
kb O
region O
located O
immediately O
upstream O
from O
the O
JH B
cluster I
. O

Promoter O
region O
of O
the O
human B
alpha I
2A I
adrenergic I
receptor I
gene I
. O

Thus O
, O
the O
in O
vivo O
function O
of O
Gle2p O
is O
strictly O
coupled O
to O
the O
short O
GLEBS B
within O
Nup116p O
which O
links O
this O
putative O
mRNA O
transport O
factor O
to O
the O
nuclear O
pores O
. O

DNMT2 B
binds O
AdoHcy O
in O
the O
same O
conformation O
as O
confirmed O
m B
( I
5 I
) I
C I
MTases I
and O
, O
while O
DNMT2 B
shares O
all O
sequence O
and O
structural O
features O
with O
m B
( I
5 I
) I
C I
MTases I
, O
it O
has O
failed O
to O
demonstrate O
detectable O
transmethylase O
activity O
. O

The O
structure O
of O
the O
murine B
Dtk I
gene I
has O
been O
determined O
. O

In O
previous O
studies O
, O
we O
showed O
that O
the O
nuclear O
import O
of O
SREBP B
- I
2 I
occurs O
via O
the O
direct O
interaction O
of O
importin B
beta I
with O
the O
HLH O
- O
Zip O
domain O
. O

In O
the O
normal O
controls O
the O
plasma B
FPA I
level O
( O
mean O
+ O
/ O
- O
SD O
) O
was O
1 O
. O
43 O
+ O
/ O
- O
0 O
. O
46 O
ng O
/ O
ml O
. O

In O
this O
study O
we O
cloned O
the O
cDNA O
of O
AD1 B
Ag I
from O
a O
rat O
basophilic O
leukemia O
2H3 O
cDNA O
library O
. O

Regulation O
of O
the O
p21 O
- O
activated O
kinase O
( O
PAK O
) O
by O
a O
human B
Gbeta I
- I
like I
WD O
- O
repeat O
protein O
, O
hPIP1 B
. O

These O
studies O
suggest O
that O
tandem O
alpha O
- O
helices O
located O
near O
the O
C O
- O
terminus O
of O
PC B
- I
TP I
facilitate O
membrane O
binding O
and O
extraction O
of O
phosphatidylcholines O
. O

APL O
patients O
showed O
a O
low O
, O
yet O
variable O
, O
level O
of O
JEM B
- I
1 I
mRNA I
in O
bone O
marrow O
. O

Cell O
lines O
expressing O
single O
amino O
acid O
substitutions O
of O
the O
carboxyl O
- O
terminal O
asparagine O
of O
CD2 B
are O
incapable O
of O
avidity O
regulation O
by O
TCR O
signaling O
, O
PMA O
treatment O
, O
or O
elevation O
of O
intracellular O
cAMP O
levels O
, O
demonstrating O
that O
each O
of O
these O
stimuli O
utilizes O
a O
common O
structural O
element O
for O
regulating O
CD2 B
avidity O
. O

The O
atpA B
reading O
frame O
ends O
with O
four O
tandem O
UGA O
codons O
which O
overlap O
four O
tandem O
AUG O
codons O
initiating O
an O
unidentified O
reading O
frame O
, O
orf214 O
. O

When O
transfected O
into O
HepG2 O
cells O
, O
which O
lack O
C O
/ O
EBP O
alpha O
, O
the O
mouse B
ob I
promoter I
was O
only O
weakly O
active O
. O

Nicotinic B
receptor I
antagonists O
mecamylamine O
( O
0 O
. O
5 O
and O
1 O
mg O
/ O
kg O
) O
and O
hexamethonium O
( O
5 O
and O
10 O
mg O
/ O
kg O
) O
reduced O
the O
response O
induced O
by O
nicotine O
( O
0 O
. O
25 O
mg O
/ O
kg O
) O
. O

We O
also O
show O
that O
psbH O
and O
psbT O
are O
transcribed O
from O
the O
upstream O
psbB B
gene I
promoter I
, O
and O
that O
the O
psbH B
mRNA I
has O
its O
own O
target O
sequence O
for O
Mbb1 B
function O
. O

O5257 B
shows O
homology O
with O
the O
SAS2 B
protein I
and O
another O
hypothetical O
protein O
from O
yeast O
. O

Messenger O
RNA O
for O
the O
Ad2 B
DNA I
binding I
protein I
: O
DNA O
sequences O
encoding O
the O
first O
leader O
and O
heterogenity O
at O
the O
mRNA O
5 O
' O
end O
. O

Consistent O
with O
this O
hypothesis O
, O
stimulation O
of O
A B
( I
2A I
) I
- I
R I
or O
PKA O
enhanced O
nuclear B
aPKC I
activity O
. O

Following O
immunization O
of O
transgenic O
mice O
, O
hybrid O
molecules O
were O
isolated O
from O
B O
cell O
DNA O
which O
contained O
the O
transgene O
recombined O
with O
the O
endogenous B
IgH I
locus I
. O

Transforming O
growth O
factor O
beta O
activates O
the O
promoter O
of O
cyclin O
- O
dependent O
kinase O
inhibitor O
p15INK4B O
through O
an O
Sp1 B
consensus I
site I
. O

The O
hyperpigmentation O
is O
linked O
to O
the O
presence O
of O
numerous O
single O
melanosomes O
and O
polymelanosomes O
in O
keratinocytes O
at O
all O
levels O
of O
the O
epidermis O
, O
and O
in O
dermal O
Factor B
XIIIa I
- O
positive O
dendrocytes O
. O

Previously O
, O
we O
identified O
two O
human B
SMC I
family I
proteins I
, O
hCAP B
- I
C I
and O
hCAP B
- I
E I
, O
which O
form O
a O
heterodimeric O
complex O
( O
hCAP B
- I
C I
- O
hCAP B
- I
E I
) O
in O
the O
cell O
. O

The O
mouse B
alpha I
A I
- I
CRYBP1 I
gene I
specifies O
a O
2 O
, O
688 O
- O
amino O
acid O
protein O
with O
72 O
% O
amino O
acid O
identity O
to O
its O
human O
homologue O
, O
PRDII B
- I
BF1 I
. O

Methylation O
interference O
analysis O
established O
at O
single O
nucleotide O
resolution O
that O
purified O
recombinant O
Fos O
and O
Jun B
proteins I
bind O
in O
a O
sequence O
- O
specific O
manner O
to O
the O
AP B
- I
1 I
sites I
within O
the O
VDRE O
and O
OC B
box I
. O

These O
include O
urinalysis O
, O
chest O
X O
- O
P O
, O
ECG O
, O
hematological O
examinations O
( O
RBC O
, O
WBC O
, O
Ht O
, O
Hb O
, O
PLT O
and O
ESR O
) O
and O
biochemical O
tests O
( O
AST O
, O
ALT O
, O
ALP O
, O
gamma O
GTP O
, O
LDH O
, O
CPK O
, O
Chol O
, O
T O
- O
Bil O
, O
TP O
, O
Alb B
, O
TG O
, O
BUN O
, O
Cr O
, O
Glu O
, O
Na O
, O
K O
, O
Ca O
, O
P O
and O
CRP O
) O
. O

Both O
the O
inactive O
domain B
II I
P68 I
mutant I
and O
the O
deletion O
mutant O
lacking O
aa O
91 O
- O
243 O
were O
less O
inhibitory O
to O
growth O
in O
yeast O
due O
to O
the O
reduced O
ability O
to O
phosphorylate O
initiation B
factor I
2 I
alpha I
in O
vivo O
. O

Mad3 B
and O
Mad4 B
: O
novel O
Max O
- O
interacting O
transcriptional O
repressors O
that O
suppress O
c O
- O
myc O
dependent O
transformation O
and O
are O
expressed O
during O
neural O
and O
epidermal O
differentiation O
. O

The O
pcaR B
regulatory I
locus I
has O
been O
found O
to O
be O
required O
for O
both O
induction O
of O
all O
of O
the O
genes O
within O
the O
pca B
regulon I
( O
pcaBDC B
, O
pcaIJ B
, O
and O
pcaF B
) O
and O
the O
chemotactic O
response O
of O
the O
bacteria O
to O
aromatic O
compounds O
. O

Furthermore O
, O
we O
have O
identified O
the O
major O
open O
reading O
frame O
( O
RF4 O
; O
2 O
. O
3 O
kb O
) O
as O
being O
essential O
for O
activation O
, O
and O
we O
have O
shown O
that O
the O
NF O
kappa O
B O
, O
SP1 O
, O
and O
TATA O
box O
motifs O
in O
the O
human B
immunodeficiency I
virus I
LTR I
are O
all O
required O
for O
full O
induction O
of O
the O
promoter O
by O
the O
HHV B
- I
6 I
- I
encoded I
transactivator I
. O

Transfer O
of O
F O
- O
like O
plasmids O
is O
regulated O
by O
the O
FinOP B
system O
, O
which O
controls O
the O
expression O
of O
traJ B
, O
a O
positive O
regulator O
of O
the O
transfer O
operon O
. O

PKCI B
- I
1 I
is O
a O
member O
of O
the O
HIT B
family I
of O
proteins O
, O
shown O
by O
sequence O
identity O
to O
be O
conserved O
in O
a O
broad O
range O
of O
organisms O
including O
mycoplasma O
, O
plants O
, O
and O
humans O
. O

It O
was O
found O
that O
on O
the O
14th O
and O
21st O
day O
after O
cimetidine O
administration O
serum B
gastrin I
levels O
were O
significantly O
elevated O
. O

Dual O
signal O
peptides O
mediate O
the O
signal B
recognition I
particle I
/ O
Sec O
- O
independent O
insertion O
of O
a O
thylakoid O
membrane O
polyprotein O
, O
PsbY B
. O

Soluble O
extracts O
from O
FGF O
- O
treated O
as O
compared O
with O
quiescent O
fibroblasts O
exhibited O
up O
to O
3 O
- O
fold O
higher O
kinase O
activity O
towards O
S6 B
in O
exogenously O
added O
rat B
liver I
40S I
ribosomes I
and O
a O
synthetic O
peptide O
, O
RRLSSLRA O
. O

In O
bell O
pepper O
, O
a O
gene O
encoding O
a O
major O
plastid O
- O
lipid O
associated O
protein O
is O
expressed O
as O
both O
partially O
and O
totally O
spliced O
transcripts O
( O
respectively O
PAP2 B
and O
PAP1 B
) O
. O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC O
- O
1 O
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB O
- O
binding O
protein O
( O
CBP O
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT O
) O
] O
without O

Immunoblot O
analyses O
revealed O
that O
the O
loss O
of O
activator O
function O
coincides O
with O
selective O
removal O
of O
the O
C B
- I
terminal I
domain I
( I
CTD I
) I
- I
hyperphosphorylated I
RNAP I
IIO I
along O
with O
NC2 B
. O

TFIIIB B
assembles O
autonomously O
on O
the O
upstream O
promoter O
of O
the O
yeast B
U6 I
snRNA I
( O
SNR6 B
) O
gene O
in O
vitro O
, O
through O
the O
interaction O
of O
its O
TBP B
subunit I
with O
a O
consensus O
TATA O
box O
located O
at O
base O
pair O
- O
30 O
. O

Mutational O
analysis O
of O
the O
IME2 B
UAS I
reveals O
two O
critical O
sequence O
elements O
: O
a O
G O
+ O
C O
- O
rich O
sequence O
( O
called O
URS1 O
) O
, O
previously O
identified O
at O
many O
meiotic O
genes O
, O
and O
a O
newly O
described O
element O
, O
the O
T4C O
site O
, O
that O
we O
found O
at O
a O
subset O
of O
meiotic O
genes O
. O

Our O
results O
show O
that O
a O
combination O
of O
Pfu B
exo I
( I
- I
) I
at O
the O
primer O
extension O
step O
and O
Taq B
at O
the O
PCR O
amplification O
step O
is O
ideal O
for O
in O
vivo O
DNA O
analysis O
and O
DNA O
damage O
mapping O
using O
LMPCR O
. O

Using O
lacZ O
- O
inducible O
T O
cells O
as O
a O
probe O
, O
we O
screened O
a O
splenic O
cDNA O
library O
in O
transiently O
transfected O
antigen O
- O
presenting O
cells O
( O
APCs O
) O
and O
isolated O
a O
cDNA O
clone O
that O
allowed O
expression O
of O
the O
appropriate O
peptide B
/ I
Kb I
MHC I
complex I
in O
APC O
. O

A O
significant O
reduction O
in O
total O
cellular O
p27 B
protein I
levels O
and O
a O
moderate O
reduction O
in O
p27 B
mRNA I
are O
observed O
, O
but O
no O
changes O
in O
Cdk O
regulatory O
kinases O
and O
phosphatases O
occur O
. O

Genetic O
linkage O
mapping O
of O
the O
CYP11A1 O
gene O
encoding O
the O
cholesterol O
side O
- O
chain O
cleavage O
P450scc O
close O
to O
the O
CYP1A1 B
gene I
and O
D15S204 B
in O
the O
chromosome O
15q22 O
. O
33 O
- O
q23 O
region O
. O

Genetic O
and O
physiological O
experiments O
suggest O
a O
close O
relationship O
between O
cdc27 B
+ I
and O
the O
cdc2 B
+ I
gene I
, O
a O
key O
regulator O
of O
mitosis O
in O
yeast O
and O
also O
in O
higher O
eukaryotic O
cells O
. O

The O
cloned O
rRNA O
operon O
was O
transcribed O
in O
vitro O
by O
using O
purified B
RNA I
polymerase I
of I
Escherichia I
coli I
. O

The O
sequence O
of O
the O
gene O
upstream O
to O
the O
cap O
site O
contains O
characteristic O
RNA B
polymerase I
II I
promoter I
- I
binding I
sites I
: O
a O
putative O
TATA O
box O
at O
position O
- O
29 O
and O
a O
Sp B
1 I
binding I
site I
( O
GGGGCGGAGA O
) O
at O
position O
- O
48 O
. O

This O
action O
could O
be O
antagonized O
by O
aminophylline O
, O
a O
competitive O
antagonist O
on O
P1 B
purinoceptors I
. O

Evidence O
for O
Gcr1p B
/ O
Gcr2p B
interaction O
has O
been O
presented O
earlier O
and O
is O
now O
supported O
by O
the O
isolation O
of O
mutations O
in O
Gcr1p B
suppressing O
gcr2 B
, O
as O
assessed O
by O
growth O
and O
enzyme O
assay O
. O

Promoter O
constructs O
containing O
mutations O
in O
the O
PTRE B
sequence I
that O
selectively O
abolished O
the O
binding O
of O
either O
one O
or O
both O
complexes O
exerted O
opposite O
effects O
on O
the O
transcriptional O
activity O
of O
trypsin B
promoters I
in O
A O
. O
gambiae O
and O
Aedes O
aegypti O
cell O
lines O
. O

The O
Rep78 B
protein I
of O
adeno O
- O
associated O
virus O
( O
AAV O
) O
contains O
amino O
acid O
sequence O
motifs O
common O
to O
rolling B
- I
circle I
replication I
( I
RCR I
) I
initiator I
proteins I
. O

Nuclear O
transcription O
assays O
confirmed O
that O
cys B
- I
3 I
+ I
was O
under O
sulfur O
- O
regulated O
transcriptional O
control O
and O
that O
cys B
- I
3 I
+ I
transcription O
was O
constitutive O
in O
sulfur B
controller I
( O
scon B
) O
- O
negative O
regulator O
mutants O
. O

The O
rifampicin O
resistance O
of O
uvsW B
- O
repressed O
replication O
suggests O
that O
it O
involves O
either O
tertiary O
initiation O
or O
some O
novel O
mode O
of O
initiation O
. O

Deletion O
mutagenesis O
of O
the O
promoter O
indicated O
that O
a O
positive O
regulatory O
element O
( O
PRE O
) O
was O
likely O
to O
exist O
downstream O
of O
the O
UL94 B
mRNA I
start I
site I
, O
while O
a O
negative O
regulatory O
element O
( O
NRE O
) O
was O
present O
upstream O
of O
the O
TATA O
box O
. O

Expression O
of O
Helios B
was O
detected O
in O
the O
earliest O
hematopoietic O
sites O
of O
the O
embryo O
, O
in O
hematopoietic O
stem O
cells O
in O
the O
adult O
and O
was O
subsequently O
restricted O
to O
a O
subset O
of O
cells O
in O
the O
T O
cell O
lineage O
. O

Using O
probes O
containing O
C O
/ O
EBP O
- O
binding O
sites O
from O
the O
iNOS B
gene I
revealed O
further O
binding O
of O
different O
complexes O
, O
all O
of O
which O
were O
strongly O
inducible O
by O
cAMP O
and O
to O
a O
lower O
extent O
also O
by O
IL O
- O
1beta O
. O

The O
Pi O
signals O
are O
conveyed O
to O
PHO8 B
by O
binding O
of O
PHO4 B
protein I
, O
a O
positive O
regulatory O
factor O
, O
to O
a O
promoter O
region O
of O
PHO8 B
( O
PHO8p B
) O
under O
the O
influence O
of O
the O
PHO B
regulatory O
circuit O
. O

It O
would O
seem O
that O
caution O
should O
be O
exercised O
in O
using O
HPL B
values O
as O
an O
index O
of O
placental O
function O
in O
anaemic O
women O
. O

The O
adenovirus B
E1B I
19 I
, I
000 I
- I
molecular I
- I
weight I
( I
19K I
) I
protein I
is O
a O
potent O
inhibitor O
of O
apoptosis O
and O
cooperates O
with O
E1A O
to O
transform O
primary O
rodent O
cells O
. O

Desensitization O
of O
the O
growth O
hormone O
- O
induced O
Janus B
kinase I
2 I
( O
Jak B
2 I
) O
/ O
signal B
transducer I
and I
activator I
of I
transcription I
5 I
( O
Stat5 O
) O
- O
signaling O
pathway O
requires O
protein O
synthesis O
and O
phospholipase B
C I
. O

Two O
adjacent O
, O
highly O
homologous B
endoglucanase I
genes I
, O
celD B
and O
celE B
from O
Fibrobacter O
succinogenes O
S85 O
, O
which O
were O
separated O
by O
an O
AT O
- O
rich O
223 O
- O
nucleotide O
intergenic O
region O
were O
characterized O
. O

We O
generated O
" O
signature O
" O
oligonucleotides O
from O
these O
CDR3s B
and O
probed O
PCR O
amplified O
V B
kappa I
products I
from O
the O
synovium O
and O
PBLs O
of O
the O
same O
patient O
, O
and O
from O
PBLs O
and O
spleen O
of O
individuals O
without O
rheumatic O
disease O
. O

Induction O
of O
interferon O
- O
alpha O
( O
IFNalpha B
) O
gene O
expression O
in O
virus O
- O
infected O
cells O
requires O
phosphorylation O
- O
induced O
activation O
of O
the O
transcription O
factors O
IRF3 B
and O
IRF7 B
. O

METHODS O
: O
The O
prevalence O
of O
haemagglutination B
inhibiting I
( I
HI I
) I
antibodies I
to O
JE O
virus O
( O
JEV O
) O
, O
West O
Nile O
virus O
( O
WNV O
) O
and O
dengue O
- O
2 O
virus O
( O
DEN O
- O
2 O
) O
was O
detected O
by O
HI O
test O
and O
IgM B
antibody I
capture O
ELISA O
( O
MAC O
ELISA O
) O
was O
performed O
to O
determine O
recent O
infections O
with O
JE O
virus O
. O

Moreover O
, O
since O
the O
integrated O
transforming O
DNA O
was O
not O
altered O
or O
lost O
expression O
of O
the O
RbcS2 B
: O
: O
aadA B
: O
: O
RbcS2 B
gene I
( I
s I
) I
appears O
to O
be O
repressed O
. O

Further O
, O
more O
recent O
communications O
suggest O
that O
liver O
disease O
led O
to O
a O
differential O
alteration O
of O
the O
cytochrome B
P I
- I
450s I
with O
regard O
to O
protein O
content O
and O
activity O
. O

Mutations O
in O
nifR1 B
( O
ntrC O
) O
and O
nifR4 B
( O
rpoN O
, O
encoding O
sigma54 B
) O
had O
no O
influence O
on O
xdh B
gene I
expression O
. O

We O
therefore O
propose O
that O
PRR2 B
, O
and O
not O
PVR B
, O
is O
the O
true O
human O
homolog O
of O
MPH B
. O

In O
contrast O
, O
vRel B
lacks O
a O
strong O
C O
- O
terminal O
gene O
activation O
function O
, O
since O
a O
LexA B
fusion I
protein I
containing O
C B
- I
terminal I
vRel I
sequences I
alone O
only O
weakly O
activated O
transcription O
. O

The O
crystal O
structure O
of O
the O
yeast O
Phe B
- I
tRNAPhe I
ternary I
complex I
with O
Thermus O
aquaticus O
EF B
- I
Tu I
- O
GDPNP O
( O
Phe B
- I
TC I
) O
has O
previously O
been O
determined O
as O
one O
representative O
of O
this O
general O
yet O
highly O
discriminating O
complex O
formation O
. O

Quantitative O
measurement O
of O
antigamma B
globulin I
factors I
( O
rheumatoid O
factors O
) O
using O
laser O
- O
nephelometry O
in O
comparison O
with O
the O
latex O
agglutination O
test O
and O
the O
Waaler O
- O
Rose O
test O

Base O
substitutions O
within O
this O
NFIL B
- I
6 I
site I
resulted O
in O
virtual O
elimination O
of O
LPS O
- O
induced O
IL B
- I
1 I
beta I
gene I
transcription O
. O

A O
Drosophila O
subobscura O
genomic O
fragment O
containing O
all O
the O
exons O
and O
the O
late O
and O
early O
promotors O
in O
the O
Sxl B
gene I
of I
D I
. I
melanogaster I
was O
isolated O
. O

Collectively O
, O
a O
unique O
mechanism O
involving O
NF B
- I
ATp I
appears O
to O
regulate O
the O
cell O
type O
- O
specific O
and O
activation O
- O
dependent O
expression O
of O
the O
SCM B
- I
1 I
genes I
. O

The O
sensitivity O
of O
central B
dopamine I
receptors I
was O
assessed O
with O
the O
growth O
hormone O
response O
to O
apomorphine O
application O
. O

Oral O
basal O
body O
temperature O
( O
BBT O
) O
recordings O
of O
46 O
women O
that O
conceived O
by O
donor O
insemination O
and O
who O
had O
midcycle O
monitoring O
of O
luteinising B
hormone I
( O
LH O
) O
were O
analysed O
to O
establish O
features O
associated O
with O
an O
optimal O
cycle O
. O

A O
DNA O
fragment O
that O
complements O
the O
uvs B
- I
2 I
mutation O
was O
subcloned O
by O
monitoring O
its O
ability O
to O
transform O
the O
uvs B
- I
2 I
mutant I
to O
MMS O
resistance O
. O

The O
human B
lbc I
oncogene I
product I
is O
a O
guanine O
nucleotide O
exchange O
factor O
that O
specifically O
activates O
the O
Rho B
small I
GTP I
binding I
protein I
, O
thus O
resulting O
in O
biologically O
active O
, O
GTP O
- O
bound O
Rho O
, O
which O
in O
turn O
mediates O
actin O
cytoskeletal O
reorganization O
, O
gene O
transcription O
, O
and O
entry O
into O
the O
mitotic O
S O
phase O
. O

Insulin O
- O
stimulated O
autophosphorylation O
at O
specific O
sites O
in O
the O
tyrosine O
kinase O
domain O
of O
the O
receptor O
' O
s O
beta O
- O
subunit O
is O
correlated O
kinetically O
with O
activation O
of O
kinase O
- O
catalyzed O
phosphorylation O
of O
a O
model O
substrate O
( O
reduced O
and O
carboxyamidomethylated O
lysozyme O
; O
RCAM B
- I
lysozyme I
) O
. O

The O
results O
of O
these O
studies O
indicate O
that O
EHV B
- I
1 I
gp13 I
is O
the O
structural O
homolog O
of O
herpes B
simplex I
virus I
glycoprotein I
C I
and O
further O
suggest O
that O
the O
epitope O
- O
containing O
N O
- O
terminal O
amino O
acid O
sequences O
of O
the O
herpesvirus B
gC I
- I
like I
glycoproteins I
have O
undergone O
more O
extensive O
evolutionary O
divergence O
than O
the O
C O
- O
terminal O
sequences O
. O

By O
contrast O
, O
footprint O
II O
at O
position O
- O
125 O
is O
common O
to O
both O
HeLa O
and O
GH3 O
cell O
extracts O
and O
overlies O
a O
15 O
- O
base O
- O
pair O
sequence O
found O
in O
all O
members O
of O
the O
growth B
hormone I
gene I
family I
. O

The O
gene O
responsible O
for O
multiple O
endocrine O
neoplasia O
type O
1 O
( O
MEN1 B
) O
, O
a O
heritable O
predisposition O
to O
endocrine O
tumours O
in O
man O
, O
has O
recently O
been O
identified O
. O

Specifically O
, O
we O
engineered O
two O
chimeras O
in O
which O
the O
N O
- O
terminal O
lobe O
of O
the O
SH1 B
domain I
of O
c O
- O
Abl O
was O
swapped O
with O
that O
of O
v O
- O
Src O
. O

The O
cDNA O
contains O
a O
reading O
frame O
for O
a O
145 O
- O
amino O
- O
acid O
protein O
and O
it O
lacks O
the O
UGA O
codons O
, O
which O
have O
been O
found O
in O
the O
reading O
frame O
of O
the O
mouse B
MCS I
cDNA I
and O
have O
been O
presumed O
to O
encode O
the O
selenocysteine O
in O
the O
amino O
terminal O
of O
the O
deduced O
mouse O
amino O
acid O
sequence O
. O

These O
results O
suggest O
that O
repetitive O
GAA O
sequences O
enhance O
splicing O
by O
binding O
a O
protein O
complex O
containing O
a O
sequence O
- O
specific O
RNA O
binding O
protein O
and O
a O
general O
splicing O
activator O
that O
, O
in O
turn O
, O
recruit O
additional O
SR B
proteins I
. O

Highly O
conserved O
regions O
called O
src O
homology O
2 O
and O
3 O
( O
SH2 O
and O
SH3 O
) O
, O
comprising O
amino O
acid O
residues O
88 O
to O
250 O
, O
are O
believed O
to O
modulate O
the O
protein O
- O
tyrosine O
kinase O
activity O
present O
in O
the O
carboxy O
- O
terminal O
halves O
of O
the O
src B
proteins I
. O

Interestingly O
, O
the O
NES B
mutant I
proteins I
appeared O
to O
have O
altered O
interactions O
with O
the O
splicing O
complex O
, O
binding O
more O
tightly O
to O
SC35 O
in O
co O
- O
immunoprecipitation O
assays O
. O

We O
show O
that O
sae1 B
- I
1 I
and O
sae3 B
- I
1 I
mutations I
each O
confer O
a O
distinct O
defect O
in O
meiotic O
recombination O
. O

sae1 B
- I
1 I
produces O
recombinants O
but O
very O
slowly O
and O
ultimately O
to O
less O
than O
half O
the O
wild O
- O
type O
level O
; O
sae3 B
- I
1 I
makes O
persistent O
hyper O
- O
resected O
meiotic O
double O
- O
strand O
breaks O
and O
has O
a O
severe O
defect O
in O
formation O
of O
recombinants O
. O

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine O
beta O
- O
synthase O

; O
G6670 B
is O
identical O
to O
ORF2 O
located O
close O
to O
CYS4 B
; O
G6673 B
is O
PEM1 B
/ O
CHO2 B
encoding O
a O
phosphatidylethanolamine B
methyltransferase I
; O
G7001 B
is O
the O
NSR1 B
gene I
coding O
for O
a O
nuclear O
signal O
recognition O
protein O
. O

Transcriptional O
analysis O
of O
this O
gene O
cluster O
was O
performed O
by O
detecting O
the O
presence O
of O
mRNAs O
spanning O
adjacent O
genes O
as O
well O
as O
by O
using O
a O
promoterless O
lacZ B
reporter I
gene I
fused O
to O
each O
of O
the O
seven O
genes O
contained O
in O
the O
tol B
- O
oprL B
locus O
. O

Therefore O
the O
effect O
of O
GAL11 B
on O
PGK O
transcription O
must O
be O
mediated O
at O
the O
PGK B
UAS I
, O
presumably O
as O
part O
of O
the O
activation O
complex O
. O

RNase O
protection O
analysis O
reveals O
a O
10 O
- O
fold O
increase O
in O
the O
expression O
of O
SCD2 B
mRNA I
during O
3T3 O
- O
L1 O
preadipocyte O
differentiation O
. O

To O
determine O
whether O
transcription O
of O
orfX O
and O
vfr B
are O
controlled O
by O
the O
same O
mechanisms O
that O
control O
transcription O
of O
the O
region O
of O
the O
divergent O
ORF O
( O
dorf O
) O
and O
of O
crp O
, O
we O
compared O
the O
vfr B
- O
orfX O
and O
crp O
- O
dorf O
intergenic O
regions O
. O

As O
a O
member O
of O
the O
uncoupling B
protein I
family I
, O
UCP2 O
is O
ubiquitously O
expressed O
in O
rodents O
and O
humans O
, O
implicating O
a O
major O
role O
in O
thermogenesis O
. O

Meq O
/ O
c O
- O
Jun O
heterodimers O
bind O
to O
an O
AP1 B
- I
like I
sequence I
in O
the O
meq B
promoter I
region I
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq O
/ O
Meq O
or O
c O
- O
Jun O
/ O
c O
- O
Jun O
homodimers O
. O

To O
probe O
the O
inter O
- O
relationship O
between O
the O
virion O
- O
anchoring O
function O
and O
the O
oligomerization O
function O
, O
we O
constructed O
two O
serotype O
3 O
( O
T3 O
) O
sigma B
1 I
deletion O
mutants O
in O
SV40 O
expression O
vectors O
, O
one O
lacking O
the O
hydrophobic O
tail O
and O
the O
hinge O
, O
and O
the O
other O
lacking O
an O
adjacent O
region O
which O
constituted O
part O
of O
the O
coiled O
- O
coil O
. O

In O
contrast O
, O
overexpression O
of O
the O
DREB2A B
cDNA I
induced O
weak O
expression O
of O
the O
target O
genes O
under O
unstressed O
conditions O
and O
caused O
growth O
retardation O
of O
the O
transgenic O
plants O
. O

Site O
- O
directed O
mutagenesis O
shows O
that O
sites O
throughout O
the O
IRE B
alter O
negative O
control O
and O
IRE B
- I
BP I
binding O
reflecting O
the O
fact O
that O
the O
footprint O
of O
the O
IRE B
- I
BP I
is O
over O
the O
entire O
IRE B
. O

An O
alternative O
approach O
to O
random O
integration O
of O
large O
DNA O
fragments O
into O
plants O
is O
to O
utilize O
one O
of O
several O
site O
- O
specific O
recombination O
( O
SSR O
) O
systems O
, O
such O
as O
Cre B
/ O
lox B
. O

Recombinant B
mouse I
GSTT1 I
- I
1 I
was O
catalytically O
active O
towards O
1 O
, O
2 O
- O
epoxy O
- O
3 O
- O
( O
p O
- O
nitrophenoxy O
) O
propane O
, O
4 O
- O
nitrobenzyl O
chloride O
and O
dichloromethane O
. O

Nonlethal O
sec71 B
- I
1 I
and O
sec72 B
- I
1 I
mutations I
eliminate O
proteins O
associated O
with O
the O
Sec63p B
- O
BiP O
complex O
from O
S O
. O
cerevisiae O
. O

Sequence O
and O
deletion O
analysis O
of O
the O
recombination B
enhancement I
gene I
( O
ref B
) O
of O
bacteriophage O
P1 O
: O
evidence O
for O
promoter O
- O
operator O
and O
attenuator O
- O
antiterminator O
control O
. O

Eph O
receptors O
and O
their O
membrane O
- O
associated O
ephrin B
ligands I
regulate O
cell O
- O
cell O
interactions O
during O
development O
. O

By O
using O
methanol O
- O
0 O
. O
15 O
M O
borate O
buffer O
of O
pH O
8 O
. O
0 O
, O
cate B
- I
chol I
- I
O I
- I
methyltransferase I
activity O
might O
be O
assayed O
. O

Transcripts O
appear O
to O
be O
initiated O
from O
an O
upstream O
promoter O
, O
P1 O
, O
located O
in O
front O
of O
the O
tRNA B
( I
met1 I
) I
gene I
and O
from O
three O
internal O
promoters O
: O
P2 O
is O
located O
immediately O
in O
front O
of O
the O
tRNA B
( I
met2 I
) I
gene I
; O
PL10 O
is O
near O
the O
beginning O
of O
the O
L1 O
- O
L10 B
intergenic O
space O
, O
and O
PL12 O
is O
at O
the O
end O
of O
the O
L10 B
gene I
sequence I
. O

Based O
on O
the O
deduced O
amino O
acid O
sequence O
identity O
we O
designated O
GAPC1 B
and O
GAPC2 B
as O
group O
I O
( O
97 O
% O
identical O
) O
and O
GAPC3 B
and O
GAPC4 B
as O
group O
II O
( O
99 O
. O
4 O
% O
identical O
) O
. O

Saturated O
fatty O
acids O
induce O
a O
1 O
. O
6 O
- O
fold O
increase O
in O
transcription O
activity O
, O
whereas O
a O
large O
family O
of O
unsaturated O
fatty O
acids O
repress O
OLE1 B
transcription O
as O
much O
as O
60 O
- O
fold O
. O

This O
polypeptide O
includes O
the O
first O
three O
zinc O
fingers O
of O
the O
TFIIIA B
DNA I
binding I
domain I
. O

An O
exception O
is O
the O
Bcl B
- I
6 I
gene I
, O
encoding O
a O
transcription O
factor O
, O
which O
was O
found O
to O
be O
mutated O
in O
normal O
human O
memory O
B O
cells O
. O

Similarly O
, O
TAM B
- I
67 I
reverted O
the O
morphology O
of O
the O
AdoMetDC B
- I
antisense I
expressors I
. O

Cotransfection O
of O
expression O
plasmids O
encoding O
the O
protein O
kinase O
A O
inhibitor O
, O
or O
an O
inactive O
protein O
kinase O
A O
( O
PKA O
) O
catalytic O
beta O
subunit O
, O
inhibited O
both O
forskolin O
and O
PACAP O
activation O
of O
chromogranin B
A I
transcription O
, O
revealing O
that O
PACAP O
- O
induced O
trans O
- O
activation O
is O
highly O
dependent O
on O
PKA O
. O

GH O
induced O
rapid O
tyrosine O
phosphorylation O
of O
a O
protein O
at O
approximately O
93 O
kDa O
in O
normal O
fibroblasts O
, O
and O
Western O
blotting O
with O
STAT B
- I
specific I
antibodies I
revealed O
STAT5 O
activation O
( O
phosphorylation O
) O
by O
GH O
. O

The O
cdc42W97R B
temperature I
- I
sensitive I
allele I
in O
S O
. O
cerevisiae O
displayed O
the O
same O
cell O
- O
division O
- O
cycle O
arrest O
phenotype O
( O
large O
, O
round O
unbudded O
cells O
) O
as O
the O
cdc42 B
- I
1ts I
mutant I
. O

The O
cyanobacterial B
phycobilisome I
is O
a O
large O
protein O
complex O
located O
on O
the O
photosynthetic O
membrane O
. O

Furthermore O
, O
CBP O
/ O
p300 O
stimulated O
both O
TGF O
- O
beta O
- O
and O
Smad O
- O
induced O
transcription O
in O
a O
Smad4 O
/ O
DPC4 B
- O
dependent O
fashion O
. O

Sequences O
within O
and O
flanking O
hypersensitive O
sites O
3 O
and O
2 O
of O
the O
beta O
- O
globin O
locus O
control O
region O
required O
for O
synergistic O
versus O
additive O
interaction O
with O
the O
epsilon B
- I
globin I
gene I
promoter I
. O

Sequence O
analysis O
revealed O
100 O
% O
homology O
of O
all O
RA O
- O
derived O
PTEN B
fragments I
to O
those O
from O
normal O
SF O
as O
well O
as O
to O
the O
published O
GenBank O
sequence O
( O
accession O
number O
U93051 B
) O
. O

The O
most O
frequent O
abnormality O
was O
GH O
deficiency O
( O
six O
cases O
) O
, O
followed O
by O
gonadotropin O
( O
four O
cases O
) O
, O
cortisol O
( O
four O
cases O
) O
, O
and O
TSH O
( O
one O
case O
) O
, O
whereas O
four O
patients O
showed O
high O
serum B
PRL I
values O
. O

Recombinant O
vaccinia O
viruses O
that O
express O
the O
bacteriophage B
T3 I
RNA I
polymerase I
( O
VV B
- I
T3pol I
) O
or O
the O
Escherichia B
coli I
lac I
repressor I
( O
VV B
- I
lacI I
) O
under O
control O
of O
the O
early B
- I
late I
vaccinia I
promoter I
P7 I
. I
5 I
were O
constructed O
. O

Internal O
controls O
over O
the O
volume O
of O
milk O
suckled O
do O
not O
appear O
until O
infant O
rats O
are O
about O
2 O
weeks O
of O
age O
at O
which O
time O
gastric O
distension O
, O
milk O
, O
systemic O
dehydration O
, O
and O
intestinal B
hormone I
cholecystokinin I
suppress O
milk O
intake O
derived O
through O
suckling O
. O

Concerning O
the O
practical O
approach O
in O
a O
clinical O
setting O
, O
it O
has O
to O
be O
pointed O
out O
that O
with O
these O
diseases O
a O
hepatitis O
C O
infection O
has O
to O
be O
considered O
and O
testing O
for O
hepatitis B
C I
antibodies I
and O
, O
if O
positive O
, O
hepatitis B
C I
- I
RNA I
is O
indicated O
. O

In O
both O
cell O
types O
, O
insulin O
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 O
domain O
of O
the O
p85 O
regulatory O
subunit O
of O
PI O
- O
3 O
kinase O
, O
and O
also O
increased O
the O
amount O
of O
PI O
kinase O
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

The O
Xenopus B
annexin I
II I
heavy I
chain I
lacks O
the O
highly O
conserved O
tyrosine O
at O
position O
23 O
which O
is O
the O
site O
of O
src B
oncogene I
tyrosine O
kinase O
phosphorylation O
in O
the O
murine O
protein O
. O

Plasmids O
bearing O
the O
P B
. I
stipitis I
URA3 I
gene I
and O
ARS2 O
element O
produced O
more O
than O
30 O
, O
000 O
transformants O
per O
micrograms O
of O
plasmid O
DNA O
. O

Cloning O
, O
sequence O
analysis O
, O
and O
expression O
of O
the O
gene B
encoding I
formaldehyde I
dismutase I
from I
Pseudomonas I
putida I
F61 I
. O

Protease O
digestion O
and O
alkaline O
extraction O
of O
microsomes O
containing O
labeled O
mutant O
proteins O
further O
showed O
that O
segment O
3 O
was O
sufficient O
for O
stable O
membrane O
anchoring O
of O
the O
glycoproteins O
, O
indicating O
that O
this O
segment O
may O
specify O
the O
transmembrane O
domain O
of O
the O
gB B
glycoprotein I
. O

A O
gene O
( O
FMR B
- I
1 I
) O
was O
identified O
within O
a O
four O
cosmid O
contig O
of O
YAC O
DNA O
that O
expresses O
a O
4 O
. O
8 O
kb O
message O
in O
human O
brain O
. O

Detailed O
comparison O
of O
the O
sequences O
of O
cp35 B
and O
human B
calpactin I
II I
shows O
that O
the O
only O
substantial O
sequence O
dissimilarity O
is O
a O
domain O
encoding O
amino O
acids O
between O
residues O
20 O
and O
40 O
which O
includes O
a O
tyrosine O
phosphorylation O
site O
in O
the O
human O
molecule O
, O
along O
with O
other O
residues O
of O
possible O
physiological O
significance O
. O

Plasma B
insulin I
responses O
to O
glucose O
in O
femoral O
, O
hepatic O
, O
and O
pancreatic O
veins O
in O
dogs O
. O

Elevated O
potassium O
stimulation O
of O
GAL B
mRNA I
was O
completely O
blocked O
, O
but O
pituitary O
adenylyl B
cyclase I
- I
activating I
polypeptide I
and O
histamine O
stimulations O
were O
only O
partially O
blocked O
, O
by O
cycloheximide O
. O

In O
lyzozyme B
activity O
there O
was O
periodicity O
in O
three O
groups O
but O
not O
in O
the O
youngest O
foals O
. O

GBF1 O
and O
GBF2 B
mRNA I
is O
present O
in O
light O
and O
dark O
grown O
leaves O
as O
well O
as O
in O
roots O
. O

A O
transient O
induction O
of O
both O
c O
- O
fos O
and O
c B
- I
jun I
mRNAs I
by O
TPA O
was O
observed O
in O
both O
cell O
populations O
, O
together O
with O
an O
associated O
suppression O
of O
BSP B
mRNA I
in O
the O
fetal O
rat O
calvarial O
cells O
. O

This O
enhancer O
element O
functioned O
in O
a O
position O
- O
and O
orientation O
- O
independent O
manner O
both O
on O
the O
Pax B
- I
QNR I
P0 I
promoter I
and O
the O
heterologous B
thymidine I
kinase I
promoter I
. O

Gene B
1 I
of I
the I
murine I
coronavirus I
, I
MHV I
- I
A59 I
, O
encodes O
approximately O
800 O
kDa O
of O
protein O
products O
within O
two O
overlapping O
open O
reading O
frames O
( O
ORFs O
1a O
and O
1b O
) O
. O

For O
this O
interaction O
, O
the O
C O
- O
terminal O
part O
of O
Sp1 O
and O
the O
N O
terminus O
of O
E2F1 O
, O
a O
domain O
also O
present O
in O
E2F2 O
and O
E2F3 B
but O
absent O
in O
E2F4 B
and O
E2F5 B
, O
were O
essential O
. O

Our O
results O
suggest O
a O
biological O
role O
for O
Elf B
- I
1 I
in O
the O
regulation O
of O
IgH B
gene I
expression O
, O
attribute O
a O
functional O
role O
for O
receptor O
- O
induced O
AP O
- O
1 O
proteins O
in O
B O
lymphocytes O
and O
provide O
evidence O
for O
a O
direct O
link O
between O
IgM B
receptor I
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

CD4 O
degradation O
mediated O
by O
Vpu O
does O
not O
require O
the O
ER O
chaperone O
calnexin B
and O
is O
dependent O
on O
an O
intact O
ubiquitin O
- O
conjugating O
system O
. O

The O
maternal B
par I
genes I
and O
the O
segregation O
of O
cell O
fate O
specification O
activities O
in O
early O
Caenorhabditis O
elegans O
embryos O
. O

Detailed O
analysis O
of O
the O
predicted O
amino O
acid O
sequence O
revealed O
sequence O
elements O
which O
are O
conserved O
in O
many O
DNA B
and I
RNA I
polymerases I
. O

The O
CydDC B
system I
appears O
to O
be O
the O
first O
prokaryotic O
example O
of O
a O
heterodimeric B
ABC I
transport I
system I
in O
which O
each O
polypeptide O
contains O
both O
hydrophobic O
and O
ATP O
- O
binding O
domains O
. O

The O
single O
- O
copy O
U20 B
sequence I
is O
located O
on O
the O
same O
DNA O
strand O
as O
the O
nucleolin B
mRNA I
. O

Gel O
shift O
and O
southwestern O
experiments O
revealed O
nuclear O
proteins O
of O
43 O
kDa O
and O
30 O
kDa O
in O
GC O
and O
fish O
cells O
, O
respectively O
, O
that O
bind O
specifically O
to O
the O
tGH B
CRE O
, O
suggesting O
the O
involvement O
of O
CRE O
- O
binding O
- O
protein O
/ O
activating B
- I
transcription I
- I
factor I
- I
l I
- O
related O
peptides O
in O
cAMP O
response O
. O

The O
coding O
sequence O
of O
rat B
MEK I
kinase I
1 I
( O
MEKK1 O
) O
has O
been O
determined O
from O
multiple O
, O
independent O
cDNA O
clones O
. O

On O
the O
basis O
of O
experiments O
with O
mutant O
virus O
and O
transfection O
with O
isolated O
genes O
, O
the O
herpes B
simplex I
virus I
immediate I
- I
early I
gene I
product O
ICP4 O
is O
known O
to O
positively O
regulate O
the O
transcription O
of O
viral B
early I
and I
late I
genes I
and O
negatively O
regulate O
expression O
from O
its O
own O
promoter O
. O

These O
results O
suggest O
an O
essential O
role O
of O
the O
binding O
of O
HNF O
- O
4 O
and O
/ O
or O
HNF B
- I
4 I
- I
related I
nuclear I
factors I
to O
the O
6 O
beta O
A O
- O
A O
site O
on O
the O
basal O
transcriptional O
activation O
of O
the O
CYP3A2 B
gene I
in O
liver O
cells O
. O

Restriction O
mapping O
showed O
that O
the O
two O
recombinant O
plasmids O
shared O
an O
EcoRI B
fragment I
of O
8 O
. O
9 O
kb O
. O

Profilins B
IIa I
and I
IIb I
are O
also O
present O
in O
humans O
, O
suggesting O
that O
all O
mammals O
have O
three O
profilin B
isoforms I
. O

Using O
the O
yeast O
two O
- O
hybrid O
system O
, O
we O
have O
isolated O
an O
835 O
amino O
acid O
RING O
finger O
( O
C3HC4 O
zinc O
finger O
) O
protein O
, O
TIF1 B
beta I
( O
also O
named O
KAP O
- O
1 O
) O
, O
that O
specifically O
interacts O
with O
the O
KRAB B
domain I
of O
the O
human O
zinc O
finger O
factor O
KOX1 B
/ O
ZNF10 B
. O

The O
reduced O
expression O
caused O
by O
multimerization O
of O
UAS2 O
in O
the O
native O
promoter O
was O
observed O
only O
in O
the O
presence O
of O
ADR1 B
. O

VP4 B
differentially O
regulates O
TRAF2 O
signaling O
, O
disengaging O
JNK O
activation O
while O
directing O
NF O
- O
kappa O
B O
to O
effect O
rotavirus O
- O
specific O
cellular O
responses O
. O

The O
purified O
RAG1 B
protein I
overexpressed O
in O
E O
. O
coli O
exhibited O
the O
expected O
cleavage O
activity O
when O
combined O
with O
RAG2 B
purified O
from O
transfected O
293T O
cells O
. O

Moreover O
, O
we O
show O
that O
GATA O
- O
1 O
and O
Sp1 O
synergize O
from O
a O
distance O
in O
constructs O
designed O
to O
mimic O
the O
architecture O
of O
globin B
locus I
control I
regions I
and O
downstream O
globin B
promoters I
. O

Mammalian O
chromosome O
ends O
contain O
long O
arrays O
of O
TTAGGG O
repeats O
that O
are O
complexed O
to O
a O
telomere O
specific O
protein O
, O
the O
TTAGGG B
repeat I
binding I
factor I
, O
TRF1 B
. O

Adhesion O
was O
inhibited O
by O
mAbs O
against O
the O
COOH O
- O
terminus O
and O
central O
cell O
binding O
domains O
of O
fibronectin O
, O
as O
well O
as O
by O
the O
corresponding O
CS1 O
and O
RGD B
peptides I
. O

Activation O
of O
the O
mitogen O
- O
activated O
protein O
kinase O
( O
MAPK O
) O
pathway O
enhances O
long O
- O
range O
transactivation O
by O
the O
beta B
- I
globin I
locus I
control I
region I
( O
LCR O
) O
( O
W O
. O

In O
situ O
hybridization O
of O
whole O
- O
mount O
mouse O
embryos O
with O
Mex5 B
antisense I
RNA I
provide O
no O
evidence O
for O
the O
exclusion O
of O
Mex5 B
during O
embryonic O
development O
. O

The O
Ick B
protein O
tyrosine O
kinase O
is O
not O
involved O
in O
antibody O
- O
mediated O
CD4 O
( O
CDR3 B
- I
loop I
) O
signal O
transduction O
that O
inhibits O
HIV O
- O
1 O
transcription O
. O

Deletion O
analysis O
of O
the O
7 B
. I
3 I
- I
kb I
GATA I
- I
2 I
promoter I
region I
revealed O
that O
a O
1 O
. O
1 O
- O
kb O
DNA O
sequence O
is O
critical O
for O
expression O
of O
GATA B
- I
2 I
in O
neurons O
. O

Consistent O
with O
this O
, O
rh5 B
expression O
in O
R8 B
disappears O
when O
R7 O
cells O
are O
absent O
( O
in O
sevenless B
mutant I
) O
. O

The O
fusion O
gene O
cassette O
was O
placed O
under O
the O
control O
of O
a O
vaccinia B
virus I
early I
promoter I
and O
cloned O
in O
a O
host O
- O
restricted O
fowlpox O
viral O
vector O
. O

Fulminant O
hepatic O
failure O
in O
these O
cases O
could O
be O
characterized O
by O
: O
( O
1 O
) O
rapid O
decrease O
in O
serum B
alanine I
transaminase I
( O
ALT O
) O
level O
after O
discontinuation O
of O
ecarazine O
, O
( O
2 O
) O
prolonged O
jaundice O
despite O
discontinuation O
of O
ecarazine O
, O
( O
3 O
) O
high O
incidence O
of O
anti B
- I
nuclear I
antibody I
( O
ANA B
) O
( O
57 O
% O
) O
, O
and O
( O
4 O
) O
histological O
findings O
of O
extensive O
hepatocellular O
necrosis O
ranging O
from O
bridging O
necrosis O
to O
massive O
necrosis O
. O

These O
data O
suggest O
that O
the O
secreted O
, O
truncated O
receptor O
encoded O
by O
the O
2 B
. I
6 I
- I
kb I
c I
- I
erbB I
transcript I
can O
bind O
to O
TGF O
alpha O
and O
may O
play O
an O
important O
growth O
- O
regulatory O
function O
in O
vitro O
. O

A O
close O
homologue O
of O
the O
APK2a B
gene I
, O
named O
APK2b B
, O
was O
also O
isolated O
from O
the O
Arabidopsis O
cDNA O
library O
. O

Using O
the O
same O
approach O
we O
have O
shown O
that O
hFIRE B
binds O
the O
stimulatory O
proteins O
Sp1 O
and O
Sp3 O
in O
addition O
to O
CBF O
. O

The O
cyclin O
- O
dependent O
kinase O
Cdk2 O
associates O
with O
cyclins B
A I
, I
D I
, I
and I
E I
and O
has O
been O
implicated O
in O
the O
control O
of O
the O
G1 O
to O
S O
phase O
transition O
in O
mammals O
. O

The O
amino B
- I
terminal I
gag I
- I
encoded I
region I
of O
P140gag B
- O
fps O
contains O
a O
phosphotyrosine O
residue O
in O
addition O
to O
normal O
gag O
phosphorylation O
sites O
. O

Rad18 B
is O
required O
for O
DNA O
repair O
and O
checkpoint O
responses O
in O
fission O
yeast O
. O

This O
substrate O
was O
cleaved O
efficiently O
in O
trans O
by O
protease B
3C I
derived O
from O
another O
recombinant O
vaccinia O
virus O
expressing O
a O
3C B
precursor I
protein I
. O

In O
particular O
, O
lacZ B
transcripts I
synthesised O
this O
way O
are O
highly O
unstable O
and O
yield O
little O
beta O
- O
galactosidase O
. O

Six O
cDNAs O
represent O
human O
homologs O
of O
genes O
known O
in O
other O
species O
, O
namely O
, O
mouse B
HSPE71 I
, O
Rat B
RhoGAP I
protein I
, O
S B
cerevisiae I
leucyl I
tRNA I
synthetase I
and O
S B
cerevisiae I
chromosome I
II I
ORF I
YBLO44W I
. O

All O
three O
SSV O
- O
transformed O
cells O
secreted O
v B
- I
sis I
gene I
product I
( O
p44 O
) O
. O

To O
determine O
the O
role O
of O
elevated O
FAK O
expression O
in O
facilitating O
epidermal O
growth O
factor O
( O
EGF O
) O
- O
stimulated O
human O
adenocarcinoma O
( O
A549 O
) O
cell O
motility O
, O
antisense O
oligonucleotides O
were O
used O
to O
reduce O
FAK B
protein I
expression O
> O
75 O
% O
. O

The O
BRSV B
L I
gene I
is O
6573 O
nt O
in O
length O
and O
the O
derived O
polypeptide O
has O
2162 O
aa O
. O

By O
contrast O
, O
CIS B
failed O
to O
affect O
the O
IL B
- I
9 I
response O
. O

We O
have O
analyzed O
the O
function O
of O
these O
putative O
SL O
structures O
in O
RNA O
translation O
by O
constructing O
chimeric B
chloramphenicol I
acetyltransferase I
( B
CAT I
) I
RNAs I
, O
flanked O
either O
by O
both O
5 O
' O
- O
and O
3 O
' O
- O
terminal O
sequence O
domains O
from O
the O
RV O
genome O
or O
several O
deletion O
derivatives O
of O
the O
same O
sequences O
. O

Despite O
the O
fact O
that O
biochemical O
estimates O
of O
bone O
turnover O
indicate O
that O
( O
short O
- O
term O
) O
administration O
of O
rhGH B
and O
IGF O
- O
I O
stimulates O
bone O
metabolism O
in O
non O
- O
osteoporotic O
older O
people O
, O
no O
significant O
changes O
have O
been O
observed O
in O
bone O
mineral O
density O
at O
the O
proximal O
femur O
. O

However O
, O
FosB B
- I
L I
and O
FosB B
- I
S I
do O
not O
differ O
in O
all O
trans O
- O
regulatory O
properties O
: O
Trans O
- O
activation O
of O
a O
5x O
TRE B
- I
CAT I
reporter O
construct O
in O
HeLa O
and O
NIH O
- O
3T3 O
cells O
was O
found O
with O
both O
FosB O
forms O
. O

Mutations O
in O
glnB B
, O
nifR1 B
( O
ntrC O
) O
, O
and O
NifR4 B
( O
ntrA B
encoding O
sigma O
54 O
) O
had O
no O
influence O
on O
put B
gene I
expression O
. O

Disruption O
of O
INP53 O
, O
but O
not O
the O
related O
INP51 B
and O
INP52 B
genes I
, O
resulted O
in O
alpha O
- O
factor O
maturation O
defects O
and O
exacerbated O
alpha O
- O
factor O
maturation O
defects O
when O
combined O
with O
chc1 B
- I
521 I
. O

Cotransfection O
of O
a O
junB O
stimulated O
the O
basal O
activity O
of O
the O
alpha B
2 I
( I
I I
) I
collagen I
promoter I
93 O
- O
fold O
, O
respectively O
. O

Furthermore O
, O
rubella B
IgM I
antibody I
was O
never O
detected O
after O
immunization O
in O
women O
who O
were O
HAI O
- O
negative O
and O
LA O
- O
positive O
during O
pregnancy O
. O

5 O
' O
- O
Deletion O
of O
the O
Stat B
- I
binding I
sites I
abolished O
all O
promoter O
- O
reporter O
activity O
in O
response O
to O
PRL O
. O

Plasma B
beta I
- I
thromboglobulin I
( O
beta O
- O
TG O
) O
, O
a O
platelet O
- O
specific O
protein O
, O
is O
a O
marker O
of O
intravascular O
platelet O
degranulation O
. O

The O
RTI40 B
gene I
spans O
35 O
kilobase O
pairs O
; O
it O
contains O
6 O
exons O
and O
at O
least O
6 O
rat O
Identifier O
repetitive O
elements O
. O

The O
DNA O
element O
through O
which O
EBNA O
- O
3C O
activates O
the O
LMP B
- I
1 I
promoter I
includes O
a O
Spi B
- I
1 I
/ O
Spi B
- I
B I
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA B
- I
2 I
response I
element I
. O

DP O
- O
1 O
and O
DP B
- I
2 I
encode O
maternally O
stored O
transcripts O
that O
are O
expressed O
during O
early O
development O
. O

Furthermore O
, O
deletion O
of O
two O
potential O
Ste11 B
recognition I
sites I
in O
the O
fus1 B
promoter I
region O
abolished O
transcription O
, O
and O
expression O
could O
be O
restored O
when O
we O
inserted O
a O
different O
Ste11 B
site I
from O
the O
mat1 B
- I
P I
promoter I
. O

However O
, O
an O
analogous O
myristoylated O
peptide O
derived O
from O
c B
- I
Yes I
also O
has O
no O
inhibitory O
activity O
. O

Finally O
, O
we O
demonstrate O
that O
animals O
carrying O
a O
snf O
mutation O
that O
converts O
SNF O
from O
a O
bifunctional O
protein O
to O
a O
U1 B
snRNP I
- I
specific I
protein I
are O
viable O
. O

Using O
reporter O
gene O
constructs O
driven O
by O
the O
CD4 B
promoter I
, O
we O
report O
that O
HHV O
- O
6 O
can O
efficiently O
transactivate O
such O
genetic O
elements O
. O

Characterization O
of O
a O
cDNA B
encoding I
CNN I
predicts O
a O
novel O
structural O
protein O
with O
three O
leucine O
zipper O
motifs O
and O
several O
coiled O
- O
coil O
domains O
exhibiting O
limited O
homology O
to O
the O
rod O
portion O
of O
myosin O
. O

A O
preformed O
SREBP B
- I
1a I
: I
[ I
32P I
] I
DNA I
complex I
bound O
specifically O
to O
membrane O
- O
immobilized O
GST O
- O
CBP O
fusion O
proteins O
that O
contained O
amino O
- O
terminal O
portions O
of O
CBP O
. O

Previous O
work O
established O
that O
the O
TAL1 B
proteins I
are O
phosphorylated O
exclusively O
on O
serine O
and O
identified O
Ser122 O
as O
a O
substrate O
for O
the O
mitogen O
- O
activated O
protein O
kinase O
ERK O
- O
1 O
. O

When O
cotransfected O
with O
the O
HIV O
LTR O
CAT O
into O
CV O
- O
1 O
cells O
, O
both O
the O
pCD41 B
and O
pGD41 B
clones O
trans O
- O
activated O
the O
HIV O
LTR O
. O

The O
induction O
of O
the O
composite O
H B
- I
PK I
/ O
Tag O
and O
SV B
- I
PK I
/ O
Tag O
transgenes O
by O
a O
carbohydrate O
- O
rich O
diet O
in O
the O
liver O
was O
similar O
to O
that O
of O
the O
endogenous B
L I
- I
PK I
gene I
. O

To O
understand O
this O
dramatic O
effect O
, O
we O
examined O
the O
localization O
of O
SR B
proteins I
and O
found O
that O
SC35 O
was O
shifted O
to O
the O
cytoplasm O
in O
sky1Delta B
yeast O
, O
although O
this O
phenomenon O
was O
not O
obvious O
with O
ASF O
/ O
SF2 O
, O
indicating O
that O
nuclear O
import O
of O
SR B
proteins I
may O
be O
differentially O
regulated O
by O
phosphorylation O
. O

We O
conclude O
that O
in O
the O
presence O
of O
fatty O
acids O
in O
the O
medium O
transcription O
of O
SPS19 B
is O
directly O
regulated O
by O
both O
Pip2p B
- O
Oaf1p B
and O
Adr1p O
. O

The O
primary O
structures O
of O
the O
human B
KB I
cell I
( I
FR I
- I
KB1 I
) I
folate I
receptor I
( O
FR B
) O
and O
of O
a O
human B
placental I
( I
FR I
- I
P2 I
) I
FR I
, O
proteins O
important O
in O
cellular O
accumulation O
of O
folates O
, O
have O
been O
deduced O
from O
cDNA O
sequences O
. O

The O
general O
concept O
of O
RARE B
- O
cleavage O
mapping O
as O
well O
as O
its O
applications O
and O
limitations O
are O
discussed O
. O

To O
further O
investigate O
the O
role O
of O
PKR O
in O
transcriptional O
signaling O
, O
we O
expressed O
the O
wild B
type I
human I
PKR I
and O
a O
catalytically O
inactive O
dominant O
negative O
PKR B
mutant I
in O
the O
murine O
pre O
- O
B O
lymphoma O
70Z O
/ O
3 O
cells O
. O

Selective O
upper O
abdominal O
sympathectomy O
increased O
basal O
acid O
output O
in O
rats O
but O
was O
without O
effect O
on O
stimulated O
acid O
output O
, O
serum B
gastrin I
concentration O
, O
and O
gastric B
mucosal I
histidine I
decarboxylase I
activity O
. O

In O
- O
111 O
- O
BLMC O
uptake O
was O
directly O
proportional O
to O
Ki B
- I
67 I
/ O
MIB B
- I
1 I
activity O
and O
number O
of O
mitoses O
in O
tumor O
tissue O
. O

Binding O
of O
transformed O
Ah B
receptor I
complex I
to O
a O
dioxin O
responsive O
transcriptional O
enhancer O
: O
evidence O
for O
two O
distinct O
heteromeric O
DNA O
- O
binding O
forms O
. O

A O
fine O
- O
structure O
radiation O
hybrid O
map O
for O
the O
region O
that O
extends O
from O
D8S520 B
( O
distal O
) O
to O
D8S1759 B
( O
proximal O
) O
was O
prepared O
, O
followed O
by O
construction O
of O
a O
single O
, O
integrated O
YAC O
/ O
BAC O
contig O
for O
the O
interval O
. O

The O
protein O
contains O
a O
SHAQKYF O
amino O
acid O
signature O
motif O
in O
the O
second O
myb B
- I
like I
repeat I
, O
which O
is O
highly O
conserved O
in O
a O
number O
of O
recently O
identified O
plant B
myb I
- I
related I
genes I
, O
thus O
defining O
a O
new O
class O
of O
plant O
DNA O
- O
binding O
proteins O
. O

It O
has O
been O
shown O
that O
renin O
secretion O
is O
stimulated O
by O
endothelin B
, O
a O
recently O
discovered O
peptide O
with O
strong O
vasoconstrictive O
properties O
and O
stimulating O
effects O
on O
renin O
secretion O
. O

Here O
we O
describe O
the O
cloning O
and O
initial O
characterization O
of O
IPP B
, O
a O
novel O
human O
gene O
that O
predicts O
a O
kelch B
family I
protein I
homologous O
to O
the O
mouse B
Ipp I
gene I
, O
a O
previously O
described O
kelch B
family I
member I
. O

The O
encoded O
260 B
- I
amino I
- I
acid I
( I
aa I
) I
( I
H1 I
- I
I I
) I
and O
240 B
- I
aa I
( I
H1 I
- I
II I
) I
polypeptides I
possess O
the O
typical O
tripartite O
organization O
of O
animal B
H1 I
histones I
, O
with O
variable O
N O
- O
and O
C O
- O
terminal O
domains O
flanking O
a O
conserved O
' O
globular O
' O
DNA O
- O
binding O
domain O
. O

Instead O
, O
the O
large O
difference O
in O
ssDNA O
- O
binding O
affinities O
reflects O
the O
loss O
of O
hexamerization O
ability O
by O
uvsY B
, O
suggesting O
that O
a O
form O
of O
intrahexamer O
synergism O
or O
cooperativity O
between O
binding O
sites O
within O
the O
uvsY B
hexamer I
leads O
to O
its O
high O
observed O
affinity O
for O
ssDNA O
. O

The O
PK O
domain O
showed O
pairwise O
in O
vitro O
binding O
interactions O
with O
the O
pseudokinase O
, O
HisRS B
, O
and O
C O
- O
term O
domains O
; O
additionally O
, O
the O
HisRS B
domain I
interacted O
with O
the O
C O
- O
term O
region O
. O

The O
AmyI B
specific O
3 O
' O
- O
UTR O
is O
characterized O
by O
the O
absence O
of O
IR O
sequences O
and O
the O
presence O
of O
a O
putative O
' O
AATAAA O
' O
polyadenylation O
signal O
. O

Furthermore O
, O
addition O
of O
the O
recombinant B
NF I
- I
YA I
subunit I
restores O
NF O
- O
Y O
binding O
. O

Our O
results O
suggest O
that O
Sp1 O
binding O
site O
can O
function O
as O
a O
distinct O
TGF B
- I
beta I
responsive I
element I
for O
TGF O
- O
beta O
mediated O
promoter O
expression O
and O
Sp1 O
per O
se O
can O
mediate O
this O
response O
. O

Prolongation O
of O
prothrombin O
time O
was O
not O
due O
to O
depletion O
of O
vitamin O
K O
- O
dependent O
coagulation O
factors O
or O
manifest O
fibrinolysis O
, O
but O
due O
to O
the O
presence O
of O
circulating O
fibrinogen B
fibrinmonomer I
- O
FDP O
complexes O
. O

Mutation O
of O
K14 O
in O
H3 B
, O
which O
serves O
as O
the O
major O
target O
of O
recombinant B
Gcn5p I
acetylation O
in O
vitro O
, O
confers O
a O
strong O
, O
synthetic O
growth O
defect O
in O
gcn5 O
cells O
. O

In O
addition O
, O
we O
found O
that O
the O
transactivation O
mediated O
by O
the O
p68c B
- I
ets I
- I
1 I
pr I
p55erg B
through O
the O
Polyomavirus B
enhancer I
sequence I
is O
specifically O
inhibited O
by O
the O
p46kDaPax B
- I
QNR I
in O
transient O
transfection O
assay O
. O

Conversely O
, O
as O
a O
GAL B
- I
4 I
chimera I
, O
the O
isolated O
LAZ3 O
/ O
BCL6 O
BTB O
/ O
POZ O
domain O
appears O
nearly O
as O
efficient O
as O
the O
entire O
protein O
at O
inducing O
transcriptional O
repression O
. O

A O
new O
myocyte B
- I
specific I
enhancer I
- I
binding I
factor I
that O
recognizes O
a O
conserved O
element O
associated O
with O
multiple O
muscle O
- O
specific O
genes O
. O

Diclofenac O
sodium O
: O
blood O
concentration O
of O
the O
slow O
- O
release O
form O
and O
influence O
on O
the O
metabolism O
of O
kallikrein B
. O

The O
LS B
gene I
promoter I
sequence I
has O
homology O
with O
Escherichia O
coli O
promoter O
sequences O
; O
its O
terminator O
sequence O
is O
capable O
of O
forming O
a O
stem O
- O
and O
- O
loop O
structure O
. O

Overexpression O
of O
either O
Sp1 O
or O
phosphorylated B
CREB I
transactivated O
the O
mCgA B
promoter I
dose O
dependently O
, O
while O
coexpression O
of O
both O
transcription O
factors O
resulted O
in O
an O
additive O
mCgA B
promoter I
response O
. O

mCgA B
- O
92 O
to O
- O
64 O
bp O
, O
comprising O
the O
Sp1 O
/ O
Egr O
- O
1 O
site O
and O
the O
CRE O
motif O
, O
conferred O
gastrin O
responsiveness O
to O
a O
heterologous B
thymidine I
kinase I
promoter I
system O
, O
and O
therefore O
functions O
as O
a O
" O
true O
" O
enhancer O
element O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP B
response I
element I
modulator I
protein I
( O
CREM O
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB B
mutant I
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB B
beta I
may O
also O
contribute O
to O
compensation O
within O
the O
CREB O
/ O
ATF O
family O
of O
transcription O
factors O
, O
when O
CREB B
delta I
and O
CREB B
alpha I
are O
absent O
. O

Individual O
and O
combined O
effects O
of O
fumonisin B
B1 I
present O
in O
Fusarium O
moniliforme O
culture O
material O
and O
diacetoxyscirpenol O
or O
ochratoxin O
A O
in O
turkey O
poults O
. O

The O
Grb2 O
SH3 B
( I
C I
) I
binding I
region I
of O
Gab1 O
has O
significant O
homology O
to O
a O
region O
of O
the O
adapter B
protein I
SLP I
- I
76 I
. O

Activation O
of O
the O
cytotactin B
promoter I
by O
the O
homeobox B
- I
containing I
gene I
Evx I
- I
1 I
. O

Rat B
p8 I
mRNA I
was O
discovered O
because O
of O
its O
strong O
activation O
in O
pancreas O
during O
the O
acute O
phase O
of O
pancreatitis O
. O

When O
furA B
alone O
was O
introduced O
into O
the O
Delta O
( O
furA B
- O
katG B
) O
mutant O
, O
survival O
in O
mouse O
lungs O
was O
moderately O
increased O
, O
suggesting O
that O
FurA B
could O
regulate O
genes O
, O
other O
than O
katG B
, O
that O
are O
involved O
in O
pathogenesis O
. O

Subclones O
of O
R15 O
which O
reverted O
to O
kappa B
light I
chain I
production O
contained O
genomic O
deletions O
of O
R15ns O
and O
/ O
or O
the O
surrounding O
intron O
. O

The O
delayed O
activation O
of O
the O
prostaglandin B
G I
/ I
H I
synthase I
- I
2 I
promoter O
in O
bovine O
granulosa O
cells O
is O
associated O
with O
down O
- O
regulation O
of O
truncated O
upstream B
stimulatory I
factor I
- I
2 I
. O

More O
important O
, O
ligand O
- O
activated O
insulin O
and O
IGF B
- I
I I
receptors I
phosphorylate O
SHC O
proteins O
in O
vitro O
, O
indicating O
that O
SHC O
proteins O
could O
be O
direct O
substrates O
for O
insulin O
and O
IGF B
- I
I I
receptors I
. O

Two O
human B
beta I
- I
1 I
, I
6 I
- I
N I
- I
acetylglucosaminyltransferases I
forming O
the O
core O
2 O
O O
- O
glycan O
branch O
, O
C2GnT O
and O
the O
I B
antigen I
, O
IGnT B
, O
are O
homologous O
to O
each O
other O
in O
three O
regions O
of O
the O
catalytic O
domain O
( O
A O
, O
B O
, O
C O
) O
and O
their O
genes O
reside O
at O
the O
same O
locus O
, O
chromosome O
9 O
, O
band O
q21 O
( O
Bierhuizen O
, O
M O
. O
F O
. O
A O
. O
, O
Mattei O
, O
M O
. O
- O
G O
. O
and O
Fukuda O
, O
M O
. O
, O
Genes O
Dev O
. O
, O
7 O
, O

Developmental O
regulation O
of O
expression O
of O
the O
malate B
synthase I
gene I
in O
transgenic O
plants O
. O

In O
contrast O
, O
no O
change O
in O
the O
level O
of O
either O
p53 O
or O
activation O
of O
mdm2 B
protein I
by O
p53 O
was O
observed O
in O
hamster O
UV61 O
cells O
after O
UV O
exposure O
. O

Transcriptional O
activation O
of O
the O
proopiomelanocortin B
gene I
by O
cyclic B
AMP I
- I
responsive I
element I
binding I
protein I
. O

The O
NF1 B
family I
members O
and O
HNF4 B
interacted O
with O
overlapping O
sequences O
of O
the O
L O
- O
II O
element O
, O
wherein O
the O
5 O
' O
half O
- O
site O
was O
more O
critical O
for O
NF1 O
binding O
, O
and O
the O
3 O
' O
site O
was O
more O
important O
for O
HNF4 B
binding O
. O

RAP O
has O
been O
shown O
to O
be O
a O
useful O
vaccine O
target O
site O
, O
and O
RIP B
and O
inhibitory O
AIPs B
as O
therapeutic O
molecules O
to O
prevent O
and O
suppress O
S O
. O
aureus O
infections O
. O

The O
mouse O
lactoferrin B
gene O
promoter O
was O
active O
in O
human O
endometrium O
carcinoma O
RL O
95 O
- O
2 O
cells O
and O
in O
rat O
glioma O
C6 O
cells O
. O

Analysis O
of O
1 O
Mb O
of O
published O
sequence O
from O
the O
region O
of O
conserved O
synteny O
on O
human O
chromosome O
5q31 O
- O
q33 O
identified O
45 O
gene O
candidates O
, O
including O
35 O
expressed O
genes O
in O
the O
human B
IL I
- I
4 I
cytokine I
gene I
cluster O
. O

There O
is O
no O
indication O
from O
these O
experiments O
that O
linker B
histones I
bind O
fundamentally O
differently O
to O
5 B
S I
and O
bulk O
nucleosomes O
. O

Km O
values O
of O
the O
uncoupled O
enzymes O
IIGlc B
for O
glucose O
ranged O
from O
0 O
. O
5 O
to O
2 O
. O
5 O
mM O
, O
2 O
orders O
of O
magnitude O
higher O
than O
the O
value O
of O
normal O
IIGlc B
. O

Cytochrome B
bd I
biosynthesis O
in O
Escherichia O
coli O
: O
the O
sequences O
of O
the O
cydC B
and O
cydD B
genes I
suggest O
that O
they O
encode O
the O
components O
of O
an O
ABC B
membrane I
transporter I
. O

In O
contrast O
, O
inhibition O
of O
MAPK O
activity O
by O
MAPK B
kinase I
inhibitor O
( O
PD O
98059 O
) O
or O
by O
overexpression O
of O
kinase O
- O
deficient O
MAPKs B
activated O
basal O
and O
GnRH O
- O
A O
- O
stimulated O
GnRHR B
- O
Luc O
activity O
. O

Historically O
, O
Cyps B
were O
first O
identified O
by O
their O
ability O
to O
bind O
the O
immunosuppressive O
agent O
cyclosporin O
A O
( O
CsA O
) O
with O
high O
affinity O
; O
they O
later O
were O
found O
to O
have O
peptidyl O
- O
prolyl O
cis O
- O
trans O
isomerase O
( O
PPIase O
) O
activity O
, O
which O
catalyzes O
the O
folding O
of O
oligopeptides O
at O
proline O
- O
peptide O
bonds O
in O
vitro O
and O
may O
be O
important O
for O
protein O
folding O
in O
vivo O
. O

Thus O
, O
oxyR B
mutants I
are O
locked O
on O
for O
Ag43 B
expression O
, O
whereas O
dam B
mutants I
are O
locked O
off O
for O
Ag43 B
expression O
. O

A O
rare O
tRNA B
- I
Arg I
( I
CCU I
) I
that O
regulates O
Ty1 B
element I
ribosomal O
frameshifting O
is O
essential O
for O
Ty1 O
retrotransposition O
in O
Saccharomyces O
cerevisiae O
. O

Several O
35 O
- O
mm O
slides O
of O
dystrophin B
- O
, O
laminin O
- O
, O
and O
concanavalin O
A O
( O
ConA O
) O
- O
stained O
muscle O
sections O
were O
used O
to O
calculate O
myofiber O
cross O
- O
sectional O
areas O
and O
to O
compare O
different O
techniques O
and O
settings O
of O
an O
image O
capture O
system O
. O

New O
, O
selective O
catechol B
- I
O I
- I
methyltransferase I
inhibitors O
as O
therapeutic O
agents O
in O
Parkinson O
' O
s O
disease O
. O

We O
describe O
a O
novel O
stat B
- I
related I
factor I
, O
p93 B
, O
that O
is O
found O
in O
EGF O
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine B
fibroblast I
growth I
factor I
( O
bFGF O
) O
, O
IFN O
- O
gamma O
, O
tumor O
necrosis O
factor O
- O
alpha O
( O
TNF O
- O
alpha O
) O
, O
and O
untreated O
cells O
. O

p93 B
appears O
to O
be O
antigenically O
related O
to O
stat91 B
. O

p185c B
- O
neu O
+ O
, O
EGFr O
+ O
( O
M1 B
) O
, O
and O
p185c B
- O
neu O
- O
kinase O
inactive O
, O
EGFr O
+ O
( O
NEN757 B
) O
expressing O
cells O
undergo O
different O
mitotic O
responses O
to O
EGF O
. O

When O
single O
- O
point O
mutation O
was O
introduced O
to O
each O
GC O
box O
, O
EBS B
, O
and O
GT O
box O
in O
PFP9a20 B
, O
at O
least O
3 O
- O
fold O
less O
CAT O
activity O
was O
observed O
in O
CTLL O
- O
R8 O
cells O
. O

Ribosome O
association O
of O
GCN2 B
protein I
kinase I
, O
a O
translational O
activator O
of O
the O
GCN4 B
gene I
of O
Saccharomyces O
cerevisiae O
. O

Treatment O
with O
H7 O
did O
not O
affect O
IL B
- I
4R I
- O
mediated O
immediate O
signaling O
events O
such O
as O
tyrosine O
phosphorylation O
of O
Jak1 O
, O
Jak3 O
, O
insulin B
receptor I
substrate I
( I
IRS I
) I
- I
1 I
and O
IRS O
- O
2 O
, O
or O
tyrosine O
phosphorylation O
and O
DNA O
binding O
of O
Stat6 O
. O

Thus O
, O
STK1 B
is O
most O
likely O
the O
human B
homologue I
of I
MO15 I
. O

BACKGROUND O
: O
Recent O
iterative O
methods O
for O
sequence O
alignment O
have O
indicated O
that O
the O
380 O
kDa O
motor O
unit O
of O
dynein B
belongs O
to O
the O
AAA B
class I
of O
chaperone B
- I
like I
ATPases I
. O

When O
the O
VBP B
- I
1 I
protein I
was O
solely O
expressed O
, O
it O
located O
to O
the O
cytoplasm O
and O
did O
not O
localize O
to O
the O
nucleus O
. O

Transfection O
assays O
using O
the O
first O
600 O
bp O
of O
the O
upstream O
nucleotide O
sequences O
indicated O
that O
a O
region O
from O
- O
75 O
to O
- O
120 O
was O
necessary O
for O
the O
ALDH2 B
gene I
expression O
, O
and O
especially O
NF O
- O
Y O
/ O
CP1 B
binding O
site O
from O
- O
92 O
to O
- O
96 O
( O
CCAAT O
box O
) O
is O
important O
in O
the O
expression O
of O
the O
gene O
. O

This O
distinct O
biochemical O
difference O
between O
STAT5A O
and O
STAT5B O
was O
confirmed O
with O
purified O
activated O
STAT5 B
recombinant I
proteins I
. O

Blood B
coagulation I
Factor I
X I
and O
its O
activated O
form O
Factor B
Xa I
play O
an O
essential O
role O
in O
the O
midphase O
of O
the O
clotting O
cascade O
. O

The O
exon O
sequences O
determined O
from O
genomic O
DNA O
sequencing O
showed O
some O
differences O
when O
compared O
to O
the O
published O
rat B
GLUT2 I
cDNA I
. O

Intramolecular O
interaction O
is O
believed O
to O
result O
in O
the O
formation O
of O
MxA B
monomers I
, O
whereas O
intermolecular O
interaction O
may O
induce O
the O
formation O
of O
large B
MxA I
oligomers I
. O

The O
psbA B
gene I
encodes O
the O
D1 B
protein I
of O
photosystem B
II I
, O
which O
is O
synthesized O
at O
very O
high O
rates O
in O
the O
light O
in O
order O
to O
replace O
photodamaged O
protein O
. O

Specifically O
, O
we O
demonstrate O
that O
this O
25 O
- O
base O
pair O
region O
mediates O
the O
up O
- O
regulatory O
effect O
of O
TGF O
- O
beta O
on O
COL1A2 B
promoter I
activity O
and O
allows O
antagonistic O
activity O
of O
TNF O
- O
alpha O
on O
the O
TGF O
- O
beta O
effect O
. O

Sin4 O
and O
Srb10 O
, O
components O
of O
specific O
RNA B
polymerase I
II I
sub I
- I
complexes I
that O
are O
required O
for O
Ssn6 B
- O
Tup1 B
repression O
activity O
, O
are O
found O
to O
be O
required O
for O
Sfl1 B
repression O
function O
. O

Translation O
of O
mok B
is O
tightly O
regulated O
by O
Sok B
RNA I
, O
and O
Sok B
RNA I
thus O
regulates O
hok B
translation O
indirectly O
through O
mok B
. O

These O
Tlr B
family I
members I
, O
unlike O
others O
reported O
to O
date O
, O
were O
identified O
within O
a O
genomic O
database O
. O

In O
this O
study O
, O
transcriptional O
fusions O
were O
constructed O
between O
the O
xcpP B
and O
xcpR B
genes I
and O
the O
lacZ B
reporter I
. O

To O
explore O
the O
mechanism O
of O
insulin O
receptor O
phosphorylation O
we O
have O
used O
NIH3T3 O
cells O
transfected O
with O
two O
receptor O
constructs O
: O
one O
encoding O
a O
chimeric O
receptor O
composed O
of O
the O
extracellular O
domain O
of O
the O
human B
EGF I
receptor I
and O
the O
cytosolic O
domain O
of O
the O
human B
insulin I
receptor I
beta I
- I
subunit I
, O
and O
a O
second O
construct O
encoding O
a O
kinase O
- O
defiecient O
human B
insulin I
receptor I
. O

Hematopoietic O
progenitor O
kinase O
1 O
( O
HPK1 O
) O
is O
a O
member O
of O
the O
mitogen B
- I
activated I
protein I
kinase I
kinase I
kinase I
kinase I
( O
MAP4K B
) O
family O
and O
an O
upstream O
activator O
of O
the O
c O
- O
Jun O
N O
- O
terminal O
kinase O
( O
JNK O
) O
signaling O
cascade O
. O

Finally O
, O
the O
conservation O
of O
the O
two O
residues O
most O
sensitive O
to O
mutations O
( O
Y949 O
and O
Y953 O
) O
in O
TM11 O
, O
and O
in O
the O
homologous O
TM5 O
, O
of O
all O
mammalian B
P I
- I
gps I
and O
also O
in O
other O
ABC B
transporters I
, O
suggests O
that O
these O
residues O
and O
domains O
may O
play O
an O
important O
role O
in O
structural O
as O
well O
as O
mechanistic O
aspects O
common O
to O
this O
family O
of O
proteins O
. O

Based O
on O
the O
requirement O
for O
CREM O
/ O
ICER O
and O
Rad6B B
proteins I
in O
spermatogenesis O
, O
we O
determined O
expression O
of O
Cdc34 O
, O
Rad6B B
, O
CREM O
/ O
ICER O
isoforms O
, O
and O
the O
Skp1 O
- O
Cullin B
- O
F O
- O
box O
ubiquitin O
protein O
ligase O
subunits O
Cul B
- I
1 I
and O
Cul B
- I
2 I
, O
which O
are O
associated O
with O
Cdc34 O
activity O
during O
murine O
testicular O
development O
. O

Transcription B
factor I
IIIC I
( O
TFIIIC B
) O
is O
required O
for O
the O
assembly O
of O
a O
preinitiation O
complex O
on O
5S B
RNA I
, O
tRNA O
, O
and O
adenovirus B
VA I
RNA O
genes O
and O
contains O
two O
separable O
components O
, O
TFIIIC1 B
and O
TFIIIC2 B
. O

Furthermore O
, O
we O
show O
that O
Nck B
- I
2 I
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth B
factor I
receptor I
kinase I
- O
signaling O
pathways O
including O
EGF B
receptors I
, O
PDGF B
receptor I
- I
beta I
, O
and O
IRS O
- O
1 O
. O

These O
two O
enhancer O
elements O
also O
enhanced O
transcription O
when O
fused O
separately O
to O
the O
basal O
promoter O
region O
of O
the O
chicken B
vimentin I
gene I
. O

Protein O
sequencing O
, O
electrophoretic O
mobility O
shift O
assay O
, O
and O
immunoblot O
analyses O
identify O
p54 O
and O
p47 B
/ I
48 I
as O
members O
of O
the O
hepatocyte O
nuclear O
factor O
3 O
( O
HNF3 B
[ O
forkhead O
] O
) O
family O
of O
transcription O
factors O
. O

p54 O
belongs O
to O
the O
subfamily O
of O
HNF3 B
beta I
proteins I
, O
while O
p47 B
/ I
48 I
binding O
activity O
includes O
HNF3 B
gamma I
. O

Promoter O
activity O
was O
assayed O
by O
transient O
transfection O
of O
luciferase B
reporter I
constructs I
containing O
nested O
deletions O
of O
the O
upstream O
sequence O
in O
the O
human O
RPE O
cell O
lines O
ARPE19 O
and O
D407 O
, O
as O
well O
as O
in O
the O
SK O
- O
Mel O
- O
28 O
and O
HeLa O
cell O
lines O
. O

Although O
the O
elevated O
signalling O
is O
eliminated O
by O
deletion O
of O
Ste20p O
( O
or O
components O
downstream O
of O
Ste20p O
) O
, O
the O
growth O
and O
morphological O
abnormalities O
of O
cells O
lacking O
Akr1p B
are O
not O
rescued O
by O
deletion O
of O
any O
of O
the O
known O
pheromone O
response O
pathway O
components O
. O

Southern O
hybridization O
of O
genomic O
DNA O
from O
WT O
and O
Lp B
/ O
Lp B
embryos O
failed O
to O
identify O
specific O
rearrangements O
at O
or O
near O
the O
Nhlh1 B
locus I
, O
and O
Northern O
RNA O
blotting O
and O
RT O
- O
PCR O
evaluation O
of O
Nhlh1 B
mRNA I
expression O
indicated O
that O
both O
the O
levels O
and O
types O
of O
Nhlh1 B
mRNAs I
produced O
in O
WT O
and O
Lp B
/ O
Lp B
embryos O
were O
indistinguishable O
. O

In O
addition O
, O
mrp17 B
- I
1 I
, O
in O
combination O
with O
some O
mutations O
affecting O
another O
mitochondrial O
ribosomal O
protein O
, O
caused O
a O
synthetic O
defective O
phenotype O
. O

Expression O
, O
characterization O
, O
and O
genomic O
structure O
of O
carp B
JAK1 I
kinase I
gene I
. O

Significantly O
, O
the O
murine B
P I
- I
selectin I
gene I
had O
several O
features O
not O
found O
in O
the O
human O
gene O
. O

Transient O
- O
expression O
assay O
analysis O
of O
subclones O
of O
pPstI O
- O
G O
localized O
the O
trans O
- O
active O
factor O
to O
a O
3 B
. I
0 I
- I
kilobase I
XbaI I
fragment I
. O

MGF B
is O
a O
novel O
member O
of O
the O
cytokine B
- I
regulated I
transcription I
factor I
gene I
family I
. O

This O
is O
the O
first O
report O
that O
the O
PH O
domain O
of O
an O
IRS B
protein I
can O
function O
in O
a O
dominant O
negative O
manner O
to O
inhibit O
insulin O
signaling O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged O
V B
kappa I
- O
C B
kappa I
gene O
. O

C O
. O
glabrata O
cells O
containing O
the O
CBF1 B
gene I
under O
the O
influence O
of O
a O
shutdown O
promoter O
( O
tetO O
- O
ScHOP O
) O
arrested O
their O
growth O
after O
5 O
h O
of O
cultivation O
in O
the O
presence O
of O
the O
reactive O
drug O
doxycycline O
. O

SF1 O
/ O
mBBP B
utilizes O
a O
" B
maxi I
- I
K I
homology I
" I
( O
maxi B
- I
KH I
) O
domain O
for O
recognition O
of O
the O
single O
- O
stranded O
BPS O
and O
requires O
a O
cooperative O
interaction O
with O
splicing O
factor O
U2AF65 O
bound O
to O
an O
adjacent O
polypyrimidine O
tract O
( O
PPT O
) O
for O
high O
- O
affinity O
binding O
. O

An O
X O
- O
linked O
zinc O
finger O
gene O
mapping O
to O
Xq21 O
. O
1 O
- O
q21 O
. O
3 O
closely O
related O
to O
ZFX B
and O
ZFY B
: O
possible O
origins O
from O
a O
common O
ancestral O
gene O
. O

In O
addition O
, O
there O
was O
an O
increase O
in O
the O
amount O
of O
p120 B
Ras I
- O
specific O
GTPase O
- O
activating O
protein O
( O
GAP O
) O
and O
GAP O
- O
associated O
p190 O
. O

The O
5 B
- I
HT3 I
antagonist O
ondansetron O
reduced O
alcohol O
intake O
in O
both O
the O
medium O
and O
high O
alcohol O
preferring O
rats O
at O
doses O
between O
0 O
. O
01 O
and O
0 O
. O
16 O
mg O
/ O
kg O
. O

The O
relationship O
between O
donor O
status O
for O
antibody O
to O
hepatitis B
B I
core I
antigen I
and O
the O
occurrence O
of O
non O
- O
A O
, O
non O
- O
B O
posttransfusion O
hepatitis O
in O
the O
recipient O
was O
prospectively O
studied O
in O
112 O
patients O
undergoing O
open O
- O
heart O
surgery O
who O
were O
followed O
for O
6 O
. O
5 O
months O
after O
surgery O
. O

The O
pepI B
gene I
was O
overexpressed O
in O
Escherichia O
coli O
. O

SH3A B
competes O
with O
the O
SH3 O
domains O
of O
Grb2 O
in O
binding O
to O
mSos1 B
, O
and O
the O
intersectin B
- O
mSos1 B
complex O
can O
be O
separated O
from O
Grb2 O
by O
sucrose O
gradient O
centrifugation O
. O

Xnr3 B
is O
transcriptionally O
activated O
by O
wnt O
signaling O
during O
gastrulation O
in O
the O
Xenopus O
embryo O
. O

The O
sequences O
of O
two O
previously O
known O
tail B
genes I
, O
R O
and O
S B
, O
of O
the O
temperate O
bacteriophage O
P2 O
and O
the O
sequence O
of O
an O
additional O
open O
reading O
frame O
( O
orf O
- O
30 O
) O
located O
between O
S B
and O
V B
, O
were O
determined O
. O

GH O
signals O
by O
interacting O
with O
GH O
receptor O
( O
GHR B
) O
. O

The O
extraordinary O
high O
substrate O
specificity O
of O
rPulA B
together O
with O
its O
thermal O
stability O
makes O
this O
enzyme O
a O
good O
candidate O
for O
biotechnological O
applications O
in O
the O
starch O
- O
processing O
industry O
. O

Analysis O
of O
pseudo B
VH I
gene I
segment I
recombination I
products I
reveals O
no O
bias O
in O
D B
gene I
segment I
reading O
frame O
utilization O
. O

A O
new O
B O
- O
cell O
- O
specific O
enhancer O
element O
has O
been O
identified O
3 O
' O
of O
E4 B
and O
the O
octamerlike O
motifs O
in O
the O
human B
immunoglobulin I
heavy I
- I
chain I
gene I
enhancer I
. O

Genetic O
mutation O
or O
loss O
of O
activin O
/ O
transforming B
growth I
factor I
- I
beta I
( I
TGFbeta I
) I
receptor I
function O
has O
been O
shown O
in O
human O
lymphoid O
, O
breast O
, O
and O
colorectal O
tumors O
as O
well O
as O
Hep2B O
and O
Mv1Lu O
cell O
lines O
. O

We O
now O
describe O
a O
HepG2 B
cell I
casein I
kinase I
II I
beta I
subunit I
cDNA I
of O
2 O
. O
57 O
kb O
containing O
96 O
bases O
of O
5 O
' O
untranslated O
sequence O
, O
645 O
bases O
of O
open O
reading O
frame O
, O
and O
1832 O
bases O
of O
3 O
' O
untranslated O
sequence O
with O
two O
polyadenylation O
consensus O
signal O
sequences O
and O
two O
poly O
( O
A O
) O
stretches O
. O

Brome B
mosaic I
virus I
polymerase I
- O
like O
protein B
2a I
is O
directed O
to O
the O
endoplasmic O
reticulum O
by O
helicase O
- O
like O
viral B
protein I
1a I
. O

Diagnostic O
importance O
of O
determining O
leucine B
aminotransferase I
activity O
in O
acute O
pancreatitis O

The O
Mer1 B
protein I
contains O
the O
KH O
motif O
found O
in O
some O
RNA O
- O
binding O
proteins O
, O
and O
RNA O
gel O
mobility O
shift O
assays O
demonstrate O
that O
Mer1 B
binds O
specifically O
to O
MER2 B
RNA I
. O

The O
mutant O
strain O
carries O
three O
tandem O
copies O
of O
the O
18 O
bp O
sequence O
that O
is O
duplicated O
in O
the O
amdI66 B
mutation O
. O

Although O
cDNA O
encoding O
a O
human B
phagocyte I
formyl I
peptide I
- I
binding I
protein I
has O
been O
reported O
recently O
( O
Boulay O
, O
F O
. O
, O
Tardif O
, O
M O
. O
, O
Brouchon O
, O
L O
. O
, O
and O
Vignais O
, O
P O
. O

In O
NIH O
3T3 O
fibroblasts O
the O
high O
affinity O
IL B
- I
2R I
bearing O
a O
deletion O
of O
a O
region O
rich O
in O
acidic O
amino O
acids O
( O
the O
" O
acidic O
" O
region O
) O
in O
the O
IL B
- I
2R I
beta I
- I
chain I
failed O
to O
induce O
the O
tyrosine O
phosphorylation O
of O
MAP O
kinase O
as O
well O
as O
the O
expression O
of O
the O
all O
three O
nuclear O
proto O
- O
oncogenes O
. O

A O
small O
molecule O
ILK O
inhibitor O
suppresses O
the O
phosphorylation O
of O
PKB O
at O
the O
Ser O
- O
473 O
but O
not O
the O
Thr O
- O
308 O
site O
in O
the O
PTEN B
mutant O
cells O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta O
gag O
- O
mht O
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v O
- O
myc O
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta O
gag O
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v O
- O
myc O
are O
cell O
- O
drived O
sequences O
. O

Of O
3841 O
serum O
samples O
from O
sows O
received O
from O
the O
Tennessee O
State O
Diagnostic O
Laboratory O
in O
1991 O
- O
1992 O
, O
1130 O
were O
positive O
for O
Toxoplasma B
gondii I
antibody I
. O

These O
findings O
also O
demonstrate O
that O
unless O
excluded O
by O
other O
factors O
, O
the O
C B
proteins I
are O
likely O
to O
be O
located O
along O
the O
length O
of O
nascent O
transcripts O
. O

We O
have O
now O
completed O
the O
primary O
structure O
of O
fibrillin B
, O
elucidated O
the O
exon O
/ O
intron O
organization O
of O
the O
gene O
and O
derived O
a O
physical O
map O
of O
the O
genetic O
locus O
. O

To O
gain O
additional O
insights O
into O
this O
novel O
apoptotic O
checkpoint O
, O
we O
have O
now O
characterized O
the O
mouse B
survivin I
locus I
. O

Both O
proteins O
share O
sequence O
similarity O
with O
the O
myelin B
- I
associated I
glycoprotein I
, O
an O
adhesion O
molecule O
of O
oligodendrocytes O
and O
Schwann O
cells O
that O
has O
been O
implicated O
in O
the O
process O
of O
myelination O
, O
raising O
the O
important O
question O
of O
whether O
myelin B
- I
associated I
glycoprotein I
is O
also O
a O
sialic B
acid I
- I
binding I
protein I
. O

Localized O
Bicaudal B
- I
C I
RNA I
encodes O
a O
protein O
containing O
a O
KH O
domain O
, O
the O
RNA O
binding O
motif O
of O
FMR1 B
. O

To O
facilitate O
the O
characterization O
of O
NF O
- O
E2 O
functions O
in O
human O
cells O
, O
we O
isolated O
cDNAs O
encoding O
two O
members O
of O
the O
small B
Maf I
family I
, O
MafK B
and O
MafG O
. O

In O
contrast O
to O
the O
restricted O
tissue O
expression O
of O
gonadotropin O
and O
TSH B
receptors I
in O
gonads O
and O
thyroid O
, O
respectively O
, O
LGR4 B
is O
expressed O
in O
diverse O
tissues O
including O
ovary O
, O
testis O
, O
adrenal O
, O
placenta O
, O
thymus O
, O
spinal O
cord O
, O
and O
thyroid O
, O
whereas O
LGR5 B
is O
found O
in O
muscle O
, O
placenta O
, O
spinal O
cord O
, O
and O
brain O
. O

The O
JNK O
/ O
SAPK O
activator O
mixed B
lineage I
kinase I
3 I
( O
MLK3 B
) O
transforms O
NIH O
3T3 O
cells O
in O
a O
MEK O
- O
dependent O
fashion O
. O

Members O
of O
the O
steroid B
/ I
hormone I
nuclear I
receptor I
superfamily I
regulate O
target O
gene O
transcription O
via O
recognition O
and O
association O
with O
specific O
cis O
- O
acting O
sequences O
of O
DNA O
, O
called O
hormone O
response O
elements O
( O
HREs O
) O
. O

Indeed O
, O
DEX O
also O
enhanced O
the O
RA O
- O
dependent O
increase O
in O
RARbeta B
mRNA I
in O
a O
cycloheximide O
- O
sensitive O
manner O
. O

Avian B
EMILIN I
was O
extracted O
from O
19 O
- O
day O
- O
old O
embryonic O
chick O
aortas O
and O
associated O
blood O
vessels O
and O
purified O
by O
ion O
- O
exchange O
chromatography O
and O
gel O
filtration O
. O

CYP51P1 B
is O
96 O
. O
5 O
% O
identical O
to O
the O
human B
CYP51 I
coding O
sequence O
and O
is O
not O
interrupted O
with O
introns O
but O
has O
six O
in O
- O
frame O
stop O
codons O
resulting O
from O
point O
mutations O
. O

Three O
RasV12 B
mutants I
( O
S35 B
, O
G37 B
, O
and O
C40 B
) O
which O
differ O
by O
their O
ability O
to O
bind O
to O
Ras B
effectors I
( O
Raf O
, O
Ral B
- I
GEFs I
, O
and O
the O
p110 B
subunit I
of I
PI I
3 I
- I
kinase I
, O
respectively O
) O
were O
able O
to O
induce O
sustained O
NR O
cell O
proliferation O
, O
although O
none O
of O
these O
mutants O
was O
reported O
to O
transform O
NIH O
3T3 O
cells O
. O

Here O
, O
we O
characterize O
TCR O
/ O
CD48 B
and O
TCR O
/ O
CD28 O
costimulation O
in O
T O
cells O
expressing O
Lck O
Src O
homology O
3 O
( O
SH3 O
) O
mutants O
. O

High O
expression O
of O
p51A B
( O
TAp63gamma B
) O
in O
the O
skeletal O
muscle O
tissue O
drove O
us O
to O
investigate O
a O
differentiation O
- O
inducible O
myoblastic O
cell O
line O
which O
showed O
increased O
p51A B
expression O
after O
differentiation O
induction O
. O

These O
results O
induce O
that O
the O
putative O
TATA O
box O
and O
initiator O
are O
not O
involved O
in O
the O
promoter O
activity O
, O
and O
that O
the O
vitronectin B
promoter I
lacks O
the O
TATA O
box O
, O
initiator O
and O
GC O
box O
. O

Using O
the O
interaction O
- O
trap O
assay O
to O
identify O
candidate O
proteins O
that O
bind O
the O
cytoplasmic O
region O
of O
the O
LAR B
transmembrane I
protein I
tyrosine I
phosphatase I
( O
PT B
- I
Pase I
) O
, O
we O
isolated O
a O
cDNA O
encoding O
a O
2861 O
- O
amino O
acid O
protein O
termed O
Trio B
that O
contains O
three O
enzyme O
domains O
: O
two O
functional O
GEF B
domains I
and O
a O
protein B
serine I
/ I
threonine I
kinase I
( O
PSK B
) O
domain O
. O

We O
have O
isolated O
two O
H19 B
cDNAs I
( O
AP O
and O
ES B
) O
that O
contain O
this O
ORF4 O
and O
correspond O
to O
incomplete O
copies O
of O
the O
unique O
2 B
. I
3 I
kb I
H19 I
RNA I
. O

The O
combined O
in O
vitro O
effects O
of O
ethanol O
wih O
methaqualone O
, O
phenobarbital O
, O
pyrazole O
or O
disulfiram O
were O
studied O
using O
rat B
brain I
microsomal I
NA I
- I
K I
- I
ATPase I
. O

The O
related O
adhesion B
focal I
tyrosine I
kinase I
is O
tyrosine O
- O
phosphorylated O
after O
beta1 B
- I
integrin I
stimulation O
in O
B O
cells O
and O
binds O
to O
p130cas O
. O

Earlier O
reports O
have O
localized O
mutations O
which O
affect O
the O
processing O
and O
transport O
of O
herpes O
simplex O
virus O
1 O
glycoproteins O
to O
a O
region O
located O
between O
the O
genes O
specifying O
glycoprotein B
B I
and O
the O
major O
viral O
DNA O
- O
binding O
protein O
( O
beta B
8 I
) O
. O

These O
results O
indicate O
that O
the O
2127 O
- O
bp O
cDNA O
encodes O
a O
functional O
feline O
L B
/ I
B I
/ I
K I
- I
type I
ALP I
expressed O
on O
cell O
surfaces O
via O
phosphatidylinositol O
- O
glycan O
linkage O
. O

p56 O
( O
lck O
) O
utilizes O
Shc O
and O
Grb2 B
adaptors I
to O
mediate O
activation O
of O
p21 O
( O
ras O
) O
in O
the O
thymoblast O
lines O
by O
promoting O
tyrosine O
phosphorylation O
of O
the O
Shc B
protein I
and O
constitutive O
interaction O
between O
Shc O
and O
Grb2 O
. O

The O
rec8 B
( I
+ I
) I
, O
rec10 B
( I
+ I
) I
, O
and O
rec11 B
( I
+ I
) I
genes I
of I
the I
fission I
yeast I
Schizosaccharomyces I
pombe I
exhibit O
similar O
specificities O
for O
meiotic O
recombination O
and O
rec8 B
( I
+ I
) I
is O
required O
for O
sister O
chromatid O
cohesion O
and O
homolog O
pairing O
. O

Based O
on O
the O
results O
of O
this O
analysis O
, O
we O
also O
predict O
that O
the O
budding B
yeast I
arsenate I
resistance I
protein I
Acr2 B
and O
the O
ORF B
Ygr203w I
encode O
protein O
phosphatases O
with O
catalytic O
properties O
similar O
to O
that O
of O
the O
Cdc25 B
family I
. O

The O
PHO5 B
gene I
is O
activated O
by O
the O
Pho4p B
transcription I
factor I
, O
which O
itself O
is O
negatively O
regulated O
through O
phosphorylation O
by O
the O
products O
of O
PHO80 B
and O
PHO85 O
. O

Analysis O
of O
the O
DNA O
sequence O
upstream O
of O
the O
narQ B
gene I
, O
which O
encodes O
the O
second O
nitrate O
- O
responsive O
sensor O
- O
transmitter O
protein O
in O
Escherichia O
coli O
, O
revealed O
an O
open O
reading O
frame O
( O
ORF O
) O
whose O
product O
shows O
a O
high O
degree O
of O
similarity O
to O
a O
number O
of O
iron B
- I
sulfur I
proteins I
as O
well O
as O
to O
the O
beta O
subunit O
of O
glutamate B
synthase I
( O
gltD B
) O
of O
E O
. O
coli O
. O

We O
suggest O
that O
the O
responses O
to O
types B
I I
and I
II I
collagen I
were O
caused O
by O
a O
cross O
- O
reaction O
with O
type O
III O
collagen O
peptides O
. O

The O
5 O
' O
half O
of O
the O
EWS O
gene O
has O
recently O
been O
described O
to O
be O
fused O
to O
the O
3 O
' O
regions O
of O
genes O
encoding O
the O
DNA O
- O
binding O
domain O
of O
several O
transcriptional O
regulators O
, O
including O
ATF1 O
, O
FLI O
- O
1 O
, O
and O
ERG B
, O
in O
several O
human O
tumors O
. O

Recombinant B
apoA I
- I
I I
protein I
recovered O
from O
the O
soluble O
fraction O
of O
the O
bacterial O
cell O
pellet O
was O
purified O
to O
greater O
than O
95 O
% O
homogeneity O
by O
reversed O
- O
phase O
high O
- O
performance O
liquid O
chromatography O
. O

Thus O
, O
transgene O
expression O
directed O
by O
both O
the O
human O
and O
mouse B
Rb I
promoters I
is O
restricted O
to O
a O
subset O
of O
tissues O
in O
which O
Rb O
is O
normally O
expressed O
during O
embryogenesis O
. O

Thus O
, O
Tax1 O
activates O
CArG O
- O
mediated O
transcription O
without O
mitogenic O
signals O
through O
interaction O
with O
a O
CArG B
- I
binding I
factor I
, O
p67SRF B
. O

Although O
RAD17 B
, O
RAD24 O
and O
MEC3 B
are O
not O
required O
for O
cell O
cycle O
arrest O
when O
S O
phase O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU O
, O
possibly O
because O
they O
are O
required O
for O
the O
repair O
of O
HU O
- O
induced O
DNA O
damage O
. O

PTP1 B
- O
lacZ O
studies O
indicate O
that O
PTP1 B
is O
spatially O
localized O
to O
prestalk O
and O
anterior O
- O
like O
cell O
types O
. O

When O
translated O
in O
- O
frame O
with O
PKC O
zeta O
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi B
PKC I
zeta I
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC O
zeta O
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC O
zeta O
, O
and O
synthetic O
psi B
PKC I
zeta I
RNA I
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

Like O
Rev O
- O
Erb O
, O
BD73 B
binds O
as O
a O
monomer O
to O
a O
DNA O
sequence O
which O
consists O
of O
a O
specific O
A O
/ O
T O
- O
rich O
sequence O
upstream O
of O
the O
consensus O
hexameric O
half O
- O
site O
specified O
by O
the O
P O
box O
of O
the O
DNA O
- O
binding O
domain O
. O

In O
contrast O
, O
the O
holo B
- I
dTFIIA I
( O
L O
/ O
S O
) O
binds O
TBP O
with O
high O
affinity O
. O

Overexpression O
of O
wild O
type O
and O
SeCys O
/ O
Cys O
mutant O
of O
human B
thioredoxin I
reductase I
in O
E O
. O
coli O
: O
the O
role O
of O
selenocysteine O
in O
the O
catalytic O
activity O
. O

Western O
and O
immunocytochemical O
analysis O
implied O
that O
PREB B
accumulates O
specifically O
in O
GH3 O
cell O
nuclei O
. O

Two O
genes O
from O
the O
family O
encoding O
mouse B
ribosomal I
protein I
S16 I
were O
cloned O
, O
sequenced O
, O
and O
analyzed O
. O

A O
novel O
serine B
kinase I
activated O
by O
rac1 O
/ O
CDC42Hs O
- O
dependent O
autophosphorylation O
is O
related O
to O
PAK65 B
and O
STE20 B
. O

The O
deduced O
gene O
product O
was O
found O
to O
have O
significant O
sequence O
similarity O
to O
the O
yeast B
and I
prokaryotic I
RNA I
polymerase I
subunits I
involved O
with O
subunit O
assembly O
. O

Maximum O
overexpression O
of O
holoenzyme O
activity O
was O
achieved O
by O
the O
inclusion O
in O
such O
plasmids O
of O
Salmonella O
typhimurium O
cysG O
, O
which O
encodes O
a O
uroporphyrinogen B
III I
methyltransferase I
required O
for O
the O
synthesis O
of O
siroheme O
, O
a O
cofactor O
for O
the O
hemoprotein O
. O

Overexpression O
of O
SNURF B
in O
cultured O
mammalian O
cells O
enhanced O
not O
only O
androgen O
, O
glucocorticoid O
, O
and O
progesterone O
receptor O
- O
dependent O
transactivation O
but O
also O
basal O
transcription O
from O
steroid O
- O
regulated O
promoters O
. O

The O
human O
protein O
binds O
most O
strongly O
to O
the O
SH3 O
domain O
from O
the O
abl B
proto I
- I
oncogene I
. O

Foamy O
viruses O
( O
FVs O
) O
express O
the O
Gag B
protein I
as O
a O
precursor O
with O
a O
molecular O
mass O
of O
74 O
kDa O
( O
pr74 B
) O
from O
which O
a O
70 O
- O
kDa O
protein O
( O
p70 O
) O
is O
cleaved O
by O
the O
viral O
protease O
. O

Our O
results O
suggest O
that O
at O
least O
some O
chloroplast B
- I
like I
tRNA I
genes I
in O
wheat O
mtDNA O
are O
transcribed O
, O
with O
transcripts O
undergoing O
processing O
, O
post O
- O
transcriptional O
modification O
and O
3 O
' O
- O
CCA O
addition O
, O
to O
produce O
mature O
tRNAs O
that O
may O
participate O
in O
mitochondrial O
protein O
synthesis O
. O

The O
occurrence O
of O
the O
different O
types O
of O
TCRB B
rearrangement O
patterns O
has O
implications O
for O
PCR O
- O
based O
clonality O
assessment O
and O
for O
PCR O
- O
based O
detection O
of O
minimal O
residual O
disease O
via O
TCRB B
gene I
analysis O
. O

No O
patient O
demonstrated O
a O
decrease O
in O
bone O
marrow O
fibrosis O
as O
determined O
by O
serial O
procollagen B
( O
PC B
III I
) O
serum O
level O
analysis O
. O

Uncoupling O
gene O
activity O
from O
chromatin O
structure O
: O
promoter O
mutations O
can O
inactivate O
transcription O
of O
the O
yeast B
HSP82 I
gene I
without O
eliminating O
nucleosome O
- O
free O
regions O
. O

Unlike O
these O
contaminant O
- O
responsive O
T O
cells O
, O
those O
that O
are O
truly O
specific O
for O
natural O
AChR B
epitopes I
appear O
less O
heterogeneous O
and O
therefore O
more O
suitable O
targets O
for O
selective O
immunotherapy O
. O

Because O
the O
wa B
- I
2 I
mutation I
was O
mapped O
previously O
to O
the O
vicinity O
of O
the O
EGF B
/ I
TGF I
- I
alpha I
receptor I
( O
EGFR O
) O
gene O
on O
mouse O
chromosome O
11 O
, O
we O
hypothesized O
that O
the O
wa B
- I
2 I
phenotype I
might O
result O
from O
a O
defect O
in O
either O
the O
expression O
or O
activity O
of O
EGFR O
, O
or O
both O
. O

Southern O
zoo O
blot O
analysis O
indicated O
that O
ZNF236 B
is O
conserved O
in O
the O
genomes O
of O
all O
mammalian O
species O
tested O
, O
but O
not O
in O
yeast O
. O

RNA O
determinants O
required O
for O
L4 B
- O
mediated O
attenuation O
control O
of O
the O
S10 B
r I
- I
protein I
operon I
of I
Escherichia I
coli I
. O

Spodoptera O
frugiperda O
( O
Sf9 O
) O
cells O
have O
proved O
a O
suitable O
cell O
system O
in O
which O
to O
study O
this O
association O
and O
to O
produce O
recombinant B
CR3 I
, O
and O
we O
show O
here O
that O
another O
lepidopteran O
cell O
line O
, O
Trichoplusia O
niTN O
- O
5B1 O
- O
4 O
( O
High O
- O
Five O
) O
cells O
, O
allows O
the O
recovery O
of O
large O
amounts O
of O
functional B
recombinant I
CR3 I
. O

INTERVENTIONS O
: O
Postoperative O
follow O
- O
up O
consisted O
of O
serial O
determination O
of O
different O
biochemical O
markers O
( O
CK O
, O
CK O
- O
MB O
, O
cTnI B
) O
, O
ECGs O
, O
and O
echocardiography O
. O

The O
recruitment O
of O
constitutively O
phosphorylated O
p185 B
( O
neu O
) O
and O
the O
activated O
mitogenic O
pathway O
proteins O
to O
this O
membrane O
- O
microfilament O
interaction O
site O
provides O
a O
physical O
model O
for O
integrating O
the O
assembly O
of O
the O
mitogenic O
pathway O
with O
the O
transmission O
of O
growth O
factor O
signal O
to O
the O
cytoskeleton O
. O

The O
point O
mutation O
Asp O
- O
316 O
- O
- O
> O
Asn O
in O
the O
C O
- O
terminus O
of O
p38 O
, O
analogous O
to O
the O
ERK2 O
( O
extracellular B
- I
signal I
- I
regulated I
kinase I
2 I
) O
sevenmaker B
mutation O
, O
dramatically O
decreases O
its O
binding O
to O
MKP O
- O
1 O
and O
substantially O
compromises O
its O
stimulatory O
effect O
on O
the O
catalytic O
activity O
of O
this O
phosphatase O
. O

In O
one O
trial O
, O
116 O
subjects O
with O
transfusion O
- O
related O
chronic O
hepatitis O
C O
were O
treated O
with O
lymphoblastoid B
interferon I
( O
5 O
MU O
/ O
m2 O
three O
times O
a O
week O
for O
2 O
mo O
, O
then O
3 O
MU O
/ O
m2 O
three O
times O
a O
week O
for O
4 O
or O
10 O
mo O
) O
. O

Mutations O
in O
Saccharomyces O
cerevisiae O
that O
block O
meiotic O
prophase O
chromosome O
metabolism O
and O
confer O
cell O
cycle O
arrest O
at O
pachytene O
identify O
two O
new O
meiosis B
- I
specific I
genes I
SAE1 I
and O
SAE3 B
. O

Isolation O
and O
characterization O
of O
human O
orthologs O
of O
yeast O
CCR4 B
- O
NOT B
complex O
subunits O
. O

Thus O
, O
the O
i B
- I
leader I
protein I
is O
a O
viral O
gene O
product O
of O
unknown O
function O
and O
high O
stability O
that O
is O
made O
in O
large O
quantities O
at O
intermediate O
times O
of O
productive O
infection O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Therefore O
, O
we O
have O
reevaluated O
the O
age O
- O
related O
changes O
in O
serum B
leptin I
levels O
and O
their O
relationship O
with O
adiposity O
and O
androgen O
levels O
in O
a O
large O
group O
of O
community O
dwelling O
men O
. O

Expression O
of O
the O
E2 O
protein O
resulted O
in O
rapid O
repression O
of O
HPV B
E6 I
and O
E7 O
expression O
, O
followed O
approximately O
12 O
h O
later O
by O
profound O
inhibition O
of O
cellular O
DNA O
synthesis O
. O

Immunoblotting O
with O
antiphosphotyrosine O
antibody O
showed O
that O
many O
yeast O
proteins O
, O
including O
the O
p34CDC28 B
kinase I
, O
became O
phosphorylated O
at O
tyrosine O
in O
cells O
expressing O
v O
- O
src O
. O

The O
RHO1 B
gene I
encodes O
a O
homolog O
of O
the O
mammalian O
RhoA B
small I
GTP I
- I
binding I
protein I
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

As O
regards O
the O
short O
stature O
, O
they O
have O
proved O
that O
the O
syndrome O
is O
related O
to O
low O
levels O
of O
somatomedin O
C O
( O
SmC B
) O
. O

HBO O
had O
marked O
effects O
on O
these O
enzymes O
: O
lung B
SOD I
increased O
( O
guinea O
pigs O
47 O
% O
, O
rats O
88 O
% O
) O
and O
CAT O
and O
GSHPx B
activities O
decreased O
( O
33 O
% O
) O
in O
brain O
and O
lung O
. O

Thus O
the O
Hi O
- O
RARE O
represents O
a O
new O
type O
of O
RA O
response O
element O
with O
a O
role O
in O
the O
modulation O
of O
the O
expression O
of O
MHC B
class I
1 I
family O
genes O
. O

Although O
indomethacin O
is O
useful O
for O
examining O
the O
role O
of O
cyclooxygenase B
products I
in O
asthmatic O
responses O
, O
it O
should O
not O
be O
considered O
in O
the O
treatment O
of O
asthma O
. O

Incidence O
of O
beta O
- O
thalassemia O
carriers O
and O
those O
deficient O
in O
erythrocyte B
glucose I
- I
6 I
- I
phosphate I
dehydrogenase I
in O
the O
greater O
Buenos O
Aires O
area O

Both O
v B
- I
Myb I
and O
c O
- O
Myb O
bind O
specifically O
to O
delta B
E3 I
. O

An O
hcr1 B
null O
mutant O
was O
viable O
, O
but O
showed O
slight O
reduction O
of O
growth O
when O
compared O
with O
the O
wild O
- O
type O
strain O
. O

Serum O
levels O
of O
total O
and O
specific B
immunoglobulin I
E I
( O
IgE O
) O
have O
been O
determined O
by O
radioimmunoassays O
in O
sixty O
- O
nine O
allergic O
subjects O
. O

IgE B
- I
binding I
proteins I
of O
Psocoptera O
were O
determined O
by O
immunoblotting O
experiments O
. O

We O
also O
show O
that O
the O
products O
of O
both O
the O
GIY B
- I
YIG I
ORF O
and O
the O
non O
- O
canonical O
LAGLI B
- I
DADG I
- I
GIY I
- I
YIG I
ORF O
, O
which O
is O
generated O
by O
its O
integration O
, O
have O
endonuclease O
activities O
which O
recognize O
and O
cut O
the O
insertion O
site O
of O
the O
optional O
sequence O
. O

Further O
, O
we O
find O
that O
the O
BMI1 B
protein I
can O
also O
interact O
with O
itself O
. O

Indeed O
, O
ectopic O
expression O
of O
MOX4 B
in O
aerobic O
cells O
resulted O
in O
partially O
constitutive O
expression O
of O
DAN1 B
. O

Hybridization O
was O
detected O
between O
polyadenylated B
H I
chain I
mRNA I
, O
isolated O
from O
the O
majority O
of O
the O
hybridomas O
, O
and O
the O
VH O
probe O
. O

Identification O
of O
a O
putative O
infC B
- O
rpmI B
- O
rplT B
operon O
flanked O
by O
long O
inverted O
repeats O
in O
Mycoplasma O
fermentans O
( O
incognitus O
strain O
) O
. O

The O
proliferative O
potential O
of O
the O
pilocytic O
astrocytoma O
: O
the O
relation O
between O
MIB B
- I
1 I
labeling O
and O
clinical O
and O
neuro O
- O
radiological O
follow O
- O
up O
. O

Dominant O
- O
negative O
upf1 O
mutations O
were O
isolated O
following O
in O
vitro O
mutagenesis O
of O
a O
plasmid O
containing O
the O
UPF1 B
gene I
. O

We O
previously O
identified O
a O
highly O
conserved O
L O
- O
X O
- O
X O
- O
L O
- O
F O
sequence O
near O
the O
C O
terminus O
of O
the O
p6 B
domain I
of O
the O
Gag B
precursor I
as O
the O
major O
virion O
association O
motif O
for O
HIV B
- I
1 I
Vpr I
. O

The O
human B
CA11 I
gene I
appears O
to O
be O
located O
between O
the O
secretor B
type I
alpha I
( I
1 I
, I
2 I
) I
- I
fucosyltransferase I
gene I
cluster I
( O
FUT1 O
- O
FUT2 B
- O
FUT2P B
) O
and O
the O
D B
- I
site I
binding I
protein I
gene I
( O
DBP O
) O
on O
chromosome O
19q13 O
. O
3 O
. O

Second O
, O
overexpression O
of O
RIM11 B
can O
suppress O
an O
ime1 O
missense O
mutation O
( O
ime1 B
- I
L321F I
) O
but O
not O
an O
ime1 O
deletion O
. O

This O
50 O
- O
kDa O
protein O
contains O
two O
SH2 O
domains O
and O
an O
inter B
- I
SH2 I
domain I
of O
p85alpha O
, O
but O
the O
SH3 O
and O
bcr B
homology I
domains I
of O
p85alpha O
were O
replaced O
by O
a O
unique O
6 O
- O
amino O
acid O
sequence O
. O

In O
the O
present O
study O
, O
we O
report O
the O
entire O
genomic O
structure O
of O
KCNQ1 B
, O
which O
consists O
of O
19 O
exons O
spanning O
400 O
kb O
on O
chromosome O
11p15 O
. O
5 O
. O

Kettin B
is O
a O
large O
modular O
protein O
associated O
with O
thin O
filaments O
in O
the O
Z O
- O
disc O
region O
of O
insect O
muscles O
. O

However O
, O
microinjection O
of O
reconstituted O
mRNPs O
into O
Xenopus O
oocytes O
demonstrates O
that O
although O
translational O
repression O
occurs O
in O
the O
absence O
of O
consensus O
RNA O
binding O
sequences O
for O
FRGY2 B
, O
the O
presence O
of O
FRGY2 B
recognition I
elements I
within O
mRNA O
potentiates O
translational O
repression O
. O

We O
have O
determined O
the O
complete O
cDNA O
sequence O
of O
rat B
plectin I
from O
a O
number O
of O
well O
- O
characterized O
overlapping O
lambda O
gt11 O
clones O
. O

In O
contrast O
to O
p62 O
( O
dok B
) O
, O
DOKL B
lacks O
YxxP O
motifs O
in O
the O
C O
terminus O
and O
does O
not O
bind O
to O
Ras B
GTPase I
- I
activating I
protein I
( O
RasGAP B
) O
upon O
phosphorylation O
. O

A O
higher O
percentage O
of O
children O
with O
cerebral O
malaria O
( O
40 O
per O
cent O
) O
than O
with O
non O
- O
cerebral O
malaria O
( O
29 O
per O
cent O
) O
or O
controls O
( O
20 O
per O
cent O
) O
also O
had O
either O
serum O
ferritin O
< O
100 O
micrograms O
/ O
l O
and O
inflammation O
or O
sTfR B
> O
7 O
. O
3 O
mg O
/ O
l O
or O
both O
. O

UV O
cross O
- O
linking O
and O
Southwestern O
analysis O
suggested O
that O
KTP1 B
is O
a O
DNA O
- O
binding O
protein O
clearly O
distinct O
from O
AP2 O
, O
and O
this O
protein O
may O
be O
responsible O
for O
the O
basal O
keratinocyte O
- O
specific O
expression O
of O
the O
BPAG1 B
gene I
. O

The O
model O
of O
the O
complex O
provides O
a O
rationale O
for O
conserved O
ITAM B
residues O
, O
substrate O
specificity O
, O
and O
suggests O
that O
substrate O
binds O
only O
the O
active O
conformation O
of O
the O
Src B
family I
tyrosine I
kinase I
, O
unlike O
the O
ATP O
cofactor O
, O
which O
can O
bind O
the O
inactive O
form O
. O

The O
peptides O
are O
generated O
in O
the O
cytosol O
, O
then O
translocated O
across O
the O
membrane O
of O
the O
endoplasmic O
reticulum O
by O
the O
transporter B
associated I
with I
antigen I
processing I
( O
TAP B
) O
. O

It O
competes O
with O
the O
calcium O
ion O
which O
brings O
about O
inhibition O
of O
myosine B
kinase I
, O
and O
therefore O
a O
drop O
in O
phosphorylated O
myosine O
. O

Injection O
of O
horseradish O
peroxidase O
( O
HRP B
) O
into O
the O
cerebellar O
flocculus O
of O
the O
rat O
was O
employed O
to O
identify O
neurons O
in O
the O
abducens O
nucleus O
that O
project O
to O
the O
flocculus O
. O

To O
assay O
for O
sequences O
that O
could O
potentially O
regulate O
Xenopus B
proenkephalin I
expression O
, O
we O
transfected O
constructs O
that O
contained O
upstream O
genomic O
sequences O
linked O
to O
the O
CAT O
reporter O
gene O
into O
various O
eukaryotic O
cell O
lines O
. O

This O
suggests O
that O
the O
ratio O
of O
IL O
- O
6 O
to O
IL B
- I
10 I
may O
be O
used O
to O
predict O
the O
injury O
severity O
after O
trauma O
. O

UVB O
- O
induced O
association O
of O
tumor B
necrosis I
factor I
( I
TNF I
) I
receptor I
1 I
/ O
TNF B
receptor I
- I
associated I
factor I
- I
2 I
mediates O
activation O
of O
Rel O
proteins O
. O

Experimental O
studies O
and O
clinical O
application O
of O
plasma B
ACTH I
radioimmunoassay O
kit O
without O
extraction O
process O

Nuclear O
export O
of O
proteins O
in O
plants O
: O
AtXPO1 B
is O
the O
export O
receptor O
for O
leucine O
- O
rich O
nuclear O
export O
signals O
in O
Arabidopsis O
thaliana O
. O

Thus O
, O
CR2 B
possesses O
an O
essential O
function O
besides O
pRb O
- O
binding O
. O

K562 O
erythroleukemia O
cells O
stably O
transfected O
with O
constructs O
containing O
the O
human B
Agamma I
- I
globin I
promoter I
linked O
to O
an O
enhanced B
green I
fluorescent I
protein I
( O
EGFP O
) O
reporter O
, O
with O
or O
without O
HS2 O
, O
were O
analyzed O
for O
EGFP O
expression O
by O
flow O
cytometry O
. O

Gastrin O
stimulates O
transcription O
of O
the O
human B
histidine I
decarboxylase I
( O
HDC B
) O
gene O
through O
binding O
to O
the O
G O
- O
protein O
- O
coupled O
cholecystokinin B
- I
B I
/ O
gastrin O
receptor O
. O

Here O
, O
we O
report O
the O
isolation O
of O
a O
new O
spindle O
checkpoint O
gene O
, O
mph1 B
( O
Mps1p B
- I
like I
pombe I
homolog I
) O
, O
in O
the O
fission O
yeast O
Schizosaccharomyces O
pombe O
, O
that O
is O
required O
for O
checkpoint O
activation O
in O
response O
to O
spindle O
defects O
. O

mph1 B
functions O
upstream O
of O
mad2 O
, O
a O
previously O
characterized O
component O
of O
the O
spindle O
checkpoint O
. O

Structure O
and O
chromosomal O
localization O
of O
the O
human O
gene O
of O
the O
phosphotyrosyl B
phosphatase I
activator I
( O
PTPA B
) O
of O
protein O
phosphatase O
2A O
. O

These O
transcripts O
directed O
the O
synthesis O
of O
three O
proteins O
: O
the O
virus B
trans I
- I
activator I
protein I
( O
EIAV B
Tat I
) O
encoded O
by O
ORF O
S1 O
, O
a O
protein O
of O
unknown O
function O
encoded O
by O
ORF O
S2 O
, O
and O
the O
virus O
envelope B
glycoprotein I
. O

We O
therefore O
investigated O
whether O
the O
promoter O
activity O
of O
the O
mouse B
TRH I
gene I
is O
directly O
regulated O
by O
RA O
using O
a O
transient O
transfection O
assay O
into O
CV O
- O
1 O
cells O
. O

The O
unusual O
properties O
of O
TRAC O
activity O
and O
its O
relationship O
, O
if O
any O
, O
with O
the O
enigmatic O
Ku B
protein I
, O
are O
discussed O
. O

We O
have O
isolated O
and O
determined O
the O
complete O
nucleotide O
sequence O
of O
another O
operon O
, O
cpeCD B
, O
that O
encodes O
the O
linker O
proteins O
associated O
with O
phycoerythrin B
hexamers I
in O
the O
phycobilisome B
. O

A B
. I
thaliana I
cystathionine I
beta I
- I
lyase I
exhibits O
22 O
% O
sequence O
identity O
with O
the O
E O
. O
coli O
corresponding O
enzyme O
and O
contains O
a O
70 O
amino O
acid O
N O
- O
terminal O
additional O
sequence O
compared O
with O
the O
bacterial O
protein O
. O

The O
enzyme B
ACC I
oxidase I
catalyses O
the O
last O
step O
of O
ethylene O
biosynthesis O
in O
plants O
, O
converting O
1 O
- O
aminocyclopropane O
- O
1 O
- O
carboxylic O
acid O
( O
ACC O
) O
to O
ethylene O
. O

When O
expressed O
in O
thymidine O
kinase O
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C O
/ O
EBPalpha O
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F B
binding I
sites I
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F O
- O
1 O
and O
dihydrofolate B
reductase I
( O
DHFR O
) O
. O

Members O
of O
the O
CRE O
- O
binding O
protein O
( O
CREB O
) O
/ O
activating B
transcription I
factor I
transcription O
family O
as O
well O
as O
members O
of O
the O
Jun O
/ O
Fos O
family O
have O
been O
shown O
to O
bind O
to O
this O
sequence O
. O

Csk O
( O
C O
- O
terminal O
Src O
kinase O
) O
is O
a O
protein O
tyrosine O
kinase O
that O
phosphorylates O
Src B
family I
member I
C I
- I
terminal I
tails I
, O
resulting O
in O
downregulation O
of O
Src O
family O
members O
. O

Role O
of O
double B
- I
stranded I
RNA I
- I
dependent I
protein I
kinase I
in O
mediating O
hypersensitivity O
of O
Fanconi O
anemia O
complementation O
group O
C O
cells O
to O
interferon O
gamma O
, O
tumor O
necrosis O
factor O
- O
alpha O
, O
and O
double O
- O
stranded O
RNA O
. O

Our O
results O
suggest O
a O
dose O
- O
dependent O
activity O
of O
lysine B
vasopressin I
on O
the O
EEG O
, O
which O
might O
be O
similar O
to O
that O
observed O
in O
animal O
and O
man O
after O
administration O
of O
nicotine O
. O

Mutations O
of O
the O
human B
PTEN I
gene I
. O

Guanylyl B
cyclase I
C I
, O
the O
apparent O
guanylin B
receptor I
, O
was O
found O
in O
abundant O
amounts O
in O
the O
intestine O
by O
Northern O
analysis O
, O
and O
by O
the O
polymerase O
chain O
reaction O
or O
cDNA O
cloning O
it O
was O
also O
found O
in O
adrenal O
gland O
, O
airway O
epithelial O
cells O
, O
brain O
, O
and O
olfactory O
and O
tracheal O
mucosa O
. O

In O
the O
present O
study O
we O
have O
used O
Southern O
blot O
analysis O
to O
demonstrate O
that O
TSG6 B
is O
a O
single O
- O
copy O
gene O
in O
the O
human O
and O
murine O
species O
. O

The O
Polycomb B
group I
proteins I
are O
involved O
in O
maintenance O
of O
the O
silenced O
state O
of O
several O
developmentally O
regulated O
genes O
. O

Uncertainty O
exists O
about O
the O
function O
of O
these O
potential O
isoforms O
of O
the O
Cbfa1 B
gene I
. O

Human B
CD38 I
, O
a O
leukocyte O
receptor O
and O
ectoenzyme O
, O
is O
a O
member O
of O
a O
novel O
eukaryotic O
gene O
family O
of O
nicotinamide B
adenine I
dinucleotide I
+ I
- I
converting I
enzymes I
: O
extensive O
structural O
homology O
with O
the O
genes O
for O
murine B
bone I
marrow I
stromal I
cell I
antigen I
1 I
and O
aplysian B
ADP I
- I
ribosyl I
cyclase I
. O

It O
is O
noteworthy O
that O
under O
more O
physiological O
conditions O
mimicking O
the O
cellular O
GDP O
/ O
GTP O
ratio O
, O
Raf O
enhances O
the O
GEF O
- O
stimulated O
GDP O
/ O
GTP O
exchange O
on O
Ha O
- O
Ras O
, O
in O
agreement O
with O
the O
sequestration O
of O
Ras B
. I
GTP I
by O
Raf O
. O

When O
O O
- O
2A O
/ O
c O
- O
myc O
cells O
underwent O
terminal O
differentiation O
APprog B
complexes I
were O
lost O
and O
conventional O
AP O
- O
1 O
DNA O
- O
binding O
activity O
became O
evident O
, O
particularly O
in O
astrocytes O
. O

From O
the O
deduced O
amino O
acid O
sequence O
, O
a O
molecular O
weight O
of O
38 O
, O
549 O
was O
calculated O
for O
the O
ADH B
subunit I
. O

TAF B
- I
1 I
activates O
transcription O
constitutively O
and O
was O
mapped O
to O
the O
first O
32 O
amino O
acids O
of O
the O
A O
- O
region O
. O

The O
cDNA O
is O
predicted O
to O
encode O
a O
polypeptide O
of O
298 O
amino O
acids O
that O
is O
homologous O
to O
the O
Y B
- I
box I
( I
inverted I
CCAAT I
) I
family I
of I
DNA I
- I
binding I
transcription I
factors I
. O

Site O
- O
directed O
mutagenesis O
of O
the O
conserved O
cysteine O
residue O
( O
tom1C3235A B
) O
in O
the O
hect B
- I
domain I
, O
supposed O
to O
be O
necessary O
for O
thioester O
- O
bond O
formation O
with O
ubiquitin O
, O
abolished O
the O
gene O
function O
. O

The O
two O
yeast B
pheromone I
receptors I
, O
the O
a B
and I
alpha I
- I
factor I
receptors I
, O
share O
many O
functional O
similarities O
: O
both O
G O
protein O
- O
coupled O
receptors O
couple O
to O
the O
same O
downstream O
signal O
transduction O
pathway O
, O
and O
both O
receptors O
undergo O
feedback O
regulation O
involving O
increased O
phosphorylation O
on O
their O
C O
- O
terminal O
domains O
in O
response O
to O
ligand O
challenge O
. O

Moreover O
, O
the O
formation O
of O
the O
complex O
between O
IclR B
and O
the O
operator O
/ O
promoter O
region O
has O
been O
found O
to O
be O
impaired O
by O
phosphoenol O
pyruvate O
but O
insensitive O
to O
acetate O
, O
acetyl O
- O
CoA O
, O
pyruvate O
, O
and O
oxaloacetate O
. O

The O
expression O
pattern O
of O
the O
reporter O
gene O
was O
compared O
to O
that O
of O
the O
endogenous B
PDGFbeta I
r I
gene I
. O

The O
two O
SH3 O
domains O
are O
separated O
by O
a O
54 O
amino O
acid O
linker O
region O
, O
whose O
length O
is O
highly O
conserved O
in O
xenopus O
, O
chicken O
, O
and O
mamalian B
Crk I
II I
proteins I
. O

The O
fz B
- I
1 I
and O
fz B
- I
2 I
genes I
are O
widely O
expressed O
in O
rat O
tissues O
with O
the O
highest O
steady O
- O
state O
levels O
of O
mRNA O
in O
kidney O
, O
liver O
, O
heart O
, O
uterus O
, O
and O
ovary O
. O

fz B
- I
1 I
and I
- I
2 I
mRNA I
levels O
were O
greater O
in O
neonatal O
than O
in O
corresponding O
adult O
tissues O
. O

In O
this O
report O
, O
we O
establish O
that O
the O
heteromeric O
CCAAT B
- I
binding I
factor I
CBF O
is O
the O
major O
component O
of O
the O
C1 B
- I
binding I
factor I
( O
C1F O
) O
in O
human O
cells O
. O

A O
40 O
- O
fold O
stimulation O
of O
chloramphenicol O
acetyltransferase O
activity O
mediated O
by O
four O
tandem O
repeats O
of O
the O
SNE B
could O
be O
induced O
within O
2 O
h O
( O
and O
up O
to O
250 O
- O
fold O
within O
6 O
h O
) O
after O
addition O
of O
TPA O
in O
DNA O
- O
transfected O
U O
- O
937 O
cells O
, O
indicating O
that O
the O
stimulation O
appeared O
likely O
to O
be O
a O
true O
protein O
kinase O
C O
- O
mediated O
signal O
transduction O
event O
rather O
than O
a O
differentiation O
response O
. O

Deletion O
mutants O
of O
the O
human B
CHOP I
promoter I
identify O
a O
region O
comprising O
nucleotides O
- O
75 O
to O
- O
104 O
required O
for O
both O
constitutive O
and O
ER O
- O
stress O
- O
inducible O
expression O
. O

In O
contrast O
, O
an O
N B
- I
terminal I
RNAP I
mutant I
that O
has O
a O
decreased O
capacity O
to O
bind O
single O
- O
stranded O
RNA O
forms O
halted O
complexes O
with O
much O
lower O
levels O
of O
stability O
than O
the O
WT O
enzyme O
, O
and O
these O
complexes O
are O
not O
stabilized O
by O
the O
presence O
of O
the O
NT O
strand O
. O

A O
mouse O
brain O
cDNA O
library O
in O
lambdagt11 O
was O
screened O
for O
this O
association O
, O
and O
two O
positive O
clones O
encoding O
tyrosine B
phosphatase I
SH O
- O
PTP2 O
were O
isolated O
. O

To O
elucidate O
the O
molecular O
mechanism O
by O
which O
the O
Ras O
signaling O
pathway O
activates O
a O
cell O
- O
type O
- O
specific O
gene O
, O
we O
have O
used O
the O
pituitary B
- I
specific I
rat I
prolactin I
( O
rPRL B
) O
promoter O
as O
a O
target O
of O
oncogenic O
Ras O
and O
Raf O
in O
GH4 O
rat O
pituitary O
cells O
. O

The O
human O
RFC B
- I
1 I
gene I
differs O
from O
the O
mouse O
and O
hamster O
genes O
both O
in O
terms O
of O
the O
total O
number O
of O
exons O
and O
in O
regard O
to O
alternatives O
of O
exon O
1 O
which O
encode O
5 O
' O
end O
heterogeneity O
. O

HGF O
treatment O
increased O
cyclin O
A O
, O
cyclin B
G1 I
and O
nuclear O
transcriptional O
factor O
( O
NFkappaB O
) O
protein O
expression O
. O

The O
1 O
. O
6 O
- O
kb O
cDNA O
( O
CBF O
- O
A O
) O
encoding O
285 O
amino O
acids O
( O
aa O
) O
was O
obtained O
, O
and O
a O
beta B
- I
galactosidase I
fusion I
protein I
, O
bacterially O
produced O
from O
the O
cDNA O
, O
bound O
to O
DNA O
fragments O
containing O
several O
CArG O
boxes O
. O

Mutant B
M I
proteins I
were O
tested O
for O
their O
ability O
to O
complement O
growth O
of O
the O
temperature O
- O
sensitive O
M B
protein I
mutant I
virus O
tsO23 O
at O
the O
nonpermissive O
temperature O
. O

The O
yjr041c B
delta I
haploid O
cells O
gave O
rise O
to O
microcolonies O
comprising O
about O
20 O
to O
50 O
cells O
. O

Two O
mutants O
, O
mapping O
at O
the O
HindIII B
site I
( O
between O
the O
consensus O
sequences O
) O
of O
the O
pSC101 B
tetA I
promoter I
, O
were O
studied O
: O
MA2 O
corresponds O
to O
a O
4 O
bp O
deletion O
between O
positions O
- O
12 O
and O
- O
15 O
; O
B30 O
bears O
a O
44 O
bp O
insertion O
C O
( O
TA O
) O
21 O
G O
at O
the O
HindIII B
site I
. O

Comparison O
of O
the O
footprint O
patterns O
of O
the O
mouse B
and I
human I
HPRT I
genes I
demonstrated O
that O
the O
in O
vivo O
binding O
of O
regulatory O
proteins O
between O
these O
species O
is O
generally O
conserved O
but O
not O
identical O
. O

Our O
Northern O
and O
Southern O
blot O
analyses O
of O
meningiomas O
clearly O
suggest O
the O
CLH B
- I
22 I
gene I
may O
be O
involved O
in O
the O
tumor O
development O
and O
can O
be O
considered O
as O
a O
candidate O
for O
a O
tumor O
suppressor O
. O

The O
c B
- I
Jun I
delta I
- I
domain I
inhibits O
neuroendocrine O
promoter O
activity O
in O
a O
DNA O
sequence O
- O
and O
pituitary O
- O
specific O
manner O
. O

The O
Valpha B
and O
Vbeta B
domains I
have O
the O
canonical O
features O
of O
known O
teleost B
and I
mammalian I
TCR I
V I
domains I
, O
including O
conserved O
residues O
in O
the O
beginning O
of O
FR2 B
and O
at O
the O
end O
of O
FR3 B
. O

The O
exact O
function O
of O
IP B
- I
30 I
is O
not O
yet O
known O
, O
but O
it O
may O
play O
a O
role O
in O
gamma O
- O
interferon O
mediated O
immune O
reactions O
. O

In O
this O
report O
, O
we O
demonstrate O
that O
FRS2 B
forms O
a O
complex O
with O
the O
N B
- I
terminal I
SH2 I
domain I
of O
the O
protein B
tyrosine I
phosphatase I
Shp2 I
in O
response O
to O
FGF O
stimulation O
. O

The O
H5 B
mutants I
were O
: O
DH5 B
( O
all O
amino O
acids O
in O
D O
configuration O
) O
and O
H5F B
( O
where O
all O
His O
are O
replaced O
by O
Phe O
at O
positions O
3 O
, O
7 O
, O
8 O
, O
15 O
, O
18 O
, O
19 O
, O
21 O
) O
. O

These O
results O
establish O
that O
the O
DNA O
fragment O
we O
have O
isolated O
contains O
the O
human B
gp130 I
promoter I
and O
that O
interleukin B
- I
6 I
type I
cytokines I
may O
influence O
the O
activity O
of O
this O
promoter O
via O
activated O
STATs O
. O

When O
targeted O
to O
the O
GAL1 B
promoter I
by O
fusing O
with O
the O
Gal4p B
DNA I
- I
binding I
domain I
, O
Sko1p O
acts O
as O
an O
Ssn6 B
/ O
Tup1p B
- O
dependent O
repressor O
regulated O
by O
osmotic O
stress O
. O

The O
unexpected O
prevalence O
of O
c O
- O
myc O
and O
alpha B
- I
tubulin I
in O
the O
S O
- O
phase O
library O
is O
supported O
by O
Northern O
analysis O
of O
RNA O
from O
phase O
- O
synchronous O
cells O
. O

Growth O
factors O
promote O
cell O
survival O
through O
phosphorylation O
of O
Bad O
, O
resulting O
in O
its O
dissociation O
from O
Bcl O
- O
2 O
and O
Bcl O
- O
x O
( O
L O
) O
and O
its O
association O
with O
14 B
- I
3 I
- I
3tau I
. O

However O
, O
in O
each O
case O
in O
which O
either O
the O
DQ B
alpha I
- I
or I
DQ I
beta I
- I
chain I
was O
exchanged O
, O
major O
alterations O
or O
reversals O
of O
this O
pattern O
of O
interaction O
were O
observed O
. O

Only O
the O
native O
structure O
of O
phosphorylated O
ERK O
was O
recognized O
by O
VHR B
and O
was O
inactivated O
with O
a O
second O
- O
order O
rate O
constant O
of O
40 O
, O
000 O
M O
- O
1 O
s O
- O
1 O
. O

We O
used O
an O
immobilized O
template O
- O
based O
assay O
to O
examine O
transcription O
termination O
by O
VA1 B
, O
7SL B
, O
and O
Alu B
class I
III I
templates O
and O
the O
role O
of O
transcript O
release O
in O
the O
pol O
III O
terminator O
- O
dependent O
inhibition O
of O
processing O
of O
B1 B
- O
Alu O
transcripts O
. O

Immunofluorescence O
tests O
for O
Borrelia B
burgdorferi I
serum I
antibodies I
had O
positive O
results O
, O
but O
G O
- O
penicillin O
treatment O
was O
ineffective O
. O

Nuclear O
runoff O
assays O
show O
that O
complementation O
by O
HPV16 B
E7 I
restores O
the O
ability O
of O
the O
E1A B
mutants I
to O
stimulate O
early O
gene O
expression O
at O
the O
level O
of O
transcription O
. O

Functional O
uncoupling O
of O
the O
Janus B
kinase I
3 I
- O
Stat5 O
pathway O
in O
malignant O
growth O
of O
human O
T O
cell O
leukemia O
virus O
type O
1 O
- O
transformed O
human O
T O
cells O
. O

The O
herpesvirus B
entry I
mediator I
C I
( O
HveC B
) O
, O
previously O
known O
as O
poliovirus B
receptor I
- I
related I
protein I
1 I
( O
PRR1 B
) O
, O
and O
the O
herpesvirus B
Ig I
- I
like I
receptor I
( O
HIgR B
) O
are O
the O
bona O
fide O
receptors O
employed O
by O
herpes O
simplex O
virus O
- O
1 O
and O
- O
2 O
( O
HSV O
- O
1 O
and O
- O
2 O
) O
for O
entry O
into O
the O
human O
cell O
lines O
most O
frequently O
used O
in O
HSV O
studies O
. O

The O
combination O
of O
ICP47 B
and O
US11 B
rendered O
fibroblasts O
negative O
for O
surface B
class I
I I
MHC I
and O
allowed O
a O
class B
I I
MHC I
- O
low O
population O
of O
T O
cells O
to O
be O
sorted O
by O
flow O
cytometry O
. O

Although O
IRS B
- I
1 I
, I
- I
2 I
, I
and I
- I
4 I
are O
similar O
in O
overall O
structure O
, O
IRS O
- O
3 O
is O
approximately O
50 O
% O
shorter O
and O
differs O
with O
respect O
to O
sites O
of O
tyrosine O
phosphorylation O
. O

In O
addition O
, O
we O
mapped O
a O
putative O
hnRNP O
A1 O
binding O
site O
in O
U5 O
RNA O
and O
demonstrated O
that O
p40CRS O
( O
hnRNP B
A1 I
) O
binding O
to O
that O
site O
correlates O
with O
CRS O
function O
. O

In O
HepG2 O
cells O
, O
SREBP B
- I
1c I
mRNA I
and O
precursor O
protein O
levels O
were O
induced O
by O
treatment O
with O
22 O
( O
R O
) O
- O
hydroxycholesterol O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
confirming O
that O
endogenous O
LXR B
- O
RXR O
activation O
can O
induce O
endogenous B
SREBP I
- I
1c I
expression O
. O

This O
integration O
results O
in O
the O
production O
of O
MMTV B
/ I
mdr3 I
fusion I
transcripts I
that O
originate O
from O
the O
antisense O
5 B
' I
LTR I
of O
the O
provirus O
. O

Sequence O
comparisons O
reveal O
that O
the O
P B
. I
woesei I
GTP I
- I
binding I
protein I
is O
strikingly O
related O
in O
sequence O
to O
eubacterial B
FtsZ I
and O
is O
marginally O
more O
similar O
to O
eukaryotic B
tubulins I
than O
are O
bacterial B
FtsZ I
proteins I
. O

Vav O
and O
Dbl O
are O
members O
of O
a O
novel O
class O
of O
oncogene O
proteins O
that O
share O
significant O
sequence O
identity O
in O
a O
approximately O
250 O
- O
amino O
- O
acid O
domain O
, O
designated O
the O
Dbl B
homology I
domain I
. O

Unlike O
LANA1 B
, O
LANA2 O
does O
not O
elicit O
a O
serologic O
response O
from O
patients O
with O
KS O
, O
PEL O
, O
or O
CD O
as O
measured O
by O
Western O
blot O
hybridization O
. O

However O
, O
this O
posttranslational O
modification O
of O
the O
gar2 B
protein I
does O
not O
appear O
to O
be O
essential O
for O
normal O
production O
of O
18S O
rRNA O
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
CYT O
- O
18 O
with O
a O
small O
RNA O
( O
P4 B
- I
P6 I
RNA I
) O
corresponding O
to O
the O
isolated O
P4 B
- I
P6 I
domain I
of O
the O
N B
. I
crassa I
mitochondrial I
large I
subunit I
ribosomal I
RNA I
intron I
. O

The O
deduced O
amino O
acid O
sequence O
of O
PutR B
( O
154 O
amino O
acid O
residues O
) O
showed O
homology O
to O
the O
small O
regulatory O
proteins O
Lrp O
, O
BkdR B
, O
and O
AsnC B
. O

When O
yeast O
cells O
reach O
a O
critical O
size O
in O
late O
G1 O
they O
simultaneously O
start O
budding O
, O
initiate O
DNA O
synthesis O
, O
and O
activate O
transcription O
of O
a O
set O
of O
genes O
that O
includes O
G1 B
cyclins I
CLN1 O
, O
CLN2 O
, O
and O
many O
DNA O
synthesis O
genes O
. O

Blockade O
of O
T O
cell O
activation O
using O
a O
surface O
- O
linked O
single O
- O
chain O
antibody O
to O
CTLA O
- O
4 O
( O
CD152 B
) O
. O

4 O
) O
Mutation O
of O
the O
three O
extracellular O
cysteine O
residues O
of O
GFKAR B
beta I
indicated O
that O
the O
two O
conserved O
cysteine O
residues O
( O
C305 O
and O
C385 O
) O
, O
located O
between O
two O
transmembrane O
segments O
, O
form O
a O
solvent O
- O
accessible O
disulfide O
bond O
. O

In O
this O
work O
, O
we O
have O
used O
Xenopus O
oocyte O
maturation O
as O
a O
read O
- O
out O
for O
examining O
the O
ability O
of O
the O
neu O
tyrosine O
kinase O
( O
p185neu B
) O
to O
participate O
with O
the O
epidermal B
growth I
factor I
( I
EGF I
) I
receptor I
in O
a O
common O
signal O
transduction O
pathway O
. O

In O
contrast O
, O
MAPK O
activation O
stimulated O
by O
the O
Gq B
- O
coupled O
alpha O
1B O
AR O
or O
M1 B
muscarinic B
cholinergic I
receptor I
is O
unaffected O
by O
expression O
of O
beta B
ARKct I
or O
RasN17 B
expression O
or O
by O
PTK O
inhibitors O
, O
but O
is O
blocked O
by O
expression O
of O
N B
delta I
Raf I
or O
by O
PKC O
depletion O
. O

Transcriptional O
analysis O
indicates O
that O
human B
TBP I
functions O
poorly O
at O
promoters O
recognized O
by O
RNA B
polymerases I
I I
and I
III I
and O
at O
RNA B
Pol I
II I
promoters I
lacking O
a O
conventional O
TATA O
element O
. O

The O
steady O
- O
state O
levels O
of O
Cdk2 O
, O
Cdk4 O
and O
Cyclin B
A I
proteins I
were O
unaffected O
by O
HPR O
, O
while O
those O
of O
Cyclin O
D1 O
were O
significantly O
reduced O
in O
all O
three O
cell O
lines O
. O

Mapping O
the O
5 O
' O
and O
3 O
' O
termini O
of O
TED B
RNAs I
indicated O
that O
the O
LTRs O
have O
a O
retroviral O
U3 O
- O
R O
- O
U5 O
structural O
organization O
that O
is O
capable O
of O
directing O
the O
synthesis O
of O
transcripts O
that O
represent O
potential O
substrates O
for O
reverse O
transcription O
and O
intermediates O
in O
transposition O
. O

These O
proteins O
were O
detected O
by O
an O
antibody O
which O
recognizes O
the O
N O
- O
terminus O
of O
SRK3 B
and O
, O
in O
an O
F2 O
progeny O
segregating O
for O
the O
S3 B
haplotype I
, O
were O
only O
expressed O
in O
plants O
possessing O
the O
S3 B
haplotype I
. O

The O
animals O
were O
followed O
over O
a O
1 O
- O
to O
6 O
- O
h O
posttraumatic O
course O
, O
and O
processed O
for O
the O
LM O
and O
TEM O
visualization O
of O
HRP B
. O

Three O
experiments O
using O
20 O
microM O
2 O
- O
( O
hydroxyamino O
) O
- O
1 O
- O
methyl O
- O
6 O
- O
phenylimidazo O
[ O
4 O
, O
5 O
- O
b O
] O
pyridine O
( O
N O
- O
OH O
- O
PhIP O
) O
were O
performed O
to O
induce O
mutations O
in O
the O
dihydrofolate B
reductase I
( O
DHFR O
) O
gene O
of O
a O
hemizygous O
Chinese O
hamster O
ovary O
( O
CHO O
) O
cell O
line O
( O
UA21 O
) O
. O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct O
- O
1 O
and O
probably O
Sp1 O
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF O
- O
kappa O
B O
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 O
+ O
CD8 O
+ O
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF O
- O
AT O
and O
AP O
- O
1 O
, O
that O
can O
be O
activated O

in O
mature O
( O
CD4 O
+ O
CD8 O
- O
TcRhigh B
) O
and O
immature O
( O
CD4 O
- O
CD8 O
- O
TcR O
- O
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 O
+ O
CD8 O
+ O
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB O
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

Of O
these O
four O
PP2C B
genes I
, O
the O
expression O
of O
the O
PP2Cbeta B
gene I
has O
been O
reported O
to O
be O
tissue O
- O
specific O
and O
development O
- O
dependent O
. O

The O
induction O
by O
dexamethasone O
of O
rat B
liver I
CYP3A1 I
differs O
from O
classical O
glucocorticoid O
gene O
regulation O
in O
part O
because O
both O
glucocorticoids O
and O
antiglucocorticoids O
such O
as O
pregnenolone O
16 O
alpha O
- O
carbonitrile O
( O
PCN O
) O
induce O
CYP3A1 B
through O
transcriptional O
gene O
activation O
. O

Moreover O
, O
antibody O
binding O
to O
the O
same O
two O
determinants O
was O
also O
inhibited O
when O
ZAP O
- O
70 O
or O
the O
SH2 O
domains O
bound O
to O
the O
zeta O
chain O
or O
to O
a O
2pY B
- I
ITAM I
. O

We O
examined O
the O
contribution O
of O
the O
M B
- I
MuLV I
enhancers I
to O
the O
transcriptional O
activity O
and O
pathogenesis O
of O
M O
- O
MuLV O
by O
constructing O
LTRs O
containing O
heterologous O
enhancer O
elements O
. O

Northern O
blot O
analysis O
confirmed O
that O
ADAMTS B
- I
1 I
was O
up O
- O
regulated O
in O
both O
metaphyseal O
( O
14 O
- O
to O
35 O
- O
fold O
) O
and O
diaphyseal O
( O
4 O
. O
2 O
- O
fold O
) O
bone O
1 O
h O
after O
PTH B
- I
( I
1 I
- I
38 I
) I
injection O
and O
returned O
to O
control O
levels O
by O
24 O
h O
. O

The O
transcriptional B
transactivator I
( O
Tas B
) O
of O
simian O
foamy O
virus O
type O
1 O
strongly O
augments O
gene O
expression O
directed O
by O
both O
the O
promoter O
in O
the O
viral O
long O
terminal O
repeat O
and O
the O
newly O
discovered O
internal O
promoter O
located O
within O
the O
env O
gene O
. O

Deletion O
of O
this O
consensus O
element O
from O
the O
spo6 B
promoter I
abolished O
the O
transcription O
of O
spo6 B
+ I
and O
resulted O
in O
a O
sporulation O
deficiency O
. O

We O
have O
generated O
transgenic O
fly O
strains O
with O
mutations O
affecting O
specific O
TRA B
- I
2 I
isoforms I
to O
investigate O
their O
individual O
roles O
in O
regulating O
the O
alternative O
processing O
of O
doublesex B
, O
exuperantia B
and O
tra B
- I
2 I
pre I
- I
mRNA I
. O

The O
IR4 O
ORF O
exhibits O
significant O
homology O
to O
the O
immediate O
- O
early O
gene O
US1 B
( O
ICP22 B
) O
of O
herpes O
simplex O
virus O
type O
1 O
and O
to O
the O
ICP22 B
homologs O
of O
varicella O
- O
zoster O
virus O
( O
ORF63 B
) O
, O
pseudorabies O
virus O
( O
RSp40 B
) O
, O
and O
equine O
herpesvirus O
4 O
( O
ORF4 O
) O
. O

We O
were O
able O
to O
demonstrate O
a O
significant O
statistical O
interaction O
effect O
between O
gender O
and O
globulin B
protein I
concentration O
on O
Vu O
( O
p O
= O
0 O
. O
022 O
) O
. O

These O
include O
not O
only O
antioxidants O
, O
N B
- I
methyl I
- I
D I
- I
aspartate I
receptor I
antagonists O
, O
inhibitors O
of O
glutamate O
release O
, O
calcium O
channel O
blockers O
, O
polyamine O
antagonists O
, O
and O
nitric O
oxide O
synthase O
inhibitors O
, O
but O
cannabinoids O
, O
aspirin O
, O
melatonin O
, O
and O
vitamin O
B O
- O
12 O
. O

CrkII B
and O
CrkL O
constitutively O
formed O
complex O
with O
the O
guanine O
nucleotide O
exchange O
factor O
C3G O
, O
in O
unstimulated O
as O
well O
as O
PDGF O
- O
stimulated O
cells O
. O

In O
further O
support O
of O
the O
biological O
significance O
of O
these O
DNA O
- O
protein O
interactions O
, O
the O
IL2RA B
oligonucleotide O
from O
- O
291 O
to O
- O
245 O
proved O
to O
be O
sufficient O
in O
either O
orientation O
to O
confer O
PMA O
inducibility O
to O
the O
mitogen O
- O
insensitive O
thymidine B
kinase I
gene I
promoter I
in O
Jurkat O
cells O
. O

The O
RPC31 B
gene I
encoding O
the O
C31 B
subunit I
of I
Saccharomyces I
cerevisiae I
RNA I
polymerase I
C I
( I
III I
) I
has O
been O
isolated O
, O
starting O
from O
a O
C O
- O
terminal O
fragment O
cloned O
on O
a O
lambda O
gt11 O
library O
. O

Electrophoretic O
mobility O
shift O
assays O
demonstrated O
that O
sequences O
within O
this O
region O
bind O
members O
of O
the O
Sp1 B
family I
of I
transcription I
factors I
. O

As O
to O
the O
side O
effects O
of O
SISO O
, O
cylindruria O
with O
aggravation O
of O
microscopic O
hematuria O
and O
elevations O
of O
GOT B
, O
GPT O
and O
A1 B
- I
P I
were O
observed O
each O
one O
of O
them O
, O
respectively O
. O

Serum B
C3 I
was O
measured O
in O
1 O
, O
282 O
school O
children O
with O
abnormal O
urinary O
findings O
between O
1980 O
and O
1997 O
. O

Computer O
analysis O
revealed O
that O
the O
human B
protein I
P1 I
sequence I
corresponding O
to O
amino O
acid O
residues O
within O
the O
N O
- O
terminal O
RNA O
binding O
domain O
displays O
high O
homology O
( O
greater O
than O
54 O
% O
identity O
; O
61 O
to O
94 O
% O
similarity O
) O
with O
two O
animal O
virus O
proteins O
which O
possess O
RNA O
binding O
activity O
( O
vaccinia B
virus I
E3L I
; O
rotavirus B
VP2 I
) O
and O
two O
proteins O
of O
unknown O
function O
( O
murine B
TIK I
; O
rotavirus B
NS34 I
) O
, O
but O
which O
are O
likely O
RNA O
binding O
proteins O
. O

Finally O
, O
transfection O
of O
Grb10 B
genes I
with O
specific O
mutations O
in O
their O
SH2 O
domains O
induces O
apoptosis O
in O
HTC O
- O
IR O
and O
COS O
- O
7 O
cells O
. O

We O
have O
demonstrated O
that O
a O
putative O
HOX B
cofactor I
, O
PBX1A B
, O
participates O
in O
cooperative O
DNA O
binding O
with O
HOXA B
- I
1 I
and O
the O
Deformed B
group O
protein O
HOXD B
- I
4 I
. O

The O
CHL B
1 I
( O
CTF B
1 I
) O
gene O
product O
of O
Saccharomyces O
cerevisiae O
is O
important O
for O
chromosome O
transmission O
and O
normal O
cell O
cycle O
progression O
in O
G2 O
/ O
M O
. O

Heterotrimeric O
guanine B
nucleotide I
- I
binding I
proteins I
( O
G O
- O
proteins O
) O
function O
as O
signal O
transducers O
for O
a O
variety O
of O
hormone O
- O
coupled O
enzyme O
and O
ion O
transport O
systems O
in O
eukaryotic O
cells O
. O

There O
was O
a O
highly O
significant O
decrease O
in O
serum B
eosinophil I
cationic I
protein I
in O
patients O
with O
elevated O
AGA B
. O

Sequence O
analysis O
revealed O
that O
Hv B
- I
p68 I
belongs O
to O
the O
large O
family O
of O
FAD B
- I
dependent I
glucose I
methanol I
choline I
oxidoreductases I
and O
that O
it O
shares O
significant O
sequence O
identity O
( O
> O
67 O
% O
) O
with O
the O
alcohol B
oxidases I
of O
the O
methylotrophic O
yeasts O
. O

Small B
t I
also O
inhibited O
the O
dephosphorylation O
of O
cAMP O
- O
dependent O
protein O
kinase O
( O
PKA O
) O
- O
phosphorylated O
CREB O
in O
rat O
liver O
nuclear O
extracts O
. O

Presently O
, O
we O
made O
chain O
pair O
switch O
, O
chimeric O
, O
and O
site O
mutant B
gamma I
delta I
TCRs I
and O
transfected O
them O
into O
TCR O
- O
mutant O
Jurkat O
T O
cells O
to O
examine O
the O
effects O
of O
changing O
the O
TCR B
gamma I
junctional I
region I
sequences I
on O
reactivity O
to O
prenyl B
pyrophosphate I
Ags I
. O

Activated B
Ki I
- I
Ras I
suppresses O
12 O
- O
O O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
- O
induced O
activation O
of O
the O
c B
- I
Jun I
NH2 I
- I
terminal I
kinase I
pathway I
in O
human O
colon O
cancer O
cells O
. O

Electromobility O
shift O
analysis O
using O
oligonucleotides O
encompassing O
the O
proximal O
, O
distal O
, O
and O
BED O
/ O
AP O
- O
1 O
- O
binding O
regions O
failed O
to O
demonstrate O
selective O
transactivation O
after O
CD2 B
signaling O
of O
LPMC O
. O

Despite O
their O
high O
degree O
of O
sequence O
similarity O
, O
all O
five O
RFC B
genes I
are O
essential O
for O
cell O
proliferation O
in O
S O
. O
cerevisiae O
. O

Moreover O
, O
we O
show O
that O
ectopic O
expression O
of O
the O
E2A B
protein I
E12 O
in O
this O
macrophage O
line O
results O
in O
the O
induction O
of O
many O
B O
lineage O
genes O
, O
including O
EBF B
, O
IL7Ralpha B
, O
lambda5 B
, O
and O
Rag B
- I
1 I
, O
and O
the O
ability O
to O
induce O
kappa B
light I
chain I
in O
response O
to O
mitogen O
. O

Also O
, O
anti B
- I
HIV I
gp120 I
and O
anti B
- I
CD4 I
crosslinking O
induced O
a O
10 O
- O
15 O
- O
fold O
increase O
in O
levels O
of O
both O
PI B
3 I
- I
and I
PI I
4 I
- I
kinase I
activity O
in O
anti B
- I
CD4 I
precipitates O
. O

One O
of O
the O
ORFs O
in O
the O
Methanococcus O
jannaschii O
genome O
possesses O
high O
similarity O
to O
the O
M B
. I
aeolicus I
ilvB I
, O
indicating O
that O
it O
is O
an O
authentic O
AHAS B
. O

PRP20 B
is O
related O
, O
both O
in O
structure O
and O
function O
, O
to O
the O
RCC1 B
gene I
of O
mammals O
and O
the O
PIM1 B
gene I
of O
Schizosaccharomyces O
pombe O
, O
both O
of O
which O
appear O
to O
regulate O
entry O
into O
mitosis O
and O
chromosome O
condensation O
. O

Kinase O
renaturation O
tests O
designed O
to O
detect O
reactivated O
protein O
kinases O
after O
electrophoresis O
in O
sodium O
dodecyl O
sulfate O
- O
polyacrylamide O
gels O
revealed O
the O
presence O
of O
a O
60 O
- O
kDa O
kinase O
in O
the O
washed O
immunoprecipitate O
obtained O
from O
liver O
cytosol O
using O
anti B
- I
AHR I
antibody I
( O
IgG O
) O
and O
protein O
A O
/ O
G O
/ O
agarose O
beads O
but O
not O
when O
a O
nonspecific O
IgG O
was O
used O
instead O
of O
anti B
- I
AHR I
antibody I
. O

Immunoblotting O
using O
a O
phosphospecific B
anti I
- I
Src I
( I
416Y I
) I
antibody I
showed O
a O
ceramide O
- O
induced O
increase O
in O
pp60 O
( O
src O
) O
tyrosine O
phosphorylation O
. O

In O
contrast O
, O
dominant B
negative I
Rac I
( O
N17Rac1 B
) O
inhibited O
JNK O
activation O
by O
Galpha12 O
in O
HEK293 O
cells O
as O
well O
as O
three O
other O
cell O
lines O
. O

HrpE B
is O
similar O
to O
YscL B
of O
Yersinia O
spp O
. O

The O
results O
indicate O
that O
expression O
of O
proU B
in O
E O
. O
coli O
is O
directed O
from O
two O
promoters O
, O
one O
( O
P2 O
) O
characterized O
earlier O
by O
other O
workers O
with O
the O
start O
site O
of O
transcription O
60 O
nucleotides O
upstream O
of O
the O
initiation O
codon O
of O
the O
first O
structural O
gene O
( O
proV B
) O
, O
and O
the O
other O
( O
P1 O
) O
situated O
250 O
nucleotides O
upstream O
of O
proV B
. O

Through O
interactions O
with O
the O
pre O
- O
mRNA O
and O
the O
CTD O
domain O
of O
the O
Polymerase B
II I
, O
SR B
proteins I
have O
been O
shown O
to O
regulate O
alternative O
splicing O
. O

It O
also O
produces O
an O
NH2 O
terminus O
that O
corresponds O
to O
an O
equivalent O
NH2 O
terminus O
on O
the O
processed O
matrix O
form O
of O
the O
similar O
alpha1 B
( I
XI I
) I
chain I
, O
thus O
suggesting O
physiological O
significance O
. O

Expression O
of O
Msx O
- O
1 O
and O
Msx B
- I
2 I
has O
been O
studied O
during O
development O
of O
the O
osteoblast O
phenotype O
, O
but O
the O
role O
of O
Dlx B
in O
this O
context O
and O
in O
the O
regulation O
of O
bone O
- O
expressed O
genes O
is O
unknown O
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP O
- O
1 O
) O
and O
Tat O
- O
induced O
transcription O
were O
assessed O
using O
Jun O
and O
hybrid O
Tat O
/ O
Jun O
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

Rabbit B
KCC1 I
( O
rbKCC1 B
) O
and O
rat B
KCC1 I
( O
rtKCC1 B
) O
were O
cloned O
by O
screening O
rabbit O
kidney O
and O
rat O
brain O
cDNA O
libraries O
using O
homologous O
cDNA O
probes O
. O

We O
have O
recently O
shown O
that O
induced O
expression O
of O
a O
CDK O
target O
site O
- O
deficient O
mutant O
, O
Op18 B
- O
S25A O
, O
S38A O
, O
blocks O
human O
cell O
lines O
during O
G2 O
/ O
M O
transition O
. O

One O
day O
postoperatively O
, O
the O
mononuclear O
leukocyte O
beta B
2 I
- I
receptor I
density O
decreased O
maximally O
by O
45 O
+ O
/ O
- O
11 O
% O
in O
the O
enflurane O
patients O
, O
and O
by O
53 O
+ O
/ O
- O
6 O
% O
in O
the O
neurolept O
patients O
. O

Pendulin B
, O
a O
Drosophila O
protein O
with O
cell O
cycle O
- O
dependent O
nuclear O
localization O
, O
is O
required O
for O
normal O
cell O
proliferation O
. O

Paradoxically O
there O
is O
a O
decrease O
in O
the O
level O
of O
soluble B
A I
beta I
secreted O
from O
the O
cells O
. O

Internalization O
of O
prolactin B
receptor I
and O
prolactin O
in O
transfected O
cells O
does O
not O
involve O
nuclear O
translocation O
. O

Using O
mammalian O
expression O
vectors O
( O
pRSV O
- O
neo O
and O
pSV2 O
- O
neo O
) O
, O
antisense O
constructs O
for O
perforin O
and O
granzyme B
B I
were O
independently O
electroporated O
into O
YT O
- O
INDY O
, O
a O
human O
non O
- O
MHC O
- O
restricted O
, O
IL O
- O
2 O
- O
independent O
, O
cytotoxic O
lymphocyte O
. O

When O
expressed O
in O
Escherichia O
coli O
, O
SH O
- O
PTP2 O
displays O
tyrosine B
- I
specific I
phosphatase I
activity O
. O

The O
region O
surrounding O
the O
ZNF35 B
zinc I
finger I
protein I
gene I
on O
3p21 O
is O
of O
particular O
interest O
, O
as O
this O
region O
of O
chromosome O
3 O
is O
frequently O
involved O
in O
rearrangements O
and O
/ O
or O
deletions O
associated O
with O
various O
human O
tumors O
including O
lung O
and O
renal O
carcinoma O
. O

The O
biological O
activity O
of O
these O
mutants O
was O
tested O
by O
determining O
their O
capacity O
to O
( O
i O
) O
reconstitute O
RNA O
polymerase O
activity O
in O
vivo O
by O
cotransfection O
with O
proteins O
NP O
, O
PB1 B
, O
and O
PA O
and O
a O
virion O
- O
like O
RNA O
encoding O
the O
cat O
gene O
into O
vaccinia O
virus O
T7 O
- O
infected O
COS O
- O
1 O
cells O
and O
( O
ii O
) O
complete O
with O
the O
wild B
- I
type I
PB2 I
activity O
. O

We O
were O
unable O
to O
construct O
chvI B
or O
chvG B
insertion I
mutants I
of O
R O
. O
meliloti O
, O
whereas O
mutants O
carrying O
insertions O
outside O
of O
these O
genes O
were O
readily O
obtained O
. O

Western O
blot O
analyses O
reveals O
that O
cJun O
and O
the O
C B
/ I
EBP I
family I
member I
C O
/ O
EBP O
- O
beta O
are O
physiologically O
relevant O
transcription O
factors O
whose O
expression O
corresponds O
with O
mda B
- I
7 I
mRNA I
expression O
. O

In O
isolated O
olfactory O
cilia O
certain O
odorants O
elicit O
a O
rapid O
and O
transient O
cAMP O
response O
, O
terminated O
by O
a O
concerted O
process O
which O
requires O
the O
action O
of O
two O
protein O
kinases O
, O
protein O
kinase O
A O
( O
PKA O
) O
and O
a O
receptor B
- I
specific I
kinase I
( O
GRK3 O
) O
( O
Schleicher O
, O
S O
. O
, O
Boekhoff O
, O
I O
. O

Acetyl B
- I
CoA I
carboxylase I
from O
yeast O
is O
an O
essential O
enzyme O
and O
is O
regulated O
by O
factors O
that O
control O
phospholipid O
metabolism O
. O

To O
investigate O
the O
role O
of O
this O
domain O
in O
the O
incorporation O
of O
the O
SIV B
Env I
into O
virions O
, O
we O
generated O
a O
series O
of O
SIV B
Env I
mutants I
carrying O
small O
in O
- O
frame O
deletions O
within O
the O
cytoplasmic O
domain O
. O

Minute B
virus I
of I
mice I
NS1 I
, O
an O
83 O
- O
kDa O
mainly O
nuclear O
phosphoprotein O
, O
is O
the O
only O
viral O
nonstructural O
protein O
required O
in O
all O
cell O
types O
and O
it O
is O
involved O
in O
multiple O
processes O
necessary O
for O
virus O
propagation O
. O

However O
, O
the O
sequence O
of O
mRAR B
- I
beta I
3 I
region I
A I
differs O
from O
that O
of O
mRAR B
- I
beta I
1 I
by O
an O
additional O
27 O
C O
- O
terminal O
amino O
acids O
encoded O
in O
an O
81 O
nucleotide O
- O
long O
putative O
exon O
which O
is O
spliced O
in O
between O
the O
exons O
encoding O
the O
A B
and I
B I
regions I
of I
mRAR I
- I
beta I
1 I
. O

We O
propose O
that O
GCD7 B
and O
GCD2 B
play O
important O
roles O
in O
the O
regulatory O
interaction O
between O
eIF O
- O
2 O
and O
eIF O
- O
2B O
and O
that O
the O
suppressor O
mutations O
we O
isolated O
in O
these O
genes O
decrease O
the O
susceptibility O
of O
eIF O
- O
2B O
to O
the O
inhibitory O
effects O
of O
phosphorylated O
eIF O
- O
2 O
without O
impairing O
the O
essential O
catalytic O
function O
of O
eIF O
- O
2B O
in O
translation O
initiation O
. O

The O
3 O
' O
region O
of O
the O
transcript O
contained O
a O
fully O
conserved O
, O
correctly O
spliced O
TCR B
alpha I
C I
region I
which O
was O
polyadenylated O
at O
the O
3 O
' O
end O
. O

These O
data O
demonstrate O
that O
CCTalpha B
can O
be O
regulated O
by O
lipids O
by O
two O
independent O
domains O
: O
( O
i O
) O
the O
three O
amphipathic O
alpha O
- O
helical O
repeats O
that O
interact O
with O
both O
neutral O
and O
anionic O
lipid O
mixtures O
and O
( O
ii O
) O
the O
last O
57 O
residues O
that O
interact O
with O
anionic O
lipids O
. O

Sorting O
information O
to O
the O
chloroplastic O
inner O
envelope O
is O
contained O
in O
an O
NH2 O
- O
proximal O
part O
of O
mature B
IEP110 I
( O
110N B
) O
. O

Lack O
of O
changes O
in O
milk O
production O
and O
milk O
composition O
suggest O
that O
acute O
increases O
in O
somatotropin B
with O
concomitant O
increases O
in O
insulin O
are O
not O
sufficient O
to O
stimulate O
synthesis O
of O
milk O
and O
milk O
components O
by O
cows O
during O
established O
lactation O
. O

Since O
RIP140 O
generally O
down O
- O
regulates O
receptor O
activity O
in O
mammalian O
cells O
and O
specifically O
down O
- O
regulates O
coactivation O
mediated O
by O
SRC O
- O
1 O
, O
we O
propose O
a O
model O
in O
which O
RIP140 O
indirectly O
regulates O
nuclear B
receptor I
AF I
- I
2 I
activity O
by O
competition O
for O
coactivators O
such O
as O
SRC O
- O
1 O
. O

In O
cells O
stably O
transfected O
with O
G B
alpha I
i I
- I
2 I
or O
G B
alpha I
i I
- I
3 I
gene I
5 O
' O
- O
flanking O
sequences O
fused O
to O
firefly O
luciferase O
cDNA O
reporter O
, O
temporal O
10 O
- O
15 O
- O
fold O
transcriptional O
activation O
of O
both O
genes O
occurred O
before O
cellular O
polarization O
. O

CONCLUSIONS O
: O
These O
results O
suggest O
that O
histamine B
- I
2 I
receptor I
activation O
mechanisms O
may O
not O
be O
involved O
in O
postoperative O
IL O
- O
6 O
synthesis O
. O

Identification O
of O
a O
68 B
- I
kilodalton I
nuclear I
ATP I
- I
binding I
phosphoprotein I
encoded O
by O
bovine O
papillomavirus O
type O
1 O
. O

There O
are O
two O
regulatory O
regions O
between O
the O
US3 B
and O
the O
US6 B
transcription I
units I
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine O
proteases O
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate O
- O
specific O
antigen O
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

We O
established O
that O
, O
in O
unstimulated O
lymphocytes O
, O
the O
Src O
homology O
2 O
( O
SH2 O
) O
and O
SH3 B
domain I
- I
containing I
protein I
Grb2 O
and O
the O
p85 O
subunit O
of O
phosphatidylinositol O
3 O
- O
kinase O
, O
associate O
constitutively O
with O
Cbl O
via O
their O
SH3 O
domains O
. O

Increased O
gliadin B
antibody I
levels O
were O
found O
more O
frequently O
in O
patients O
with O
subtotal O
villous O
atrophy O
( O
9 O
out O
of O
17 O
patients O
, O
or O
53 O
% O
; O
p O
less O
than O
0 O
. O
05 O
) O
than O
in O
patients O
with O
partial O
villous O
atrophy O
( O
2 O
out O
of O
13 O
patients O
, O
or O
15 O
% O
) O
or O
normal O
villous O
appearance O
( O
2 O
out O
of O
10 O
patients O
, O
or O
20 O
% O
) O
. O

Expression O
of O
the O
Hox O
genes O
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

lin B
- I
49 I
and O
lin B
- I
59 I
transgenes I
are O
expressed O
widely O
throughout O
C O
. O
elegans O
animals O
. O

Two O
genes O
( O
ptsI B
and O
ptsA B
) O
that O
encode O
homologues O
of O
the O
energy O
coupling O
Enzyme O
I O
of O
the O
phosphoenolpyruvate B
- I
dependent I
sugar I
- I
transporting I
phosphotransferase I
system O
( O
PTS O
) O
have O
previously O
been O
identified O
on O
the O
Escherichia O
coli O
chromosome O
. O

Eight O
of O
these O
suppressors O
for O
into O
two O
complementation O
groups O
, O
designated O
KCS1 B
and O
KCS2 B
. O

Western O
blot O
experiments O
detected O
SMBP B
as O
a O
70 O
kDa O
protein O
that O
may O
be O
further O
cleaved O
into O
an O
active O
34 O
kDa O
N O
- O
terminal O
polypeptide O
. O

Taken O
together O
, O
these O
findings O
demonstrate O
that O
ZNF76 B
and O
ZNF143 B
are O
two O
members O
of O
a O
same O
family O
of O
transactivator O
proteins O
. O

For O
example O
, O
the O
presence O
of O
two O
related O
genes O
, O
b O
and O
b O
' O
, O
in O
the O
cyanobacterium O
suggests O
that O
its O
ATP B
synthase I
is O
a O
complex O
of O
nine O
polypeptides O
, O
and O
that O
it O
may O
have O
single O
copies O
of O
related O
b O
and O
b B
' I
proteins I
rather O
than O
two O
copies O
of O
identical O
b B
subunits I
as O
found O
in O
the O
E O
. O
coli O
enzyme O
. O
4 O
+ O
off O

Antiserum O
raised O
against O
rat B
liver I
S6 I
kinase I
specifically O
immunoprecipitates O
the O
purified O
32P O
- O
labeled O
H4 O
hepatoma O
insulin O
- O
stimulated O
S6 O
kinase O
. O

CRKL O
, O
an O
SH2 O
- O
SH3 O
- O
SH3 O
adapter O
protein O
, O
is O
one O
of O
the O
major O
tyrosine B
phosphoproteins I
detected O
in O
primary O
leukemic O
neutrophils O
from O
patients O
with O
CML O
. O

To O
further O
identify O
the O
residues O
responsible O
for O
the O
activity O
, O
we O
isolated O
the O
mutant O
viruses O
that O
were O
not O
neutralized O
with O
the O
soluble O
form O
of O
MHV B
receptor I
proteins I
, O
since O
such O
mutants O
were O
expected O
to O
have O
mutations O
in O
amino O
acids O
responsible O
for O
receptor O
- O
binding O
activity O
. O

In O
contrast O
, O
inactivation O
of O
the O
Sir4p B
- I
interacting I
protein I
Rap1p I
reduces O
partitioning O
by O
a O
LexA O
- O
Sir4p B
fusion O
. O

BACKGROUND O
: O
Murine B
Nramp I
is O
a O
candidate O
for O
the O
macrophage O
resistance O
gene O
Ity B
/ O
Lsh B
/ O
Bcg O
. O

The O
other O
end O
of O
this O
cluster O
contained O
the O
human B
type I
I I
cytokeratin I
K20 B
and O
K12 B
gene I
loci O
. O

However O
, O
in O
transient O
transfection O
assays O
, O
a O
truncation O
of O
as O
little O
as O
15 O
Nurr1 B
COOH O
- O
terminal O
amino O
acids O
diminished O
transcriptional O
activation O
of O
B1A B
- O
thymidine O
kinase O
- O
chloramphenicol O
acetyltransferase O
reporter O
. O

Characterization O
of O
human B
activating I
transcription I
factor I
4 I
, O
a O
transcriptional O
activator O
that O
interacts O
with O
multiple O
domains O
of O
cAMP O
- O
responsive O
element O
- O
binding O
protein O
( O
CREB O
) O
- O
binding O
protein O
. O

This O
result O
is O
consistent O
with O
the O
previous O
observation O
that O
expression O
of O
the O
hsp70 B
genes I
in I
T I
. I
brucei I
is O
mainly O
controlled O
at O
the O
posttranscriptional O
level O
. O

Chromaffin O
cells O
transfected O
with O
a O
plasmid O
with O
the O
entire O
coding O
sequence O
of O
c B
- I
Rabphilin3a I
inserted O
in O
the O
antisense O
orientation O
inhibited O
secretion O
of O
co O
- O
expressed O
GH O
by O
approximately O
30 O
% O
. O

Using O
a O
set O
of O
sera O
for O
which O
full O
chlamydial O
micro O
- O
immunofluorescence O
results O
suggested O
a O
clear O
diagnosis O
, O
we O
have O
evaluated O
the O
Chlamydia O
Spot O
- O
IF O
test O
( O
bioMerieux O
) O
, O
which O
allows O
a O
comparison O
of O
titres O
to O
Chlamydia B
trachomatis I
and I
C I
. I
psittaci I
antigens I
. O

A O
physical O
and O
genetic O
map O
covering O
the O
entire O
RP12 B
candidate I
gene I
region I
was O
constructed O
. O

The O
single O
copy O
flotillin B
- I
1 I
gene I
is O
located O
at O
6p21 O
. O
3 O
in O
the O
MHC B
class I
I I
region I
and O
consists O
of O
13 O
exons O
over O
15 O
kb O
. O

The O
in O
vivo O
response O
of O
the O
PacC B
- I
like I
decamers I
to O
external O
pH O
was O
dependent O
on O
the O
status O
of O
the O
pH O
- O
regulated O
activator O
YlRim101p B
, O
which O
is O
homologous O
to O
the O
A O
. O
nidulans O
PacC B
regulator O
. O

Electron O
microscopic O
visualization O
of O
the O
general O
population O
of O
active O
genes O
in O
flies O
overexpressing O
hnRNP B
proteins I
also O
indicated O
that O
the O
great O
majority O
of O
genes O
seemed O
normal O
in O
terms O
of O
cotranscriptional O
RNA O
processing O
events O
, O
although O
there O
were O
a O
few O
abnormalities O
consistent O
with O
rare O
exon O
- O
skipping O
events O
. O

Having O
demonstrated O
proper O
localization O
of O
GFP O
- O
calmodulin O
in O
budding O
yeast O
, O
we O
examined O
the O
localization O
of O
a O
fusion O
between O
GFP O
and O
calmodulin O
( O
GFP B
- I
Camlp I
) O
in O
fission O
yeast O
, O
where O
calmodulin O
had O
not O
been O
localized O
by O
any O
method O
. O

Northern O
blot O
analysis O
identified O
retina O
- O
specific O
transcripts O
of O
3 O
. O
0 O
kb O
for O
rod B
G I
alpha I
t I
and O
2 O
. O
6 O
kb O
for O
cone B
G I
alpha I
t I
. O

In O
the O
univariate O
models O
of O
either O
fixed O
or O
time O
dependent O
covariates O
, O
many O
variables O
were O
significantly O
associated O
with O
risk O
of O
progression O
to O
AIDS O
( O
T4 O
cell O
count O
, O
T4 O
/ O
T8 O
ratio O
, O
blastogenic O
responses O
to O
phytohemagglutinin O
, O
concanavalin O
A O
, O
and O
pokeweed B
mitogen I
, O
serum O
IgA O
, O
appearance O
of O
p24 B
antigen I
, O
and O
the O
development O
of O
oral O
hairy O
leukoplakia O
, O
thrush O
, O
or O
herpes O
zoster O
) O
. O

Adenovirus O
- O
mediated O
gene O
transfer O
of O
MMAC1 B
/ O
PTEN B
to O
glioblastoma O
cells O
inhibits O
S O
phase O
entry O
by O
the O
recruitment O
of O
p27Kip1 O
into O
cyclin O
E O
/ O
CDK2 O
complexes O
. O

These O
cells O
also O
showed O
an O
increase O
in O
cyclin O
A O
and O
cyclin B
A I
- I
and I
E I
- I
associated I
kinase I
activities O
characteristic O
of O
S O
phase O
induction O
. O

Characterization O
of O
a O
tonB B
- O
phoA B
gene O
fusion O
suggests O
that O
the O
amino O
- O
terminal O
41 O
amino O
acids O
of O
TonB B
are O
sufficient O
to O
promote O
export O
of O
the O
fusion O
protein O
and O
presumably O
TonB B
as O
well O
. O

This O
domain O
encompasses O
the O
region O
of O
ARP O
- O
1 O
/ O
COUP O
- O
TFII O
corresponding O
to O
helices O
3 O
to O
12 O
in O
the O
recently O
published O
crystal O
structure O
of O
other O
members O
of O
the O
nuclear B
receptor I
superfamily I
. O

Both O
genes B
ARO3 I
and O
ARO4 B
are O
strongly O
regulated O
under O
the O
general O
control O
regulatory O
system O
. O

Polar O
effects O
of O
transposon O
insertions O
demonstrated O
that O
all O
of O
these O
mRNAs O
arose O
from O
a O
single O
promoter O
region O
, O
where O
transcription O
initiated O
80 O
bp O
5 O
' O
to O
nifH B
. O

Importantly O
, O
a O
single O
base O
change O
in O
the O
fifth O
position O
of O
the O
c B
- I
fos I
sequence I
( O
GGTCTnnnAGACC O
to O
GGTCA O
/ O
GnnnAGACC O
) O
produced O
an O
element O
that O
bound O
the O
estrogen O
receptor O
and O
conferred O
estrogen O
- O
dependent O
transcriptional O
activation O
of O
a O
reporter O
gene O
. O

Co O
- O
expression O
of O
a O
gag O
- O
TRalpha O
fusion O
protein O
in O
AEV O
- O
transformed O
cells O
and O
addition O
of O
ligand O
derepresses O
CAII B
transcription O
. O

The O
IB2 B
gene I
( O
HGMW O
- O
approved O
symbol O
MAPK8IP2 B
) O
maps O
to O
human O
chromosome O
22q13 O
and O
contains O
10 O
coding O
exons O
. O

Transcription O
start O
sites O
of O
sal B
and O
salR B
genes I
were O
determined O
to O
lie O
30 O
- O
and O
24 O
- O
bp O
upstream O
of O
the O
respective O
initiation O
codons O
and O
separated O
from O
each O
other O
by O
78 O
nucleotides O
. O

1 O
. O
23 O
) O
as O
a O
PPARalpha B
- I
interacting I
protein I
. O

Here O
we O
demonstrate O
that O
the O
T B
cell I
antigen I
receptor I
zeta I
- I
chain I
- I
associated I
ZAP I
- I
70 I
kinase I
and O
T B
cell I
antigen I
receptor I
zeta I
- I
chain I
immunoreceptor I
tyrosine I
- I
based I
activation I
motifs I
are O
essential O
for O
the O
membrane O
recruitment O
of O
SOS O
and O
Vav O
. O

A O
mammalian O
protein O
called O
RFX B
or O
NF B
- I
X I
binds O
to O
the O
X O
box O
( O
or O
X1 O
box O
) O
in O
the O
promoters O
of O
a O
number O
of O
major B
histocompatibility I
( I
MHC I
) I
class I
II I
genes I
. O

VBP B
and O
a1 B
/ I
EBP I
could O
mediate O
the O
high O
rates O
of O
ALV O
and O
RSV B
LTR I
- O
enhanced O
transcription O
in O
bursal O
lymphoma O
cells O
and O
many O
other O
cell O
types O
. O

Developmental O
slot O
blots O
demonstrate O
that O
mRNAs O
corresponding O
to O
the O
three O
LHM B
cDNAs I
are O
transcribed O
from O
prophase O
of O
meiosis O
I O
to O
the O
uninucleate O
microspore O
stage O
, O
while O
Northern O
analysis O
reveals O
these O
tapetally O
expressed O
cDNAs O
to O
correspond O
with O
transcripts O
of O
some O
500 O
bp O
. O

The O
contribution O
of O
residues O
outside O
the O
Ras B
binding I
domain I
of O
Raf O
( O
RafRBD B
) O
to O
Ras O
- O
Raf O
interaction O
and O
Ras O
- O
dependent O
Raf O
activation O
has O
remained O
unresolved O
. O

In O
this O
study O
, O
we O
sought O
to O
determine O
the O
specific O
effect O
of O
HIV B
protease I
inhibitors O
on O
patient O
weight O
. O

To O
obtain O
information O
on O
the O
functional O
role O
of O
the O
Rac1 O
/ O
p38 O
/ O
MAPKAPK B
- I
2 I
pathway O
in O
RA O
signaling O
, O
the O
effects O
of O
pharmacological O
inhibition O
of O
p38 O
on O
RA O
- O
induced O
gene O
transcription O
and O
cell O
differentiation O
were O
determined O
. O

The O
ATF O
/ O
CRE O
site O
is O
also O
essential O
for O
CD4 B
promoter I
activation O
by O
forskolin O
, O
an O
activator O
of O
adenylate O
cyclase O
. O

Restricted O
expression O
of O
a O
novel O
murine B
atonal I
- I
related I
bHLH I
protein I
in O
undifferentiated O
neural O
precursors O
. O

We O
report O
the O
genomic O
organization O
of O
the O
mouse O
orphan B
receptor I
related I
to I
tyrosine I
kinases I
( O
Ryk B
) O
, O
a O
structurally O
unclassified O
member O
of O
the O
growth B
factor I
receptor I
family O
. O

In O
contrast O
, O
T229E B
- I
p70s6k I
migrated O
more O
slowly O
in O
SDS O
- O
polyacrylamide O
gels O
, O
but O
demonstrated O
partial O
kinase O
activity O
( O
approximately O
20 O
% O
compared O
with O
the O
wild O
type O
) O
. O

The O
structure O
and O
expression O
of O
the O
murine B
gene I
encoding I
granulocyte I
- I
macrophage I
colony I
stimulating I
factor I
: O
evidence O
for O
utilisation O
of O
alternative O
promoters O
. O

Liver O
disease O
and O
HCV O
infection O
after O
transplantation O
of O
organs O
from O
hepatitis B
C I
antibody I
positive O
donors O
. O

After O
dialysis O
online O
, O
lactate O
was O
converted O
by O
means O
of O
lactate B
oxidase I
immobilized O
to O
porous O
glass O
, O
and O
the O
depletion O
of O
oxygen O
was O
registered O
by O
means O
of O
a O
Clark O
electrode O
. O

The O
deduced O
amino O
- O
acid O
sequence O
of O
the O
mature O
enzyme O
showed O
very O
low O
homology O
( O
< O
20 O
. O
4 O
% O
identity O
) O
to O
those O
of O
known O
pectinolytic O
enzymes O
in O
the O
large O
pectate B
lyase I
superfamily I
( O
the O
polysaccharide B
lyase I
family I
1 I
) O
. O

Despite O
this O
loss O
, O
YEpFAS1 B
is O
still O
able O
to O
complement O
a O
fas1 B
mutation O
at O
the O
enoyl B
reductase I
domain O
. O

Cross O
- O
species O
characterization O
of O
the O
promoter B
region I
of I
the I
cystic I
fibrosis I
transmembrane I
conductance I
regulator I
gene I
reveals O
multiple O
levels O
of O
regulation O
. O

The O
predicted O
vav B
oncogene I
protein I
sequence I
exhibits O
several O
motifs O
reminiscent O
of O
transcriptional O
factors O
. O

Hepatitis B
B I
immune I
globulins I
and O
HIV B
antibodies I
. O

This O
gene O
is O
divided O
into O
six O
exons O
spanning O
about O
3kb O
, O
and O
encodes O
a O
175 O
amino O
acid O
protein O
with O
40 O
- O
52 O
% O
identity O
with O
the O
other O
five O
mouse B
Reg I
( O
regenerating B
gene I
product I
) O
proteins O
. O

The O
p63 B
sequence I
also O
features O
an O
acidic O
domain O
characteristic O
of O
transcriptional O
activation O
factors O
, O
as O
well O
as O
sequence O
blocks O
displaying O
limited O
similarity O
to O
positionally O
equivalent O
regions O
in O
sigma B
factors I
from O
eubacteria O
related O
to O
mitochondria O
. O

In O
contrast O
, O
a O
similar O
fusion O
protein O
( O
hGH O
- O
LDLR B
- O
DAF17 B
, O
abbreviated O
HLD B
) O
containing O
a O
fragment O
of O
the O
serine O
/ O
threonine O
- O
rich O
domain O
of O
the O
LDL B
receptor I
( O
LDLR B
) O
in O
place O
of O
the O
DAF B
- I
derived I
serine I
/ I
threonine I
- I
rich I
sequences I
, O
does O
not O
become O
GPI O
anchored O
. O

Thus O
, O
the O
pathway O
to O
Fc B
epsilonRI I
- O
mediated O
MEK O
/ O
ERK O
and O
ERK O
activation O
can O
apparently O
bypass O
Ras O
and O
Raf O
- O
1 O
. O

Successive O
5 O
' O
deletions O
of O
the O
[ O
- O
326 O
; O
+ O
20 O
] O
type B
II I
sPLA2 I
promoter I
indicated O
that O
the O
region O
upstream O
of O
position O
- O
195 O
inhibits O
the O
transcription O
activity O
sixfold O
in O
HepG2 O
cells O
but O
not O
in O
HeLa O
cells O
. O

The O
cloning O
of O
CWH43 B
showed O
that O
it O
corresponds O
to O
YCR017c B
and O
encodes O
a O
protein O
with O
14 O
- O
16 O
transmembrane O
segments O
containing O
several O
putative O
phosphorylation O
and O
glycosylation O
sites O
. O

However O
, O
strains O
in O
which O
both O
of O
the O
two O
most O
highly O
related O
genes O
, O
DdPIK1 B
and O
DdPIK2 B
, O
were O
disrupted O
showed O
both O
growth O
and O
developmental O
defects O
, O
while O
double O
knockouts O
of O
DdPIK1 B
and O
DdPIK3 B
and O
DdPIK2 B
and O
DdPIK3 B
appear O
to O
be O
lethal O
. O

This O
mechanism O
seems O
to O
be O
involved O
in O
VIP O
- O
induced O
PRL B
gene I
regulation O
. O

These O
properties O
prompted O
us O
to O
investigate O
Ets O
- O
1 O
expression O
in O
32 O
human O
astroglial O
tumors O
of O
WHO O
grades O
I O
- O
IV O
and O
to O
correlate O
the O
data O
with O
the O
expression O
pattern O
of O
VEGF O
, O
Flt B
- I
1 I
, O
and O
KDR B
. O

E1A O
+ O
cHa O
- O
ras O
transformed O
rat O
embryo O
fibroblast O
cells O
are O
characterized O
by O
high O
and O
constitutive O
DNA O
binding O
activities O
of O
AP B
- I
1 I
dimers I
with O
significantly O
altered O
composition O
. O

Nuclear O
localization O
of O
this O
SNF2 B
- I
like I
putative O
helicase O
is O
dependent O
on O
a O
nuclear O
localization O
sequence O
located O
in O
the O
NH2 O
- O
terminal O
region O
. O

The O
feasibility O
of O
creating O
CR1 O
/ O
Ig O
chimeras O
makes O
possible O
a O
new O
strategy O
of O
targeting O
complement O
inhibition O
by O
the O
use O
of O
Ig B
fusion I
partners I
having O
particular O
antigenic O
specificities O
. O

They O
are O
both O
insensitive O
to O
inhibitors O
of O
serine B
and I
aspartyl I
proteinases I
but O
are O
sensitive O
to O
sulfhydryl O
reagents O
and O
0 O
. O
5 O
mM O
ZnCl2 O
. O

Here O
we O
show O
that O
inhibition O
occurs O
with O
a O
NS1 O
- O
Rev O
chimera O
in O
which O
the O
78 O
amino O
- O
terminal O
amino O
acids O
of O
the O
NS1A B
protein I
comprising O
its O
entire O
RNA O
- O
binding O
domain O
is O
deleted O
, O
thereby O
establishing O
that O
this O
carboxyl O
portion O
of O
the O
NS1A B
protein I
can O
function O
as O
an O
independent O
effector O
domain O
. O

The O
testes O
of O
8 O
specimens O
of O
Triturus O
marmoratus O
were O
collected O
during O
each O
month O
of O
1987 O
and O
processed O
for O
electron O
microscopy O
and O
light O
microscopy O
demonstration O
of O
testosterone O
( O
T O
) O
following O
the O
ABC B
( O
avidin B
- I
biotin I
peroxidase I
complex I
) O
method O
. O

Primer O
extension O
analysis O
and O
subcloning O
of O
the O
virJ B
- O
phoA B
fusion O
indicate O
that O
the O
acetosyringone O
- O
inducible O
promoter O
lies O
directly O
upstream O
of O
the O
virJ B
structural I
gene I
. O

Using O
in O
vivo O
screening O
, O
we O
first O
identified O
a O
gene O
that O
appeared O
to O
interfere O
with O
the O
His O
- O
Asp O
phosphorelay O
between O
the O
HPt O
domain O
and O
the O
receiver O
domain O
of O
OmpR B
, O
provided O
that O
the O
gene O
product O
was O
expressed O
through O
a O
multicopy O
plasmid O
. O

The O
non B
- I
major I
histocompatibility I
complex I
( O
MHC O
) O
- O
encoded O
CD1 B
family I
has O
recently O
emerged O
as O
a O
new O
antigen O
- O
presenting O
system O
that O
is O
distinct O
from O
either O
MHC B
class I
I I
or I
class I
II I
molecules I
. O

The O
predicted O
amino O
acid O
sequence O
of O
Pst1p B
possessed O
high O
sequence O
homology O
with O
the O
Sin3 B
family I
of O
proteins O
, O
known O
for O
their O
interaction O
with O
histone B
deacetylases I
. O

Removal O
of O
ink4a O
dramatically O
reduces O
the O
lymphoid O
and O
neurological O
defects O
seen O
in O
bmi B
- I
1 I
- O
deficient O
mice O
, O
indicating O
that O
ink4a O
is O
a O
critical O
in O
vivo O
target O
for O
Bmi B
- I
1 I
. O

Administration O
of O
SnCl2 O
and O
ZnSO4 O
( O
group O
V O
) O
resulted O
in O
a O
decrease O
of O
ALA B
- I
D I
activity O
and O
in O
an O
increase O
in O
CP O
- O
U O
. O

In O
this O
study O
, O
to O
elucidate O
the O
possible O
mechanism O
of O
action O
of O
EM O
, O
we O
examined O
the O
effect O
of O
the O
drug O
on O
the O
expression O
of O
neutrophil O
adhesion O
molecules O
such O
as O
L O
- O
selectin O
and O
Mac B
- I
1 I
. O

However O
, O
PC12 O
cell O
clones O
which O
expressed O
p33rsu B
- I
1 I
at O
an O
increased O
level O
in O
a O
regulatable O
fashion O
in O
response O
to O
dexamethasone O
were O
isolated O
. O

In O
this O
study O
, O
we O
verified O
that O
PI O
3 O
- O
kinase O
associates O
with O
the O
CD4 O
: O
p56lck B
complex I
as O
judged O
by O
the O
presence O
of O
PI O
3 O
- O
phosphate O
generated O
from O
anti B
- I
CD4 I
immunoprecipitates O
and O
detected O
by O
high O
- O
pressure O
liquid O
chromatographic O
analysis O
. O

In O
this O
study O
, O
a O
site O
of O
PDGF O
- O
induced O
tyrosine O
phosphorylation O
was O
mapped O
to O
Tyr O
138 O
in O
the O
SH3 O
domain O
; O
Tyr O
138 O
is O
exposed O
on O
the O
SH3 B
peptide I
binding I
surface I
. O

We O
also O
identified O
a O
DNA O
fragment O
, O
10 O
. O
7 O
kbp O
upstream O
from O
the O
first O
coding O
exon O
of O
human B
aFGF I
, O
whose O
sequence O
is O
conserved O
in O
both O
the O
primate O
and O
rodent O
genomes O
. O

These O
events O
were O
only O
weakly O
stimulated O
by O
the O
activated B
PDGF I
alpha I
- I
receptor I
. O

Human B
plastin I
genes I
. O

C O
/ O
EBP O
delta O
( O
NFIL B
- I
6 I
beta I
) O
was O
not O
detected O
in O
complexes O
utilizing O
extracts O
from O
the O
IL O
- O
1 O
nonproducing O
T O
cell O
line O
. O

Moreover O
, O
our O
recent O
findings O
on O
the O
Tc52 B
encoding I
gene I
underline O
the O
interest O
of O
genetic O
manipulation O
of O
T O
. O
cruzi O
, O
not O
only O
making O
it O
possible O
to O
use O
more O
closely O
an O
in O
vitro O
approach O
to O
find O
out O
how O
genes O
function O
, O
but O
also O
to O
obtain O
' O
attenuated O
' O
strains O
that O
could O
be O
used O
in O
the O
development O
of O
vaccinal O
strategies O
. O

YDL003w B
( O
also O
termed O
MCD1 B
) O
is O
a O
homologue O
of O
Schizosaccharomyces B
pombe I
rad21 I
, O
an O
essential O
gene O
implicated O
in O
DNA O
double O
- O
strand O
break O
repair O
and O
nuclear O
organization O
in O
fission O
yeast O
. O

Footprints O
on O
the O
HPV B
18 I
enhancer I
show O
five O
protected O
regions O
with O
homologies O
to O
NF1 O
, O
AP1 O
and O
EFII B
transcription I
factor I
binding I
motifs I
. O

Insulin O
binding O
to O
the O
alpha O
- O
subunit O
of O
its O
receptor O
stimulates O
the O
receptor O
tyrosine O
kinase O
to O
phosphorylate O
the O
beta O
- O
subunit O
and O
several O
endogenous O
protein O
substrates O
, O
including O
pp120 O
/ O
HA4 B
, O
a O
liver O
- O
specific O
plasma O
membrane O
glycoprotein O
of O
M O
( O
r O
) O
20 O
, O
000 O
. O

We O
have O
analyzed O
herein O
the O
roles O
that O
four O
different O
PIAS B
proteins I
( O
ARIP3 B
/ O
PIASx B
alpha I
, O
Miz1 B
/ O
PIASx B
beta I
, O
GBP B
/ O
PIAS1 B
, O
and O
PIAS3 O
) O
play O
in O
the O
regulation O
of O
steroid B
receptor I
- O
or O
STAT O
- O
mediated O
transcriptional O
activation O
. O

Comparison O
of O
the O
predicted O
amino O
acid O
sequence O
with O
that O
of O
the O
Drosophila B
virilis I
gene I
shows O
that O
several O
blocks O
of O
amino O
acid O
sequence O
have O
been O
very O
highly O
conserved O
. O

A O
phase O
II O
clinical O
trial O
on O
MDS O
was O
conducted O
in O
a O
cooperative O
study O
with O
orally O
administrable O
ara O
- O
C O
analogue O
, O
PLAC O
, O
which O
is O
resistant O
to O
cytidine B
deaminase I
and O
had O
shown O
an O
anti O
- O
tumor O
activity O
on O
various O
experimental O
tumors O
by O
oral O
route O
. O

To O
address O
this O
question O
with O
respect O
to O
skeletal O
muscle O
, O
we O
have O
examined O
the O
effects O
of O
the O
Providence O
mutation O
in O
cultured O
muscle O
cells O
, O
after O
adoptive O
gene O
transfer O
to O
adult O
mice O
, O
and O
in O
two O
infants O
homozygous O
for O
spectrin B
Providence I
. O

B O
and O
C1 B
fusions I
with O
yeast B
GAL4 I
DNA I
- I
binding I
and I
transcriptional I
activation I
domains I
were O
also O
found O
to O
interact O
when O
synthesized O
and O
assayed O
in O
yeast O
. O

Because O
of O
the O
data O
, O
we O
suggest O
that O
LAC9 B
contacts O
positions O
6 O
, O
7 O
, O
and O
8 O
, O
both O
plus O
and O
minus O
, O
of O
the O
UAS O
, O
which O
are O
separated O
by O
more O
than O
one O
turn O
of O
the O
DNA O
helix O
, O
and O
twists O
part O
way O
around O
the O
DNA O
, O
thus O
protecting O
the O
broad O
region O
of O
the O
minor O
groove O
between O
the O
major O
- O
groove O
contacts O
. O

Here O
we O
show O
that O
the O
nucleotide O
in O
the O
middle O
of O
the O
anticodon O
( O
i O
. O
e O
. O
, O
psi O
35 O
) O
also O
contributes O
to O
the O
suppressor O
efficiency O
displayed O
by O
cytoplasmic B
tRNA I
( I
Tyr I
) I
. O

The O
reconstituted O
enzyme O
binds O
DNA O
with O
an O
affinity O
that O
is O
approximately O
20 O
- O
fold O
lower O
than O
that O
of O
the O
intact O
topo70 B
. O

We O
propose O
that O
optimal O
transcription O
of O
the O
gD B
gene I
depends O
on O
the O
interaction O
of O
ICP4 O
with O
multiple O
binding O
sites O
across O
the O
gene O
and O
cellular O
factors O
that O
recognize O
specific O
sequence O
elements O
in O
the O
promoter O
. O

Recently O
, O
we O
and O
other O
laboratories O
have O
identified O
a O
family O
of O
caveolin B
- I
related I
proteins I
; O
caveolin O
has O
been O
re O
- O
termed O
caveolin B
- I
1 I
. O

Role O
of O
zinc B
- I
finger I
proteins I
Sp1 I
and O
zif268 O
/ O
egr O
- O
1 O
in O
transcriptional O
regulation O
of O
the O
human B
synaptobrevin I
II I
gene I
. O

The O
human B
Fc I
gamma I
receptor I
gene I
Fc B
gamma I
RIIA I
is O
expressed O
in O
platelets O
, O
neutrophils O
, O
monocytes O
and O
macrophages O
. O

E O
. O
granulosus O
infection O
has O
been O
confirmed O
in O
25 O
patients O
( O
20 O
. O
6 O
% O
) O
, O
in O
16 O
cases O
by O
finding O
parasite O
protoscoleces O
or O
hooks O
and O
in O
nine O
cases O
by O
detection O
of O
an O
antigen O
specific O
for O
E B
. I
granulosus I
, I
antigen I
5 I
( O
Ag5 B
) O
. O

First O
, O
mutations O
in O
the O
IFNgamma B
- I
activated I
sequence I
( O
GAS O
) O
, O
either O
multimerized O
or O
in O
the O
context O
of O
the O
1 B
. I
7 I
- I
kb I
IRF I
- I
1 I
promoter I
, O
failed O
to O
mediate O
a O
PRL O
response O
, O
showing O
that O
the O
IRF O
- O
1 O
GAS O
is O
a O
target O
of O
PRL O
signaling O
. O

This O
selective O
squelching O
activity O
suggests O
that O
GRIM B
can O
interact O
with O
an O
essential O
component O
of O
the O
RNA O
polymerase O
II O
transcription O
machinery O
. O

Identification O
and O
characterization O
of O
a O
yeast O
gene O
encoding O
the O
U2 B
small I
nuclear I
ribonucleoprotein I
particle I
B I
" I
protein I
. O

A O
360 O
- O
bp O
DNA O
fragment O
located O
over O
500 O
bp O
upstream O
from O
the O
cfl B
transcriptional O
start O
site O
was O
used O
in O
DNase O
I O
protection O
assays O
to O
define O
the O
specific O
bases O
bound O
by O
CorR B
. O

Nramp2 B
contains O
a O
classical O
iron O
responsive O
element O
in O
the O
3 O
' O
untranslated O
region O
that O
confers O
iron O
dependent O
mRNA O
stabilization O
. O

CONCLUSIONS O
- O
- O
Postlumbar O
puncture O
headache O
may O
be O
mediated O
by O
the O
release O
of O
substance B
P I
triggered O
by O
lumbar O
puncture O
, O
in O
patients O
predisposed O
to O
headache O
by O
a O
hypersensitivity O
to O
substance B
P I
. O

A O
mutated B
ABF1 I
site I
that O
displays O
a O
very O
low O
affinity O
for O
ABF1 B
does O
not O
functionally O
replace O
the O
ILV1 B
REB1 B
site I
. O

A O
nationwide O
survey O
uncovered O
a O
tenfold O
variation O
between O
counties O
in O
the O
prescribing O
of O
IFNB B
. O

Dominant O
- O
negative O
mutations O
in O
the O
G B
- I
protein I
- I
coupled I
alpha I
- I
factor I
receptor I
map O
to O
the O
extracellular O
ends O
of O
the O
transmembrane O
segments O
. O

By O
screening O
a O
human O
testis O
cDNA O
library O
with O
a O
probe O
containing O
the O
mouse B
PEA3 I
ETS O
domain O
, O
we O
isolated O
a O
2 O
. O
2 O
kb O
clone O
containing O
a O
510 O
AA O
open O
reading O
frame O
. O

AU O
- O
rich O
elements O
in O
the O
3 O
' O
- O
untranslated O
region O
of O
a O
new O
mucin B
- I
type I
gene I
family O
of O
Trypanosoma O
cruzi O
confers O
mRNA O
instability O
and O
modulates O
translation O
efficiency O
. O

These O
data O
suggest O
that O
weight O
gain O
or O
increased O
caloric O
intake O
, O
in O
contrast O
to O
its O
large O
effect O
on O
peripheral O
thyroid O
function O
, O
has O
relatively O
little O
effect O
on O
CNS B
TRH I
activity O
. O

In O
the O
Saccharomyces B
cerevisiae I
actin I
intron I
a O
silent O
branch O
point O
- O
like O
sequence O
( O
UACUAAG O
) O
is O
located O
7 O
nt O
upstream O
of O
the O
canonical O
sequence O
. O

The O
requirement O
for O
an O
essential O
interaction O
between O
NPH B
I I
and O
H4L B
provides O
an O
explanation O
for O
the O
observed O
restriction O
of O
transcription O
termination O
to O
early O
viral O
genes O
. O

After O
birth O
, O
there O
was O
a O
significantly O
higher O
increase O
of O
IgA O
and O
IgM B
anti I
- I
M I
. I
leprae I
antibody I
activity O
in O
sera O
taken O
3 O
- O
6 O
months O
after O
birth O
from O
babies O
of O
Group O
1 O
compared O
to O
Group O
2 O
, O
but O
the O
IgA O
and O
IgM O
activity O
in O
sera O
taken O
after O
6 O
months O
of O
age O
showed O
the O
same O
increase O
in O
the O
two O
groups O
. O

The O
relation O
between O
the O
changes O
of O
bone O
density O
and O
the O
level O
of O
blood O
calcium O
, O
blood O
phosphorus O
and O
alkaline O
phosphatase O
( O
AKP B
) O
as O
well O
as O
the O
metabolism O
of O
vitamin O
D O
was O
studied O
. O

These O
results O
demonstrate O
the O
extensive O
homology O
in O
sequence O
among O
light O
chains O
of O
IgM B
kappa I
autoantibodies I
and O
indicate O
that O
a O
particular O
V B
kappa I
germ I
line I
gene I
, O
kappa B
IIIb I
, O
is O
expressed O
as O
a O
phylogenetic O
response O
to O
certain O
self O
antigens O
or O
as O
part O
of O
a O
selection O
process O
by O
which O
these O
autoimmune O
responses O
are O
regulated O
. O

Comparison O
of O
the O
sequences O
of O
the O
alpha B
- I
like I
DNA I
polymerases I
including O
E B
. I
coli I
DNA I
polymerase I
II I
showed O
that O
there O
were O
nine O
highly O
conserved O
regions O
, O
and O
we O
constructed O
an O
unrooted O
phylogenetic O
tree O
of O
the O
DNA B
polymerases I
based O
on O
the O
differences O
in O
these O
conserved O
regions O
. O

Before O
and O
6 O
and O
12 O
months O
after O
H O
. O
pylori O
eradication O
the O
patients O
were O
evaluated O
for O
fasting O
gastrinemia O
and O
pepsinogen B
I I
, O
basal O
and O
peak O
acid O
output O
, O
and O
detailed O
histological O
assessment O
including O
the O
ECL O
cell O
proliferative O
patterns O
. O

trans O
- O
activation O
of O
the O
HIV O
- O
1 O
LTR O
by O
the O
HIV B
- I
1 I
Tat I
and O
HTLV B
- I
I I
Tax I
proteins I
is O
mediated O
by O
different O
cis O
- O
acting O
sequences O
. O

Acidic O
carboxyl O
- O
terminal O
domain O
of O
gene B
2 I
. I
5 I
protein I
of I
bacteriophage I
T7 I
is O
essential O
for O
protein O
- O
protein O
interactions O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged B
V I
kappa I
- I
C I
kappa I
gene I
. O

NSD1 B
contains O
a O
SET B
domain I
and O
multiple O
PHD O
fingers O
. O

We O
have O
introduced O
the O
same O
change O
in O
a O
yeast B
tRNA I
( I
Trp I
) I
gene I
and O
demonstrated O
that O
the O
tRNA O
acts O
as O
an O
efficient O
amber O
suppressor O
in O
vivo O
. O

Among O
women O
, O
plasma B
factor I
VII I
: O
Ag O
was O
inversely O
associated O
with O
income O
. O

A O
novel O
protein O
kinase O
C O
( O
PKC O
) O
- O
interacting O
protein O
was O
identified O
by O
the O
yeast O
two O
- O
hybrid O
screening O
using O
the O
regulatory O
domain O
of O
PKC B
beta I
I I
as O
a O
bait O
. O

One O
of O
the O
repeating O
domains O
( O
Yheb1 B
) O
, O
consisting O
of O
67 O
amino O
acids O
, O
was O
cloned O
from O
the O
E O
. O
coli O
chromosome O
and O
purified O
by O
metal O
chelating O
chromatography O
. O

Inhibition O
of O
endogenous B
Cdk2 I
by O
dominant B
negative I
Cdk2 I
attenuated O
phosphorylation O
of O
Thr447 O
, O
Thr490 O
and O
Thr497 O
, O
but O
had O
no O
effect O
upon O
Ser581 O
modification O
. O

A O
rabbit O
antiserum O
raised O
against O
a O
unique O
( O
V3 O
domain O
) O
bacterially O
expressed O
PKC B
theta I
fragment I
immunoprecipitated O
specifically O
an O
82 O
- O
kDa O
protein O
from O
Jurkat O
cell O
lysates O
. O

Complementary O
DNA O
libraries O
from O
liver O
and O
ovary O
of O
an O
immature O
female O
channel O
catfish O
were O
screened O
with O
a O
homologous B
ERalpha I
cDNA I
probe O
. O

VLA B
- I
4 I
integrin I
cross O
- O
linking O
on O
human O
monocytic O
THP O
- O
1 O
cells O
induces O
tissue O
factor O
expression O
by O
a O
mechanism O
involving O
mitogen O
- O
activated O
protein O
kinase O
. O

However O
, O
studies O
using O
the O
A20 B
promoter I
demonstrated O
that O
LMP1 O
transcriptionally O
activates O
the O
A20 B
gene I
through O
cis O
- O
acting O
kappa B
B I
sites I
. O

Finally O
, O
we O
demonstrated O
that O
although O
the O
DNA O
- O
binding O
domain O
of O
c O
- O
myb O
is O
required O
for O
both O
the O
differentiation O
block O
and O
the O
shift O
in O
cell O
cycle O
after O
PMA O
treatment O
, O
phosphorylation O
by O
casein B
kinase I
II I
and O
mitogen O
- O
activated O
protein O
kinase O
at O
positions O
11 O
and O
12 O
or O
532 O
of O
c O
- O
myb O
, O
respectively O
, O
are O
not O
. O

The O
activation O
of O
NF O
- O
kappaB O
- O
dependent O
reporter O
gene O
transcription O
by O
E1A O
was O
potently O
suppressed O
upon O
coexpression O
of O
the O
E1B B
19 I
- I
kDa I
protein I
( I
19K I
) I
. O

The O
myeloid B
zinc I
finger I
gene I
1 I
( O
MZF1 B
) O
encodes O
a O
C B
( I
2 I
) I
H I
( I
2 I
) I
zinc I
finger I
transcription I
factor I
that O
regulates O
granulopoiesis O
and O
may O
have O
a O
regulatory O
role O
in O
cellular O
proliferation O
and O
oncogenesis O
. O

We O
conclude O
that O
GRF1 O
and O
GRF2 B
can O
form O
homo O
- O
and O
hetero O
- O
oligomers O
via O
their O
DH B
domains I
, O
that O
mutational O
inactivation O
of O
oligomer O
formation O
by O
GRF1 O
is O
associated O
with O
impaired O
biological O
and O
signaling O
activities O
, O
and O
that O
in O
293T O
cells O
GRF1 O
mediates O
at O
least O
two O
pathways O
for O
Raf O
activation O
: O
one O
a O
constitutive O
signal O
that O
is O
mainly O
Ras O
- O
dependent O
, O
and O
one O
an O
ionomycin O
- O
induced O
signal O
that O
cooperates O
with O
the O
constitutive O
signal O
without O
further O
augmenting O
the O
level O
of O
GTP O
- O
Ras O

Influenza O
virus O
- O
induced O
NF B
- I
kappaB I
- I
dependent I
gene I
expression O
is O
mediated O
by O
overexpression O
of O
viral O
proteins O
and O
involves O
oxidative O
radicals O
and O
activation O
of O
IkappaB O
kinase O
. O

Protein O
kinase O
C O
( O
PKC O
) O
activation O
after O
treatment O
of O
human O
neuroblastoma O
SK O
- O
N O
- O
BE O
( O
2 O
) O
C O
cells O
with O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
was O
found O
to O
enhance O
transcription O
of O
the O
human O
dopamine B
beta I
- I
hydroxylase I
( O
DBH O
) O
in O
those O
cells O
. O

The O
genomic O
organization O
in O
this O
region O
is O
similar O
to O
the O
neural O
- O
restricted O
family O
members O
, O
Hel B
- I
N1 I
( O
ELAVL2 B
) O
and O
mHuD B
( O
Elavl4 B
) O
. O

Promoter O
elements O
and O
transcriptional O
control O
of O
the O
mouse B
acetylcholinesterase I
gene I
. O

These O
morphological O
changes O
are O
associated O
with O
a O
marked O
induction O
of O
P450arom B
gene I
expression O
. O

cDNA O
cloning O
and O
transcriptional O
properties O
of O
a O
novel O
GC B
box I
- I
binding I
protein I
, O
BTEB2 B
. O

This O
activity O
creates O
a O
4 O
- O
bp O
staggered O
cut O
with O
3 O
' O
OH O
overhangs O
within O
a O
specific O
sequence O
of O
the O
21S B
rRNA I
gene I
of O
omega O
- O
strains O
. O

Replacement O
of O
Val20 O
- O
Leu21 O
with O
Ala O
- O
Ala O
produced O
a O
dimeric B
RII I
beta I
protein I
that O
binds O
AKAP75 B
approximately O
4 O
% O
as O
avidly O
as O
wild B
- I
type I
RII I
beta I
. O

The O
temporal O
expression O
of O
CRAlBP B
is O
similar O
to O
IRBP B
while O
bFGF O
is O
not O
expressed O
until O
after O
photoreceptor O
differentiation O
is O
complete O
. O

Replacement O
of O
a O
valine O
( O
V68 O
) O
in O
the O
ETS O
domain O
of O
SAP1a O
by O
aspartic O
acid O
( O
as O
found O
in O
c O
- O
Ets O
- O
1 O
, O
Elk O
- O
1 O
, O
and O
Net B
) O
enhanced O
ternary O
complex O
formation O
by O
more O
than O
60 O
- O
fold O
. O

The O
NF O
- O
kappaB O
/ O
Rel O
transcription O
factors O
participate O
in O
the O
activation O
of O
immune O
system O
regulatory O
genes O
and O
viral O
early O
genes O
including O
the O
human B
immunodeficiency I
virus I
type I
1 I
long I
terminal I
repeat I
. O

cDNA O
cloning O
reveals O
two O
mouse B
beta5 I
integrin I
transcripts I
distinct O
in O
cytoplasmic O
domains O
as O
a O
result O
of O
alternative O
splicing O
. O

Like O
other O
known O
GCD B
genes I
, O
GCD14 B
and O
GCD15 B
are O
therefore O
probably O
required O
for O
general O
translation O
initiation O
in O
addition O
to O
their O
roles O
in O
GCN4 O
- O
specific O
translational O
control O
. O

This O
gene O
is O
named O
PKNOX1 B
by O
the O
Human O
Nomenclature O
Committee O
. O

No O
effect O
of O
4 O
beta O
- O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
was O
observed O
on O
the O
expression O
of O
hnRNP B
H I
. O

The O
atf1 B
+ I
gene I
of I
Schizosaccharomyces I
pombe I
encodes O
a O
bZIP B
transcription I
factor I
with O
strong O
homology O
to O
the O
mammalian B
factor I
ATF I
- I
2 I
. O

Multiple O
attempts O
aimed O
at O
disruption O
of O
the O
chromosomal B
fabG I
gene I
were O
unsuccessful O
. O

Thus O
, O
the O
mutants O
are O
deficient O
in O
production O
of O
the O
O B
- I
antigen I
polymerase I
and O
were O
termed O
rfc B
mutants I
. O

The O
D443N B
substitution I
is O
an O
activating O
mutation O
that O
increases O
the O
activity O
of O
SCAP O
and O
renders O
it O
resistant O
to O
inhibition O
by O
25 O
- O
hydroxycholesterol O
. O

Regulation O
of O
activating B
transcription I
factor I
- I
1 I
and O
the O
cAMP O
response O
element O
- O
binding O
protein O
by O
Ca2 B
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinases I
type I
I I
, I
II I
, I
and I
IV I
. O

Serum B
amyloid I
A I
( O
SAA B
) O
is O
a O
plasma O
protein O
which O
has O
been O
associated O
with O
several O
diseases O
, O
including O
amyloidosis O
, O
arthritis O
, O
and O
atherosclerosis O
, O
and O
its O
abnormal O
expression O
, O
particularly O
in O
nonhepatic O
cells O
, O
is O
implicated O
in O
the O
pathogenesis O
of O
these O
diseases O
. O

The O
human B
p18 I
gene I
spans O
at O
least O
7 O
. O
5 O
kb O
and O
is O
composed O
of O
three O
exons O
, O
two O
of O
which O
encode O
the O
p18 B
protein I
. O

Serum O
creatinine B
kinase I
activity O
was O
7 O
, O
800 O
- O
17 O
, O
500 O
U O
/ O
l O
, O
making O
acute O
muscle O
damage O
likely O
, O
probably O
rhabdomyolysis O
. O

The O
nucleotide O
sequence O
of O
a O
PCR O
- O
amplified O
SMT3A B
genomic O
DNA O
fragment O
was O
found O
to O
be O
identical O
to O
that O
of O
SMT3A B
cDNA I
, O
indicating O
the O
absence O
of O
intron O
( O
s O
) O
in O
its O
protein O
coding O
region O
. O

Mutant O
p53 B
DNA I
clones O
from O
human O
colon O
carcinomas O
cooperate O
with O
ras O
in O
transforming O
primary O
rat O
cells O
: O
a O
comparison O
of O
the O
" O
hot O
spot O
" O
mutant O
phenotypes O
. O

The O
SEC27 B
gene I
was O
cloned O
, O
and O
the O
sequence O
predicts O
a O
99 O
. O
4 O
- O
kDa O
protein O
with O
45 O
% O
sequence O
identity O
to O
mammalian O
beta B
' I
- I
COP I
. O

Therefore O
, O
it O
appears O
that O
GCN2 B
protein I
kinase I
function O
is O
stimulated O
posttranslationally O
in O
amino O
acid O
- O
starved O
cells O
. O

A O
positive O
FTA B
- I
ABS I
- I
19S I
- I
IgM I
test O
indicates O
the O
necessity O
of O
treatment O
. O

The O
promoter O
for O
HMG B
- I
CoA I
synthase I
contains O
two O
binding O
sites O
for O
the O
sterol O
regulatory O
element O
- O
binding O
proteins O
( O
SREBPs O
) O
. O

Characterization O
and O
targeted O
disruption O
of O
murine B
Nup50 I
, O
a O
p27 O
( O
Kip1 O
) O
- O
interacting O
component O
of O
the O
nuclear O
pore O
complex O
. O

p27 O
( O
Kip1 O
) O
is O
a O
member O
of O
the O
Cip B
- O
Kip B
family O
of O
cyclin O
- O
dependent O
kinase O
( O
Cdk O
) O
inhibitors O
that O
binds O
to O
cyclin O
- O
Cdk O
complexes O
and O
inhibits O
their O
catalytic O
activity O
in O
response O
to O
antiproliferative O
stimuli O
. O

Therefore O
, O
the O
Ogg1 O
protein O
is O
a O
eukaryotic O
DNA O
glycosylase O
/ O
AP B
lyase I
. O

Mutations O
of O
SIN4 O
, O
ROX3 B
, O
SRB8 B
, O
SRB9 B
, O
SRB10 O
, O
SRB11 B
, O
and O
two O
novel O
genes O
, O
NUT1 B
and O
NUT2 B
, O
relieve O
the O
requirement O
of O
Swi4p B
for O
expression O
of O
this O
reporter O
. O

For O
Thermus O
strain O
ZO5 B
dihydroorotase I
( O
DHOase B
; O
encoded O
by O
pyrC B
) O
, O
the O
highest O
similarity O
scores O
( O
about O
40 O
% O
identity O
) O
were O
obtained O
with O
DHOases B
from O
B O
. O
caldolyticus O
and O
Bacillus O
subtilis O
. O

These O
data O
suggest O
that O
the O
fibrinogen B
gamma I
chain I
region I
Gly190 I
- I
Val202 I
functions O
as O
a O
minimal O
recognition O
sequence O
for O
the O
leukocyte O
integrin O
CD11b B
/ O
CD18 B
. O

We O
recently O
described O
the O
isolation O
and O
characterization O
of O
nontoxic O
PAP B
mutants I
, O
NT123 O
- O
2 O
, O
which O
has O
a O
point O
mutation O
( O
E176V O
) O
in O
the O
active O
site O
that O
abolishes O
enzymatic O
activity O
, O
and O
NT124 O
- O
3 O
, O
which O
has O
a O
nonsense O
mutation O
that O
results O
in O
deletion O
of O
the O
C O
- O
terminal O
25 O
aa O
( O
W237Stop O
) O
. O

Toxicity O
of O
benzoyl O
chloride O
( O
2 O
, O
4 O
, O
6 O
- O
trichlorophenyl O
) O
hydrazone O
( O
Banamite O
) O
and O
potential O
metabolites O
to O
twospotted O
spider O
mites O
and O
potency O
as O
inhibitors O
of O
rat B
liver I
monoamine I
oxidase I
. O

The O
genes O
expressed O
during O
the O
embryonic O
( O
zeta B
) O
or O
fetal O
and O
adult O
stage O
( O
alpha B
2 I
and O
alpha O
1 O
) O
can O
be O
modified O
by O
point O
mutations O
which O
affect O
either O
the O
processing O
- O
translation O
of O
mRNA O
or O
make O
the O
polypeptide O
chains O
extremely O
unstable O
. O

Kaposi O
' O
s O
sarcoma O
- O
associated O
herpesvirus O
/ O
human O
herpesvirus O
- O
8 O
ORF50 B
gene O
product O
contains O
a O
potent O
C O
- O
terminal O
activation O
domain O
which O
activates O
gene O
expression O
via O
a O
specific O
target O
sequence O
. O

Genomic O
Southern O
blot O
analysis O
suggests O
that O
the O
human O
haploid O
genome O
contains O
a O
single O
Gs B
alpha I
gene I
. O

Furthermore O
, O
we O
demonstrate O
that O
in O
myeloid O
and O
B O
cell O
extracts O
, O
PU O
. O
1 O
forms O
a O
novel O
, O
specific O
, O
more O
slowly O
migrating O
complex O
( O
PU B
- I
SF I
) O
when O
binding O
the O
GM O
- O
CSF O
receptor O
alpha O
promoter O
PU O
. O
1 O
site O
. O

Immunoblotting O
showed O
that O
both O
the O
( O
1 O
- O
404 O
) O
- O
peptide O
and O
( O
1 O
- O
506 O
) O
- O
peptide O
are O
recognized O
by O
95J10 B
, O
a O
monoclonal O
antibody O
that O
was O
previously O
raised O
against O
perlecan B
- I
( I
24 I
- I
404 I
) I
- I
peptide I
expressed O
in O
Escherichia O
coli O
. O

To O
gain O
further O
insights O
into O
these O
events O
, O
the O
porcine B
G I
alpha I
i I
- I
3 I
gene I
minimal I
promoter I
was O
characterized O
and O
found O
67 O
base O
pairs O
upstream O
from O
the O
major O
transcription O
start O
site O
. O

Many O
human O
malignant O
cells O
lack O
methylthioadenosine B
phosphorylase I
( O
MTAP B
) O
enzyme O
activity O
. O

G B
- I
box I
binding I
factors I
( O
GBFs B
) O
constitute O
a O
family O
of O
plant O
DNA O
- O
binding O
proteins O
that O
bind O
to O
the O
G O
- O
box O
motif O
, O
a O
regulatory O
cis O
element O
present O
in O
many O
plant O
genes O
with O
a O
palindromic O
DNA O
motif O
of O
CACGTG O
. O

These O
results O
extend O
our O
knowledge O
of O
this O
SNF2 B
- I
like I
family I
member I
and O
suggest O
a O
role O
for O
PASG B
in O
leukemogenesis O
. O

The O
difference O
between O
the O
results O
in O
the O
high O
dose O
AHLG B
and O
in O
the O
control O
group O
was O
significant O
( O
p O
less O
than O
0 O
. O
05 O
) O
. O

Retinoic O
acid O
, O
which O
inhibits O
the O
progression O
of O
certain O
cancers O
, O
repressed O
v O
- O
src O
- O
induced O
MMP B
- I
1 I
transcription O
. O

The O
pattern O
of O
net B
RNA I
expression O
in O
adult O
mouse O
tissues O
is O
different O
. O

Immunoprecipitation O
of O
spinophilin B
or O
neurabin B
from O
crude O
brain O
extracts O
selectively O
coprecipitated O
PP1gamma B
( I
1 I
) I
over O
PP1beta B
. O

Reduction O
of O
p53 O
protein O
was O
detected O
after O
1 O
day O
of O
OM B
treatment O
and O
reached O
maximal O
suppression O
of O
10 O
- O
20 O
% O
of O
control O
after O
3 O
days O
in O
H3922 O
and O
40 O
% O
of O
control O
after O
4 O
days O
in O
MCF O
- O
7 O
cells O
. O

Association O
of O
Syk O
protein O
tyrosine O
kinase O
( O
PTK O
) O
with O
LMP2A O
occurs O
at O
the O
two O
tyrosines O
of O
the O
LMP2A B
immunoreceptor I
tyrosine O
- O
based O
activation O
motif O
, O
and O
it O
is O
hypothesized O
that O
Lyn O
PTK O
associates O
with O
the O
YEEA O
amino O
acid O
motif O
at O
LMP2A O
tyrosine O
112 O
( O
Y112 O
) O
. O

The O
treatment O
with O
glucocorticoids O
and O
immunosuppressants O
resulted O
in O
a O
more O
noticeable O
decrease O
in O
the O
levels O
of O
T3 O
and O
E B
- I
RCF I
. O

Four O
of O
these O
fibroblast O
clones O
were O
infected O
with O
a O
retrovirus O
containing O
the O
cDNA B
encoding I
myoD I
and O
a O
puromycin O
selection O
marker O
. O

Suppression O
of O
the O
cka1 B
delta I
cka2 I
- I
8 I
mutant I
phenotype O
occurs O
by O
interaction O
of O
CKB1 B
with O
the O
defective O
, O
cka2 B
- I
8 I
- O
encoded O
, O
catalytic O
subunit O
. O

Similarly O
, O
antisense B
TGF I
- I
beta I
type I
II I
receptor I
oligodeoxynucleotides I
( I
40 I
microM I
) I
resulted O
in O
a O
58 O
% O
increase O
in O
branching O
, O
compared O
to O
scrambled O
and O
mismatched O
sequence O
controls O
, O
while O
TGF B
- I
beta I
, I
type I
II I
receptor I
mRNA I
and O
its O
protein O
expression O
levels O
were O
suppressed O
by O
95 O
and O
84 O
% O
, O
respectively O
. O

Taken O
together O
, O
these O
results O
indicate O
that O
ICSBP O
and O
PU O
. O
1 O
are O
critical O
elements O
for O
IL B
- I
18 I
gene I
expression O
. O

An O
additional O
stimulation O
of O
D1 B
receptors I
by O
giving O
SKF38393 O
30 O
min O
later O
produced O
an O
almost O
continuous O
pattern O
of O
jaw O
openings O
but O
less O
closure O
movements O
from O
the O
rest O
position O
, O
and O
the O
openings O
were O
accompanied O
by O
frequent O
tongue O
protrusions O
. O

To O
determine O
the O
role O
of O
the O
transmembrane O
region O
of O
HN O
on O
fusion O
- O
promoting O
activity O
, O
mutant B
HN I
proteins I
were O
expressed O
and O
their O
biological O
activities O
examined O
. O

Transient O
transfection O
assays O
indicated O
that O
the O
( O
- O
4551 O
) O
UCP1 B
- O
CAT O
construct O
, O
containing O
the O
5 O
' O
- O
regulatory O
region O
of O
the O
rat B
ucp I
- I
1 I
gene I
, O
was O
activated O
by O
PPARalpha O
co O
- O
transfection O
in O
a O
dose O
- O
dependent O
manner O
and O
this O
activation O
was O
potentiated O
by O
Wy O
14 O
, O
643 O
and O
retinoid B
X I
receptor I
alpha I
. O

Human B
CR2 I
has O
a O
restricted O
cellular O
distribution O
, O
being O
expressed O
on O
B O
lymphocytes O
, O
dendritic O
cells O
of O
the O
spleen O
, O
pharyngeal O
epithelial O
cells O
, O
and O
at O
low O
levels O
on O
some O
T O
lymphocytes O
. O

ADR1 B
in O
extracts O
made O
from O
glucose O
- O
repressed O
and O
- O
derepressed O
cells O
bound O
UAS1 O
DNA O
with O
similar O
affinities O
despite O
having O
greatly O
different O
abilities O
to O
activate O
ADH2 B
gene I
expression O
in O
vivo O
. O

Furthermore O
, O
agonist O
action O
at O
a O
5 B
- I
HT1 I
receptor I
and O
antagonist O
action O
at O
5 B
- I
HT2 I
receptors I
both O
appear O
to O
contribute O
to O
antidepressant O
- O
like O
activity O
on O
the O
DRL O
72 O
- O
s O
schedule O
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil O
DNA O
glycosylase O
, O
AP O
endonuclease O
, O
DNA O
polymerase O
beta O
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

Likewise O
, O
the O
consensus O
signal O
believed O
to O
be O
involved O
in O
terminating O
VV B
early I
gene I
transcription O
, O
TTTTTNT O
, O
was O
evident O
at O
the O
3 O
' O
- O
boundary O
of O
both O
the O
N2 O
and O
M1 O
ORFs O
suggesting O
that O
these O
genes O
may O
be O
VV B
early I
genes I
. O

In O
this O
report O
we O
describe O
the O
structure O
and O
DNA O
sequence O
of O
transcriptional O
control O
regions O
from O
both O
human B
and I
Wistar I
- I
rat I
single I
copy I
EGF I
genes I
and O
their O
functional O
analysis O
in O
epithelial O
cell O
cultures O
. O

A O
V1 B
mutant I
generated O
in O
vivo O
with O
11 O
of O
the O
14 O
N O
- O
terminal O
amino O
acids O
altered O
, O
was O
viable O
and O
produced O
symptoms O
typical O
of O
a O
wild O
- O
type O
infection O
. O

We O
have O
demonstrated O
that O
the O
specific O
determination O
and O
identification O
of O
plasma O
FbDP B
alone O
is O
not O
sufficient O
to O
follow O
the O
effectiveness O
of O
thrombolytic O
therapy O
. O

Located O
between O
the O
3 O
' O
trans O
- O
spliced O
leader O
acceptor O
site O
and O
the O
translational O
initiation O
codon O
of O
the O
GP63 B
gene I
is O
an O
area O
of O
conserved O
hexanucleotide O
direct O
repeats O
( O
CTCGCC O
) O
which O
vary O
in O
number O
according O
to O
species O
. O

We O
have O
previously O
demonstrated O
that O
pyrene O
in O
diesel O
- O
exhaust O
particles O
( O
DEP O
) O
has O
an O
adjuvant O
activity O
on O
immunoglobulin O
E O
( O
IgE O
) O
antibody O
production O
in O
mice O
immunized O
with O
Japanese O
cedar O
pollen O
allergen O
( O
JCPA O
) O
or O
ovalbumin B
( O
OA B
) O
intraperitoneally O
. O

Partial O
characterization O
of O
the O
CCAAT O
box O
in O
the O
promoter O
of O
the O
hLGFBP B
- I
1 I
gene I
: O
interaction O
with O
negatively O
acting O
transcription O
factors O
in O
decidualized O
human O
endometrial O
stromal O
cells O
. O

We O
conclude O
that O
transcription O
of O
both O
SCD1 B
and O
SCD2 B
genes I
is O
responsive O
to O
cellular O
sterol O
levels O
and O
to O
the O
levels O
of O
nuclear O
SREBP O
/ O
ADD1 O
and O
that O
transcriptional O
induction O
requires O
three O
spatially O
conserved O
cis O
elements O
, O
that O
bind O
SREBP O
and O
NF O
- O
Y O
. O

Three O
transcriptional O
control O
elements O
within O
300 O
base O
pairs O
of O
the O
5 O
' O
- O
flanking O
region O
of O
the O
rat B
glucagon I
gene I
interact O
with O
regulatory O
cellular O
proteins O
and O
direct O
transcription O
only O
in O
glucagon O
- O
producing O
islet O
cells O
. O

A O
role O
for O
phosphatidylinositol O
3 O
- O
kinase O
in O
the O
regulation O
of O
beta O
1 O
integrin O
activity O
by O
the O
CD2 B
antigen O
. O

In O
contrast O
, O
the O
sequences O
essential O
for O
the O
transcription O
of O
EFT1 B
were O
localized O
to O
the O
region O
between O
the O
start O
ATG O
and O
the O
stop O
codon O
of O
the O
VPS17 B
gene I
that O
terminates O
267 O
nt O
upstream O
on O
the O
same O
strand O
. O

In O
each O
of O
the O
studied O
HPV O
types O
, O
the O
two O
CDP O
/ O
Cut O
binding O
sites O
of O
PSM B
overlap O
with O
the O
known O
or O
presumed O
binding O
sites O
of O
the O
replication B
initiator I
protein I
E1 I
. O

ATF O
is O
formulated O
from O
the O
prothrombin O
time O
( O
PT O
) O
, O
fibrinogen O
transformation O
rate O
( O
FTR O
) O
( O
a O
representation O
of O
thrombin O
activity O
) O
, O
and O
a O
consideration O
of O
the O
fibrinogen O
( O
FBG B
) O
content O
of O
blood O
plasma O
. O

Phenotypic O
and O
molecular O
analyses O
of O
patients O
with O
partial O
chromosome O
21 O
monosomy O
enabled O
us O
to O
define O
a O
region O
, O
spanning O
2 O
. O
4 O
Mb O
between O
D21S190 B
and O
D21S226 B
, O
associated O
with O
arthrogryposis O
, O
mental O
retardation O
, O
hypertonia O
, O
and O
several O
facial O
anomalies O
. O

The O
classic O
sterol O
regulatory O
cis O
element O
( O
sre O
- O
1 O
) O
in O
the O
LDL B
receptor I
promoter O
mediates O
sterol O
regulatory O
element O
binding O
protein O
( O
SREBP O
) O
- O
binding O
and O
the O
effects O
of O
insulin O
and O
platelet O
derived O
growth O
factor O
( O
PDGF O
) O
. O

In O
Cos O
7 O
cells O
transfected O
with O
oCRF1var B
, O
cAMP O
accumulation O
was O
only O
observed O
at O
the O
highest O
concentration O
of O
oCRF B
utilized O
( O
100 O
nM O
) O
. O

Fusion O
of O
mouse B
CD8 I
+ I
class B
I I
MHC I
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 O
- O
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 B
alpha I
( O
Lyt B
- I
2 I
) O
gene O
is O
undetectable O
. O

For O
the O
P B
transcript I
from O
phage O
with O
the O
G O
( O
- O
) O
orientation O
, O
full O
termination O
activity O
required O
both O
the O
region O
containing O
the O
stem O
- O
loop O
structure O
and O
upstream O
sequences O
. O

Nb2 O
- O
11C O
cells O
expressed O
three O
PNR B
- I
related I
mRNA I
transcripts I
of O
2 O
. O
5 O
, O
3 O
. O
0 O
and O
> O
10 O
kb O
. O

These O
results O
suggest O
that O
the O
Reg1 O
- O
Glc7 O
phosphatase O
is O
a O
cytoplasmic O
component O
of O
the O
machinery O
responsible O
for O
returning O
Snf1 B
kinase I
activity O
to O
its O
basal O
level O
and O
reestablishing O
glucose O
repression O
. O

AIMS O
: O
We O
postulated O
that O
perhexiline O
, O
a O
novel O
anti O
- O
ischaemic O
agent O
with O
an O
oxygen O
- O
sparing O
metabolic O
effect O
in O
the O
myocardium O
( O
via O
inhibition O
of O
carnitine B
palmitoyltransferase I
- I
1 I
) O
and O
no O
adverse O
haemodynamic O
effects O
, O
may O
improve O
symptomatic O
status O
in O
elderly O
patients O
with O
severe O
aortic O
stenosis O
. O

The O
IFNAR B
chain I
interacts O
with O
both O
IFN B
- I
alpha I
2 I
and O
IFN O
- O
beta O
, O
as O
demonstrated O
by O
cross O
- O
linking O
. O

To O
clone O
cDNAs O
for O
the O
beta O
subunit O
of O
rabbit B
eIF I
- I
2B I
, O
amino O
acid O
sequence O
data O
was O
first O
obtained O
and O
used O
to O
design O
redundant O
oligonucleotide O
primers O
for O
use O
in O
PCR O
. O

We O
report O
the O
cloning O
of O
the O
ade1 B
gene I
on O
a O
4 B
. I
4 I
kb I
Sau3A I
insert I
in O
the O
yeast O
shuttle O
vector O
pWH5 O
. O

A O
selectable O
marker O
for O
transformation O
was O
constructed O
by O
transcriptional O
fusion O
of O
a O
Ustilago B
maydis I
heat I
shock I
gene I
promoter I
with O
the O
hygromycin B
B I
phosphotransferase I
gene I
of I
Escherichia I
coli I
. O

The O
structure O
of O
the O
mAR B
ORF O
was O
confirmed O
by O
sequence O
analysis O
of O
mAR B
cDNA O
fragments O
, O
which O
were O
obtained O
by O
PCR O
amplification O
of O
mouse O
testis O
cDNA O
, O
using O
mAR B
specific O
primers O
. O

The O
role O
of O
NUT1 B
and O
regulation O
of O
nitrogen O
metabolism O
in O
the O
disease O
process O
was O
evaluated O
by O
pathogenicity O
assays O
. O

Plasma B
LH I
and O
progesterone O
levels O
after O
single O
or O
multiple O
injections O
of O
synthetic O
LH O
- O
RH B
in O
anoestrous O
ewes O
and O
comparison O
with O
levels O
during O
the O
oestrous O
cycle O
. O

Primers O
were O
developed O
for O
specific O
amplification O
of O
9804 B
gene I
fragments I
. O

The O
promyelocytic B
leukemia I
protein I
interacts O
with O
Sp1 O
and O
inhibits O
its O
transactivation O
of O
the O
epidermal O
growth O
factor O
receptor O
promoter O
. O

The O
Saccharomyces O
cerevisiae O
targets O
of O
rapamycin O
, O
TOR1 B
and O
TOR2 O
, O
signal O
activation O
of O
cell O
growth O
in O
response O
to O
nutrient O
availability O
. O

The O
Thrombolysis O
in O
Myocardial O
Infarction O
( O
TIMI O
) O
Phase O
II O
Trial O
randomized O
3 O
, O
339 O
patients O
to O
either O
an O
invasive O
( O
INV O
, O
n O
= O
1 O
, O
681 O
) O
or O
a O
conservative O
( O
CON O
, O
n O
= O
1 O
, O
658 O
) O
strategy O
after O
intravenous O
recombinant B
tissue I
- I
type I
plasminogen I
activator I
( O
rt O
- O
PA O
) O
for O
acute O
myocardial O
infarction O
. O

In O
addition O
, O
mutations O
within O
the O
Ubx B
unit I
exons I
are O
known O
and O
most O
of O
these O
behave O
as O
null O
alleles O
. O

Here O
we O
report O
that O
point O
mutations O
of O
the O
Abd B
- I
B I
gene I
in O
trans O
suppress O
the O
Fab B
- I
7 I
phenotype I
in O
a O
pairing O
- O
dependent O
manner O
and O
thus O
represent O
a O
type O
of O
transvection O
. O

Also O
, O
residues O
273 O
to O
287 O
, O
which O
are O
identical O
in O
sequence O
to O
a O
15 O
- O
amino O
- O
acid O
segment O
near O
the O
carboxy O
terminus O
of O
the O
simian B
foamy I
virus I
transcriptional I
activator I
Taf I
, O
can O
independently O
enhance O
the O
activity O
of O
the O
minimal O
activator O
region O
. O

Alterations O
in O
TCR O
- O
MHC O
contacts O
subsequent O
to O
cross O
- O
recognition O
of O
class B
I I
MHC I
and O
singly O
substituted O
peptide O
variants O
. O

The O
cloning O
of O
human B
apo I
B I
- I
100 I
has O
provided O
new O
insights O
into O
the O
structure O
and O
physicochemical O
properties O
of O
apo B
B I
- I
100 I
and O
will O
facilitate O
studies O
on O
the O
factors O
modulating O
apo B
B I
- I
100 I
biosynthesis O
and O
the O
expression O
of O
the O
apo B
B I
- I
100 I
gene I
in O
patients O
with O
dyslipoproteinemias O
. O

Repeated O
interferon O
- O
beta O
( O
IFN O
- O
beta O
) O
silencer O
B O
motifs O
and O
a O
lysozyme B
silencer I
1 I
motif I
have O
been O
found O
in O
the O
CD95 B
gene I
at O
approximately O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respectively O
. O

Action O
against O
Vibrio O
cholerae O
O1 O
Tox B
+ I
of O
chemical O
products O
used O
in O
the O
lemon O
production O
. O

Characterization O
of O
the O
chromosome O
19 O
breakpoint O
region O
revealed O
that O
the O
transcription B
factor I
- I
encoding I
USF2 I
gene I
is O
affected O
. O

Tax O
and O
the O
active O
Tax B
mutants I
were O
able O
to O
abrogate O
the O
G1 O
arrest O
and O
apoptosis O
induced O
by O
p53 O
, O
and O
this O
effect O
does O
not O
correlate O
with O
an O
altered O
localization O
of O
nuclear B
p53 I
or O
with O
the O
disruption O
of O
p53 B
- I
DNA I
complexes I
. O

Biochemical O
studies O
have O
identified O
a O
cellular O
non B
- I
P I
element I
- I
encoded I
DNA I
binding I
protein I
, O
termed O
the O
inverted B
repeat I
binding I
protein I
( O
IRBP B
) O
, O
that O
specifically O
interacts O
with O
the O
outer O
half O
of O
the O
31 O
- O
bp O
terminal O
inverted O
repeats O
. O

A O
4 O
. O
0 O
- O
kb O
Nlk B
message I
is O
also O
present O
during O
embryogenesis O
, O
detectable O
at O
day O
E10 O
. O

In O
cells O
infected O
with O
a O
recombinant O
vaccinia O
virus O
expressing O
HCV O
structural O
proteins O
( O
core O
, O
E1 O
, O
and O
E2 O
) O
, O
DDX3 B
and O
core O
colocalized O
in O
distinct O
spots O
in O
the O
perinuclear O
region O
of O
the O
cytoplasm O
. O

The O
translational O
product O
of O
UL26 O
. O
5 O
is O
infected B
- I
cell I
protein I
35c I
, I
d I
( O
ICP35c B
, I
d I
) O
( O
F O
. O

The O
mouse B
tapasin I
gene I
was O
mapped O
about O
70 O
kilobases O
from O
H2 B
- I
K I
at O
the O
centromeric O
end O
of O
the O
mouse B
MHC I
. O

Due O
to O
significant O
homology O
to O
the O
C O
- O
terminus O
of O
the O
Mutator B
transposase I
this O
alternative O
gene O
product O
was O
named O
Trap O
( O
transposon B
- I
associated I
protein I
) O
. O

The O
c B
- I
raf I
- I
1 I
proto I
- I
oncogene I
is O
the O
cellular B
homologue I
of I
v I
- I
raf I
, O
the O
oncogene O
of O
the O
acutely O
transforming O
retrovirus O
3611 O
- O
MSV O
. O

Using O
gel O
retardation O
analysis O
, O
four O
binding O
sites O
for O
Rap1p B
have O
been O
identified O
within O
the O
promoter O
of O
the O
RAP1 B
gene I
. O

Subsequent O
analysis O
revealed O
that O
MyD88 B
possesses O
a O
unique O
modular O
structure O
, O
which O
consists O
of O
an O
N O
- O
terminal O
" O
death O
domain O
, O
" O
similar O
to O
the O
intracellular O
segments O
of O
TNF B
receptor I
1 I
and O
Fas O
, O
and O
a O
C O
- O
terminal O
region O
related O
to O
the O
cytoplasmic O
domains O
of O
the O
Drosophila B
morphogen I
Toll I
and O
vertebrate O
interleukin B
- I
1 I
receptors I
. O

RT O
- O
PCR O
analysis O
of O
FGFR B
- I
3 I
mRNA I
showed O
the O
presence O
of O
a O
splice O
variant O
in O
which O
exons O
7 O
and O
8 O
are O
deleted O
. O

In O
human O
myxoid O
liposarcoma O
, O
a O
chromosomal O
rearrangement O
leads O
to O
fusion O
of O
the O
growth O
- O
arresting O
and O
DNA O
- O
damage O
- O
inducible O
transcription O
factor O
CHOP O
( O
GADD153 O
) O
to O
a O
peptide O
fragment O
encoded O
by O
the O
TLS B
gene I
. O

We O
previously O
described O
the O
upregulation O
of O
the O
MT2 B
antigen I
during O
urodele O
limb O
regeneration O
and O
characterized O
the O
MT2 B
antigen I
as O
a O
310 O
- O
to O
325 O
- O
kDa O
chondroitin O
- O
sulfated O
glycoprotein O
with O
a O
core O
protein O
of O
285 O
- O
300 O
kDa O
. O

Analysis O
of O
the O
MCV B
- I
1 I
RPO1 I
revealed O
high O
amino O
acid O
homologies O
to O
the O
corresponding O
polypeptides O
of O
vaccinia O
and O
variola O
virus O
. O

The O
activity O
of O
platelet B
factor I
4 I
in O
plasma O
of O
healthy O
and O
high O
risk O
newborns O
. O

The O
proteins O
encoded O
by O
these O
genes O
, O
called O
GF14 B
proteins I
, O
participate O
in O
protein O
/ O
DNA O
complexes O
and O
show O
more O
than O
60 O
% O
identity O
with O
a O
highly O
conserved O
, O
widely O
distributed O
protein O
family O
, O
collectively O
referred O
to O
as O
14 B
- I
3 I
- I
3 I
proteins O
. O

The O
p58 O
( O
PITSLRE B
beta I
1 I
) O
protein O
kinase O
( O
PK O
) O
is O
a O
member O
of O
a O
large O
supergene O
family O
related O
to O
the O
master B
mitotic I
protein I
kinase I
, O
p34cdc2 O
. O

PtdIns B
( I
4 I
, I
5 I
) I
P2 I
synthesis O
, O
on O
the O
other O
hand O
, O
is O
only O
moderately O
affected O
even O
in O
fab1Delta B
mutants I
. O

Low O
serum B
C3 I
values O
were O
observed O
in O
all O
11 O
children O
at O
some O
stage O
of O
their O
illness O
. O

The O
plants O
were O
then O
brought O
to O
our O
Houston O
laboratory O
where O
they O
were O
measured O
and O
analyzed O
for O
lignin O
and O
protein O
content O
and O
for O
phenylalanine B
ammonia I
- I
lyase I
( O
PAL O
) O
and O
peroxidase O
activities O
. O

Pax O
- O
6 O
constructs O
lacking O
the O
C O
- O
terminal O
activation O
domain O
repressed O
betaB1 B
- I
crystallin I
promoter I
activity O
as O
effectively O
as O
the O
full O
- O
length O
protein O
, O
but O
the O
PD O
alone O
or O
Pax B
- I
6 I
( I
5a I
) I
, O
a O
splice O
variant O
with O
an O
altered O
PD O
affecting O
its O
DNA O
binding O
specificity O
, O
did O
not O
. O

The O
predicted O
amino O
acid O
sequence O
contained O
all O
consensus O
regions O
for O
S B
- I
adenosyl I
methionine I
methyltransferases I
and O
presented O
26 O
% O
identity O
with O
Saccharomyces B
cerevisiae I
DHHB I
- I
methyltransferase I
and O
38 O
% O
identity O
with O
the O
rat O
protein O
, O
as O
well O
as O
with O
a O
bacterial O
( O
Escherichia O
coli O
and O
Salmonella O
typhimurium O
) O
methyltransferase B
encoded O
by O
the O
UBIG B
gene I
. O

The O
introduction O
of O
FWD1 B
into O
cells O
significantly O
promotes O
ubiquitination O
and O
degradation O
of O
IkappaBalpha O
in O
concert O
with O
IkappaB B
kinases I
, O
resulting O
in O
nuclear O
translocation O
of O
NF O
- O
kappaB O
. O

Amino O
- O
terminal O
polymorphisms O
of O
the O
human B
beta I
2 I
- I
adrenergic I
receptor I
impart O
distinct O
agonist O
- O
promoted O
regulatory O
properties O
. O

Biochemical O
experiments O
and O
genome O
sequencing O
have O
shown O
that O
, O
despite O
the O
prokaryotic O
cell O
and O
genome O
organization O
, O
basal O
transcriptional O
elements O
of O
members O
of O
the O
domain O
Archaea O
( O
i O
. O
e O
. O
, O
TATA O
box O
- O
like O
sequences O
, O
RNA O
polymerase O
, O
and O
transcription O
factors O
TBP O
, O
TFIIB O
, O
and O
TFIIS B
) O
are O
of O
the O
eukaryotic O
type O
. O

Gene B
GPR I
51 I
was O
localized O
by O
radiation O
hybrid O
mapping O
to O
chromosome O
9 O
, O
4 O
. O
81 O
cR O
from O
the O
WI O
- O
8684 O
marker O
, O
and O
proximal O
to O
the O
hereditary B
sensory I
neuropathy I
type I
1 I
locus I
. O

The O
expression O
of O
the O
leukocyte B
EL I
- I
246 I
antigen I
was O
regulated O
in O
the O
same O
manner O
as O
L O
- O
selectin O
and O
EL B
- I
246 I
recognized O
anti B
- I
L I
- I
selectin I
mAb I
affinity O
- O
purified O
antigen O
in O
SDS O
/ O
PAGE O
Western O
blot O
analysis O
. O

To O
examine O
the O
functional O
relationship O
between O
distinct O
cis O
- O
active O
elements O
within O
the O
distal O
enhancer O
region O
of O
the O
rat B
PRL I
gene I
, O
we O
have O
used O
deletional O
and O
mutational O
analysis O
of O
that O
region O
in O
transient O
transfection O
studies O
in O
GH3 O
pituitary O
tumor O
cells O
. O

The O
entire O
coding O
region O
of O
an O
ovine B
endometrial I
oxytocin I
receptor I
( O
OTR B
) O
cDNA O
was O
generated O
by O
PCR O
, O
subcloned O
into O
the O
SV40 B
major I
late I
promoter I
expression O
vector O
pSVLJ O
and O
transiently O
expressed O
in O
Cos O
- O
7 O
cells O
. O

These O
operons O
encode O
subunits O
of O
photosystems B
I I
( O
psa O
) O
and O
II O
( O
psb B
) O
, O
the O
cytochrome B
bGf I
complex I
( O
pet O
) O
, O
the O
plastid O
NAD B
( I
P I
) I
H I
dehydrogenase I
( O
ndh B
) O
, O
and O
the O
unidentified O
open O
reading O
frame O
ycf9 B
. O

The O
phosphatidylglycerol B
/ I
phosphatidylinositol I
transfer I
protein I
( O
PG B
/ I
PI I
- I
TP I
) O
is O
a O
new O
and O
original O
phospholipid O
transfer O
protein O
( O
PLTP O
) O
isolated O
from O
the O
Deuteromycete O
, O
Aspergillus O
oryzae O
. O

Transcriptional O
modulation O
of O
the O
anti B
- I
apoptotic I
protein I
BCL I
- I
XL I
by O
the O
paired B
box I
transcription I
factors I
PAX3 O
and O
PAX3 O
/ O
FKHR O
. O

The O
level O
of O
expression O
of O
the O
PDE B
protein I
was O
monitored O
by O
immunoblot O
analysis O
using O
two O
specific O
cAMP B
- I
PDE I
polyclonal I
antibodies I
and O
by O
measuring O
the O
PDE B
activity O
. O

Since O
UmuD B
protein I
is O
proteolytically O
processed O
to O
an O
active O
form O
( O
UmuD O
* O
) O
in O
a O
RecA O
* O
- O
dependent O
fashion O
, O
and O
MucA O
shares O
extensive O
amino O
acid O
homology O
with O
UmuD O
, O
we O
examined O
whether O
MucA O
is O
similarly O
processed O
in O
the O
cell O
, O
using O
antiserum O
against O
a O
LacZ O
' O
- O
' O
MucA O
fusion O
protein O
. O

Genetic O
polymorphisms O
in O
the O
5 O
' O
- O
flanking O
region O
change O
transcriptional O
regulation O
of O
the O
human B
cytochrome I
P450IIE1 I
gene I
. O

These O
studies O
reveal O
that O
CREM O
, O
a O
tissue O
- O
specific O
factor O
, O
is O
expressed O
and O
regulated O
by O
gonadotropins O
in O
the O
ovary O
, O
that O
the O
predominant O
CREM O
transcripts O
encode O
the O
repressor B
protein I
ICER I
, O
and O
that O
ICER O
is O
capable O
of O
inhibiting O
cAMP O
- O
induced O
expression O
of O
the O
inhibin B
alpha I
- I
subunit I
gene I
. O

The O
Brassica B
BTH1 I
gene I
may O
correspond O
to O
the O
Arabidopsis B
TH I
- I
1 I
gene I
. O

Acanthamoeba B
myosin I
I I
heavy I
chain I
kinase I
( O
MIHCK B
) O
phosphorylates O
the O
heavy O
chains O
of O
amoeba B
myosins I
I I
, O
increasing O
their O
actin O
- O
activated O
ATPase O
activities O
. O

Mutation O
of O
the O
HNF3 B
element I
significantly O
reduced O
promoter O
activity O
in O
HepG2 O
cells O
, O
whereas O
this O
element O
in O
isolation O
conferred O
HNF3beta O
responsiveness O
to O
a O
heterologous O
promoter O
. O

The O
mitochondrial B
tyrosyl I
- I
tRNA I
synthetase I
of O
Podospora O
anserina O
is O
a O
bifunctional O
enzyme O
active O
in O
protein O
synthesis O
and O
RNA O
splicing O
. O

The O
traW B
gene I
of I
the I
Escherichia I
coli I
K I
- I
12 I
sex I
factor I
, O
F O
, O
encodes O
one O
of O
the O
numerous O
proteins O
required O
for O
conjugative O
transfer O
of O
this O
plasmid O
. O

We O
have O
utilized O
transient O
transfections O
, O
mutation O
analysis O
, O
electromobility O
gel O
- O
shifts O
, O
and O
immunoblot O
analysis O
to O
test O
the O
hypothesis O
that O
expression O
of O
the O
CTalpha B
gene I
is O
controlled O
in O
part O
by O
the O
binding O
of O
three O
trans O
- O
acting O
nuclear O
factors O
, O
Sp1 O
, O
Sp2 B
, O
and O
Sp3 O
. O

The O
evolutionary O
significance O
of O
the O
similarities O
of O
intron O
secondary O
structures O
and O
open O
reading O
frames O
of O
the O
ND3 B
, I
4 I
and I
ATPase I
6 I
genes I
is O
discussed O
, O
including O
the O
possible O
separate O
evolution O
of O
structural O
and O
coding O
sequences O
. O

We O
propose O
that O
unc B
- I
37 I
may O
be O
regulated O
by O
unc B
- I
4 I
. O

Adenovirus O
infection O
of O
hepatoma O
cells O
inhibited O
transcription O
of O
the O
phosphoenolpyruvate O
carboxykinase O
( O
GTP O
) O
( O
EC B
4 I
. I
1 I
. I
1 I
. I
32 I
) O
( O
PEPCK O
) O
gene O
and O
virtually O
eliminated O
transcription O
of O
a O
chimeric O
gene O
which O
contained O
the O
PEPCK B
promoter I
linked O
to O
the O
structural O
gene O
for O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
. O

Expression O
of O
the O
gene O
encoding O
transcription B
factor I
cyclic I
adenosine I
3 I
' I
, I
5 I
' I
- I
monophosphate I
( I
cAMP I
) I
response I
element I
- I
binding I
protein I
( O
CREB O
) O
: O
regulation O
by O
follicle O
- O
stimulating O
hormone O
- O
induced O
cAMP O
signaling O
in O
primary O
rat O
Sertoli O
cells O
. O

( O
i O
) O
The O
chimeric O
gene O
consisting O
of O
the O
coding O
and O
5 O
' O
nontranslated O
leader O
regions O
of O
the O
TK O
gene O
fused O
to O
portions O
of O
the O
domain O
of O
alpha B
gene I
0 I
extending O
largely O
upstream O
from O
the O
site O
of O
initiation O
of O
transcription O
of O
alpha B
gene I
0 I
was O
regulated O
in O
the O
same O
fashion O
as O
the O
alpha B
4 I
- I
and I
alpha I
27 I
- I
TK I
chimeras O
. O

Nuclear O
proteins O
bound O
the O
cad B
+ I
55 I
/ I
+ I
75 I
element I
in O
a O
cell O
cycle O
- O
dependent O
manner O
in O
electromobility O
shift O
assays O
; O
antibodies O
specific O
to O
USF O
and O
Max O
blocked O
the O
DNA O
- O
binding O
activity O
of O
different O
growth O
- O
regulated O
protein O
- O
DNA O
complexes O
. O

Thus O
, O
an O
unmodified O
threonine O
at O
position O
169 O
in O
Cdc28 O
is O
important O
for O
interaction O
with O
G1 B
cyclins I
. O

Additional O
genetic O
analyses O
described O
herein O
suggest O
that O
Skb1 B
is O
a O
component O
of O
the O
morphology O
control O
branch O
of O
the O
Ras O
signaling O
cascade O
in O
S O
. O
pombe O
and O
that O
it O
positively O
modulates O
Shk1 B
function O
. O

From O
a O
chromosomal O
cosmid O
library O
of O
Streptomyces O
argillaceus O
, O
a O
Mtm B
producer O
, O
a O
clone O
( O
cosAR7 O
) O
was O
isolated O
by O
homology O
to O
the O
actI B
/ I
III I
region I
of O
S O
. O
coelicolor O
and O
the O
strDEM B
genes I
of O
S O
. O
griseus O
. O

In O
this O
report O
, O
we O
investigated O
whether O
the O
cleavage O
of O
the O
RRKR O
motif O
of O
MT B
- I
MMP1 I
by O
Golgi B
- I
associated I
furin I
is O
analogous O
to O
a O
similar O
enzyme O
activation O
mechanism O
observed O
with O
stromelysin B
- I
3 I
. O

Escherichia O
coli O
strains O
carrying O
recA730 B
( O
or O
other O
recA B
* I
alleles I
) O
exhibit O
dramatic O
increases O
in O
SOS O
- O
dependent O
spontaneous O
mutator O
activity O
. O

We O
report O
the O
complete O
nucleotide O
sequence O
of O
the O
camC B
gene I
along O
with O
155 O
base O
pairs O
of O
5 O
' O
and O
175 O
base O
pairs O
of O
3 O
' O
flanking O
sequence O
. O

gp170 B
is O
generated O
by O
an O
alternatively O
spliced O
Env B
mRNA I
using O
a O
splice O
donor O
and O
splice O
acceptor O
pair O
localized O
within O
the O
env B
open I
reading I
frame I
( I
ORF I
) I
, O
which O
is O
normally O
used O
to O
generate O
Bell B
and O
Bet B
transcripts I
derived O
from O
the O
internal O
promoter O
within O
the O
env B
ORF I
. O

gp170 B
is O
expressed O
at O
a O
level O
30 O
to O
50 O
% O
of O
the O
Env B
precursor I
gp130 B
. O

In O
marked O
contrast O
to O
the O
previously O
published O
human B
CD6 I
sequence I
, O
the O
mouse O
sequence O
predicts O
a O
long O
cytoplasmic O
tail O
that O
is O
not O
closely O
related O
to O
other O
proteins O
and O
possesses O
two O
proline O
- O
rich O
motifs O
containing O
the O
SH3 B
- I
domain I
binding I
consensus I
sequence I
, O
three O
protein B
kinase I
C I
phosphorylation I
site I
motifs I
, O
nine O
casein B
kinase I
- I
2 I
phosphorylation I
site I
motifs I
, O
and O
a O
serine O
- O
threonine O
- O
rich O
motif O
repeated O
three O
times O
. O

Our O
results O
are O
consistent O
with O
TCOF1 B
mutations I
leading O
to O
the O
Treacher O
Collins O
syndrome O
phenotype O
. O

Residues O
that O
affect O
PLCbeta O
and O
adenylyl B
cyclase I
II I
activity O
are O
found O
on O
opposite O
sides O
of O
the O
central O
tunnel O
, O
suggesting O
that O
PLC B
and O
adenylyl O
cyclase O
, O
like O
the O
alpha O
subunit O
, O
make O
many O
contacts O
on O
the O
top O
surface O
. O

The O
CBS B
- I
1 I
gene I
was O
mapped O
to O
human O
chromosome O
10p12 O
between O
markers O
WI B
- I
8535 I
and O
WI B
- I
4724 I
, O
and O
is O
tightly O
linked O
to O
the O
two O
STRP O
markers O
of O
D10S1789 B
and O
D10S550 B
. O

The O
MEF B
- I
2 I
proteins I
are O
a O
family O
of O
transcriptional O
activators O
that O
have O
been O
detected O
in O
a O
wide O
variety O
of O
cell O
types O
. O

The O
ferric B
uptake I
regulation I
( O
fur O
) O
gene O
product O
participates O
in O
regulating O
expression O
of O
the O
manganese O
- O
and O
iron O
- O
containing O
superoxide B
dismutase I
genes I
of I
Escherichia I
coli I
. O

To O
date O
, O
6 O
mammalian O
GRKs B
have O
been O
identified O
by O
molecular O
cloning O
. O

Vertebrate O
U6 B
small I
nuclear I
RNA I
( O
snRNA O
) O
loci O
exemplify O
a O
novel O
class O
of O
polymerase B
III I
- O
transcribed O
genes O
that O
lack O
an O
intragenic O
control O
region O
( O
ICR O
) O
. O

Elements O
of O
the O
hAT B
transposon I
family I
, O
such O
as O
the O
maize B
activator I
( O
Ac O
) O
, O
have O
been O
discovered O
in O
a O
large O
number O
of O
eukaryotic O
species O
. O

We O
found O
both O
the O
v O
- O
Ras O
- O
and O
PC B
- I
PLC I
- O
transformed O
cells O
to O
be O
insensitive O
to O
stimulation O
with O
platelet O
- O
derived O
growth O
factor O
( O
PDGF O
) O
. O

However O
, O
the O
pre3 B
- I
2 I
mutation I
strengthened O
phenotypes O
induced O
by O
other O
20 B
S I
proteasomal I
mutations I
, O
indicating O
that O
the O
peptidylglutamyl O
peptide O
- O
hydrolyzing O
activity O
has O
to O
fulfill O
some O
rescue O
functions O
. O

The O
tro B
operon I
is O
flanked O
by O
a O
Holliday B
structure I
DNA I
helicase I
homolog O
( O
upstream O
) O
and O
two O
ORFs O
representing O
a O
purine B
nucleoside I
phosphorylase I
homolog O
and O
tpp15 B
, O
a O
previously O
characterized O
gene O
encoding O
a O
membrane O
lipoprotein O
( O
downstream O
) O
. O

In O
order O
to O
search O
for O
mutations O
in O
the O
multicopy B
RBM I
genes I
that O
might O
be O
associated O
with O
male O
infertility O
, O
we O
have O
used O
sequence O
data O
from O
the O
reported O
cDNA O
clone O
to O
determine O
the O
intron O
exon O
boundaries O
of O
the O
YRRM B
1 I
gene I
. O

By O
RT O
- O
PCR O
, O
different O
levels O
of O
E75 B
expression O
can O
be O
detected O
in O
the O
epidermis O
, O
nerve O
cord O
and O
the O
eyestalk O
of O
early O
pre O
- O
molt O
shrimp O
. O

No O
cleavage O
of O
gp B
130 I
was O
observed O
in O
analogous O
pulse O
- O
chase O
radiolabelling O
of O
Ad O
- O
gB B
- O
infected O
human O
fibroblasts O
, O
even O
though O
these O
cells O
are O
permissive O
for O
HCMV O
replication O
and O
can O
process O
the O
native B
gB I
molecule I
. O

A O
phylogenetic O
comparison O
of O
32 O
species O
showed O
minor O
differences O
in O
the O
apoB B
mRNA I
sequence I
, O
and O
the O
apoB B
mRNA I
from O
31 O
species O
was O
robustly O
edited O
in O
vitro O
. O

Sugar O
analysis O
was O
performed O
on O
alpha B
- I
TM I
to O
investigate O
a O
possible O
biosynthetic O
mechanism O
for O
part O
- O
time O
PGs O
. O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

a O
putative O
nuclear O
binding O
protein O
( O
PNBP O
) O
that O
is O
homologous O
to O
maleless B
, O
and O
a O
Copia B
- I
like I
element I
. O

TRAF2 O
has O
previously O
been O
demonstrated O
to O
activate O
both O
transcription O
factor O
nuclear O
factor O
kappaB O
( O
NFkappaB O
) O
and O
the O
c O
- O
Jun O
N O
- O
terminal O
kinase O
/ O
stress O
- O
activated O
protein O
kinase O
( O
JNK O
/ O
SAPK O
) O
pathway O
, O
which O
in O
turn O
stimulates O
transcription B
factor I
activating I
protein I
1 I
( O
AP1 O
) O
mainly O
via O
phosphorylation O
of O
the O
c O
- O
Jun O
component O
. O

A O
procaryotic O
regulatory O
factor O
with O
a O
histone B
H1 I
- I
like I
carboxy I
- I
terminal I
domain I
: O
clonal O
variation O
of O
repeats O
within O
algP B
, O
a O
gene O
involved O
in O
regulation O
of O
mucoidy O
in O
Pseudomonas O
aeruginosa O
. O

The O
host O
range O
( O
HR O
) O
of O
poliovirus O
is O
thought O
to O
be O
primarily O
determined O
by O
a O
cell O
surface O
molecule O
that O
functions O
as O
poliovirus B
receptor I
( O
PVR B
) O
, O
since O
it O
has O
been O
shown O
that O
transgenic O
mice O
are O
made O
poliovirus O
sensitive O
by O
introducing O
the O
human B
PVR I
gene I
into O
the O
genome O
. O

Human B
alcohol I
dehydrogenase I
( O
ADH O
) O
exists O
as O
a O
heterogeneous O
group O
of O
isozymes O
capable O
of O
oxidizing O
a O
wide O
variety O
of O
aliphatic O
and O
aromatic O
alcohols O
. O

This O
incompatibility O
phenotype O
requires O
the O
global O
transcriptional O
repressor O
, O
KorB B
, O
and O
the O
target O
for O
incC B
- O
mediated O
incompatibility O
is O
a O
KorB B
- I
binding I
site I
( I
O I
( I
B I
) I
) I
. O

The O
effect O
of O
the O
negative O
regulatory O
element O
is O
negated O
by O
the O
viral B
IE2 I
protein I
( O
L O
. O

RXRalpha O
/ O
RARalpha O
heterodimers O
and O
HNF B
- I
4 I
homodimers I
bind O
to O
DR O
- O
1 O
motifs O
on O
elements O
B O
and O
I4 O
, O
respectively O
. O

Evidence O
for O
involvement O
of O
proteins O
HU B
and O
RpoS O
in O
transcription O
of O
the O
osmoresponsive O
proU B
operon I
in O
Escherichia O
coli O
. O

Characterization O
of O
a O
unique O
protein O
component O
of O
yeast B
RNase I
MRP I
: O
an O
RNA O
- O
binding O
protein O
with O
a O
zinc O
- O
cluster O
domain O
. O

The O
infection O
of O
cells O
with O
Moloney O
murine O
leukemia O
virus O
( O
M O
- O
MuLV O
) O
causes O
an O
increase O
in O
specific O
cellular O
gene O
products O
, O
including O
the O
major B
histocompatibility I
complex I
( I
MHC I
) I
class I
I I
antigens I
. O

These O
data O
demonstrate O
that O
oleosin O
gene O
transcription O
is O
regulated O
in O
a O
tissue O
- O
specific O
and O
temporally O
regulated O
manner O
and O
clearly O
indicate O
that O
oleosin B
protein I
expression O
is O
co O
- O
ordinated O
primarily O
at O
the O
transcriptional O
level O
. O

The O
expression O
of O
CAPL B
, O
a O
second O
protein O
involved O
in O
calcium O
metabolism O
, O
was O
only O
moderately O
elevated O
in O
the O
doxorubicin O
- O
resistant O
cells O
. O

Despite O
this O
dependency O
, O
however O
, O
a O
B B
. I
japonicum I
fixK I
mutant I
did O
not O
have O
the O
phenotypic O
characteristics O
of O
B B
. I
japonicum I
fixL I
and O
fixJ B
mutants I
: O
the O
fixK B
mutant I
was O
neither O
Fix O
- O
in O
symbiosis O
with O
soybean O
plants O
nor O
defective O
in O
anaerobic O
respiration O
with O
nitrate O
as O
the O
terminal O
electron O
acceptor O
. O

Human B
PDNP3 I
is O
expressed O
in O
glioma O
cells O
, O
prostate O
, O
and O
uterus O
, O
but O
not O
in O
the O
alimentary O
tract O
. O

Screening O
of O
a O
human O
foetal O
brain O
genomic O
DNA O
library O
allowed O
us O
to O
isolate O
an O
EcoRI O
- O
EcoRI O
fragment O
containing O
6 O
kb O
of O
the O
5 O
' O
- O
flanking O
region O
, O
the O
open O
reading O
frame O
and O
4 O
kb O
of O
the O
3 O
' O
- O
flanking O
region O
of O
the O
alpha2C4 B
gene I
. O

Similarly O
, O
interfering O
with O
MEKK B
, O
which O
lies O
upstream O
of O
JNK1 O
, O
using O
a O
dominant O
negative O
expression O
vector O
reduced O
MMP B
- I
9 I
promoter I
activity O
over O
the O
same O
concentration O
range O
which O
repressed O
the O
AP O
- O
1 O
- O
thymidine O
kinase O
CAT O
reporter O
construct O
. O

There O
was O
no O
difference O
in O
serum B
albumin I
and O
transferrin O
levels O
, O
but O
serum B
prealbumin I
levels O
in O
the O
group O
fed O
early O
were O
more O
desirable O
than O
those O
of O
the O
control O
group O
( O
from O
15 O
. O
8 O
+ O
/ O
- O
2 O
. O
5 O
mg O
/ O
dl O
to O
28 O
. O
9 O
+ O
/ O
- O
3 O
. O
8 O
mg O
/ O
dl O
vs O
from O
18 O
. O
0 O
+ O
/ O
- O
2 O
. O
0 O
mg O
/ O
dl O
to O
25 O
. O
9 O
+ O
/ O
- O
3 O
. O
9 O
mg O
/ O
dl O
) O
. O

Northern O
blot O
analysis O
of O
enoyl B
- I
ACP I
reductase I
mRNA I
steady O
- O
state O
levels O
during O
seed O
development O
suggests O
that O
the O
increase O
in O
enzyme O
activity O
during O
the O
phase O
of O
storage O
lipid O
accumulation O
is O
regulated O
at O
the O
level O
of O
gene O
expression O
. O

This O
constant O
expression O
profile O
, O
coupled O
with O
the O
observation O
that O
over O
- O
expression O
of O
mSin3A B
does O
not O
augment O
the O
anti B
- I
Myc I
activity O
of O
Mxi1 O
- O
SR O
in O
the O
rat O
embryo O
fibroblast O
( O
REF O
) O
transformation O
assay O
, O
suggests O
that O
mSin3A B
is O
not O
a O
limiting O
factor O
in O
the O
regulation O
of O
Myc B
superfamily I
function O
. O

The O
sequences O
at O
- O
10 O
and O
- O
35 O
relative O
to O
the O
transcriptional O
starting O
site O
showed O
55 O
% O
homology O
with O
the O
consensus O
sequences O
of O
the O
Escherichia B
coli I
sigma I
70 I
- I
type I
promoter I
. O

METHODS O
: O
The O
Die O
Deutsche O
Diabetes O
Dialyse O
Studie O
is O
a O
prospective O
randomized O
placebo O
- O
controlled O
trial O
that O
tests O
the O
hypothesis O
that O
atorvastatin O
, O
a O
hydroxymethyl B
- I
glutaryl I
coenzyme I
A I
reductase I
inhibitor O
, O
decreases O
the O
rate O
of O
cardiovascular O
mortality O
and O
of O
nonfatal O
myocardial O
infarction O
in O
patients O
with O
type O
2 O
diabetes O
who O
have O
been O
on O
hemodialysis O
treatment O
for O
no O
more O
than O
two O
years O
. O

This O
unusual O
behaviour O
may O
be O
explained O
by O
the O
18 B
amino I
acid I
- I
long I
CDR I
- I
H3 I
and O
could O
be O
of O
value O
in O
the O
design O
of O
' O
single O
domain O
' O
antibodies O
. O

It O
has O
also O
been O
previously O
demonstrated O
that O
LPS O
treatment O
of O
splenic O
B O
cells O
from O
athymic O
mice O
results O
in O
a O
decrease O
in O
steady O
state O
mRNA O
encoding O
the O
A B
alpha I
class I
II I
protein I
. O

High O
- O
affinity O
binding O
was O
also O
observed O
with O
recombinant B
SH2 I
domains I
from O
v O
- O
src O
and O
v B
- I
fps I
, O
raising O
the O
possibility O
of O
protein O
- O
protein O
interactions O
between O
various O
members O
of O
the O
cytoplasmic B
PTK I
family I
. O

Mutational O
analysis O
of O
the O
putative O
effector O
domain O
of O
the O
GTP B
- I
binding I
Ypt1 I
protein I
in O
yeast O
suggests O
specific O
regulation O
by O
a O
novel O
GAP O
activity O
. O

The O
broad O
range O
protein O
tyrosine O
kinase O
inhibitor O
genistein O
and O
the O
phosphatidylinositol O
3 O
- O
kinase O
inhibitors O
wortmannin O
and O
LY O
294002 O
( O
2 O
- O
( O
4 O
- O
morpholinyl O
) O
- O
8 O
- O
phenyl O
- O
4H O
- O
1 O
- O
benzopyran O
- O
4 O
- O
one O
) O
also O
blocked O
adenosine B
A3 I
receptor I
stimulation O
of O
p42 O
/ O
p44 O
MAPK O
. O

Surprisingly O
, O
although O
Mist1 B
binds O
to O
E O
- O
boxes O
in O
vivo O
, O
the O
Mist1 B
protein I
lacks O
a O
functional O
transcription O
activation O
domain O
. O

As O
exogenously O
expressed O
PKR O
can O
form O
heterodimers O
with O
endogenous B
PKR I
, O
the O
results O
obtained O
on O
the O
functional O
characterization O
of O
mutant O
forms O
of O
PKR O
have O
been O
taken O
with O
caution O
. O

The O
metalloproteinase O
mediating O
Met B
cleavage O
was O
specifically O
inhibited O
by O
the O
tissue B
inhibitor I
of I
metalloproteinases I
( I
TIMP I
) I
- I
3 I
, O
but O
not O
by O
TIMP O
- O
1 O
or O
TIMP B
- I
2 I
. O

The O
clr1 B
locus I
regulates O
the O
expression O
of O
the O
cryptic B
mating I
- I
type I
loci I
of I
fission I
yeast I
. O

Instead O
, O
HBx O
is O
shown O
to O
activate O
the O
cyclin B
A I
promoter I
, O
induce O
cyclin O
A O
- O
cyclin B
- I
dependent I
kinase I
2 I
complexes O
, O
and O
promote O
cycling O
of O
growth O
- O
arrested O
cells O
into O
G1 O
through O
a O
pathway O
involving O
activation O
of O
Src O
tyrosine O
kinases O
. O

Growth O
hormone O
exerts O
its O
effects O
on O
the O
ovarian O
follicular O
cycle O
directly O
or O
by O
local O
production O
of O
insulin B
- I
like I
growth I
factor I
1 I
( O
IGF B
- I
1 I
) O
. O

Decidual B
/ I
trophoblast I
prolactin I
- I
related I
protein I
: O
characterization O
of O
gene O
structure O
and O
cell O
- O
specific O
expression O
. O

Fluorescence O
in O
situ O
hybridization O
was O
used O
to O
investigate O
the O
physical O
distribution O
and O
revealed O
that O
both O
retrotransposon O
families O
are O
present O
on O
all O
sugar O
beet O
chromosomes O
and O
largely O
excluded O
from O
chromosomal O
regions O
harbouring O
the O
18S B
- O
5 B
. I
8S I
- O
25S B
rRNA O
genes O
. O

An O
insertion O
sequence O
element O
( O
IS1170 O
) O
was O
identified O
upstream O
of O
the O
nimC B
gene I
. O

The O
organelles O
synthesize O
their O
own O
set O
of O
Fe O
/ O
S O
proteins O
, O
and O
they O
initiate O
the O
generation O
of O
extramitochondrial B
Fe I
/ I
S I
proteins I
. O

A O
genomic O
clone O
of O
the O
chicken B
osteopontin I
- I
encoding I
gene I
( O
opn B
) O
was O
isolated O
and O
found O
to O
be O
organized O
as O
follows O
: O
an O
untranslated O
5 O
' O
exon O
; O
a O
signal O
peptide O
; O
a O
recognition O
sequence O
for O
phosphorylation O
by O
casein B
kinase I
II I
; O
a O
domain O
containing O
a O
possible O
O O
- O
linkage O
site O
for O
glycosylation O
; O
a O
second O
casein B
kinase I
II I
phosphorylation I
site I
; O
an O
exon O
containing O
three O
functional O
regions O
, O
the O
poly O
- O
Asp O
sequence O
of O
seven O
consecutive O
Asp O
residues O
, O
the O
RGD B
integrin I
recognition I
site I
and O
a O
potential O
N O

However O
, O
neither O
SF O
- O
1 O
nor O
NGF B
- I
IB I
alone O
, O
binding O
as O
monomers O
, O
increases O
transcription O
. O

Structural O
organization O
of O
the O
human B
Elk1 I
gene I
and O
its O
processed O
pseudogene B
Elk2 I
. O

In O
addition O
, O
while O
GCN1 O
is O
required O
in O
vivo O
for O
phosphorylation O
of O
eIF O
- O
2 O
alpha O
by O
GCN2 O
, O
cell O
extracts O
from O
gcn1 B
delta I
strains O
contained O
wild O
- O
type O
levels O
of O
GCN2 O
eIF O
- O
2 O
alpha O
- O
kinase O
activity O
. O

SCOF O
- O
1 O
localized O
to O
the O
nucleus O
but O
did O
not O
bind O
directly O
to O
either O
C O
- O
repeat O
/ O
dehydration O
( O
CRT O
/ O
DRE O
) O
or O
ABA O
responsive O
element O
( O
ABRE O
) O
, O
cis O
- O
acting O
DNA O
regulatory O
elements O
present O
in O
COR B
gene I
promoters I
. O

Polymorphisms O
in O
the O
CCR5 B
genes I
of O
African O
green O
monkeys O
and O
mice O
implicate O
specific O
amino O
acids O
in O
infections O
by O
simian O
and O
human O
immunodeficiency O
viruses O
. O

Furthermore O
, O
we O
detect O
hCoch B
- I
5B2 I
on O
three O
overlapping O
YACs O
, O
two O
of O
which O
also O
contain O
one O
of O
the O
markers O
linked O
to O
DFNA9 B
. O

mCoch B
- I
5B2 I
was O
genetically O
mapped O
in O
the O
mouse O
to O
chromosome O
12 O
, O
in O
a O
region O
of O
homologous O
synteny O
with O
human O
14q11 O
. O
2 O
- O
q13 O
, O
which O
contains O
the O
asp1 B
( O
audiogenic B
seizure I
prone I
) O
locus O
in O
the O
mouse O
. O

Although O
no O
detectable O
phenotypes O
are O
associated O
with O
a O
disruption O
allele O
of O
ABP1 O
, O
mutations O
that O
create O
a O
requirement O
for O
this O
protein O
have O
now O
been O
isolated O
in O
the O
previously O
identified O
gene B
SAC6 I
and O
in O
two O
new O
genes O
, O
SLA1 B
and O
SLA2 B
. O

The O
detergent O
- O
solubilized O
complex O
oxidizes O
caldariella O
quinol O
at O
high O
rates O
and O
is O
completely O
inhibited O
by O
cyanide O
and O
by O
quinolone O
analogs O
, O
potent O
inhibitors O
of O
quinol B
oxidases I
. O

We O
have O
characterized O
a O
new O
cDNA O
, O
33k O
- O
6 O
, O
potentially O
encoding O
a O
tobacco B
33 I
kDa I
chloroplast I
RNP I
( I
cp33 I
) I
homologue I
. O

The O
Xenopus B
homeobox I
gene I
twin I
mediates O
Wnt O
induction O
of O
goosecoid B
in O
establishment O
of O
Spemann O
' O
s O
organizer O
. O

The O
vaccinia O
virus O
D6R B
open O
reading O
frame O
encodes O
the O
small O
subunit O
of O
the O
heterodimeric O
vaccinia B
virus I
early I
transcription I
factor I
( O
VETF B
) O
that O
activates O
transcription O
of O
early B
genes I
in O
vitro O
. O

We O
show O
that O
GCNF O
binds O
to O
one O
of O
the O
two O
DRO O
sequences O
in O
the O
Prm1 B
promoter I
, O
and O
to O
the O
DRO O
sequence O
in O
the O
Prm2 B
promoter I
in O
a O
specific O
manner O
. O

The O
data O
also O
suggest O
that O
gamma B
CACCC I
box I
binding I
factors I
mediate O
LCR B
- I
gamma I
interactions O
which O
normally O
enhance O
gamma O
- O
globin O
and O
suppress O
beta O
- O
globin O
gene O
expression O
in O
fetal O
erythroid O
cells O
. O

The O
major O
promoter O
element O
of O
the O
Xenopus B
laevis I
5S I
RNA I
gene I
is O
located O
within O
the O
transcribed O
region O
of O
the O
gene O
and O
forms O
the O
binding O
site O
for O
the O
transcription O
initiation O
factor O
TFIIIA O
. O

The O
gamma B
- I
GCS I
gene I
is O
expressed O
ubiquitously O
and O
induced O
coordinately O
with O
NAD B
( I
P I
) I
H I
: I
quinone I
oxidoreductase I
( I
1 I
) I
( O
NQO1 B
) O
and O
glutathione B
S I
- I
transferase I
Ya I
( O
GST B
Ya I
) O
in O
response O
to O
xenobiotics O
and O
antioxidants O
. O

Interestingly O
, O
the O
expression O
of O
Id4 B
in O
Sertoli O
cells O
is O
only O
detectable O
after O
stimulation O
with O
FSH O
or O
cAMP O
. O

We O
determined O
their O
N O
- O
terminal O
amino O
acid O
sequence O
and O
found O
that O
these O
polypeptides O
were O
CotT B
, O
YeeK B
, O
YxeE B
, O
CotF B
, O
YrbA B
( O
31 O
and O
45 O
kDa O
) O
, O
and O
SpoIVA B
, O
respectively O
. O

Therefore O
, O
in O
VDR O
- O
mediated O
transcriptional O
activation O
, O
1 O
, O
25 O
( O
OH O
) O
2D3 O
binding O
to O
VDR O
alters O
the O
conformation O
of O
the O
ligand O
binding O
domain O
such O
that O
it O
: O
( O
i O
) O
engages O
in O
strong O
heterodimerization O
with O
RXR O
to O
facilitate O
VDRE O
binding O
, O
( O
ii O
) O
influences O
the O
RXR B
ligand I
binding I
domain I
such O
that O
it O
is O
resistant O
to O
the O
binding O
of O
9 O
- O
cis O
RA O
but O
active O
in O
recruiting O
coactivator O
to O
its O
AF O
- O
2 O
and O
( O
iii O
) O
presents O
the O
AF O
- O
2 O
region O
in O
VDR O
for O
coactivator O
association O
. O

We O
have O
previously O
identified O
LIT1 B
, O
a O
paternally O
expressed O
antisense O
RNA O
within O
the O
KvLQT1 B
locus I
through O
a O
positional O
screening O
approach O
using O
human O
monochromosomal O
hybrids O
. O

The O
predicted O
amino O
acid O
sequence O
of O
the O
FlaB2 B
polypeptide I
was O
92 O
% O
identical O
to O
that O
of O
T B
. I
pallidum I
FlaB2 I
, O
with O
a O
76 O
% O
identity O
at O
the O
nucleotide O
level O
. O

The O
5 O
' O
ends O
of O
the O
P O
and O
O B
gene I
mRNAs I
are O
separated O
by O
109 O
nucleotide O
pairs O
in O
the O
DNA O
template O
. O

We O
have O
cloned O
the O
cDNA O
for O
the O
SLBP B
from O
humans O
, O
mice O
, O
and O
frogs O
, O
using O
the O
recently O
developed O
yeast O
three O
- O
hybrid O
system O
. O

Thus O
, O
the O
potential O
induction O
of O
this O
gene O
rearrangement O
by O
E1A B
gene I
therapy O
is O
unlikely O
to O
be O
clinically O
significant O
in O
the O
treatment O
of O
advanced O
malignant O
disease O
. O

Although O
the O
cDNAs O
of O
HMG O
- O
14 O
and O
HMG B
- I
17 I
do O
not O
cross O
- O
hybridize O
, O
they O
have O
several O
similar O
structural O
features O
: O
the O
open O
reading O
frame O
comprises O
only O
23 O
% O
of O
the O
transcripts O
, O
the O
5 O
' O
- O
untranslated O
region O
is O
extremely O
GC O
rich O
whereas O
the O
3 O
' O
- O
untranslated O
region O
is O
unusually O
long O
and O
AT O
rich O
. O

Previously O
, O
we O
reported O
the O
identification O
of O
a O
23 O
- O
kD O
protein O
that O
interacts O
with O
zyxin B
in O
vitro O
( O
Sadler O
et O
al O
. O
, O
1992 O
) O
. O

In O
gel O
mobility O
shift O
assays O
, O
high O
binding O
activities O
of O
ATPC B
- I
2 I
and O
low O
binding O
activities O
of O
CBF O
were O
observed O
with O
nuclear O
extracts O
from O
tissue O
with O
low O
AtpC O
expression O
levels O
, O
and O
the O
opposite O
was O
observed O
with O
extracts O
from O
tissues O
with O
high O
AtpC O
expression O
levels O
. O

Activation O
of O
tyrosine B
kinase I
- I
containing I
receptors I
, O
heterotrimeric O
G O
proteins O
, O
and O
protein O
kinase O
C O
enhanced O
the O
activities O
of O
both O
MEK B
isoforms I
in O
293 O
and O
PC12 O
cells O
. O

The O
Fugu O
rubripes O
( O
Fugu O
) O
gene O
fragment O
was O
used O
to O
isolate O
the O
GH B
gene I
from O
a O
Fugu O
genomic O
library O
. O

Partial O
proteolysis O
of O
cell O
surface O
- O
iodinated O
B B
- I
G I
molecules I
generates O
extremely O
similar O
patterns O
of O
spots O
, O
both O
within O
and O
between O
haplotypes O
. O

There O
was O
a O
57 O
% O
reduction O
in O
IGF B
IR I
mRNA I
levels O
in O
clone O
CA9 O
after O
confluence O
compared O
with O
clone O
ME10 O
. O

Oligomers O
corresponding O
to O
the O
region O
of O
the O
mlc B
- I
1 I
/ I
3 I
enhancer I
, O
which O
encompasses O
this O
conserved O
sequence O
, O
bound O
MEF O
- O
2 O
and O
competed O
for O
its O
binding O
to O
the O
mck B
enhancer O
. O

Similar O
tissue O
- O
specific O
patterns O
are O
observed O
with O
a O
fusion O
between O
the O
caufliflower B
mosaic I
virus I
35S I
RNA I
promotor I
and O
the O
GUS O
gene O
. O

This O
difference O
between O
SP B
- I
1 I
and O
SP B
- I
2 I
peptides I
was O
not O
due O
to O
their O
differential O
uptake O
by O
cell O
, O
since O
approximately O
100 O
times O
more O
SP B
- I
2 I
peptide I
could O
be O
found O
in O
cytoplasmic O
extracts O
than O
SP B
- I
1 I
peptide I
in O
experiments O
using O
radiolabeled O
peptides O
. O

Apoptosis O
triggered O
through O
Fas O
and O
F B
/ I
F I
was O
inhibited O
by O
coexpression O
of O
CrmA O
and O
p35 O
, O
but O
not O
Bcl B
- I
xL I
. O

The O
product O
of O
one O
gene O
, O
Bv80 B
, O
has O
a O
single O
divergent O
copy O
of O
a O
sequence O
of O
149 O
amino O
acids O
( O
approx O
. O

The O
1031 B
- I
bp I
wild I
- I
type I
HIT1 I
DNA I
which O
contained O
an O
open O
reading O
frame O
encoding O
a O
protein O
of O
164 O
amino O
acids O
and O
the O
AGG B
arginine I
tRNA I
gene I
complemented O
all O
hit1 B
- I
1 I
mutant I
phenotypes I
, O
indicating O
that O
the O
mutant O
phenotypes O
were O
caused O
by O
the O
deletion O
of O
these O
genes O
. O

We O
constructed O
a O
series O
of O
chimeric O
genes O
containing O
part O
of O
the O
first O
exon O
and O
increasingly O
longer O
5 O
' O
flanking O
sequences O
of O
the O
ODC B
gene I
fused O
to O
either O
bacterial O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
or O
luciferase B
reporter I
genes I
. O

The O
gene O
encoding O
the O
Neisseria B
lactamica I
III I
DNA I
methyltransferase I
( O
M B
. I
NlaIII I
) O
which O
recognizes O
the O
sequence O
CATG O
has O
been O
cloned O
and O
expressed O
in O
Escherichia O
coli O
. O

Alignment O
of O
the O
rat B
and I
human I
WIN I
cDNAs I
and O
their O
comparison O
with O
mouse O
genomic O
sequence O
revealed O
that O
the O
WIN B
DNA I
binding I
domain I
is O
encoded O
by O
four O
exons O
, O
two O
of O
which O
( O
exons O
4 O
and O
6 O
) O
are O
alternatively O
spliced O
to O
generate O
at O
least O
three O
classes O
of O
mRNA O
transcripts O
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
the O
Lactococcus B
lactis I
Ll I
. I
LtrB I
group I
II I
intron I
endonuclease I
with O
its O
DNA O
target O
site O
by O
DNA O
footprinting O
and O
modification O
- O
interference O
approaches O
. O

In O
several O
steps O
we O
converted O
the O
retinoid O
specific O
response O
element O
of O
the O
human B
retinoic I
acid I
receptor I
beta I
promoter I
into O
the O
vitamin O
D O
/ O
retinoic O
acid O
response O
element O
of O
the O
human B
osteocalcin I
promoter I
. O

The O
immediate O
5 O
' O
- O
flanking O
region O
was O
GC O
- O
rich O
with O
3 O
SP B
- I
1 I
- I
like I
and O
2 O
AP B
- I
2 I
sites I
identified O
in O
close O
proximity O
to O
the O
transcription O
start O
site O
. O

Two O
of O
the O
proteins O
UPRF B
- I
1 I
and O
UPRF B
- I
2 I
( O
which O
is O
apparently O
a O
proteolytic O
degradation O
product O
of O
UPRF B
- I
1 I
) O
bind O
inefficiently O
to O
mutant O
versions O
of O
the O
UPR O
that O
are O
unable O
to O
confer O
responsiveness O
to O
unfolded O
proteins O
to O
the O
( O
CYC1 O
) O
promoter O
. O

Identification O
of O
domains O
mediating O
transcription O
activation O
, O
repression O
, O
and O
inhibition O
in O
the O
paired B
- I
related I
homeobox I
protein I
, O
Prx2 B
( O
S8 B
) O
. O

43 O
% O
, O
6 O
/ O
14 O
; O
P O
= O
0 O
. O
013 O
) O
, O
whereas O
, O
in O
RCC O
samples O
with O
VHL B
methylation O
or O
mutation O
, O
the O
frequency O
of O
3p14 O
- O
p21 O
LOH O
did O
not O
differ O
from O
that O
of O
sp25 O
- O
p26 O
( O
72 O
% O
, O
18 O
/ O
25 O
vs O
. O

Sequences O
homologous O
to O
the O
consensus O
TUF B
- I
binding I
UAS I
boxes I
are O
present O
in O
the O
5 O
' O
flanking O
regions O
of O
both O
genes O
. O

RESULTS O
: O
Although O
low O
levels O
of O
vIRF B
- I
2 I
mRNAs I
can O
be O
detected O
in O
the O
HHV O
- O
8 O
- O
positive O
BCBL O
- O
1 O
tumor O
cell O
line O
, O
12 O
- O
0 O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
( O
TPA O
) O
treatment O
does O
not O
stimulate O
expression O
of O
vIRF B
- I
2 I
gene I
together O
with O
primary O
lytic O
cycle O
genes O
. O

DNA O
sequence O
of O
the O
UL6 B
to O
UL20 B
genes I
of O
infectious O
laryngotracheitis O
virus O
and O
characterization O
of O
the O
UL10 B
gene I
product I
as O
a O
nonglycosylated O
and O
nonessential O
virion O
protein O
. O

Coimmunoprecipitation O
analysis O
suggests O
that O
these O
residues O
likely O
contribute O
to O
the O
multimerization O
function O
required O
for O
homomeric O
complex O
formation O
or O
heteromeric O
complex O
formation O
with O
p50 O
in O
that O
no O
association O
of O
p65 B
delta I
with O
itself O
or O
with O
p50 O
was O
evident O
. O

A O
yeast O
mitochondrial O
translation O
initiation O
codon O
mutation O
affecting O
the O
gene O
for O
cytochrome B
oxidase I
subunit I
III I
( O
COX3 O
) O
was O
partially O
suppressed O
by O
a O
spontaneous O
nuclear O
mutation O
. O

Only O
the O
27 O
- O
kDa O
protein O
was O
detected O
after O
N B
- I
glycosidase I
treatment O
, O
indicating O
that O
PLP B
- I
H I
is O
a O
glycoprotein O
. O

These O
results O
demonstrate O
that O
GGTase B
- I
I I
inhibitors O
arrest O
cells O
in O
G0 O
/ O
G1 O
and O
induce O
accumulation O
of O
p21WAF B
in O
a O
p53 O
- O
independent O
manner O
and O
that O
FTase B
inhibitors O
can O
interfere O
with O
cell O
cycle O
events O
by O
a O
mechanism O
that O
involves O
neither O
p21WAF B
nor O
p27KIP B
. O

The O
potential O
biological O
significance O
of O
the O
identified O
structural O
motif O
shared O
by O
the O
human B
CCR5 I
, O
CCR3 O
, O
CCR2B B
and O
other O
GPCRs B
is O
discussed O
. O

Analysis O
of O
rat O
brain O
, O
heart O
, O
lung O
, O
liver O
, O
kidney O
and O
skeletal O
muscle O
revealed O
psi B
PKC I
zeta I
mRNA I
only O
in O
brain O
. O

Furthermore O
, O
the O
rapid O
light O
- O
mediated O
increase O
of O
CPRF B
proteins I
was O
insensitive O
to O
transcriptional O
inhibitors O
, O
suggesting O
that O
a O
post O
- O
transcriptional O
mechanism O
controls O
CPRF B
accumulation O
. O

In O
those O
patients O
who O
before O
transplantation O
were O
serological O
negative O
for O
CMV O
but O
had O
received O
organs O
from O
CMV B
- I
IgG I
positive O
donors O
, O
the O
incidence O
of O
the O
disease O
was O
highest O
. O

We O
now O
show O
that O
purified O
recombinant O
c O
- O
sis O
/ O
PDGF O
can O
induce O
this O
binding O
activity O
which O
we O
have O
termed O
SIF B
, O
for O
sis B
- I
inducible I
factor I
. O

Expression O
of O
the O
bacteriophage B
T4 I
DNA I
terminase I
genes I
16 I
and I
17 I
yields O
multiple O
proteins O
. O

The O
protein O
encoded O
by O
the O
NF2 B
gene I
has O
a O
similarity O
to O
ezrin B
, O
radixin B
and O
moesin B
( O
ERM O
) O
proteins O
that O
link O
membrane O
proteins O
to O
the O
cytoskeleton O
. O

Expression O
of O
a O
cDNA O
clone O
in O
yeast O
containing O
a O
large O
portion O
of O
the O
open O
reading O
frame O
produced O
cAMP B
PDEase I
activity O
identical O
in O
properties O
to O
the O
Drosophila O
enzyme O
affected O
by O
the O
dnc B
mutation I
. O

FdsR O
purified O
to O
homogeneity O
after O
overexpression O
of O
fdsR O
in O
E O
. O
coli O
is O
a O
130 O
kDa O
homotetramer O
binding O
to O
the O
fds B
control O
region O
located O
between O
the O
fdsR O
and O
fdsG B
genes I
. O

The O
orthologs O
of O
the O
Y B
( I
1 I
) I
and O
Y B
( I
2 I
) I
subtypes I
display O
high O
amino O
acid O
sequence O
identities O
between O
pig O
, O
human O
, O
and O
mouse O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B
( I
4 I
) I
, O
Y B
( I
5 I
) I
, O
and O
y B
( I
6 I
) I
subtypes I
display O
lower O
identities O
( O
76 O
% O
- O
87 O
% O
) O
. O

The O
leader O
peptide O
was O
hypothesized O
to O
inhibit O
ribosome O
release O
at O
the O
tnaC B
stop I
codon I
, O
thereby O
blocking O
Rho O
' O
s O
access O
to O
the O
transcript O
. O

The O
leukotriene B
receptor I
antagonist O
zafirlukast O
inhibits O
sulfur O
dioxide O
- O
induced O
bronchoconstriction O
in O
patients O
with O
asthma O
. O

HNF4alpha7 B
mRNA I
is O
also O
found O
in O
totipotent O
embryonic O
stem O
cells O
. O

Penicillamine O
- O
induced O
myasthenia O
gravis O
associated O
with O
antibodies O
to O
acetylcholine B
receptor I
. O

LCCH1 B
was O
identical O
to O
the O
Rdl B
gene I
, O
a O
known O
GABA B
receptor I
subunit I
gene I
from O
D O
. O
melanogaster O
, O
whereas O
LCCH2 B
and O
LCCH3 B
were O
novel O
D O
. O
melanogaster O
sequences O
that O
exhibited O
structural O
similarity O
to O
other O
members O
of O
the O
ligand B
- I
gated I
chloride I
channel I
gene I
family I
. O

First O
, O
the O
amino O
- O
terminal O
regulatory O
arm O
of O
the O
GDI B
binds O
to O
the O
switch O
I O
and O
II O
domains O
of O
Cdc42 O
leading O
to O
the O
inhibition O
of O
both O
GDP O
dissociation O
and O
GTP O
hydrolysis O
. O

By O
a O
combination O
of O
alternative O
promoter O
usage O
and O
exon O
splicing O
, O
each O
ROR B
gene I
generates O
several O
isoforms O
that O
differ O
only O
in O
their O
amino O
terminus O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
showed O
a O
rapid O
induction O
of O
nuclear O
proteins O
that O
bound O
to O
the O
consensus B
kappa I
B I
motif I
. O

Analysis O
of O
larger O
cDNA O
clones O
demonstrates O
that O
there O
are O
at O
least O
two O
isoforms O
of O
RIP14 B
that O
differ O
in O
the O
N O
- O
terminal O
( O
A O
and O
B O
) O
and O
hinge O
( O
D O
) O
domains O
. O

The O
major O
open O
reading O
frame O
of O
the O
cDNA O
predicts O
a O
protein O
of O
59 O
kD O
, O
with O
a O
leucine O
zipper O
situated O
adjacent O
to O
an O
myc B
- I
related I
motif I
that O
has O
been O
proposed O
to O
assume O
a O
helix O
- O
loop O
- O
helix O
structure O
. O

In O
addition O
to O
loss O
of O
digit O
identity O
and O
varying O
degrees O
of O
polydactyly O
, O
proximal O
skeletal O
elements O
are O
severely O
shortened O
in O
Xt B
; O
ld B
double O
homozygous O
limbs O
. O

The O
PEP4 O
gene O
was O
isolated O
from O
a O
genomic O
DNA O
library O
by O
complementation O
of O
the O
pep4 B
- I
3 I
mutation O
. O

A O
gene O
with O
a O
high O
degree O
of O
sequence O
identity O
with O
mammalian B
ADP I
- I
ribosylation I
factors I
( O
ARFs O
) O
, O
believed O
to O
be O
important O
in O
vesicular O
transport O
, O
was O
identified O
. O

Production O
of O
VT O
was O
also O
examined O
retrospectively O
in O
32 O
E O
. O
coli O
strains O
of O
serotype O
O26 O
: O
H11 O
isolated O
from O
children O
with O
diarrhoea O
; O
eight O
( O
25 O
% O
) O
of O
them O
produced O
moderate O
to O
high O
levels O
of O
verotoxin B
1 I
despite O
several O
years O
storage O
in O
vitro O
. O

Mapping O
of O
the O
region O
in O
KAP O
- O
1 O
required O
for O
HP1 B
interaction O
showed O
that O
amino O
acid O
substitutions O
which O
abolish O
HP1 B
binding O
in O
vitro O
reduce O
KAP O
- O
1 O
mediated O
repression O
in O
vivo O
. O

Promoter O
activity O
of O
the O
proliferating B
- I
cell I
nuclear I
antigen I
gene I
is O
associated O
with O
inducible O
CRE B
- I
binding I
proteins I
in O
interleukin O
2 O
- O
stimulated O
T O
lymphocytes O
. O

METHODS O
: O
Levels O
of O
sIL B
- I
2R I
were O
measured O
simultaneously O
in O
plasma O
and O
pleural O
fluid O
in O
111 O
patients O
with O
pleural O
effusions O
of O
unknown O
causes O
. O

The O
specificity O
of O
the O
transcriptional O
activation O
by O
ISGF3 O
is O
mediated O
by O
specific O
elements O
termed O
IFN B
- I
stimulatory I
response I
element I
( O
ISRE O
) O
located O
in O
the O
promoter O
region O
of O
IFN O
- O
inducible O
genes O
. O

Upstream O
tissue B
inhibitor I
of I
metalloproteinases I
- I
1 I
( I
TIMP I
- I
1 I
) I
element I
- I
1 I
, O
a O
novel O
and O
essential O
regulatory O
DNA O
motif O
in O
the O
human B
TIMP I
- I
1 I
gene I
promoter I
, O
directly O
interacts O
with O
a O
30 O
- O
kDa O
nuclear O
protein O
. O

To O
this O
end O
we O
generated O
a O
detailed O
physical O
map O
of O
the O
genomic O
region O
spanning O
between O
sequence O
- O
tagged O
site O
markers O
D16S518 B
and O
D16S516 B
. O

Spinophilin B
, O
a O
novel O
protein B
phosphatase I
1 I
binding I
protein I
localized O
to O
dendritic O
spines O
. O

We O
have O
found O
that O
pro B
- I
IGF I
- I
2 I
can O
initially O
form O
two O
disulfide O
isomers O
that O
undergo O
rearrangement O
to O
a O
single O
conformation O
in O
vivo O
. O

The O
existence O
of O
a O
TFIIIB B
assembly O
pathway O
leading O
to O
the O
faithful O
transcription O
of O
natural O
eukaryotic O
tRNA O
genes O
in O
the O
absence O
of O
TFIIIC B
provides O
novel O
insights O
into O
the O
functional O
flexibility O
of O
the O
eukaryotic O
tRNA O
gene O
transcription O
machinery O
and O
on O
its O
evolution O
from O
an O
ancestral O
RNA B
polymerase I
III I
system O
relying O
on O
upstream O
, O
TATA O
- O
centered O
control O
elements O
. O

Ectopic O
Xbra B
can O
induce O
Xegr B
- I
1 I
transcription O
by O
an O
indirect O
mechanism O
that O
appears O
to O
operate O
via O
primary O
activation O
of O
fibroblast B
growth I
factor I
secretion O
. O

These O
aa O
residues O
correspond O
to O
codons O
59 O
and O
108 O
in O
the O
P B
. I
falciparum I
DHFR I
active I
site I
in O
which O
similar O
aa O
substitutions O
( O
Cys O
Arg O
- O
59 O
and O
Ser O
Asn O
- O
108 O
) O
are O
associated O
with O
pyrimethamine O
resistance O
. O

Here O
we O
investigate O
the O
mechanism O
of O
TPA O
induction O
of O
FGF B
- I
BP I
gene O
expression O
in O
the O
human O
ME O
- O
180 O
SCC O
cell O
line O
. O

Between O
the O
RNA O
initiation O
site O
and O
the O
coding O
region O
is O
a O
GC O
- O
rich O
hairpin O
structure O
followed O
by O
8 O
T O
residues O
that O
looks O
like O
a O
rho B
- I
independent I
transcription I
terminator I
. O

Thus O
G17 B
targets O
the O
c B
- I
fos I
promoter I
CArG I
sequence I
via O
Rho B
A I
- O
dependent O
pathways O
, O
and O
Rho B
A I
appears O
to O
play O
an O
important O
role O
in O
the O
regulation O
of O
the O
trophic O
action O
of O
G17 B
. O

The O
MIC90 O
of O
ABK O
against O
coagulase B
type I
IV I
strains O
was O
rather O
high O
, O
12 O
. O
5 O
micrograms O
/ O
ml O
. O

These O
results O
demonstrate O
that O
m2 B
receptors I
couple O
to O
both O
G B
alpha I
i2 I
and O
G B
alpha I
i3 I
in O
vivo O
and O
that O
this O
interaction O
is O
integral O
to O
both O
positive O
and O
negative O
regulatory O
pathways O
leading O
to O
activation O
of O
PLC B
and O
desensitization O
of O
receptor O
signaling O
. O

The O
fru B
gene I
has O
seven O
exons O
spanning O
15 O
- O
kb O
encoding O
two O
transcripts O
with O
ORFs O
of O
841 O
and O
695 O
amino O
acids O
. O

HC B
- I
toxin I
exerts O
a O
potent O
cytostatic O
effect O
on O
plant O
and O
animal O
cells O
by O
inhibiting O
histone O
deacetylase O
. O

The O
human O
RIL B
gene I
: O
mapping O
to O
human O
chromosome O
5q31 O
. O
1 O
, O
genomic O
organization O
and O
alternative O
transcripts O
. O

